data_2k77_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k77 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.466 0.65 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.952 0.406 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.419 ' CG ' ' H ' ' A' ' 80' ' ' TYR . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' H ' ' CG ' ' A' ' 79' ' ' HIS . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.666 0.746 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.496 0.665 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.57 0.224 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.717 0.77 . . . . 0.0 113.012 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.308 0.575 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.405 ' CD2' ' HE ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.405 ' HE ' ' CD2' ' A' ' 131' ' ' LEU . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.407 0.146 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 110.875 -0.046 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.299 0.095 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.402 0.62 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.563 0.697 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.229 0.538 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.537 -0.172 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.473 0.177 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 120.758 0.313 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.322 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.8 tpt -144.33 155.5 43.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 110.981 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.67 55.35 1.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.884 1.673 . . . . 0.0 113.875 -173.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.63 40.62 0.79 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.599 2.047 . . . . 0.0 114.031 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -137.27 136.78 38.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.568 2.347 . . . . 0.0 110.579 -170.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt -107.7 -15.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.45 -169.81 28.19 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.41 1.005 . . . . 0.0 115.253 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.76 165.65 24.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.952 1.701 . . . . 0.0 112.886 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.59 57.58 3.54 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 167.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -124.17 30.57 6.04 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.221 1.809 . . . . 0.0 111.046 168.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.94 140.43 38.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.887 1.675 . . . . 0.0 112.757 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.6 ttm -143.09 8.06 1.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.874 1.27 . . . . 0.0 113.531 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.2 m 53.97 38.87 29.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.218 1.807 . . . . 0.0 112.946 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.9 -0.67 41.82 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -168.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m 62.55 159.8 0.07 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.061 1.345 . . . . 0.0 112.435 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.87 145.9 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 120.608 -1.308 . . . . 0.0 113.926 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 tpp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.83 147.71 28.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.471 1.909 . . . . 0.0 110.603 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.05 153.9 29.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.852 1.261 . . . . 0.0 111.375 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.13 18.66 4.44 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.498 1.047 . . . . 0.0 114.38 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -130.39 150.8 51.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.637 1.975 . . . . 0.0 111.614 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -105.0 -21.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.07 -165.51 30.35 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 119.194 0.906 . . . . 0.0 114.712 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -137.07 163.11 31.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.202 1.401 . . . . 0.0 113.282 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.36 21.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.766 1.174 . . . . 0.0 114.874 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -129.91 8.28 5.23 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.527 1.531 . . . . 0.0 114.364 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -65.26 156.94 30.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.437 1.495 . . . . 0.0 114.478 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 mmt -110.18 32.96 4.74 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.807 1.643 . . . . 0.0 112.097 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 m 53.8 57.34 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.193 1.797 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.27 150.82 44.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.967 1.307 . . . . 0.0 112.461 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 m -60.77 153.44 24.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.728 1.611 . . . . 0.0 110.742 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.77 141.71 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -74.97 155.85 36.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 0.0 112.912 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.74 -36.16 82.94 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.37 23.54 77.38 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.761 1.464 . . . . 0.0 116.761 169.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -126.53 149.33 49.45 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 119.061 1.431 . . . . 0.0 112.828 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt -111.74 -24.9 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.82 -161.95 9.63 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.79 1.186 . . . . 0.0 115.931 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -65.51 125.17 24.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.267 1.427 . . . . 0.0 109.69 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.01 -168.3 41.13 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.4 76.64 2.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.706 2.402 . . . . 0.0 108.86 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.58 70.45 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.683 1.23 . . . . 0.0 113.847 -167.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -101.67 -4.45 26.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.79 1.636 . . . . 0.0 112.921 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 47.48 81.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.612 2.365 . . . . 0.0 115.194 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.09 179.36 6.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.931 1.692 . . . . 0.0 111.052 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -54.44 133.57 45.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.967 0.907 . . . . 0.0 110.323 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.63 150.01 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.882 0.873 . . . . 0.0 112.099 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.7 ttp -152.85 137.98 17.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.723 1.209 . . . . 0.0 110.664 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -107.5 -25.23 11.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.009 1.324 . . . . 0.0 114.206 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.19 -13.75 3.32 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 117.671 1.828 . . . . 0.0 117.671 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -93.6 146.66 23.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.374 1.587 . . . . 0.0 111.928 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -111.16 -24.73 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.29 -165.69 9.3 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 124.484 1.04 . . . . 0.0 115.155 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -68.43 141.71 55.58 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 110.469 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.64 -154.13 8.69 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.79 20.33 3.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.155 2.182 . . . . 0.0 114.505 -167.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -41.5 109.86 0.14 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.0 mtm -99.55 -18.76 17.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.746 1.618 . . . . 0.0 112.658 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -157.71 159.23 36.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.986 1.714 . . . . 0.0 111.507 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -71.21 -16.97 62.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.391 1.076 . . . . 0.0 113.143 171.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -78.33 138.52 38.61 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.188 -0.945 . . . . 0.0 111.847 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.99 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.81 1.244 . . . . 0.0 113.397 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -69.1 154.67 41.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.138 0.881 . . . . 0.0 112.893 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -76.26 -36.12 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.04 6.02 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -85.23 142.79 29.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.297 1.549 . . . . 0.0 112.153 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt -106.6 -10.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.67 -133.52 44.28 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.823 0.738 . . . . 0.0 113.062 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.76 163.85 36.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.556 1.943 . . . . 0.0 110.914 173.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.15 26.57 36.42 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -76.28 59.67 1.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.41 1.605 . . . . 0.0 111.43 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -79.58 132.54 36.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.896 1.279 . . . . 0.0 112.347 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.8 mtt -133.77 -5.04 2.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.165 1.786 . . . . 0.0 112.713 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 52.62 60.69 3.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.989 1.716 . . . . 0.0 112.394 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.47 136.04 24.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.688 1.595 . . . . 0.0 109.615 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -63.75 139.42 58.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.96 131.4 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.419 ' CG ' ' H ' ' A' ' 80' ' ' TYR . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' H ' ' CG ' ' A' ' 79' ' ' HIS . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.274 27.2 ptm 51.7 172.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.167 2.587 . . . . 0.0 116.453 -172.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.94 162.19 22.8 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.911 1.284 . . . . 0.0 112.188 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.03 18.35 4.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.917 1.246 . . . . 0.0 113.772 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.83 149.57 23.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.783 1.633 . . . . 0.0 112.523 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt -105.17 -21.66 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.55 -158.81 39.22 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.138 0.875 . . . . 0.0 114.435 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -134.13 163.09 30.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.77 1.628 . . . . 0.0 111.717 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.68 23.58 59.86 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -76.31 53.19 0.81 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.067 1.434 . . . . 0.0 110.286 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.78 131.87 43.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.197 1.399 . . . . 0.0 113.434 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.7 mmt -118.38 -10.73 10.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.744 1.618 . . . . 0.0 113.149 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m 53.39 47.67 23.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.901 1.28 . . . . 0.0 111.877 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -130.08 146.84 51.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.817 2.047 . . . . 0.0 110.946 -168.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.2 m -61.92 149.4 40.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.608 1.163 . . . . 0.0 109.5 168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.26 124.96 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.185 -0.947 . . . . 0.0 112.71 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.0 ptt? 51.67 -178.64 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.813 2.445 . . . . 0.0 115.871 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -82.02 -34.5 29.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.803 1.241 . . . . 0.0 113.512 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.87 39.15 93.56 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -138.17 143.5 40.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.335 1.454 . . . . 0.0 111.809 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -111.12 8.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.39 138.47 47.97 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.688 -1.257 . . . . 0.0 114.71 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.61 74.56 0.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.574 2.35 . . . . 0.0 112.627 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.07 -176.02 30.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.231 1.396 . . . . 0.0 116.377 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 131.1 37.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.409 1.884 . . . . 0.0 112.426 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -129.96 117.22 19.76 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.379 1.071 . . . . 0.0 112.663 -168.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.77 -22.65 2.09 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.802 1.241 . . . . 0.0 113.982 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.1 t -157.81 159.03 36.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.459 1.503 . . . . 0.0 111.852 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.25 -18.09 40.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 0.0 112.09 169.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 m -80.65 125.19 29.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.133 0.973 . . . . 0.0 109.999 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.25 153.26 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.019 0.928 . . . . 0.0 113.292 -175.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.2 ptm -150.08 151.19 32.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.952 1.301 . . . . 0.0 111.998 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -90.25 -32.38 16.59 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.897 0.879 . . . . 0.0 113.179 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.02 51.11 60.56 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.227 0.918 . . . . 0.0 114.899 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -138.9 143.58 38.75 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.5 1.52 . . . . 0.0 111.536 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -105.03 0.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.52 -4.6 5.43 Favored Glycine 0 CA--C 1.542 1.771 0 CA-C-N 119.905 1.229 . . . . 0.0 115.844 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -69.37 -22.61 63.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.309 2.243 . . . . 0.0 113.968 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.39 165.14 15.39 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.346 0.974 . . . . 0.0 114.938 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -144.53 43.59 1.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.296 2.239 . . . . 0.0 109.663 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.92 126.38 27.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -167.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.08 -1.48 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.384 1.874 . . . . 0.0 113.309 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m 53.19 45.98 27.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.645 1.578 . . . . 0.0 114.412 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -139.3 169.98 16.78 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.511 1.524 . . . . 0.0 112.999 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -67.62 161.63 25.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.676 0.791 . . . . 0.0 111.874 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.6 146.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.9 ptm -144.63 157.17 44.32 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.33 1.452 . . . . 0.0 112.08 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -88.74 -51.65 5.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 112.805 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.14 51.11 Favored Glycine 0 CA--C 1.542 1.745 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -88.21 147.21 24.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.59 1.556 . . . . 0.0 111.089 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -118.96 10.63 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.36 13.37 0.26 Allowed Glycine 0 CA--C 1.545 1.933 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -80.86 -36.35 31.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.959 1.703 . . . . 0.0 113.892 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.75 103.66 0.04 OUTLIER Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.813 1.196 . . . . 0.0 114.556 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -78.08 74.51 4.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.649 1.18 . . . . 0.0 109.903 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.51 72.68 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.062 1.345 . . . . 0.0 114.178 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.8 mtm -131.24 47.33 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.061 2.145 . . . . 0.0 108.483 169.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -65.62 67.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 129.58 3.152 . . . . 0.0 116.58 -166.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -135.01 121.21 20.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.774 1.63 . . . . 0.0 109.67 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 m 54.76 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.547 2.339 . . . . 0.0 114.517 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.37 146.22 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.319 -0.863 . . . . 0.0 113.012 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 tpt -143.55 144.79 32.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.788 1.235 . . . . 0.0 110.66 171.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -75.22 -44.97 43.29 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.32 3.63 13.66 Favored Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 -80.08 137.95 36.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.23 0.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.97 0.99 5.14 Favored Glycine 0 CA--C 1.541 1.686 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -70.94 -28.61 64.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 113.802 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.32 155.7 8.4 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.362 0.982 . . . . 0.0 114.146 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.75 81.6 0.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.303 2.241 . . . . 0.0 109.391 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -120.44 120.76 36.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.043 0.937 . . . . 0.0 112.641 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -111.23 -27.43 8.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.694 1.598 . . . . 0.0 112.289 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 p -160.23 178.4 9.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.115 1.766 . . . . 0.0 111.612 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -86.54 -0.43 56.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.418 1.487 . . . . 0.0 113.142 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -82.82 121.34 26.79 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.032 -1.043 . . . . 0.0 109.636 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm -82.76 127.82 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.206 0.603 . . . . 0.0 112.179 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 ptm -143.66 172.99 12.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.854 1.261 . . . . 0.0 112.015 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -60.26 -47.99 83.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.15 1.38 . . . . 0.0 114.416 -171.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.14 -0.26 3.72 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.83 154.93 20.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.074 1.749 . . . . 0.0 112.183 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt -114.55 -17.06 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.3 -164.13 41.39 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.922 0.772 . . . . 0.0 114.455 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -131.39 137.45 48.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.557 1.543 . . . . 0.0 110.156 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.75 33.33 6.76 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.771 1.469 . . . . 0.0 116.771 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.6 61.48 1.34 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.353 1.576 . . . . 0.0 110.775 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.98 127.64 32.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.996 1.318 . . . . 0.0 113.058 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -125.43 -1.04 7.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.56 1.944 . . . . 0.0 112.616 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.9 m 53.18 51.81 14.88 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.41 1.884 . . . . 0.0 114.461 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -147.45 166.67 26.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.799 1.24 . . . . 0.0 114.216 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.8 m -61.05 148.66 39.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.176 1.391 . . . . 0.0 110.055 167.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -68.14 143.01 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.756 -0.09 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.39 138.29 39.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.017 1.327 . . . . 0.0 109.026 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -108.23 20.01 19.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.244 1.417 . . . . 0.0 113.583 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.24 37.23 1.13 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.604 2.526 . . . . 0.0 115.599 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.57 146.35 49.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.564 1.946 . . . . 0.0 109.751 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.414 HD22 ' NE2' ' A' ' 72' ' ' GLN . 2.8 p-10 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt -118.58 8.06 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.16 -2.51 5.27 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -73.92 -17.04 61.08 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.347 . . . . 0.0 113.74 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.89 165.24 25.58 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.118 0.866 . . . . 0.0 114.249 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' NE2' HD22 ' A' ' 28' ' ' ASN . 38.6 mt-30 -140.3 71.61 1.38 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.601 1.96 . . . . 0.0 108.158 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.57 114.67 23.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.719 0.808 . . . . 0.0 111.768 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -127.48 1.82 6.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.836 1.655 . . . . 0.0 113.032 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 m 52.16 48.65 22.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.819 1.647 . . . . 0.0 113.681 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.92 167.82 20.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.457 1.503 . . . . 0.0 113.776 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.2 m -67.04 146.24 54.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.757 1.623 . . . . 0.0 109.38 167.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.62 139.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.586 -0.154 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.37 165.86 30.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 0.0 112.275 172.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -98.53 -27.56 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.405 1.482 . . . . 0.0 114.266 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.92 -1.91 15.01 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.63 139.26 38.57 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.661 1.984 . . . . 0.0 111.544 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt -107.25 -25.34 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.48 -158.73 12.53 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.408 1.004 . . . . 0.0 115.301 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -67.51 132.91 48.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.262 1.025 . . . . 0.0 109.945 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.15 -167.79 42.04 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 119.04 2.376 . . . . 0.0 119.04 -167.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -75.27 75.84 2.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.791 2.436 . . . . 0.0 108.771 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -85.37 65.75 9.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.885 1.326 . . . . 0.0 112.509 -168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.3 mmt -92.27 -44.24 8.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.828 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -167.38 -165.06 0.64 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.211 1.804 . . . . 0.0 110.317 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -99.35 -177.51 3.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.804 2.042 . . . . 0.0 110.66 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.8 m 63.69 91.38 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.555 1.942 . . . . 0.0 112.71 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.44 146.22 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 125.522 1.529 . . . . 0.0 112.213 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.405 ' CD2' ' HE ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.405 ' HE ' ' CD2' ' A' ' 131' ' ' LEU . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 168.16 16.98 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.198 0.999 . . . . 0.0 113.049 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -63.9 -43.2 96.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.218 1.007 . . . . 0.0 113.056 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.91 3.96 18.65 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.43 143.19 31.35 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.982 1.713 . . . . 0.0 111.647 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt -109.86 -17.97 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.0 24.39 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.396 0.998 . . . . 0.0 115.055 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -123.09 153.86 39.36 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.832 1.653 . . . . 0.0 111.935 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.12 92.43 0.24 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.893 1.235 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -140.03 53.54 1.66 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 108.533 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -83.7 136.76 34.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.687 1.195 . . . . 0.0 113.893 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 mtt -134.55 7.21 3.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.661 2.384 . . . . 0.0 111.565 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 55.44 5.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 114.541 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -150.06 173.3 14.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.977 1.311 . . . . 0.0 113.467 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.1 t -75.21 173.15 11.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.426 1.091 . . . . 0.0 110.907 167.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.84 142.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -169.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.5 mmm -67.88 153.27 44.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.348 1.059 . . . . 0.0 112.623 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -77.37 3.6 12.8 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.521 1.128 . . . . 0.0 113.713 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 8.47 58.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.396 1.95 . . . . 0.0 116.536 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.87 149.65 46.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.772 1.229 . . . . 0.0 109.127 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -99.97 -7.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.89 73.13 0.85 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.897 1.237 . . . . 0.0 113.141 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -132.12 -25.02 2.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.643 1.977 . . . . 0.0 113.683 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.7 134.99 0.78 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.187 1.851 . . . . 0.0 113.803 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.12 6.68 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.44 127.37 31.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.763 -1.211 . . . . 0.0 112.897 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 mmt -113.48 39.57 2.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.82 1.648 . . . . 0.0 112.247 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 m 54.71 49.91 16.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.746 1.619 . . . . 0.0 113.824 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -135.86 150.05 49.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.792 1.637 . . . . 0.0 111.449 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -69.82 169.04 13.84 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.42 145.04 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 tpp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.324 -0.37 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.261 22.7 ptt? 52.29 177.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 128.336 2.654 . . . . 0.0 116.219 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -84.19 54.69 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.833 1.253 . . . . 0.0 112.284 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.53 36.06 0.69 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.795 2.14 . . . . 0.0 115.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -140.16 146.17 38.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.141 2.176 . . . . 0.0 110.777 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -108.02 -17.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.79 -171.9 37.35 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -86.58 33.31 0.64 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.284 1.834 . . . . 0.0 115.024 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.76 -170.56 52.73 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 117.816 1.887 . . . . 0.0 117.816 168.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.01 -28.27 5.18 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.756 2.022 . . . . 0.0 113.19 -169.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 42.14 65.86 0.82 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.542 2.737 . . . . 0.0 115.888 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 62.5 mtt -98.6 -37.41 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.623 1.169 . . . . 0.0 113.305 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -159.97 161.84 34.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.48 1.512 . . . . 0.0 112.095 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -81.39 -13.88 57.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.524 0.73 . . . . 0.0 112.422 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.8 m -78.81 121.01 24.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 109.991 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.5 150.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.375 1.07 . . . . 0.0 112.951 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.2 tpt -153.91 143.99 22.03 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.984 1.313 . . . . 0.0 109.939 172.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -126.8 -43.75 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 20.91 74.12 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 115.027 0.771 . . . . 0.0 115.027 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -116.54 146.69 42.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.458 1.903 . . . . 0.0 111.528 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.94 -23.06 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.75 161.84 10.97 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.282 0.944 . . . . 0.0 113.708 -175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -141.43 152.81 44.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.32 -1.106 . . . . 0.0 113.541 -170.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.5 17.36 62.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.402 1.477 . . . . 0.0 113.928 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -90.91 54.98 2.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.528 1.531 . . . . 0.0 111.946 -170.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.97 140.94 28.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.872 1.269 . . . . 0.0 113.792 -174.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.21 -31.73 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.879 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.3 p -156.17 176.44 12.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.979 1.311 . . . . 0.0 112.826 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -107.15 -172.5 2.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.443 1.897 . . . . 0.0 112.466 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 m 64.76 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.181 2.192 . . . . 0.0 113.086 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.07 147.34 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -71.6 133.12 45.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.627 0.771 . . . . 0.0 110.583 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -108.2 -46.36 3.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.573 1.149 . . . . 0.0 113.857 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.05 7.49 44.14 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -80.62 138.44 36.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.718 2.007 . . . . 0.0 110.875 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt -115.93 11.71 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.39 47.68 0.7 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.359 1.457 . . . . 0.0 114.809 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.3 -27.81 4.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.457 2.303 . . . . 0.0 113.345 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.71 160.73 11.06 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.584 1.564 . . . . 0.0 114.818 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -143.78 95.08 2.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.268 2.227 . . . . 0.0 107.963 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -60.1 -179.86 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.895 2.078 . . . . 0.0 114.825 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 68.58 47.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.883 2.073 . . . . 0.0 111.219 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 m -82.47 127.99 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.285 1.434 . . . . 0.0 113.293 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -38.25 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.864 1.666 . . . . 0.0 111.757 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.6 t -149.52 157.26 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.356 1.862 . . . . 0.0 110.078 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.37 149.14 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 20.1 ttt 63.57 158.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.82 2.048 . . . . 0.0 114.417 -173.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -69.29 -43.4 73.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.4 2.64 7.59 Favored Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 -84.08 143.57 29.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.677 1.591 . . . . 0.0 111.776 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' CE1' HE22 ' A' ' 72' ' ' GLN . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt -105.99 -17.41 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.31 -162.53 49.51 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 119.329 0.968 . . . . 0.0 114.673 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -147.66 164.68 32.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.909 1.683 . . . . 0.0 113.282 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.14 31.85 50.91 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.447 HE22 ' CE1' ' A' ' 26' ' ' HIS . 2.2 mp0 -66.15 -43.94 85.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.671 1.736 . . . . 0.0 111.818 171.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 37.26 70.77 0.16 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.599 2.76 . . . . 0.0 113.94 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -1.09 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -146.29 175.29 10.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 112.203 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -136.56 142.97 43.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.689 1.996 . . . . 0.0 109.784 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.8 m 64.32 130.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.506 1.922 . . . . 0.0 112.57 -168.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.67 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.248 -0.908 . . . . 0.0 113.241 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.374 0.131 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.94 157.56 34.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.759 0.823 . . . . 0.0 112.644 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -66.77 -35.57 80.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.537 1.135 . . . . 0.0 113.588 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.84 68.64 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -110.73 145.5 37.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.246 1.818 . . . . 0.0 110.957 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.6 1.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.15 27.12 0.99 Allowed Glycine 0 N--CA 1.475 1.273 0 C-N-CA 125.65 1.595 . . . . 0.0 116.362 -170.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -103.31 -4.79 23.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.984 1.713 . . . . 0.0 112.868 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.83 -165.03 48.81 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.052 0.834 . . . . 0.0 114.687 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.33 -170.89 3.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.964 1.705 . . . . 0.0 110.482 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.88 170.51 8.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.787 1.635 . . . . 0.0 111.229 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 49.45 43.48 23.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.73 2.012 . . . . 0.0 114.509 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 p -66.29 81.96 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.6 1.96 . . . . 0.0 113.609 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -158.38 167.57 29.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.943 2.497 . . . . 0.0 110.075 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.7 m 42.77 70.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.517 1.927 . . . . 0.0 113.403 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.96 145.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.444 0.164 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.1 mmm -77.63 156.18 30.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.782 0.833 . . . . 0.0 111.909 174.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.8 -40.61 54.78 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.6 18.35 71.86 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -109.37 141.58 41.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.257 1.423 . . . . 0.0 111.726 -178.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -107.27 -23.88 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.0 -169.5 7.4 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.809 1.195 . . . . 0.0 115.137 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -69.92 132.1 45.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.669 -0.901 . . . . 0.0 109.557 169.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.15 -168.45 29.83 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 122.895 1.275 . . . . 0.0 115.793 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -80.83 53.12 1.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.902 2.481 . . . . 0.0 109.665 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.89 111.4 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.472 1.909 . . . . 0.0 116.133 -165.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.4 mmt -128.76 -19.44 3.69 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.317 1.847 . . . . 0.0 112.658 170.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 57.64 83.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.195 2.198 . . . . 0.0 112.727 -175.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -138.28 171.22 14.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.179 1.791 . . . . 0.0 110.383 -174.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 m -53.51 128.21 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.134 0.973 . . . . 0.0 111.393 174.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.95 148.46 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.833 0.853 . . . . 0.0 112.647 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -145.41 131.31 19.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.867 1.667 . . . . 0.0 108.339 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -77.78 -53.46 7.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -167.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.73 17.21 68.92 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 123.641 0.638 . . . . 0.0 114.365 -169.275 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -112.04 138.17 49.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.232 1.813 . . . . 0.0 110.66 -177.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.54 3.22 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.13 7.0 0.59 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.237 1.875 . . . . 0.0 117.448 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -78.09 -25.93 47.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.646 1.579 . . . . 0.0 112.897 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.72 162.29 21.63 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.707 1.146 . . . . 0.0 114.466 -177.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -140.95 64.86 1.41 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.84 2.056 . . . . 0.0 108.315 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.04 90.35 7.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.945 0.898 . . . . 0.0 112.07 -169.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.7 mtt -126.99 -2.85 6.47 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.358 1.463 . . . . 0.0 113.163 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . 0.277 86.5 p 50.8 29.42 4.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.759 2.424 . . . . 0.0 116.895 175.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -73.1 150.57 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 169.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -54.23 137.79 40.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.141 0.976 . . . . 0.0 108.9 167.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.29 134.57 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.016 0.825 . . . . 0.0 111.522 -174.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.03 166.73 30.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.436 1.494 . . . . 0.0 110.597 169.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -95.99 141.66 29.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.529 1.132 . . . . 0.0 112.149 175.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.18 -2.38 60.69 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.764 1.173 . . . . 0.0 115.199 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 -82.53 137.23 34.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.81 1.305 . . . . 0.0 111.807 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.52 -25.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.9 -161.45 10.37 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.206 0.912 . . . . 0.0 114.321 -174.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -71.26 141.47 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.52 -0.988 . . . . 0.0 110.862 169.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 -173.65 45.49 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -169.178 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.46 66.91 0.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.132 2.173 . . . . 0.0 111.2 172.33 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.53 108.58 3.36 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.717 1.607 . . . . 0.0 112.912 -168.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.0 mtm -135.88 1.07 2.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.106 1.763 . . . . 0.0 113.615 -175.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.2 m 55.88 26.96 10.32 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.761 1.624 . . . . 0.0 114.975 -176.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -82.14 150.54 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.533 1.533 . . . . 0.0 111.402 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -61.47 144.36 54.33 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.692 1.197 . . . . 0.0 109.625 168.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -66.81 136.81 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.4 ttt -74.37 152.97 39.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.971 0.908 . . . . 0.0 111.888 176.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -71.43 8.55 1.03 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.587 1.955 . . . . 0.0 115.172 176.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.21 7.22 61.01 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.47 1.51 . . . . 0.0 116.585 -174.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -73.58 148.62 42.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.097 1.359 . . . . 0.0 110.537 175.208 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt -112.0 -17.13 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.52 -163.5 31.74 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.023 0.828 . . . . 0.0 114.755 -178.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -141.71 165.11 28.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.762 1.625 . . . . 0.0 112.546 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.39 20.14 59.21 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.846 1.212 . . . . 0.0 114.869 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -78.84 48.08 0.8 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.681 1.592 . . . . 0.0 112.133 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.76 128.45 40.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.841 1.256 . . . . 0.0 113.04 -169.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.07 -15.76 1.48 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.251 2.221 . . . . 0.0 113.013 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.0 t -155.3 -167.91 2.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.821 2.448 . . . . 0.0 109.203 -176.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -119.93 9.13 11.18 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.268 -1.52 . . . . 0.0 112.808 170.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -115.55 154.74 28.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.317 1.847 . . . . 0.0 111.161 -177.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.59 150.72 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.565 1.546 . . . . 0.0 113.554 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 38.0 ttp -148.16 160.52 42.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.907 1.283 . . . . 0.0 111.233 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -65.08 -4.85 5.3 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.939 1.696 . . . . 0.0 114.944 175.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.11 9.45 32.54 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.016 1.77 . . . . 0.0 116.389 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -65.93 158.63 27.56 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.011 1.406 . . . . 0.0 111.219 169.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -102.83 -1.43 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 9.69 2.59 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 -170.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -66.88 -24.89 66.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.583 1.553 . . . . 0.0 114.545 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.32 139.3 0.89 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.914 1.245 . . . . 0.0 113.235 -171.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.57 74.9 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.184 1.793 . . . . 0.0 108.76 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -99.83 128.57 45.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.668 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -122.85 -2.66 8.74 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 113.009 178.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 t 52.62 57.92 5.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.541 1.536 . . . . 0.0 111.963 -175.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -139.94 151.11 45.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.1 m -56.28 143.03 35.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.361 1.065 . . . . 0.0 110.029 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.18 142.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.2 mtp -127.34 162.52 26.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.618 1.567 . . . . 0.0 111.062 173.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.53 -42.81 99.77 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.67 74.97 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -110.47 135.1 51.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.497 1.519 . . . . 0.0 111.669 -174.161 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -109.29 -18.29 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.86 -164.53 35.3 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 122.009 0.783 . . . . 0.0 114.674 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 36.7 ttp-105 -128.47 138.85 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 111.118 -176.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.46 96.57 0.25 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.528 1.537 . . . . 0.0 114.26 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -133.43 30.83 3.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.326 1.85 . . . . 0.0 111.2 169.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.84 120.43 17.42 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.838 1.255 . . . . 0.0 113.068 -169.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.6 mtm -133.13 -15.29 2.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.928 2.091 . . . . 0.0 112.88 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -146.0 176.66 9.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.909 2.084 . . . . 0.0 110.578 176.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -119.82 5.52 10.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.545 1.538 . . . . 0.0 113.703 -178.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -123.81 134.43 53.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.366 1.466 . . . . 0.0 110.013 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.31 146.37 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -143.6 166.81 23.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.77 1.228 . . . . 0.0 111.807 171.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.2 140.67 41.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.351 1.46 . . . . 0.0 111.255 175.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.56 4.17 59.72 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.931 1.253 . . . . 0.0 114.682 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.58 128.26 34.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.991 1.316 . . . . 0.0 111.357 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -109.38 -39.95 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 34.91 -134.65 0.42 Allowed Glycine 0 CA--C 1.54 1.656 0 C-N-CA 126.565 2.031 . . . . 0.0 116.139 -179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 55.96 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 130.982 3.713 . . . . 0.0 119.248 168.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.5 131.12 1.51 Allowed Glycine 0 CA--C 1.538 1.479 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -165.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.99 76.76 1.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.876 1.27 . . . . 0.0 110.332 -169.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.74 105.31 15.29 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.526 1.13 . . . . 0.0 112.009 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtm -129.36 -6.14 4.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.903 2.081 . . . . 0.0 112.563 173.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.9 t -149.97 166.76 28.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.566 1.946 . . . . 0.0 111.4 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -95.36 -16.72 22.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.007 1.723 . . . . 0.0 112.531 177.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.15 155.46 34.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.226 1.41 . . . . 0.0 112.041 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.7 147.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.1 tpt -144.05 131.73 21.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.637 1.175 . . . . 0.0 110.152 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -86.86 -37.82 17.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.7 27.26 58.71 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.227 1.394 . . . . 0.0 114.773 -173.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -133.63 134.6 43.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.075 1.75 . . . . 0.0 111.188 -169.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt -123.86 7.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 51.7 1.43 Allowed Glycine 0 CA--C 1.541 1.705 0 C-N-CA 125.598 1.57 . . . . 0.0 116.743 -171.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -138.2 -16.02 1.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.694 1.998 . . . . 0.0 115.447 -177.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.28 -176.45 30.85 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.441 1.02 . . . . 0.0 114.742 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -140.75 -43.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.871 1.668 . . . . 0.0 112.303 177.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 45.61 72.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.236 2.615 . . . . 0.0 114.857 173.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -122.2 -22.99 5.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.268 1.827 . . . . 0.0 113.519 -178.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 t -148.63 169.45 20.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.198 1.399 . . . . 0.0 112.653 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -94.32 -19.24 20.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.166 1.786 . . . . 0.0 112.477 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.24 154.93 35.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.93 148.71 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 tpp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.6 mtp 58.8 172.15 0.06 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.633 1.973 . . . . 0.0 114.68 -174.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -75.77 -28.28 58.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.496 1.119 . . . . 0.0 113.92 -175.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.1 18.2 62.23 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 169.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -115.36 138.2 51.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.692 1.597 . . . . 0.0 111.788 -173.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt -115.44 -19.4 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.06 -153.95 41.2 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 119.102 0.864 . . . . 0.0 114.107 -176.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -145.04 163.09 35.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.375 1.47 . . . . 0.0 113.014 -175.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.21 25.5 33.63 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 168.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -76.59 58.15 1.33 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.869 1.835 . . . . 0.0 110.415 168.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.57 88.17 6.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.623 1.569 . . . . 0.0 113.849 -166.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.25 43.18 2.95 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 108.154 168.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 m -90.09 134.06 34.48 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -166.238 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -158.04 -49.52 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.988 1.715 . . . . 0.0 110.336 167.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -135.89 129.97 33.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.552 1.541 . . . . 0.0 108.675 175.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.72 148.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -173.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -74.67 155.2 38.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.839 0.856 . . . . 0.0 112.875 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -77.09 -35.61 56.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.88 0.93 22.28 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 175.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -78.65 137.57 37.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.872 1.669 . . . . 0.0 111.697 -178.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.93 -24.28 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.65 -165.27 19.2 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.444 1.021 . . . . 0.0 114.659 -178.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -66.06 141.09 58.27 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.904 0.882 . . . . 0.0 111.327 173.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.28 -171.12 42.75 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 -169.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.02 -22.78 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.112 1.765 . . . . 0.0 112.787 -169.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 48.24 63.65 1.98 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.703 2.401 . . . . 0.0 115.105 172.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.7 mtm -115.3 -14.59 11.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.9 1.68 . . . . 0.0 112.442 169.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 m 51.04 41.63 27.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.728 2.011 . . . . 0.0 115.004 169.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.45 20.37 10.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.424 1.89 . . . . 0.0 114.266 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.334 1.1 t 59.99 167.18 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.113 2.165 . . . . 0.0 113.184 -166.07 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm -77.33 143.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.466 0.65 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.952 0.406 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.4 ' HA ' HG22 ' A' ' 103' ' ' VAL . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 92' ' ' MET . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 38' ' ' LEU . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.666 0.746 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.496 0.665 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.57 0.224 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.717 0.77 . . . . 0.0 113.012 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.308 0.575 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.407 0.146 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 13' ' ' VAL . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 110.875 -0.046 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.299 0.095 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 131' ' ' LEU . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 46' ' ' ALA . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 38' ' ' LEU . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.402 0.62 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.563 0.697 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 131' ' ' LEU . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.229 0.538 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.537 -0.172 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.473 0.177 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 120.758 0.313 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 131' ' ' LEU . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.322 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.8 tpt -144.33 155.5 43.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 110.981 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.67 55.35 1.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.884 1.673 . . . . 0.0 113.875 -173.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.63 40.62 0.79 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.599 2.047 . . . . 0.0 114.031 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -137.27 136.78 38.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.568 2.347 . . . . 0.0 110.579 -170.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt -107.7 -15.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.45 -169.81 28.19 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.41 1.005 . . . . 0.0 115.253 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.76 165.65 24.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.952 1.701 . . . . 0.0 112.886 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.59 57.58 3.54 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 167.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -124.17 30.57 6.04 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.221 1.809 . . . . 0.0 111.046 168.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.94 140.43 38.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.887 1.675 . . . . 0.0 112.757 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.6 ttm -143.09 8.06 1.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.874 1.27 . . . . 0.0 113.531 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.2 m 53.97 38.87 29.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.218 1.807 . . . . 0.0 112.946 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.9 -0.67 41.82 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -168.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m 62.55 159.8 0.07 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.061 1.345 . . . . 0.0 112.435 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.87 145.9 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 120.608 -1.308 . . . . 0.0 113.926 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 tpp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.83 147.71 28.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.471 1.909 . . . . 0.0 110.603 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.05 153.9 29.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.852 1.261 . . . . 0.0 111.375 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.13 18.66 4.44 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.498 1.047 . . . . 0.0 114.38 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -130.39 150.8 51.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.637 1.975 . . . . 0.0 111.614 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -105.0 -21.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.07 -165.51 30.35 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 119.194 0.906 . . . . 0.0 114.712 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -137.07 163.11 31.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.202 1.401 . . . . 0.0 113.282 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.36 21.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.766 1.174 . . . . 0.0 114.874 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -129.91 8.28 5.23 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.527 1.531 . . . . 0.0 114.364 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -65.26 156.94 30.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.437 1.495 . . . . 0.0 114.478 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 mmt -110.18 32.96 4.74 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.807 1.643 . . . . 0.0 112.097 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 m 53.8 57.34 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.193 1.797 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.27 150.82 44.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.967 1.307 . . . . 0.0 112.461 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 m -60.77 153.44 24.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.728 1.611 . . . . 0.0 110.742 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.77 141.71 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -74.97 155.85 36.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 0.0 112.912 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.74 -36.16 82.94 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.37 23.54 77.38 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.761 1.464 . . . . 0.0 116.761 169.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -126.53 149.33 49.45 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 119.061 1.431 . . . . 0.0 112.828 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt -111.74 -24.9 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.82 -161.95 9.63 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.79 1.186 . . . . 0.0 115.931 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -65.51 125.17 24.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.267 1.427 . . . . 0.0 109.69 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.01 -168.3 41.13 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.4 76.64 2.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.706 2.402 . . . . 0.0 108.86 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.58 70.45 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.683 1.23 . . . . 0.0 113.847 -167.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -101.67 -4.45 26.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.79 1.636 . . . . 0.0 112.921 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 47.48 81.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.612 2.365 . . . . 0.0 115.194 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.09 179.36 6.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.931 1.692 . . . . 0.0 111.052 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -54.44 133.57 45.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.967 0.907 . . . . 0.0 110.323 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.63 150.01 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.882 0.873 . . . . 0.0 112.099 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.7 ttp -152.85 137.98 17.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.723 1.209 . . . . 0.0 110.664 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -107.5 -25.23 11.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.009 1.324 . . . . 0.0 114.206 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.19 -13.75 3.32 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 117.671 1.828 . . . . 0.0 117.671 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -93.6 146.66 23.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.374 1.587 . . . . 0.0 111.928 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -111.16 -24.73 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.29 -165.69 9.3 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 124.484 1.04 . . . . 0.0 115.155 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -68.43 141.71 55.58 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 110.469 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.64 -154.13 8.69 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.79 20.33 3.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.155 2.182 . . . . 0.0 114.505 -167.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -41.5 109.86 0.14 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.0 mtm -99.55 -18.76 17.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.746 1.618 . . . . 0.0 112.658 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -157.71 159.23 36.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.986 1.714 . . . . 0.0 111.507 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -71.21 -16.97 62.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.391 1.076 . . . . 0.0 113.143 171.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -78.33 138.52 38.61 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.188 -0.945 . . . . 0.0 111.847 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.99 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.81 1.244 . . . . 0.0 113.397 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.4 ' HA ' HG22 ' A' ' 103' ' ' VAL . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 92' ' ' MET . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -69.1 154.67 41.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.138 0.881 . . . . 0.0 112.893 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -76.26 -36.12 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.04 6.02 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -85.23 142.79 29.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.297 1.549 . . . . 0.0 112.153 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 38' ' ' LEU . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt -106.6 -10.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.67 -133.52 44.28 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.823 0.738 . . . . 0.0 113.062 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.76 163.85 36.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.556 1.943 . . . . 0.0 110.914 173.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.15 26.57 36.42 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -76.28 59.67 1.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.41 1.605 . . . . 0.0 111.43 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -79.58 132.54 36.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.896 1.279 . . . . 0.0 112.347 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.8 mtt -133.77 -5.04 2.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.165 1.786 . . . . 0.0 112.713 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 52.62 60.69 3.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.989 1.716 . . . . 0.0 112.394 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.47 136.04 24.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.688 1.595 . . . . 0.0 109.615 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -63.75 139.42 58.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.96 131.4 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.274 27.2 ptm 51.7 172.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.167 2.587 . . . . 0.0 116.453 -172.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.94 162.19 22.8 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.911 1.284 . . . . 0.0 112.188 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.03 18.35 4.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.917 1.246 . . . . 0.0 113.772 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.83 149.57 23.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.783 1.633 . . . . 0.0 112.523 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt -105.17 -21.66 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.55 -158.81 39.22 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.138 0.875 . . . . 0.0 114.435 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -134.13 163.09 30.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.77 1.628 . . . . 0.0 111.717 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.68 23.58 59.86 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -76.31 53.19 0.81 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.067 1.434 . . . . 0.0 110.286 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.78 131.87 43.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.197 1.399 . . . . 0.0 113.434 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.7 mmt -118.38 -10.73 10.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.744 1.618 . . . . 0.0 113.149 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m 53.39 47.67 23.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.901 1.28 . . . . 0.0 111.877 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -130.08 146.84 51.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.817 2.047 . . . . 0.0 110.946 -168.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.2 m -61.92 149.4 40.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.608 1.163 . . . . 0.0 109.5 168.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.26 124.96 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.185 -0.947 . . . . 0.0 112.71 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.0 ptt? 51.67 -178.64 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.813 2.445 . . . . 0.0 115.871 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -82.02 -34.5 29.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.803 1.241 . . . . 0.0 113.512 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.87 39.15 93.56 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -138.17 143.5 40.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.335 1.454 . . . . 0.0 111.809 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -111.12 8.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.39 138.47 47.97 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.688 -1.257 . . . . 0.0 114.71 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.61 74.56 0.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.574 2.35 . . . . 0.0 112.627 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.07 -176.02 30.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.231 1.396 . . . . 0.0 116.377 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 131.1 37.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.409 1.884 . . . . 0.0 112.426 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -129.96 117.22 19.76 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.379 1.071 . . . . 0.0 112.663 -168.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.77 -22.65 2.09 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.802 1.241 . . . . 0.0 113.982 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.1 t -157.81 159.03 36.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.459 1.503 . . . . 0.0 111.852 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.25 -18.09 40.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 0.0 112.09 169.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 m -80.65 125.19 29.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.133 0.973 . . . . 0.0 109.999 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.25 153.26 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.019 0.928 . . . . 0.0 113.292 -175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.2 ptm -150.08 151.19 32.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.952 1.301 . . . . 0.0 111.998 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -90.25 -32.38 16.59 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.897 0.879 . . . . 0.0 113.179 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.02 51.11 60.56 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.227 0.918 . . . . 0.0 114.899 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -138.9 143.58 38.75 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.5 1.52 . . . . 0.0 111.536 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -105.03 0.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.52 -4.6 5.43 Favored Glycine 0 CA--C 1.542 1.771 0 CA-C-N 119.905 1.229 . . . . 0.0 115.844 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -69.37 -22.61 63.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.309 2.243 . . . . 0.0 113.968 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.39 165.14 15.39 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.346 0.974 . . . . 0.0 114.938 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -144.53 43.59 1.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.296 2.239 . . . . 0.0 109.663 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.92 126.38 27.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -167.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.08 -1.48 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.384 1.874 . . . . 0.0 113.309 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m 53.19 45.98 27.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.645 1.578 . . . . 0.0 114.412 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -139.3 169.98 16.78 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.511 1.524 . . . . 0.0 112.999 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -67.62 161.63 25.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.676 0.791 . . . . 0.0 111.874 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.6 146.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.9 ptm -144.63 157.17 44.32 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.33 1.452 . . . . 0.0 112.08 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -88.74 -51.65 5.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 112.805 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.14 51.11 Favored Glycine 0 CA--C 1.542 1.745 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -88.21 147.21 24.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.59 1.556 . . . . 0.0 111.089 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -118.96 10.63 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.36 13.37 0.26 Allowed Glycine 0 CA--C 1.545 1.933 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -80.86 -36.35 31.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.959 1.703 . . . . 0.0 113.892 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.75 103.66 0.04 OUTLIER Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.813 1.196 . . . . 0.0 114.556 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -78.08 74.51 4.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.649 1.18 . . . . 0.0 109.903 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.51 72.68 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.062 1.345 . . . . 0.0 114.178 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.8 mtm -131.24 47.33 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.061 2.145 . . . . 0.0 108.483 169.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -65.62 67.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 129.58 3.152 . . . . 0.0 116.58 -166.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -135.01 121.21 20.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.774 1.63 . . . . 0.0 109.67 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 m 54.76 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.547 2.339 . . . . 0.0 114.517 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.37 146.22 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.319 -0.863 . . . . 0.0 113.012 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 tpt -143.55 144.79 32.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.788 1.235 . . . . 0.0 110.66 171.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -75.22 -44.97 43.29 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.32 3.63 13.66 Favored Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 -80.08 137.95 36.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.23 0.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.97 0.99 5.14 Favored Glycine 0 CA--C 1.541 1.686 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -70.94 -28.61 64.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 113.802 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.32 155.7 8.4 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.362 0.982 . . . . 0.0 114.146 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.75 81.6 0.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.303 2.241 . . . . 0.0 109.391 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -120.44 120.76 36.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.043 0.937 . . . . 0.0 112.641 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -111.23 -27.43 8.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.694 1.598 . . . . 0.0 112.289 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 p -160.23 178.4 9.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.115 1.766 . . . . 0.0 111.612 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -86.54 -0.43 56.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.418 1.487 . . . . 0.0 113.142 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -82.82 121.34 26.79 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.032 -1.043 . . . . 0.0 109.636 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm -82.76 127.82 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.206 0.603 . . . . 0.0 112.179 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 ptm -143.66 172.99 12.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.854 1.261 . . . . 0.0 112.015 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -60.26 -47.99 83.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.15 1.38 . . . . 0.0 114.416 -171.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.14 -0.26 3.72 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.83 154.93 20.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.074 1.749 . . . . 0.0 112.183 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt -114.55 -17.06 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.3 -164.13 41.39 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.922 0.772 . . . . 0.0 114.455 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -131.39 137.45 48.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.557 1.543 . . . . 0.0 110.156 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.75 33.33 6.76 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.771 1.469 . . . . 0.0 116.771 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.6 61.48 1.34 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.353 1.576 . . . . 0.0 110.775 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.98 127.64 32.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.996 1.318 . . . . 0.0 113.058 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -125.43 -1.04 7.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.56 1.944 . . . . 0.0 112.616 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.9 m 53.18 51.81 14.88 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.41 1.884 . . . . 0.0 114.461 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -147.45 166.67 26.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.799 1.24 . . . . 0.0 114.216 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.8 m -61.05 148.66 39.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.176 1.391 . . . . 0.0 110.055 167.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -68.14 143.01 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.756 -0.09 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.39 138.29 39.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.017 1.327 . . . . 0.0 109.026 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -108.23 20.01 19.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.244 1.417 . . . . 0.0 113.583 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.24 37.23 1.13 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.604 2.526 . . . . 0.0 115.599 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.57 146.35 49.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.564 1.946 . . . . 0.0 109.751 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt -118.58 8.06 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.16 -2.51 5.27 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -73.92 -17.04 61.08 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.347 . . . . 0.0 113.74 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.89 165.24 25.58 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.118 0.866 . . . . 0.0 114.249 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -140.3 71.61 1.38 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.601 1.96 . . . . 0.0 108.158 171.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.57 114.67 23.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.719 0.808 . . . . 0.0 111.768 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -127.48 1.82 6.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.836 1.655 . . . . 0.0 113.032 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 m 52.16 48.65 22.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.819 1.647 . . . . 0.0 113.681 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.92 167.82 20.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.457 1.503 . . . . 0.0 113.776 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.2 m -67.04 146.24 54.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.757 1.623 . . . . 0.0 109.38 167.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.62 139.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.586 -0.154 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.37 165.86 30.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 0.0 112.275 172.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -98.53 -27.56 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.405 1.482 . . . . 0.0 114.266 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.92 -1.91 15.01 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.63 139.26 38.57 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.661 1.984 . . . . 0.0 111.544 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt -107.25 -25.34 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.48 -158.73 12.53 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.408 1.004 . . . . 0.0 115.301 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -67.51 132.91 48.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.262 1.025 . . . . 0.0 109.945 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.15 -167.79 42.04 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 119.04 2.376 . . . . 0.0 119.04 -167.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -75.27 75.84 2.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.791 2.436 . . . . 0.0 108.771 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -85.37 65.75 9.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.885 1.326 . . . . 0.0 112.509 -168.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.3 mmt -92.27 -44.24 8.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.828 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -167.38 -165.06 0.64 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.211 1.804 . . . . 0.0 110.317 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -99.35 -177.51 3.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.804 2.042 . . . . 0.0 110.66 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.8 m 63.69 91.38 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.555 1.942 . . . . 0.0 112.71 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.44 146.22 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 125.522 1.529 . . . . 0.0 112.213 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 168.16 16.98 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.198 0.999 . . . . 0.0 113.049 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -63.9 -43.2 96.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.218 1.007 . . . . 0.0 113.056 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.91 3.96 18.65 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.43 143.19 31.35 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.982 1.713 . . . . 0.0 111.647 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt -109.86 -17.97 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.0 24.39 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.396 0.998 . . . . 0.0 115.055 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -123.09 153.86 39.36 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.832 1.653 . . . . 0.0 111.935 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.12 92.43 0.24 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.893 1.235 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -140.03 53.54 1.66 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 108.533 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -83.7 136.76 34.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.687 1.195 . . . . 0.0 113.893 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 mtt -134.55 7.21 3.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.661 2.384 . . . . 0.0 111.565 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 55.44 5.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 114.541 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -150.06 173.3 14.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.977 1.311 . . . . 0.0 113.467 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.1 t -75.21 173.15 11.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.426 1.091 . . . . 0.0 110.907 167.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.84 142.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -169.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.5 mmm -67.88 153.27 44.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.348 1.059 . . . . 0.0 112.623 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -77.37 3.6 12.8 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.521 1.128 . . . . 0.0 113.713 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 8.47 58.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.396 1.95 . . . . 0.0 116.536 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.87 149.65 46.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.772 1.229 . . . . 0.0 109.127 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -99.97 -7.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.89 73.13 0.85 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.897 1.237 . . . . 0.0 113.141 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -132.12 -25.02 2.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.643 1.977 . . . . 0.0 113.683 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.7 134.99 0.78 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.187 1.851 . . . . 0.0 113.803 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.12 6.68 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.44 127.37 31.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.763 -1.211 . . . . 0.0 112.897 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 mmt -113.48 39.57 2.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.82 1.648 . . . . 0.0 112.247 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 m 54.71 49.91 16.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.746 1.619 . . . . 0.0 113.824 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -135.86 150.05 49.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.792 1.637 . . . . 0.0 111.449 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -69.82 169.04 13.84 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.42 145.04 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 tpp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.324 -0.37 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.261 22.7 ptt? 52.29 177.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 128.336 2.654 . . . . 0.0 116.219 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -84.19 54.69 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.833 1.253 . . . . 0.0 112.284 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.53 36.06 0.69 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.795 2.14 . . . . 0.0 115.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -140.16 146.17 38.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.141 2.176 . . . . 0.0 110.777 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 13' ' ' VAL . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -108.02 -17.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.79 -171.9 37.35 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -86.58 33.31 0.64 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.284 1.834 . . . . 0.0 115.024 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.76 -170.56 52.73 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 117.816 1.887 . . . . 0.0 117.816 168.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.01 -28.27 5.18 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.756 2.022 . . . . 0.0 113.19 -169.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 42.14 65.86 0.82 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.542 2.737 . . . . 0.0 115.888 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 62.5 mtt -98.6 -37.41 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.623 1.169 . . . . 0.0 113.305 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -159.97 161.84 34.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.48 1.512 . . . . 0.0 112.095 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -81.39 -13.88 57.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.524 0.73 . . . . 0.0 112.422 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.8 m -78.81 121.01 24.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 109.991 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.5 150.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.375 1.07 . . . . 0.0 112.951 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.2 tpt -153.91 143.99 22.03 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.984 1.313 . . . . 0.0 109.939 172.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -126.8 -43.75 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 20.91 74.12 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 115.027 0.771 . . . . 0.0 115.027 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -116.54 146.69 42.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.458 1.903 . . . . 0.0 111.528 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.94 -23.06 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.75 161.84 10.97 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.282 0.944 . . . . 0.0 113.708 -175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -141.43 152.81 44.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.32 -1.106 . . . . 0.0 113.541 -170.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.5 17.36 62.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.402 1.477 . . . . 0.0 113.928 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -90.91 54.98 2.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.528 1.531 . . . . 0.0 111.946 -170.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.97 140.94 28.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.872 1.269 . . . . 0.0 113.792 -174.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.21 -31.73 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.879 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.3 p -156.17 176.44 12.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.979 1.311 . . . . 0.0 112.826 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -107.15 -172.5 2.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.443 1.897 . . . . 0.0 112.466 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 m 64.76 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.181 2.192 . . . . 0.0 113.086 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.07 147.34 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -71.6 133.12 45.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.627 0.771 . . . . 0.0 110.583 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -108.2 -46.36 3.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.573 1.149 . . . . 0.0 113.857 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.05 7.49 44.14 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -80.62 138.44 36.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.718 2.007 . . . . 0.0 110.875 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt -115.93 11.71 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.39 47.68 0.7 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.359 1.457 . . . . 0.0 114.809 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.3 -27.81 4.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.457 2.303 . . . . 0.0 113.345 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.71 160.73 11.06 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.584 1.564 . . . . 0.0 114.818 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -143.78 95.08 2.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.268 2.227 . . . . 0.0 107.963 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -60.1 -179.86 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.895 2.078 . . . . 0.0 114.825 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 68.58 47.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.883 2.073 . . . . 0.0 111.219 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 m -82.47 127.99 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.285 1.434 . . . . 0.0 113.293 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -38.25 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.864 1.666 . . . . 0.0 111.757 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.6 t -149.52 157.26 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.356 1.862 . . . . 0.0 110.078 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.37 149.14 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 20.1 ttt 63.57 158.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.82 2.048 . . . . 0.0 114.417 -173.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -69.29 -43.4 73.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.4 2.64 7.59 Favored Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 -84.08 143.57 29.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.677 1.591 . . . . 0.0 111.776 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.441 ' CE1' HE22 ' A' ' 72' ' ' GLN . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt -105.99 -17.41 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.31 -162.53 49.51 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 119.329 0.968 . . . . 0.0 114.673 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -147.66 164.68 32.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.909 1.683 . . . . 0.0 113.282 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.14 31.85 50.91 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.441 HE22 ' CE1' ' A' ' 26' ' ' HIS . 2.2 mp0 -66.15 -43.94 85.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.671 1.736 . . . . 0.0 111.818 171.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 37.26 70.77 0.16 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.599 2.76 . . . . 0.0 113.94 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -1.09 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -146.29 175.29 10.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 112.203 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -136.56 142.97 43.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.689 1.996 . . . . 0.0 109.784 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.8 m 64.32 130.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.506 1.922 . . . . 0.0 112.57 -168.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.67 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.248 -0.908 . . . . 0.0 113.241 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.374 0.131 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.94 157.56 34.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.759 0.823 . . . . 0.0 112.644 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -66.77 -35.57 80.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.537 1.135 . . . . 0.0 113.588 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.84 68.64 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -110.73 145.5 37.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.246 1.818 . . . . 0.0 110.957 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.6 1.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.15 27.12 0.99 Allowed Glycine 0 N--CA 1.475 1.273 0 C-N-CA 125.65 1.595 . . . . 0.0 116.362 -170.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -103.31 -4.79 23.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.984 1.713 . . . . 0.0 112.868 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.83 -165.03 48.81 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.052 0.834 . . . . 0.0 114.687 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.33 -170.89 3.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.964 1.705 . . . . 0.0 110.482 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.88 170.51 8.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.787 1.635 . . . . 0.0 111.229 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 49.45 43.48 23.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.73 2.012 . . . . 0.0 114.509 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 p -66.29 81.96 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.6 1.96 . . . . 0.0 113.609 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -158.38 167.57 29.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.943 2.497 . . . . 0.0 110.075 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.7 m 42.77 70.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.517 1.927 . . . . 0.0 113.403 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.96 145.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.4 HD12 ' H ' ' A' ' 131' ' ' LEU . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.444 0.164 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.1 mmm -77.63 156.18 30.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.782 0.833 . . . . 0.0 111.909 174.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.8 -40.61 54.78 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.6 18.35 71.86 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -109.37 141.58 41.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.257 1.423 . . . . 0.0 111.726 -178.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 46' ' ' ALA . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 38' ' ' LEU . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -107.27 -23.88 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.0 -169.5 7.4 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.809 1.195 . . . . 0.0 115.137 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -69.92 132.1 45.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.669 -0.901 . . . . 0.0 109.557 169.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.15 -168.45 29.83 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 122.895 1.275 . . . . 0.0 115.793 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -80.83 53.12 1.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.902 2.481 . . . . 0.0 109.665 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.89 111.4 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.472 1.909 . . . . 0.0 116.133 -165.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.4 mmt -128.76 -19.44 3.69 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.317 1.847 . . . . 0.0 112.658 170.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 57.64 83.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.195 2.198 . . . . 0.0 112.727 -175.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -138.28 171.22 14.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.179 1.791 . . . . 0.0 110.383 -174.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 m -53.51 128.21 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.134 0.973 . . . . 0.0 111.393 174.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.95 148.46 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.833 0.853 . . . . 0.0 112.647 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -145.41 131.31 19.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.867 1.667 . . . . 0.0 108.339 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -77.78 -53.46 7.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -167.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.73 17.21 68.92 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 123.641 0.638 . . . . 0.0 114.365 -169.275 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -112.04 138.17 49.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.232 1.813 . . . . 0.0 110.66 -177.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.54 3.22 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.13 7.0 0.59 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.237 1.875 . . . . 0.0 117.448 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -78.09 -25.93 47.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.646 1.579 . . . . 0.0 112.897 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.72 162.29 21.63 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.707 1.146 . . . . 0.0 114.466 -177.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -140.95 64.86 1.41 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.84 2.056 . . . . 0.0 108.315 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.04 90.35 7.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.945 0.898 . . . . 0.0 112.07 -169.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.7 mtt -126.99 -2.85 6.47 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.358 1.463 . . . . 0.0 113.163 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . 0.277 86.5 p 50.8 29.42 4.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.759 2.424 . . . . 0.0 116.895 175.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -73.1 150.57 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 169.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -54.23 137.79 40.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.141 0.976 . . . . 0.0 108.9 167.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.29 134.57 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.016 0.825 . . . . 0.0 111.522 -174.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 131' ' ' LEU . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.03 166.73 30.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.436 1.494 . . . . 0.0 110.597 169.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -95.99 141.66 29.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.529 1.132 . . . . 0.0 112.149 175.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.18 -2.38 60.69 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.764 1.173 . . . . 0.0 115.199 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 -82.53 137.23 34.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.81 1.305 . . . . 0.0 111.807 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.52 -25.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.9 -161.45 10.37 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.206 0.912 . . . . 0.0 114.321 -174.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -71.26 141.47 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.52 -0.988 . . . . 0.0 110.862 169.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 -173.65 45.49 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -169.178 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.441 ' H ' ' CD ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -72.46 66.91 0.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.132 2.173 . . . . 0.0 111.2 172.33 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.53 108.58 3.36 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.717 1.607 . . . . 0.0 112.912 -168.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.0 mtm -135.88 1.07 2.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.106 1.763 . . . . 0.0 113.615 -175.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.2 m 55.88 26.96 10.32 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.761 1.624 . . . . 0.0 114.975 -176.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -82.14 150.54 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.533 1.533 . . . . 0.0 111.402 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -61.47 144.36 54.33 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.692 1.197 . . . . 0.0 109.625 168.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -66.81 136.81 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.4 ttt -74.37 152.97 39.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.971 0.908 . . . . 0.0 111.888 176.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -71.43 8.55 1.03 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.587 1.955 . . . . 0.0 115.172 176.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.21 7.22 61.01 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.47 1.51 . . . . 0.0 116.585 -174.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -73.58 148.62 42.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.097 1.359 . . . . 0.0 110.537 175.208 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt -112.0 -17.13 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.52 -163.5 31.74 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.023 0.828 . . . . 0.0 114.755 -178.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -141.71 165.11 28.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.762 1.625 . . . . 0.0 112.546 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.39 20.14 59.21 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.846 1.212 . . . . 0.0 114.869 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -78.84 48.08 0.8 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.681 1.592 . . . . 0.0 112.133 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.76 128.45 40.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.841 1.256 . . . . 0.0 113.04 -169.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.07 -15.76 1.48 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.251 2.221 . . . . 0.0 113.013 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.0 t -155.3 -167.91 2.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.821 2.448 . . . . 0.0 109.203 -176.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -119.93 9.13 11.18 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.268 -1.52 . . . . 0.0 112.808 170.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -115.55 154.74 28.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.317 1.847 . . . . 0.0 111.161 -177.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.59 150.72 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.565 1.546 . . . . 0.0 113.554 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 38.0 ttp -148.16 160.52 42.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.907 1.283 . . . . 0.0 111.233 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -65.08 -4.85 5.3 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.939 1.696 . . . . 0.0 114.944 175.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.11 9.45 32.54 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.016 1.77 . . . . 0.0 116.389 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -65.93 158.63 27.56 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.011 1.406 . . . . 0.0 111.219 169.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -102.83 -1.43 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 9.69 2.59 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 -170.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -66.88 -24.89 66.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.583 1.553 . . . . 0.0 114.545 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.32 139.3 0.89 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.914 1.245 . . . . 0.0 113.235 -171.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.57 74.9 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.184 1.793 . . . . 0.0 108.76 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -99.83 128.57 45.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.668 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -122.85 -2.66 8.74 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 113.009 178.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 t 52.62 57.92 5.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.541 1.536 . . . . 0.0 111.963 -175.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -139.94 151.11 45.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.1 m -56.28 143.03 35.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.361 1.065 . . . . 0.0 110.029 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.18 142.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.2 mtp -127.34 162.52 26.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.618 1.567 . . . . 0.0 111.062 173.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.53 -42.81 99.77 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.67 74.97 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -110.47 135.1 51.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.497 1.519 . . . . 0.0 111.669 -174.161 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -109.29 -18.29 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.86 -164.53 35.3 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 122.009 0.783 . . . . 0.0 114.674 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 36.7 ttp-105 -128.47 138.85 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 111.118 -176.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.46 96.57 0.25 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.528 1.537 . . . . 0.0 114.26 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -133.43 30.83 3.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.326 1.85 . . . . 0.0 111.2 169.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.84 120.43 17.42 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.838 1.255 . . . . 0.0 113.068 -169.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.6 mtm -133.13 -15.29 2.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.928 2.091 . . . . 0.0 112.88 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -146.0 176.66 9.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.909 2.084 . . . . 0.0 110.578 176.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -119.82 5.52 10.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.545 1.538 . . . . 0.0 113.703 -178.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -123.81 134.43 53.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.366 1.466 . . . . 0.0 110.013 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.31 146.37 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -143.6 166.81 23.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.77 1.228 . . . . 0.0 111.807 171.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.2 140.67 41.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.351 1.46 . . . . 0.0 111.255 175.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.56 4.17 59.72 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.931 1.253 . . . . 0.0 114.682 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.58 128.26 34.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.991 1.316 . . . . 0.0 111.357 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -109.38 -39.95 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 34.91 -134.65 0.42 Allowed Glycine 0 CA--C 1.54 1.656 0 C-N-CA 126.565 2.031 . . . . 0.0 116.139 -179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 55.96 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 130.982 3.713 . . . . 0.0 119.248 168.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.5 131.12 1.51 Allowed Glycine 0 CA--C 1.538 1.479 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -165.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.99 76.76 1.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.876 1.27 . . . . 0.0 110.332 -169.157 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.74 105.31 15.29 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.526 1.13 . . . . 0.0 112.009 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtm -129.36 -6.14 4.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.903 2.081 . . . . 0.0 112.563 173.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.9 t -149.97 166.76 28.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.566 1.946 . . . . 0.0 111.4 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -95.36 -16.72 22.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.007 1.723 . . . . 0.0 112.531 177.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.15 155.46 34.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.226 1.41 . . . . 0.0 112.041 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.7 147.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.1 tpt -144.05 131.73 21.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.637 1.175 . . . . 0.0 110.152 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -86.86 -37.82 17.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.7 27.26 58.71 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.227 1.394 . . . . 0.0 114.773 -173.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -133.63 134.6 43.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.075 1.75 . . . . 0.0 111.188 -169.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt -123.86 7.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 51.7 1.43 Allowed Glycine 0 CA--C 1.541 1.705 0 C-N-CA 125.598 1.57 . . . . 0.0 116.743 -171.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -138.2 -16.02 1.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.694 1.998 . . . . 0.0 115.447 -177.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.28 -176.45 30.85 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.441 1.02 . . . . 0.0 114.742 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -140.75 -43.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.871 1.668 . . . . 0.0 112.303 177.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 45.61 72.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.236 2.615 . . . . 0.0 114.857 173.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -122.2 -22.99 5.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.268 1.827 . . . . 0.0 113.519 -178.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 t -148.63 169.45 20.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.198 1.399 . . . . 0.0 112.653 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -94.32 -19.24 20.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.166 1.786 . . . . 0.0 112.477 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.24 154.93 35.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.93 148.71 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 tpp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.6 mtp 58.8 172.15 0.06 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.633 1.973 . . . . 0.0 114.68 -174.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -75.77 -28.28 58.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.496 1.119 . . . . 0.0 113.92 -175.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.1 18.2 62.23 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 169.668 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -115.36 138.2 51.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.692 1.597 . . . . 0.0 111.788 -173.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt -115.44 -19.4 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.06 -153.95 41.2 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 119.102 0.864 . . . . 0.0 114.107 -176.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -145.04 163.09 35.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.375 1.47 . . . . 0.0 113.014 -175.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.21 25.5 33.63 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 168.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -76.59 58.15 1.33 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.869 1.835 . . . . 0.0 110.415 168.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.57 88.17 6.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.623 1.569 . . . . 0.0 113.849 -166.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.25 43.18 2.95 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 108.154 168.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 m -90.09 134.06 34.48 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -166.238 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -158.04 -49.52 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.988 1.715 . . . . 0.0 110.336 167.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -135.89 129.97 33.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.552 1.541 . . . . 0.0 108.675 175.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.72 148.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -173.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 131' ' ' LEU . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -74.67 155.2 38.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.839 0.856 . . . . 0.0 112.875 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -77.09 -35.61 56.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.88 0.93 22.28 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 175.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -78.65 137.57 37.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.872 1.669 . . . . 0.0 111.697 -178.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.93 -24.28 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.65 -165.27 19.2 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.444 1.021 . . . . 0.0 114.659 -178.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -66.06 141.09 58.27 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.904 0.882 . . . . 0.0 111.327 173.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.28 -171.12 42.75 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 -169.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.02 -22.78 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.112 1.765 . . . . 0.0 112.787 -169.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 48.24 63.65 1.98 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.703 2.401 . . . . 0.0 115.105 172.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.7 mtm -115.3 -14.59 11.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.9 1.68 . . . . 0.0 112.442 169.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 m 51.04 41.63 27.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.728 2.011 . . . . 0.0 115.004 169.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.45 20.37 10.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.424 1.89 . . . . 0.0 114.266 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.334 1.1 t 59.99 167.18 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.113 2.165 . . . . 0.0 113.184 -166.07 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm -77.33 143.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 111.614 0.227 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.466 0.65 . . . . 0.0 112.099 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.952 0.406 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.4 ' HA ' HG22 ' A' ' 103' ' ' VAL . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 92' ' ' MET . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 38' ' ' LEU . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.666 0.746 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 121.496 0.665 . . . . 0.0 112.71 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 120.57 0.224 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.717 0.77 . . . . 0.0 113.012 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 111.35 0.13 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.308 0.575 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt . . . . . 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 111.647 0.239 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 120.407 0.146 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 13' ' ' VAL . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.528 0.196 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 110.875 -0.046 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.299 0.095 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 131' ' ' LEU . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 46' ' ' ALA . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 38' ' ' LEU . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.402 0.62 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.563 0.697 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 131' ' ' LEU . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 121.229 0.538 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm . . . . . 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 110.537 -0.172 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.473 0.177 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 120.758 0.313 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.418 ' H ' HD12 ' A' ' 131' ' ' LEU . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.322 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.8 tpt -144.33 155.5 43.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.307 1.443 . . . . 0.0 110.981 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.67 55.35 1.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.884 1.673 . . . . 0.0 113.875 -173.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.63 40.62 0.79 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 126.599 2.047 . . . . 0.0 114.031 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -137.27 136.78 38.35 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.568 2.347 . . . . 0.0 110.579 -170.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -116.78 148.26 41.33 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.338 1.455 . . . . 0.0 109.561 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -65.27 162.72 16.8 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 121.239 -0.913 . . . . 0.0 111.493 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -60.99 -34.46 74.83 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.59 -1.319 . . . . 0.0 111.464 173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -63.63 -41.47 98.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.608 1.163 . . . . 0.0 111.517 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.34 -42.31 59.64 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.648 1.179 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -57.53 -35.86 70.85 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 111.631 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -63.87 -42.89 97.42 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.232 -0.89 . . . . 0.0 112.587 173.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -36.5 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.387 1.449 . . . . 0.0 111.646 175.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 98.7 mt -72.75 -32.6 65.77 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.14 -39.5 78.82 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.231 -0.918 . . . . 0.0 111.993 170.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.74 -33.71 76.23 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.389 -0.819 . . . . 0.0 112.014 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.21 75.67 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.195 0.907 . . . . 0.0 112.69 172.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -69.29 -44.59 71.51 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.417 0.687 . . . . 0.0 111.713 172.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.63 -39.86 95.16 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.711 -0.618 . . . . 0.0 111.694 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -70.82 -40.07 72.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.04 0.936 . . . . 0.0 112.594 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.1 76.92 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.173 0.897 . . . . 0.0 110.83 170.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.77 -29.74 68.19 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 72.1 ttp85 -64.92 -45.22 86.78 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.81 1.187 . . . . 0.0 112.098 171.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mp -70.54 -15.48 62.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.407 1.083 . . . . 0.0 112.568 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.04 42.56 19.39 Favored Glycine 0 CA--C 1.532 1.146 0 O-C-N 121.307 -0.871 . . . . 0.0 112.477 -173.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -115.36 136.19 53.35 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.723 2.009 . . . . 0.0 109.781 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -93.8 27.96 2.54 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.731 0.812 . . . . 0.0 112.665 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.99 148.24 31.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.392 1.077 . . . . 0.0 113.387 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.9 mt -100.74 115.93 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 125.579 1.551 . . . . 0.0 108.43 168.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.77 -179.29 32.01 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.42 1.486 . . . . 0.0 111.811 168.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -54.92 -41.47 71.04 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.629 -0.924 . . . . 0.0 111.047 171.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.19 -49.23 43.7 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 129.171 2.988 . . . . 0.0 113.85 170.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -73.26 -32.24 64.57 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.11 0.564 . . . . 0.0 111.479 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.8 mt -67.95 -43.09 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 118.658 0.663 . . . . 0.0 110.662 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.85 -41.51 97.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.103 0.865 . . . . 0.0 111.348 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.68 -36.54 80.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.83 0.852 . . . . 0.0 112.218 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.61 -37.65 95.06 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.683 1.135 . . . . 0.0 113.063 171.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.96 -55.61 32.69 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.536 1.135 . . . . 0.0 112.533 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -29.37 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.274 0.943 . . . . 0.0 113.095 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.31 -21.73 63.83 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -78.7 -52.27 8.64 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.502 0.721 . . . . 0.0 109.402 168.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.04 -17.17 3.97 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 117.465 1.746 . . . . 0.0 117.465 168.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -108.94 -29.34 8.65 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 120.035 1.918 . . . . 0.0 112.543 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -51.91 148.46 10.3 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.274 0.94 . . . . 0.0 113.0 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mm -52.66 -41.06 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.789 1.236 . . . . 0.0 112.376 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.1 -47.27 80.68 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.48 94.33 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.158 -0.964 . . . . 0.0 111.524 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -63.33 -36.8 84.88 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.104 0.962 . . . . 0.0 111.85 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.85 -40.57 83.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.632 1.173 . . . . 0.0 112.758 173.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.76 -46.89 88.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.02 0.827 . . . . 0.0 111.413 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -66.64 -34.06 77.04 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.92 -33.29 75.37 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.078 -1.014 . . . . 0.0 112.752 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.16 9.15 3.26 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.358 1.463 . . . . 0.0 113.909 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.45 77.37 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.982 1.277 . . . . 0.0 115.243 174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -79.3 -176.86 5.41 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.697 1.248 . . . . 0.0 111.602 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.37 158.47 31.39 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.441 1.496 . . . . 0.0 110.921 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -58.99 -42.04 89.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -67.51 -32.72 73.71 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -68.41 -49.26 61.32 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.902 0.881 . . . . 0.0 110.128 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.5 mt -67.32 -44.18 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.191 0.996 . . . . 0.0 110.204 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -61.27 -45.87 92.7 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.119 0.872 . . . . 0.0 112.932 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -65.74 -37.55 86.67 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.557 0.617 . . . . 0.0 112.352 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.94 -37.12 70.04 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.182 0.901 . . . . 0.0 113.288 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.34 -56.43 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.4 1.0 . . . . 0.0 110.22 171.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -66.64 -29.51 69.55 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -69.08 -22.25 64.02 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.46 -36.04 12.05 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.076 0.951 . . . . 0.0 113.24 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.9 pt -107.7 -15.16 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.45 -169.81 28.19 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.41 1.005 . . . . 0.0 115.253 177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -132.76 165.65 24.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.952 1.701 . . . . 0.0 112.886 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.59 57.58 3.54 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 116.691 1.436 . . . . 0.0 116.691 167.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -124.17 30.57 6.04 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.221 1.809 . . . . 0.0 111.046 168.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -78.94 140.43 38.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.887 1.675 . . . . 0.0 112.757 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.6 ttm -143.09 8.06 1.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.874 1.27 . . . . 0.0 113.531 -173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.2 m 53.97 38.87 29.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.218 1.807 . . . . 0.0 112.946 -176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.9 -0.67 41.82 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -168.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m 62.55 159.8 0.07 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.061 1.345 . . . . 0.0 112.435 -170.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.87 145.9 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 120.608 -1.308 . . . . 0.0 113.926 -170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -130.33 154.0 48.1 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.275 2.23 . . . . 0.0 109.669 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -90.45 135.24 33.82 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.032 -1.043 . . . . 0.0 110.534 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.9 p -67.29 162.92 51.06 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.926 -0.484 . . . . 0.0 111.117 172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.18 -35.27 90.5 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.375 2.05 . . . . 0.0 113.372 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -75.24 -37.27 61.11 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 175.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.41 -41.84 88.69 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.715 1.143 . . . . 0.0 111.046 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -58.91 -42.74 90.34 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.245 1.018 . . . . 0.0 111.345 171.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.72 -43.59 94.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.538 0.735 . . . . 0.0 111.788 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.5 t -63.47 -36.76 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 119.784 1.174 . . . . 0.0 112.227 176.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.14 -39.24 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.549 1.068 . . . . 0.0 111.302 173.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.83 -40.17 66.0 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.99 -1.069 . . . . 0.0 113.21 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.8 mt -72.64 -39.1 67.45 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.305 1.042 . . . . 0.0 112.079 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 66.5 p -64.22 -34.1 77.31 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.147 0.885 . . . . 0.0 112.191 172.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttm -70.12 -37.64 75.39 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.853 0.861 . . . . 0.0 112.436 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -65.67 -40.49 92.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.831 0.853 . . . . 0.0 112.598 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -64.31 -40.72 96.48 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.121 0.968 . . . . 0.0 111.871 173.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.97 95.2 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.472 -0.768 . . . . 0.0 111.986 174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttp85 -64.29 -40.12 95.31 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.903 0.881 . . . . 0.0 112.438 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -61.18 -34.32 74.87 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.301 1.04 . . . . 0.0 112.844 173.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.5 mp -82.08 -7.02 59.6 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.615 1.166 . . . . 0.0 114.069 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.05 15.43 79.85 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.505 1.05 . . . . 0.0 114.759 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -80.77 131.55 35.43 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.575 1.188 . . . . 0.0 110.375 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.2 p -82.17 11.84 4.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 -176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -161.43 161.96 30.39 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.744 2.417 . . . . 0.0 110.241 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.83 117.21 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.38 175.73 46.17 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.468 1.033 . . . . 0.0 113.726 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.6 p -59.46 -41.42 89.67 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.571 -0.958 . . . . 0.0 110.88 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -48.46 -53.43 17.94 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.401 2.28 . . . . 0.0 111.468 169.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -69.18 -32.88 72.49 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.902 0.881 . . . . 0.0 112.895 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.6 mt -56.73 -48.92 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.435 1.016 . . . . 0.0 110.354 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 37.0 tp -63.8 -43.27 96.78 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.651 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.5 mt -56.87 -34.85 68.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.166 0.893 . . . . 0.0 112.015 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.14 -44.78 93.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.434 1.016 . . . . 0.0 113.869 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -59.52 -46.16 89.67 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.654 1.227 . . . . 0.0 112.377 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.02 -31.79 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -64.94 -31.58 72.88 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.556 1.071 . . . . 0.0 112.558 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.1 -51.19 68.9 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.744 0.818 . . . . 0.0 109.801 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.85 -4.26 23.54 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 118.166 2.027 . . . . 0.0 118.166 167.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -132.0 -23.7 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 120.071 1.936 . . . . 0.0 113.414 -173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.88 171.84 11.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.561 1.553 . . . . 0.0 113.426 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.33 -36.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.818 . . . . 0.0 111.406 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.95 -48.43 78.36 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.212 0.915 . . . . 0.0 112.872 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.45 -38.09 85.96 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.764 -0.585 . . . . 0.0 111.865 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -71.34 -39.13 71.53 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.335 1.054 . . . . 0.0 113.562 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.02 -47.9 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.231 1.012 . . . . 0.0 110.828 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.52 -46.4 90.31 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.818 -0.551 . . . . 0.0 111.271 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -68.17 -34.35 76.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . 0.252 1.4 p-10 -78.36 -21.66 49.13 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 119.718 1.145 . . . . 0.0 113.307 178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.88 -38.15 28.55 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.579 1.152 . . . . 0.0 112.062 169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.44 -4.04 3.68 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.132 1.349 . . . . 0.0 115.88 171.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 69.2 t -76.52 142.57 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.835 1.254 . . . . 0.0 110.671 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -129.14 162.42 27.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.085 1.354 . . . . 0.0 110.003 -176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.63 -47.95 58.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.744 1.218 . . . . 0.0 112.173 -174.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.64 -28.52 58.81 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -69.04 -48.94 61.63 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.222 0.919 . . . . 0.0 110.416 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.5 92.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.174 0.99 . . . . 0.0 111.389 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -55.87 -52.99 62.13 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.188 0.904 . . . . 0.0 112.159 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -62.3 -40.63 96.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.495 1.043 . . . . 0.0 112.852 -176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.12 -41.15 70.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.5 1.046 . . . . 0.0 112.541 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -67.11 -45.73 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 119.521 1.055 . . . . 0.0 111.133 178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.86 -25.36 65.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.554 1.142 . . . . 0.0 113.019 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -80.78 -54.44 5.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.759 0.709 . . . . 0.0 111.35 168.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.2 -19.0 65.49 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.32 -10.4 42.42 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.76 -5.19 0.16 Allowed Glycine 0 CA--C 1.538 1.482 0 N-CA-C 116.415 1.326 . . . . 0.0 116.415 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.6 m -103.3 -4.04 24.79 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.923 1.689 . . . . 0.0 114.224 -176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.434 1.893 . . . . 0.0 112.028 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 tpp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.738 -0.173 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.83 147.71 28.3 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.471 1.909 . . . . 0.0 110.603 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.05 153.9 29.84 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.852 1.261 . . . . 0.0 111.375 171.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.13 18.66 4.44 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.498 1.047 . . . . 0.0 114.38 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -130.39 150.8 51.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.637 1.975 . . . . 0.0 111.614 -175.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -117.44 151.78 36.36 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.103 1.761 . . . . 0.0 109.731 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.4 p -66.44 165.69 13.88 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.998 -1.064 . . . . 0.0 112.076 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.77 -35.85 81.16 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.704 -1.247 . . . . 0.0 112.155 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.54 -40.23 85.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.877 0.871 . . . . 0.0 111.63 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.45 84.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.938 0.895 . . . . 0.0 111.883 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -61.63 -35.99 79.47 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.297 0.639 . . . . 0.0 111.864 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -61.91 -45.13 95.05 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 117.701 -1.143 . . . . 0.0 112.537 169.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -38.84 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.921 1.691 . . . . 0.0 111.6 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -73.48 -33.32 64.78 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.46 -41.54 80.06 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.41 -0.806 . . . . 0.0 111.928 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -67.19 -34.59 77.85 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.026 0.93 . . . . 0.0 111.948 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.9 -34.6 71.86 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.351 0.978 . . . . 0.0 113.174 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -67.85 -45.13 75.47 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.646 -0.659 . . . . 0.0 111.528 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -69.58 -36.44 76.26 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.683 -0.636 . . . . 0.0 111.592 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -64.19 -39.02 93.11 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.256 -0.902 . . . . 0.0 112.071 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.46 -52.07 66.06 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.681 0.673 . . . . 0.0 111.302 170.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.03 -35.28 80.66 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -64.08 -39.33 93.82 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.437 1.495 . . . . 0.0 112.054 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.62 -3.5 50.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.47 1.108 . . . . 0.0 113.087 174.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.95 37.18 44.59 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 120.775 -1.203 . . . . 0.0 113.832 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -109.74 142.2 41.27 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.436 1.894 . . . . 0.0 110.166 171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 p-10 -101.46 16.17 26.52 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.134 1.374 . . . . 0.0 113.848 175.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.84 149.22 40.03 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.409 1.084 . . . . 0.0 112.169 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.7 mt -89.39 116.44 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.027 0.931 . . . . 0.0 109.261 169.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.97 175.72 33.98 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.54 1.543 . . . . 0.0 111.368 167.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.3 p -54.83 -40.31 69.47 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.89 0.852 . . . . 0.0 110.8 169.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -50.46 -47.2 56.99 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.924 2.89 . . . . 0.0 113.693 169.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -75.99 -32.68 59.57 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.283 -0.885 . . . . 0.0 111.82 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -63.88 -41.66 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.18 0.592 . . . . 0.0 110.214 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -40.88 93.13 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.696 -0.628 . . . . 0.0 112.071 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.8 mp -62.27 -41.74 98.74 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.325 -0.86 . . . . 0.0 112.181 171.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.66 -43.43 91.41 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 123.645 0.64 . . . . 0.0 112.408 172.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 mt -57.58 -58.0 10.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.751 1.22 . . . . 0.0 112.835 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -25.12 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -73.97 -26.7 60.62 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.277 0.944 . . . . 0.0 112.723 171.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.73 -48.95 51.88 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 168.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.2 -17.17 1.89 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 118.251 2.061 . . . . 0.0 118.251 167.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -111.2 -22.81 11.21 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.086 1.943 . . . . 0.0 113.859 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.44 153.24 13.76 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.135 0.874 . . . . 0.0 112.942 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.4 mm -51.17 -44.61 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.008 1.323 . . . . 0.0 111.83 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.48 -45.33 87.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.29 -37.57 87.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.297 -0.877 . . . . 0.0 111.862 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -73.17 -27.43 61.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.472 -0.775 . . . . 0.0 112.846 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.42 81.43 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.568 1.076 . . . . 0.0 111.8 169.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.72 -49.5 76.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.869 0.758 . . . . 0.0 111.124 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -58.66 -39.48 80.73 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.642 0.777 . . . . 0.0 112.923 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.85 -33.15 75.33 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.202 1.001 . . . . 0.0 113.272 176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.18 8.86 2.34 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.204 1.402 . . . . 0.0 113.575 171.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.53 7.23 76.05 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.231 1.396 . . . . 0.0 114.546 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.77 -171.92 3.9 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.207 1.004 . . . . 0.0 111.376 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -178.18 163.28 31.29 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.594 1.569 . . . . 0.0 110.985 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 p -59.04 -45.3 91.1 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -66.65 -34.25 77.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -66.53 -47.68 72.12 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.901 0.88 . . . . 0.0 110.977 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.9 mt -70.53 -43.56 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 110.732 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -56.74 -48.1 78.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.672 1.189 . . . . 0.0 111.406 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -62.61 -48.63 78.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.218 0.607 . . . . 0.0 111.857 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -65.91 -33.67 76.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.933 0.788 . . . . 0.0 113.084 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.9 t -64.89 -54.57 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 118.883 0.765 . . . . 0.0 110.871 170.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -58.52 -33.3 69.7 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.982 0.81 . . . . 0.0 112.926 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.7 m -66.84 -18.44 65.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.583 1.153 . . . . 0.0 113.385 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -105.45 -34.28 7.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.208 1.403 . . . . 0.0 113.28 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -105.0 -21.2 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -172.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.07 -165.51 30.35 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 119.194 0.906 . . . . 0.0 114.712 -175.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 94.9 mtm-85 -137.07 163.11 31.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.202 1.401 . . . . 0.0 113.282 -175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.4 55.36 21.27 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.766 1.174 . . . . 0.0 114.874 169.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -129.91 8.28 5.23 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.527 1.531 . . . . 0.0 114.364 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -65.26 156.94 30.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.437 1.495 . . . . 0.0 114.478 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 mmt -110.18 32.96 4.74 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.807 1.643 . . . . 0.0 112.097 173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.9 m 53.8 57.34 6.13 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.193 1.797 . . . . 0.0 114.019 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.27 150.82 44.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.967 1.307 . . . . 0.0 112.461 -172.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 m -60.77 153.44 24.33 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.728 1.611 . . . . 0.0 110.742 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -67.77 141.71 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -170.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -124.07 155.41 38.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.327 2.251 . . . . 0.0 108.568 167.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -91.09 132.39 36.07 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.075 -1.015 . . . . 0.0 109.384 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 p -62.57 161.94 23.8 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 123.682 0.793 . . . . 0.0 111.716 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.77 -38.86 85.41 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.575 2.183 . . . . 0.0 113.449 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -72.59 -36.5 68.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 118.489 -0.767 . . . . 0.0 112.795 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.04 80.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 120.091 1.314 . . . . 0.0 112.162 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -63.23 -39.52 94.86 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 121.149 -0.969 . . . . 0.0 111.742 173.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -62.19 -43.14 99.5 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 111.902 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 t -60.03 -45.13 95.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 117.832 -1.08 . . . . 0.0 111.649 172.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.4 mm -58.45 -45.23 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.36 1.436 . . . . 0.0 111.123 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.83 -38.15 82.84 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.643 -0.66 . . . . 0.0 112.776 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.3 -35.67 73.84 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.304 -0.873 . . . . 0.0 112.121 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.2 m -63.82 -42.9 97.55 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.595 1.158 . . . . 0.0 110.705 174.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.4 ttm -62.9 -43.96 97.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.838 0.855 . . . . 0.0 111.616 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.43 -33.15 73.7 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.69 -42.89 90.68 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.827 -1.171 . . . . 0.0 111.743 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.54 93.3 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.333 -0.854 . . . . 0.0 111.989 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.89 -40.12 95.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.891 2.077 . . . . 0.0 112.488 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -62.36 -42.39 99.36 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.651 1.58 . . . . 0.0 112.082 172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -77.69 -15.9 58.85 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.89 33.71 75.63 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.963 0.792 . . . . 0.0 113.085 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -77.26 3.55 12.67 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -169.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 43.8 m 63.81 -23.73 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 128.33 2.652 . . . . 0.0 116.435 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.26 159.3 38.77 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.278 2.231 . . . . 0.0 110.247 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.6 t -79.17 113.9 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.874 0.87 . . . . 0.0 110.011 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.82 172.1 41.94 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.71 0.672 . . . . 0.0 113.4 174.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.3 p -57.36 -40.05 77.29 Favored 'General case' 0 N--CA 1.481 1.115 0 O-C-N 121.816 -0.814 . . . . 0.0 110.943 171.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -45.4 -54.0 7.9 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.646 2.379 . . . . 0.0 111.739 169.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -74.23 -27.93 61.01 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 118.256 -0.878 . . . . 0.0 113.028 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.7 mt -60.84 -47.81 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.267 0.939 . . . . 0.0 110.752 169.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.46 -45.06 92.56 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.673 -0.642 . . . . 0.0 111.546 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.19 -36.43 70.81 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.708 0.686 . . . . 0.0 111.805 175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.67 -44.7 97.14 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-N 119.361 0.982 . . . . 0.0 114.036 170.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.0 mt -57.61 -45.65 85.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.82 1.31 . . . . 0.0 112.228 176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.67 -34.17 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -69.48 -26.48 64.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.844 0.858 . . . . 0.0 112.786 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -65.72 -48.99 70.1 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.621 0.646 . . . . 0.0 110.213 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.46 -2.33 30.65 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 118.728 2.251 . . . . 0.0 118.728 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -113.96 -36.21 4.85 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 120.349 2.074 . . . . 0.0 112.603 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.14 167.16 23.15 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.191 1.377 . . . . 0.0 114.555 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 80.1 t -57.18 -35.74 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.39 1.076 . . . . 0.0 112.084 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.7 -46.83 83.82 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.608 1.095 . . . . 0.0 112.95 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.79 -36.33 83.23 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.59 -0.694 . . . . 0.0 111.855 174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -60.45 -47.57 85.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.938 1.295 . . . . 0.0 112.136 175.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -61.72 -47.08 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.18 1.792 . . . . 0.0 111.482 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.89 -42.59 98.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.38 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -67.98 -34.98 77.58 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -64.41 -41.53 96.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.26 0.936 . . . . 0.0 112.082 173.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.4 mt -74.74 -30.88 61.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.316 1.046 . . . . 0.0 112.508 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.73 3.98 7.53 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.581 1.563 . . . . 0.0 115.488 170.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 70.2 t -83.06 144.36 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.695 1.598 . . . . 0.0 111.013 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -120.09 164.06 16.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.276 1.43 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.64 -38.66 60.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.901 1.28 . . . . 0.0 111.489 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -77.97 -46.99 19.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.876 0.87 . . . . 0.0 113.107 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -65.57 -39.62 91.88 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.908 0.776 . . . . 0.0 111.632 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.69 -43.4 80.22 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 118.2 -0.905 . . . . 0.0 112.43 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -53.99 -51.22 64.63 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.68 1.127 . . . . 0.0 111.617 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -60.17 -42.64 95.41 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.319 0.963 . . . . 0.0 112.942 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.72 -40.97 72.49 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.636 1.107 . . . . 0.0 112.686 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 97.3 t -69.1 -43.34 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.044 0.838 . . . . 0.0 110.982 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.34 -23.81 64.74 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.389 1.076 . . . . 0.0 113.361 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -80.43 -53.02 6.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.488 0.585 . . . . 0.0 111.535 168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.9 tp -70.11 -19.56 63.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.71 -6.38 7.78 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.96 -11.17 0.92 Allowed Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.981 1.277 . . . . 0.0 114.886 176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.4 m -85.45 -13.81 48.08 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.189 1.396 . . . . 0.0 114.189 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.215 0 C-N-CA 126.283 1.833 . . . . 0.0 110.987 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -74.97 155.85 36.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.937 0.895 . . . . 0.0 112.912 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.74 -36.16 82.94 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -169.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.37 23.54 77.38 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 116.761 1.464 . . . . 0.0 116.761 169.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -126.53 149.33 49.45 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 119.061 1.431 . . . . 0.0 112.828 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -120.31 154.74 34.57 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.38 1.872 . . . . 0.0 110.417 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -68.08 165.84 17.23 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.363 -0.836 . . . . 0.0 111.903 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -61.99 -38.96 90.57 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.642 -1.286 . . . . 0.0 111.505 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -65.53 -35.03 79.65 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.1 -40.13 47.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.675 0.79 . . . . 0.0 112.858 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -57.37 -36.75 71.61 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.446 0.698 . . . . 0.0 111.831 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -60.62 -46.05 91.75 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.44 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -37.71 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 120.161 1.346 . . . . 0.0 111.659 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.74 -32.68 65.85 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.94 76.82 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.327 -0.858 . . . . 0.0 112.025 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.4 mt -70.92 -32.66 69.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.048 0.939 . . . . 0.0 112.131 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.64 69.23 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.868 0.867 . . . . 0.0 112.528 173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -67.01 -42.66 84.59 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.489 0.586 . . . . 0.0 111.96 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -66.37 -42.85 87.38 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.828 0.74 . . . . 0.0 111.504 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -69.76 -36.4 75.75 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.479 -0.763 . . . . 0.0 112.547 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.02 -50.57 72.98 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.019 0.827 . . . . 0.0 110.975 170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -64.81 -35.35 80.83 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -62.93 -41.8 99.6 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.016 0.926 . . . . 0.0 112.067 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.9 mt -79.42 -2.47 41.98 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.895 1.278 . . . . 0.0 113.664 173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.86 17.04 79.21 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.352 0.977 . . . . 0.0 114.865 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -88.63 123.88 33.53 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.482 1.641 . . . . 0.0 109.521 172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -81.5 11.15 4.81 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -146.94 155.75 42.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.755 1.622 . . . . 0.0 111.189 -176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.8 mt -96.49 122.32 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.168 1.387 . . . . 0.0 110.003 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.41 176.45 25.4 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.347 1.927 . . . . 0.0 111.797 168.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.4 p -55.9 -39.86 72.19 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.229 1.011 . . . . 0.0 111.215 173.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -51.08 -47.01 61.94 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 129.334 3.053 . . . . 0.0 113.655 169.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -75.71 -31.54 59.71 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.23 0.612 . . . . 0.0 111.558 -177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.53 -44.22 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 118.467 0.576 . . . . 0.0 110.381 170.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.75 -45.42 89.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.274 0.943 . . . . 0.0 111.556 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -65.44 -36.14 83.01 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 0.0 112.081 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.39 -36.92 94.04 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.503 1.049 . . . . 0.0 112.768 169.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -60.16 -53.15 61.18 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.845 1.258 . . . . 0.0 112.514 172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -21.44 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -70.51 -33.7 71.49 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.982 0.81 . . . . 0.0 111.768 168.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -71.24 -46.19 61.59 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.803 0.729 . . . . 0.0 111.3 171.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.83 -27.07 0.63 Allowed Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.383 1.468 . . . . 0.0 116.728 169.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.85 -18.05 16.58 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.323 1.449 . . . . 0.0 113.565 -171.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.78 159.31 39.32 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.133 0.873 . . . . 0.0 113.015 174.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.3 mm -58.37 -42.65 84.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.944 0.898 . . . . 0.0 111.65 -175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -66.54 -40.41 89.09 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.68 -39.93 88.34 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.289 0.95 . . . . 0.0 111.099 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -62.15 -37.91 87.01 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.704 0.802 . . . . 0.0 111.74 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.21 -41.26 86.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.45 1.1 . . . . 0.0 112.714 173.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.57 -48.56 81.23 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.106 0.867 . . . . 0.0 111.281 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.44 -38.38 86.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.654 0.781 . . . . 0.0 112.582 173.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.09 77.49 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.352 0.978 . . . . 0.0 112.931 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.2 mt -76.37 8.1 3.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.449 1.5 . . . . 0.0 113.32 169.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.56 4.06 87.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.564 1.554 . . . . 0.0 115.024 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.4 mt -92.14 88.09 6.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.878 1.339 . . . . 0.0 111.164 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.04 151.25 48.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 122.13 -0.356 . . . . 0.0 112.242 169.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 m -55.1 -37.35 66.73 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -171.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -63.35 -36.82 84.98 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.231 1.012 . . . . 0.0 112.903 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -68.6 -44.07 75.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.654 0.781 . . . . 0.0 111.326 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.7 mt -64.96 -47.45 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.035 0.934 . . . . 0.0 110.411 172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -57.14 -45.7 83.32 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.773 0.829 . . . . 0.0 112.868 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.9 mmtt -75.03 -28.86 60.62 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.29 -36.81 71.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.354 0.979 . . . . 0.0 112.288 169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.8 t -60.03 -56.24 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 119.398 0.999 . . . . 0.0 110.055 170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -59.06 -37.87 78.07 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.698 0.799 . . . . 0.0 112.738 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.0 m -67.68 -20.66 65.32 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -97.72 -30.06 13.03 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.456 1.102 . . . . 0.0 113.391 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.9 pt -111.74 -24.9 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.82 -161.95 9.63 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 124.79 1.186 . . . . 0.0 115.931 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -65.51 125.17 24.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.267 1.427 . . . . 0.0 109.69 170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.01 -168.3 41.13 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 -168.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.4 76.64 2.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.706 2.402 . . . . 0.0 108.86 176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -83.58 70.45 10.28 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.683 1.23 . . . . 0.0 113.847 -167.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -101.67 -4.45 26.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.79 1.636 . . . . 0.0 112.921 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 47.48 81.71 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.612 2.365 . . . . 0.0 115.194 169.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -142.09 179.36 6.94 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.931 1.692 . . . . 0.0 111.052 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 84.2 m -54.44 133.57 45.68 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.967 0.907 . . . . 0.0 110.323 168.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.63 150.01 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.882 0.873 . . . . 0.0 112.099 -176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -133.72 158.87 42.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.909 1.283 . . . . 0.0 110.837 169.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -92.81 132.72 36.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.642 0.777 . . . . 0.0 110.862 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.9 p -64.86 160.76 52.24 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.346 0.658 . . . . 0.0 111.664 171.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -56.31 -33.92 92.57 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.623 2.215 . . . . 0.0 113.664 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -78.56 -32.16 47.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.7 -39.84 84.36 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.124 1.329 . . . . 0.0 111.418 169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -60.0 -43.63 95.06 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.122 0.969 . . . . 0.0 111.699 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -61.26 -43.08 99.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.256 1.023 . . . . 0.0 111.953 173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.97 -46.92 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 119.831 1.196 . . . . 0.0 111.554 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.4 mm -59.72 -44.97 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.348 0.977 . . . . 0.0 111.316 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.41 -39.12 81.74 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.369 -0.832 . . . . 0.0 112.897 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.28 -38.36 87.59 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.909 0.777 . . . . 0.0 111.701 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -62.03 -38.7 89.66 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.917 0.887 . . . . 0.0 111.173 175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 ttm -76.16 -31.61 58.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.16 -40.6 82.31 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.857 -1.152 . . . . 0.0 112.254 170.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.2 -47.42 86.01 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.152 0.981 . . . . 0.0 111.567 170.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.26 71.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.695 0.68 . . . . 0.0 111.616 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -61.25 -44.26 97.54 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 112.963 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -64.45 -31.56 72.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.19 0.996 . . . . 0.0 113.34 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.3 mp -87.77 1.19 54.5 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.341 1.456 . . . . 0.0 113.089 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.5 14.54 73.42 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.798 1.19 . . . . 0.0 115.566 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -96.57 131.35 43.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.033 1.333 . . . . 0.0 110.63 174.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -71.79 -47.5 52.96 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.69 -0.631 . . . . 0.0 111.19 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -93.48 157.28 16.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.545 1.538 . . . . 0.0 112.69 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.6 t -91.47 119.71 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.151 1.38 . . . . 0.0 111.063 -178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.2 172.54 39.97 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.206 0.908 . . . . 0.0 114.201 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.2 p -56.93 -41.64 78.57 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.554 -0.968 . . . . 0.0 111.422 170.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -47.35 -55.32 9.06 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.134 2.174 . . . . 0.0 111.075 169.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -68.57 -31.74 71.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.207 1.003 . . . . 0.0 113.183 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.96 -49.25 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.02 0.827 . . . . 0.0 110.502 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 38.6 tp -63.86 -42.48 97.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.364 -0.827 . . . . 0.0 111.492 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 48.3 mt -58.08 -35.37 71.29 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.192 0.906 . . . . 0.0 112.398 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.83 -45.34 92.88 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.864 0.745 . . . . 0.0 113.053 169.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.0 mt -62.61 -35.4 79.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.734 1.214 . . . . 0.0 114.259 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -78.01 -40.99 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 119.217 0.917 . . . . 0.0 112.172 173.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -68.74 -23.46 64.34 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.918 0.887 . . . . 0.0 113.18 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.42 -45.63 69.47 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.102 1.761 . . . . 0.0 113.446 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.71 -30.96 0.38 Allowed Glycine 0 CA--C 1.541 1.668 0 C-N-CA 126.239 1.876 . . . . 0.0 116.902 175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -97.4 -23.87 15.88 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.885 1.274 . . . . 0.0 113.287 -174.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.61 165.75 47.1 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.985 0.802 . . . . 0.0 114.148 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 79.0 t -62.66 -36.3 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.544 0.738 . . . . 0.0 110.079 169.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.05 -45.44 83.19 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.68 84.7 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.572 -0.705 . . . . 0.0 112.345 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.03 -43.89 81.63 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.554 0.742 . . . . 0.0 112.676 174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.9 t -57.6 -48.78 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.346 1.058 . . . . 0.0 110.994 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.7 mt -62.27 -43.55 98.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.598 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.7 -32.21 69.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.36 -40.41 93.56 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.887 0.875 . . . . 0.0 111.61 173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -76.91 -34.89 57.67 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.092 0.957 . . . . 0.0 112.64 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 134.39 0.53 3.7 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.958 1.266 . . . . 0.0 116.231 169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.0 146.98 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.342 1.457 . . . . 0.0 111.24 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.9 m -132.73 160.3 37.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.475 1.51 . . . . 0.0 110.935 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.76 -50.89 24.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.828 1.651 . . . . 0.0 112.595 -174.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -75.77 -28.42 58.43 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -75.32 -43.08 52.73 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.131 -0.98 . . . . 0.0 111.264 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -63.94 -43.77 94.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.67 0.788 . . . . 0.0 111.503 170.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 73.2 mtt-85 -53.15 -53.8 45.18 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.251 0.932 . . . . 0.0 112.153 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.66 -41.89 98.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -69.77 -42.78 73.4 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.406 1.003 . . . . 0.0 112.305 178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.4 t -66.73 -43.75 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 118.888 0.767 . . . . 0.0 111.283 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.15 -30.57 70.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.11 0.964 . . . . 0.0 113.051 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -74.02 -48.99 26.34 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -74.01 -20.4 60.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -169.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -69.29 -7.83 40.56 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.95 -17.55 0.09 OUTLIER Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.512 1.365 . . . . 0.0 116.512 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 52.2 m -82.03 -21.74 36.82 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.941 1.371 . . . . 0.0 114.025 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 126.114 1.766 . . . . 0.0 111.6 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ptm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.7 ttp -152.85 137.98 17.35 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.723 1.209 . . . . 0.0 110.664 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -107.5 -25.23 11.48 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.009 1.324 . . . . 0.0 114.206 -174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.19 -13.75 3.32 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 117.671 1.828 . . . . 0.0 117.671 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.1 ttt-85 -93.6 146.66 23.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.374 1.587 . . . . 0.0 111.928 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -106.02 160.2 15.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.594 1.957 . . . . 0.0 110.296 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -69.39 165.61 20.43 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.642 -1.286 . . . . 0.0 111.458 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -64.6 -33.98 77.18 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 120.455 -1.403 . . . . 0.0 111.896 174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -72.51 -33.85 67.21 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.282 -0.886 . . . . 0.0 112.307 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.26 76.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.677 0.791 . . . . 0.0 111.82 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -59.32 -36.49 75.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.287 0.635 . . . . 0.0 111.663 170.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.38 -44.44 96.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 117.629 -1.177 . . . . 0.0 112.633 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -38.18 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 121.01 1.732 . . . . 0.0 111.862 176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.67 -32.82 64.18 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.38 -41.63 76.24 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.361 -0.837 . . . . 0.0 111.743 171.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 82.2 mt -67.81 -31.86 72.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.733 0.813 . . . . 0.0 112.08 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -33.81 72.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.304 0.957 . . . . 0.0 112.977 174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -68.36 -44.47 75.13 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.907 0.776 . . . . 0.0 111.374 174.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.23 -42.92 79.03 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.654 -0.654 . . . . 0.0 110.958 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -62.5 -33.68 75.36 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.569 1.077 . . . . 0.0 112.488 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 -52.9 60.65 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.817 0.735 . . . . 0.0 111.199 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.4 mt -66.63 -31.89 72.86 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -64.29 -32.92 74.71 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.44 1.496 . . . . 0.0 112.444 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.5 1.05 54.59 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.321 1.448 . . . . 0.0 113.331 173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.8 21.67 79.04 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 121.179 -0.951 . . . . 0.0 114.556 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.8 m-70 -92.43 137.28 32.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.127 1.463 . . . . 0.0 110.939 172.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.64 21.45 8.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.808 0.843 . . . . 0.0 112.748 169.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -138.99 153.56 48.17 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.302 1.041 . . . . 0.0 112.334 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.7 mt -106.15 111.52 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.715 1.206 . . . . 0.0 107.954 168.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.3 178.11 36.85 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.044 1.307 . . . . 0.0 111.329 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.1 p -54.9 -39.71 69.06 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.603 -0.939 . . . . 0.0 111.106 171.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.89 -49.03 51.05 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.744 2.818 . . . . 0.0 113.719 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -74.97 -31.58 61.5 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.286 0.634 . . . . 0.0 111.68 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.8 mt -65.01 -45.25 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.666 0.667 . . . . 0.0 110.326 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.33 -42.88 96.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.274 0.943 . . . . 0.0 111.468 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.9 tp -66.06 -37.49 85.95 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.1 0.96 . . . . 0.0 112.094 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.15 -38.54 96.69 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.185 0.897 . . . . 0.0 112.463 169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -51.23 70.21 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.739 1.216 . . . . 0.0 112.47 173.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -24.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -71.68 -30.35 65.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.689 1.131 . . . . 0.0 112.211 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -68.29 -48.93 63.65 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.526 0.603 . . . . 0.0 109.514 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.25 -10.02 2.85 Favored Glycine 0 CA--C 1.536 1.379 0 N-CA-C 118.454 2.142 . . . . 0.0 118.454 166.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -118.75 -25.12 6.45 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.658 1.729 . . . . 0.0 113.852 -171.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.28 157.95 17.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.618 1.104 . . . . 0.0 113.018 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.0 mm -53.13 -43.0 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.699 1.2 . . . . 0.0 112.256 -173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.73 -46.44 82.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -36.69 85.15 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.213 -0.93 . . . . 0.0 112.036 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -68.7 -36.29 78.28 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.376 0.67 . . . . 0.0 111.647 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.44 92.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.16 0.984 . . . . 0.0 112.422 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.41 -48.49 81.43 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 118.967 0.803 . . . . 0.0 111.021 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.02 -34.59 78.06 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.22 -33.13 75.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.478 1.111 . . . . 0.0 112.912 174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -75.13 8.11 2.85 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.104 1.361 . . . . 0.0 113.658 170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.15 68.65 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.057 1.313 . . . . 0.0 114.917 173.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.3 mt -83.69 -178.06 6.9 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 118.317 1.059 . . . . 0.0 111.684 175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.92 161.45 33.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.284 1.421 . . . . 0.0 111.607 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 p -58.29 -45.87 87.14 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.692 0.797 . . . . 0.0 112.772 -174.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -70.98 -28.82 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -69.26 -48.97 60.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.861 0.864 . . . . 0.0 110.984 175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 56.2 mt -66.13 -42.95 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.774 0.829 . . . . 0.0 110.337 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -61.02 -43.7 98.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.203 1.001 . . . . 0.0 112.747 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.34 -43.66 98.31 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.753 0.706 . . . . 0.0 112.033 176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -68.41 -37.08 79.98 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.35 -56.25 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 119.408 1.004 . . . . 0.0 110.268 171.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.99 -35.39 74.92 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -67.9 -18.37 64.77 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.9 mt -102.22 -28.43 12.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.639 1.175 . . . . 0.0 113.684 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.6 pt -111.16 -24.73 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.29 -165.69 9.3 Favored Glycine 0 CA--C 1.54 1.65 0 C-N-CA 124.484 1.04 . . . . 0.0 115.155 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -68.43 141.71 55.58 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 110.469 171.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.64 -154.13 8.69 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 117.183 1.633 . . . . 0.0 117.183 -169.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.79 20.33 3.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.155 2.182 . . . . 0.0 114.505 -167.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -41.5 109.86 0.14 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -168.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.0 mtm -99.55 -18.76 17.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.746 1.618 . . . . 0.0 112.658 169.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -157.71 159.23 36.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.986 1.714 . . . . 0.0 111.507 175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -71.21 -16.97 62.53 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.391 1.076 . . . . 0.0 113.143 171.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 t -78.33 138.52 38.61 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.188 -0.945 . . . . 0.0 111.847 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.99 149.17 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.81 1.244 . . . . 0.0 113.397 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.74 147.7 51.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.815 1.646 . . . . 0.0 110.646 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -85.08 138.26 32.53 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.118 -0.988 . . . . 0.0 110.747 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.1 p -68.98 163.04 60.34 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.747 -0.596 . . . . 0.0 111.248 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -56.29 -35.74 96.15 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.258 1.972 . . . . 0.0 113.401 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 23.2 mmt85 -75.85 -35.28 59.99 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.395 0.678 . . . . 0.0 112.565 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.65 -43.14 81.02 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.517 1.053 . . . . 0.0 111.582 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -60.09 -40.98 91.5 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.456 1.103 . . . . 0.0 111.569 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.31 -44.4 97.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.257 1.023 . . . . 0.0 112.033 170.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.68 -36.83 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.948 1.249 . . . . 0.0 112.664 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.3 mm -62.6 -33.78 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.383 0.992 . . . . 0.0 111.68 173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -77.58 -41.01 40.37 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.042 -1.036 . . . . 0.0 112.979 171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -66.54 -42.45 87.14 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.277 -0.889 . . . . 0.0 111.85 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 61.1 p -64.25 -36.06 82.87 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.215 0.606 . . . . 0.0 112.193 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.4 ' HA ' HG22 ' A' ' 103' ' ' VAL . 32.3 ttm -67.74 -36.97 81.51 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.651 -0.656 . . . . 0.0 112.211 172.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.71 -37.54 79.57 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 172.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.07 -45.05 94.01 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 120.908 -1.12 . . . . 0.0 111.844 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.67 -38.75 85.95 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.521 -0.737 . . . . 0.0 111.823 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -67.59 -37.25 82.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.128 1.371 . . . . 0.0 112.986 174.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.47 -34.73 78.4 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.486 1.114 . . . . 0.0 112.447 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.85 -5.4 50.77 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.389 1.075 . . . . 0.0 113.531 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.09 20.6 73.06 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.487 1.042 . . . . 0.0 114.017 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -80.8 149.06 29.74 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.961 1.304 . . . . 0.0 111.978 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 m -76.98 -13.54 59.95 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.62 162.11 37.27 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.171 1.788 . . . . 0.0 110.917 -176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 92' ' ' MET . 10.7 t -81.31 113.75 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.239 1.016 . . . . 0.0 110.658 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.07 170.96 53.35 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.58 0.61 . . . . 0.0 113.585 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.9 p -58.42 -40.04 81.42 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 121.726 -0.867 . . . . 0.0 110.715 170.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.23 -53.44 17.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.167 2.187 . . . . 0.0 111.385 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -70.78 -31.44 68.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.925 0.89 . . . . 0.0 112.813 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.3 mt -56.81 -49.25 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.417 1.008 . . . . 0.0 109.99 168.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.0 tp -63.08 -44.66 95.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.669 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 mt -56.88 -33.75 67.18 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.326 0.966 . . . . 0.0 112.766 173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.59 -43.89 84.3 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 123.966 0.793 . . . . 0.0 113.325 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.15 -44.06 97.92 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.682 1.193 . . . . 0.0 112.813 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -69.92 -37.57 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 118.794 0.725 . . . . 0.0 112.319 174.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.98 -24.9 65.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.17 -39.35 94.4 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.758 0.823 . . . . 0.0 111.523 168.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.55 -35.32 0.57 Allowed Glycine 0 CA--C 1.539 1.574 0 N-CA-C 117.652 1.821 . . . . 0.0 117.652 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -101.41 -35.25 9.27 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 119.229 1.514 . . . . 0.0 113.111 -174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.17 163.82 8.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.063 1.316 . . . . 0.0 114.546 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.89 -38.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.724 0.81 . . . . 0.0 112.119 -169.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.0 -45.43 90.69 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.621 1.1 . . . . 0.0 113.092 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.88 -36.6 84.88 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.572 -0.705 . . . . 0.0 111.773 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.6 tpp85 -62.83 -45.74 91.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.381 1.072 . . . . 0.0 112.249 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.02 -49.27 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.838 1.655 . . . . 0.0 111.058 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.94 -41.5 99.51 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.054 -0.403 . . . . 0.0 111.95 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.67 -33.51 74.11 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -66.56 -40.4 89.0 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 119.063 0.847 . . . . 0.0 112.084 173.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.83 -33.22 64.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.275 1.03 . . . . 0.0 112.843 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.76 23.04 1.53 Allowed Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.704 1.145 . . . . 0.0 115.661 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 t -113.12 136.5 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.886 1.674 . . . . 0.0 111.278 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.3 p -106.46 172.88 6.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.882 1.673 . . . . 0.0 111.565 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 mp -54.51 -46.78 73.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.748 0.419 . . . . 0.0 110.876 172.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -72.74 -36.25 67.7 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.562 0.745 . . . . 0.0 112.884 -177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -69.89 -41.12 75.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.169 0.988 . . . . 0.0 111.902 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.12 -44.64 68.53 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.423 -0.799 . . . . 0.0 111.884 170.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -53.61 -52.05 61.06 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.572 1.078 . . . . 0.0 111.894 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -61.13 -39.58 90.56 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.413 1.006 . . . . 0.0 112.735 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -73.33 -39.79 64.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.281 0.946 . . . . 0.0 113.352 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 72.8 t -67.42 -45.11 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.127 0.876 . . . . 0.0 111.181 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.1 mt -70.28 -24.03 62.97 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 112.805 179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -77.21 -53.57 7.58 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.429 0.692 . . . . 0.0 110.951 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.4 tp -71.44 -20.03 62.16 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -169.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.69 -7.08 13.56 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.23 -7.91 0.47 Allowed Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.568 1.08 . . . . 0.0 115.477 176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.0 m -93.79 -6.29 46.31 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.246 1.818 . . . . 0.0 112.745 178.298 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 19.6 ptt? -69.1 154.67 41.68 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.138 0.881 . . . . 0.0 112.893 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -76.26 -36.12 58.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.04 6.02 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 169.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -85.23 142.79 29.17 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.297 1.549 . . . . 0.0 112.153 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -117.31 150.4 38.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.384 1.874 . . . . 0.0 109.834 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -65.38 162.93 16.64 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 120.994 -1.066 . . . . 0.0 112.092 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.66 67.79 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.815 -1.178 . . . . 0.0 112.711 171.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -42.13 66.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.173 1.389 . . . . 0.0 111.567 171.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.29 -41.75 63.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.166 1.386 . . . . 0.0 112.327 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -58.43 -33.68 69.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.511 0.725 . . . . 0.0 111.825 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.91 -38.66 83.23 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.742 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.33 -37.17 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.26 1.391 . . . . 0.0 111.568 173.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.65 -32.51 64.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.32 -41.94 84.44 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.268 -0.895 . . . . 0.0 111.603 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.28 -30.8 69.89 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.388 -0.82 . . . . 0.0 112.42 174.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.56 76.29 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.609 1.095 . . . . 0.0 112.157 172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -68.19 -46.99 69.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.522 0.729 . . . . 0.0 111.41 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -62.05 -36.38 81.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.549 0.613 . . . . 0.0 112.142 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -75.49 -37.42 60.2 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.394 1.078 . . . . 0.0 113.007 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.91 -48.34 81.77 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.774 0.715 . . . . 0.0 110.365 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.49 -37.18 86.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.747 0.819 . . . . 0.0 112.95 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -58.02 -43.05 86.5 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 119.63 1.104 . . . . 0.0 111.502 173.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.74 0.39 52.95 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.815 1.246 . . . . 0.0 113.662 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.94 19.42 77.0 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 121.09 -1.006 . . . . 0.0 114.79 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -89.88 131.75 35.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.95 1.3 . . . . 0.0 109.1 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.2 5.8 49.5 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -139.55 147.99 41.96 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.285 1.034 . . . . 0.0 111.083 171.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 mt -83.32 130.4 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.491 1.516 . . . . 0.0 111.266 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.82 176.46 22.14 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 126.403 1.954 . . . . 0.0 111.584 167.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.7 p -54.74 -38.98 67.79 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.686 -0.891 . . . . 0.0 111.514 173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.93 -49.55 49.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.905 2.882 . . . . 0.0 113.747 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -72.69 -31.57 65.13 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.48 0.582 . . . . 0.0 111.51 -178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.2 mt -66.63 -45.61 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 118.655 0.661 . . . . 0.0 110.417 172.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.6 tp -64.24 -43.8 93.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.203 0.91 . . . . 0.0 111.699 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.47 -37.92 86.17 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.542 1.137 . . . . 0.0 111.909 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.21 -36.76 92.89 Favored Glycine 0 CA--C 1.535 1.311 0 O-C-N 121.382 -0.824 . . . . 0.0 112.304 169.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -59.51 -54.03 51.31 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.076 1.35 . . . . 0.0 112.808 173.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -26.32 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -71.37 -24.84 62.16 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.801 0.728 . . . . 0.0 112.646 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -75.29 -50.62 15.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.746 0.818 . . . . 0.0 109.478 168.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.58 -8.97 6.53 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 118.132 2.013 . . . . 0.0 118.132 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -116.21 -29.59 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.989 1.895 . . . . 0.0 113.914 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.66 160.37 29.24 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.661 1.124 . . . . 0.0 113.857 175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.1 mm -52.98 -41.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.83 1.252 . . . . 0.0 112.455 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 38' ' ' LEU . . . -67.99 -44.35 76.83 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.171 0.896 . . . . 0.0 113.263 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.7 81.39 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.073 -1.017 . . . . 0.0 111.797 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -66.71 -35.94 81.32 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.959 0.904 . . . . 0.0 111.671 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.38 -42.16 92.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.406 1.083 . . . . 0.0 112.361 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -59.52 -50.38 74.13 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.832 0.742 . . . . 0.0 110.932 173.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.75 -35.45 80.62 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.12 73.6 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.491 1.116 . . . . 0.0 113.243 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.87 7.2 2.7 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.904 1.281 . . . . 0.0 113.853 170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.89 8.74 69.02 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.008 1.289 . . . . 0.0 114.335 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.2 mt -83.13 179.68 7.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 122.246 1.022 . . . . 0.0 111.685 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 152.03 22.14 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 126.061 1.791 . . . . 0.0 109.516 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -53.15 -35.58 59.91 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -66.2 -30.58 71.07 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -71.63 -44.24 64.72 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.972 0.909 . . . . 0.0 110.916 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -64.25 -49.88 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.755 0.822 . . . . 0.0 109.635 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -59.49 -36.23 75.64 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.45 0.7 . . . . 0.0 112.193 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.73 -48.57 71.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.184 0.594 . . . . 0.0 111.41 176.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -68.75 -36.86 78.91 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -61.19 -58.13 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.128 0.876 . . . . 0.0 110.257 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -67.57 -26.02 66.08 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.0 m -69.85 -22.62 63.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -96.78 -34.0 11.48 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.495 1.118 . . . . 0.0 113.247 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.3 pt -106.6 -10.54 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.67 -133.52 44.28 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-N 118.823 0.738 . . . . 0.0 113.062 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.76 163.85 36.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.556 1.943 . . . . 0.0 110.914 173.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.15 26.57 36.42 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 169.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -76.28 59.67 1.42 Allowed 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.41 1.605 . . . . 0.0 111.43 169.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -79.58 132.54 36.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.896 1.279 . . . . 0.0 112.347 -169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.8 mtt -133.77 -5.04 2.84 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.165 1.786 . . . . 0.0 112.713 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.2 m 52.62 60.69 3.63 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.989 1.716 . . . . 0.0 112.394 -176.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.47 136.04 24.26 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.688 1.595 . . . . 0.0 109.615 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.1 m -63.75 139.42 58.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.6 mm -55.96 131.4 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -134.41 174.03 10.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.022 1.729 . . . . 0.0 109.51 169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -103.58 133.54 48.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.214 1.006 . . . . 0.0 111.653 -169.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.2 p -65.88 162.53 44.32 Favored Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 123.995 0.918 . . . . 0.0 111.732 171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -56.18 -34.47 93.34 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.665 2.243 . . . . 0.0 113.819 174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -70.91 -42.17 70.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.916 0.886 . . . . 0.0 112.231 175.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.49 87.12 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.958 0.799 . . . . 0.0 112.001 173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.21 -41.62 89.02 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.031 0.932 . . . . 0.0 111.292 171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -64.41 -39.26 93.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.163 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.0 -44.42 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 119.555 1.07 . . . . 0.0 111.51 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mm -60.94 -46.09 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 120.088 1.313 . . . . 0.0 111.155 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.5 -43.94 97.97 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.737 0.815 . . . . 0.0 112.308 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.27 -36.21 71.64 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.649 -0.657 . . . . 0.0 111.858 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 m -60.0 -41.44 92.11 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.633 1.106 . . . . 0.0 110.937 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 27.7 ttm -67.63 -37.04 81.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 112.153 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -71.91 -30.04 64.95 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -68.63 -46.23 69.78 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.185 -1.572 . . . . 0.0 110.59 169.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.3 85.67 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.738 -0.602 . . . . 0.0 112.121 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -61.38 -45.71 93.23 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.077 1.351 . . . . 0.0 112.35 174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -69.92 -24.28 63.35 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.73 -6.57 51.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 0.0 112.786 167.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.79 19.55 79.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.796 1.189 . . . . 0.0 113.879 -175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -92.26 150.28 20.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.118 1.367 . . . . 0.0 112.536 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 59.6 p -90.28 -4.29 57.25 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -155.03 161.15 41.43 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.584 1.554 . . . . 0.0 111.879 176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.69 116.01 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.599 1.56 . . . . 0.0 110.517 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.55 174.25 48.36 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.645 0.64 . . . . 0.0 113.635 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.4 p -58.95 -39.13 80.75 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.677 -0.896 . . . . 0.0 110.849 170.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.09 -55.06 11.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.623 1.969 . . . . 0.0 111.069 169.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -68.12 -28.79 67.63 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.23 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.3 mt -61.27 -48.32 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.441 1.019 . . . . 0.0 110.518 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.432 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 26.7 tp -64.24 -43.93 93.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.285 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.86 -38.17 69.74 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.185 0.902 . . . . 0.0 112.025 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.29 -41.99 97.99 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 119.392 0.996 . . . . 0.0 113.703 173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 78.6 mt -61.43 -46.48 89.92 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.594 1.158 . . . . 0.0 112.256 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.485 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -72.43 -32.92 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -66.87 -32.46 73.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 119.423 1.01 . . . . 0.0 112.56 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -67.43 -46.88 71.84 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.361 0.664 . . . . 0.0 110.787 176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.29 -21.74 1.75 Allowed Glycine 0 CA--C 1.538 1.485 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 167.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -105.54 -28.39 10.82 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 120.587 2.193 . . . . 0.0 113.261 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.4 160.92 31.41 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.63 1.11 . . . . 0.0 113.57 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.36 -36.44 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.7 1.2 . . . . 0.0 112.276 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.02 -43.75 78.07 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.374 0.988 . . . . 0.0 113.378 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.96 -34.72 78.37 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.646 -0.658 . . . . 0.0 112.059 175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -67.84 -43.82 78.64 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.937 0.895 . . . . 0.0 111.926 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.9 t -56.51 -50.6 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.808 1.643 . . . . 0.0 110.859 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.74 -43.82 97.46 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 122.788 0.435 . . . . 0.0 111.657 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -66.53 -34.65 78.39 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -67.77 -38.31 83.24 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.034 0.834 . . . . 0.0 112.276 174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.37 -30.57 64.82 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.327 1.051 . . . . 0.0 112.637 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.56 14.12 4.94 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.384 1.468 . . . . 0.0 115.078 174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.6 t -101.33 134.6 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.906 1.682 . . . . 0.0 110.81 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.5 p -106.41 170.85 7.68 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.201 1.4 . . . . 0.0 111.623 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -42.97 64.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.886 0.874 . . . . 0.0 110.997 170.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -71.73 -43.12 66.4 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.956 0.902 . . . . 0.0 112.421 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -67.48 -43.57 80.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.599 0.759 . . . . 0.0 111.909 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.485 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -70.05 -42.73 72.48 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.027 -0.987 . . . . 0.0 112.341 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -54.82 -52.84 61.46 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.067 1.303 . . . . 0.0 110.827 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -61.62 -42.14 98.46 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.2 -38.6 69.01 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.778 1.172 . . . . 0.0 113.287 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.3 t -68.55 -44.71 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.269 0.94 . . . . 0.0 111.268 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.68 -26.15 65.15 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.408 1.083 . . . . 0.0 112.703 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -75.47 -49.42 18.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.558 0.743 . . . . 0.0 111.799 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -76.93 -19.5 57.31 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -169.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -67.75 -7.85 30.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.98 -10.62 0.33 Allowed Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.501 0.96 . . . . 0.0 115.501 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.8 t -76.1 -29.69 57.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.582 1.191 . . . . 0.0 112.657 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.151 0 C-N-CA 126.314 1.845 . . . . 0.0 111.98 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.413 -0.803 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.274 27.2 ptm 51.7 172.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.167 2.587 . . . . 0.0 116.453 -172.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -81.94 162.19 22.8 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.911 1.284 . . . . 0.0 112.188 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.03 18.35 4.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.917 1.246 . . . . 0.0 113.772 170.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -88.83 149.57 23.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.783 1.633 . . . . 0.0 112.523 -174.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -121.04 153.0 37.95 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.596 1.959 . . . . 0.0 109.884 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.8 p -69.14 164.73 21.93 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.787 0.835 . . . . 0.0 112.185 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -60.15 -38.93 84.61 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.241 -1.537 . . . . 0.0 112.037 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 -66.1 -42.82 88.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.781 0.832 . . . . 0.0 111.612 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -42.21 76.48 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.923 0.889 . . . . 0.0 112.061 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -62.62 -32.55 73.59 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.714 -0.616 . . . . 0.0 111.218 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -68.2 -40.93 82.04 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.75 172.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -34.7 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 121.281 1.855 . . . . 0.0 111.775 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -73.82 -34.61 64.64 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.82 -34.78 78.57 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.144 -0.973 . . . . 0.0 112.17 170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -69.96 -39.93 75.74 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.379 -0.826 . . . . 0.0 111.266 170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.24 -34.91 72.78 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.581 1.082 . . . . 0.0 113.025 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -62.1 -43.51 98.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 110.513 171.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -68.79 -34.48 75.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 118.878 -0.582 . . . . 0.0 112.315 176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -61.87 -47.73 83.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.934 1.243 . . . . 0.0 111.292 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.99 -35.89 79.86 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.735 0.814 . . . . 0.0 112.563 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.41 -47.04 45.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.995 0.918 . . . . 0.0 113.467 172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.0 mtm105 -70.23 -37.8 75.07 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 119.794 1.179 . . . . 0.0 113.586 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -78.88 -10.08 59.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 0.0 112.319 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.56 35.84 55.05 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.411 1.005 . . . . 0.0 114.319 174.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -95.55 -18.65 20.43 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.544 1.172 . . . . 0.0 113.418 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.4 m120 54.04 10.03 0.26 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.558 1.943 . . . . 0.0 115.982 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -147.95 145.91 28.77 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.02 121.58 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.716 1.206 . . . . 0.0 110.759 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.52 172.42 23.98 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.334 1.445 . . . . 0.0 111.349 166.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 40.9 p -51.42 -38.99 56.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.684 0.794 . . . . 0.0 111.073 168.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -53.0 -46.87 68.53 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.11 2.564 . . . . 0.0 113.664 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -74.14 -31.24 62.66 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.484 0.714 . . . . 0.0 111.757 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.17 -43.84 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 118.767 0.712 . . . . 0.0 110.593 172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -63.67 -42.25 98.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.892 0.769 . . . . 0.0 111.419 174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 tp -67.78 -35.76 79.25 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.59 -0.694 . . . . 0.0 112.015 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.58 -37.43 94.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.68 1.133 . . . . 0.0 113.131 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.47 -54.12 50.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.281 1.032 . . . . 0.0 111.962 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -22.91 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -66.6 -33.25 75.25 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.419 1.009 . . . . 0.0 111.613 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -71.87 -51.48 22.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.838 0.855 . . . . 0.0 110.385 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.4 -9.25 10.52 Favored Glycine 0 CA--C 1.537 1.463 0 N-CA-C 117.741 1.856 . . . . 0.0 117.741 168.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -126.76 -15.24 5.5 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 120.219 2.01 . . . . 0.0 114.445 -175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.26 154.42 37.5 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.429 1.014 . . . . 0.0 111.847 169.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -50.93 -43.23 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.645 1.178 . . . . 0.0 112.679 -171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.11 78.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.38 -35.25 80.29 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.02 -1.05 . . . . 0.0 112.01 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 tptt -67.99 -35.93 79.15 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.356 1.062 . . . . 0.0 111.623 174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.06 -40.48 82.78 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.777 1.231 . . . . 0.0 112.541 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.2 mt -59.33 -47.64 84.63 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.8 0.727 . . . . 0.0 110.891 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -66.63 -33.82 76.5 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.88 -33.0 74.72 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.044 -1.035 . . . . 0.0 112.825 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.19 7.32 4.31 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.334 1.454 . . . . 0.0 113.797 171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.65 6.21 80.56 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.045 1.307 . . . . 0.0 114.853 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 mt -79.83 -176.7 5.56 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.561 1.181 . . . . 0.0 111.408 173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.61 163.86 37.54 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.094 1.33 . . . . 0.0 111.209 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 p -59.72 -44.26 93.8 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.05 -40.85 95.34 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.904 0.882 . . . . 0.0 112.303 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.89 -47.99 80.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.917 0.887 . . . . 0.0 111.34 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.9 mt -69.08 -45.06 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.842 0.857 . . . . 0.0 110.497 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -59.06 -42.65 90.82 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.914 0.885 . . . . 0.0 112.697 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.29 -48.38 81.82 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.664 0.786 . . . . 0.0 111.544 177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -75.16 -31.08 60.91 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.9 -59.06 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 119.378 0.99 . . . . 0.0 109.842 169.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -67.16 -29.47 69.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.8 t -63.82 -31.53 72.74 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.766 0.712 . . . . 0.0 112.673 172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.65 -36.69 18.63 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.2 pt -105.17 -21.66 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -172.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.55 -158.81 39.22 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.138 0.875 . . . . 0.0 114.435 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -134.13 163.09 30.36 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.77 1.628 . . . . 0.0 111.717 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.68 23.58 59.86 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 116.217 1.247 . . . . 0.0 116.217 169.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -76.31 53.19 0.81 Allowed 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.067 1.434 . . . . 0.0 110.286 168.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.78 131.87 43.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.197 1.399 . . . . 0.0 113.434 -167.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.7 mmt -118.38 -10.73 10.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.744 1.618 . . . . 0.0 113.149 176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m 53.39 47.67 23.64 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.901 1.28 . . . . 0.0 111.877 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -130.08 146.84 51.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.817 2.047 . . . . 0.0 110.946 -168.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.2 m -61.92 149.4 40.64 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.608 1.163 . . . . 0.0 109.5 168.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.9 mm -66.26 124.96 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.185 -0.947 . . . . 0.0 112.71 -171.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -121.66 163.72 18.52 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.755 2.022 . . . . 0.0 109.973 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.83 137.19 38.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.737 0.815 . . . . 0.0 110.799 -175.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.7 p -64.25 159.05 61.0 Favored Pre-proline 0 N--CA 1.48 1.037 0 CA-C-O 119.103 -0.475 . . . . 0.0 110.778 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -55.42 -32.79 83.44 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.45 2.1 . . . . 0.0 113.253 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -44.21 74.33 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.189 0.995 . . . . 0.0 111.606 176.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.81 82.53 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.24 0.616 . . . . 0.0 112.07 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.87 -44.43 94.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.987 0.915 . . . . 0.0 111.358 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -61.83 -43.33 99.07 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.378 1.071 . . . . 0.0 111.945 173.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.3 t -58.47 -44.3 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.413 1.006 . . . . 0.0 112.14 171.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.6 mm -61.98 -43.06 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.609 1.095 . . . . 0.0 111.359 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.57 -38.7 87.62 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.539 -0.725 . . . . 0.0 112.794 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.9 mt -69.24 -30.0 68.05 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.139 -0.976 . . . . 0.0 112.274 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.1 m -66.9 -40.35 87.69 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.094 0.861 . . . . 0.0 111.7 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.9 ptp -73.75 -31.14 63.2 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.68 -40.53 92.44 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 118.66 0.663 . . . . 0.0 112.66 171.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.46 -38.14 83.99 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.369 1.068 . . . . 0.0 111.971 172.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.64 -44.77 96.36 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.168 -0.957 . . . . 0.0 112.483 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.33 -26.01 63.56 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.97 -35.61 77.23 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.165 0.986 . . . . 0.0 112.303 170.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -85.57 -5.1 59.31 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.531 1.532 . . . . 0.0 113.441 174.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.64 81.14 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.511 1.053 . . . . 0.0 114.827 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -79.93 145.47 32.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 118.625 1.213 . . . . 0.0 110.573 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 m -88.54 4.68 45.91 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 113.769 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.04 158.47 30.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.662 1.985 . . . . 0.0 110.718 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 27.4 t -85.08 116.39 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.696 1.198 . . . . 0.0 111.409 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.27 169.86 51.87 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.3 0.953 . . . . 0.0 113.056 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.0 p -58.17 -39.26 78.41 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.308 -1.113 . . . . 0.0 110.753 170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -48.57 -51.53 27.28 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.941 2.096 . . . . 0.0 111.795 169.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -71.95 -28.11 63.23 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.964 0.905 . . . . 0.0 113.079 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.53 -48.72 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.158 0.89 . . . . 0.0 110.037 168.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.4 tp -63.9 -43.1 96.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 118.388 -0.815 . . . . 0.0 111.441 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.5 mt -57.08 -35.47 69.42 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.019 0.827 . . . . 0.0 111.984 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.54 -46.39 92.48 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.316 0.962 . . . . 0.0 113.613 170.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.24 -47.21 84.27 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.853 1.261 . . . . 0.0 112.379 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.98 -34.1 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 -66.67 -29.89 70.01 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.636 1.107 . . . . 0.0 113.065 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -70.02 -50.09 44.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.478 0.711 . . . . 0.0 110.993 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.66 -6.93 36.04 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 118.694 2.238 . . . . 0.0 118.694 167.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -115.06 -30.18 6.44 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.605 2.203 . . . . 0.0 113.42 -177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.75 160.09 34.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.758 1.17 . . . . 0.0 113.293 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.52 -35.76 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.434 1.094 . . . . 0.0 112.5 -175.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.43 -45.24 76.78 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.359 0.981 . . . . 0.0 113.384 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.81 -35.93 82.7 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.46 -0.775 . . . . 0.0 112.126 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -65.83 -46.88 76.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.515 1.126 . . . . 0.0 111.455 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.11 -48.07 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.372 1.469 . . . . 0.0 111.104 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.22 -45.09 94.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 119.145 -0.455 . . . . 0.0 111.583 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -70.95 -31.87 68.58 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.57 -44.56 90.31 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.883 1.673 . . . . 0.0 111.447 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.0 mt -70.98 -34.8 71.75 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.97 0.908 . . . . 0.0 112.901 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.46 5.44 4.12 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.223 1.392 . . . . 0.0 115.891 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.9 t -90.19 136.51 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.673 1.589 . . . . 0.0 110.914 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 78.3 p -106.99 170.16 8.12 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.861 1.264 . . . . 0.0 111.529 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.85 -45.19 50.14 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.499 1.12 . . . . 0.0 111.051 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.31 -42.92 64.91 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.725 0.81 . . . . 0.0 113.005 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -65.0 -44.3 89.73 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.871 0.759 . . . . 0.0 111.751 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.37 -43.2 91.52 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.709 173.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -56.03 -52.85 62.77 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.69 1.132 . . . . 0.0 111.776 173.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -60.29 -42.51 95.61 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.827 1.194 . . . . 0.0 112.963 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -72.41 -38.36 68.43 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 119.513 1.051 . . . . 0.0 112.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.8 t -68.35 -45.21 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.447 1.021 . . . . 0.0 111.271 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.02 -25.67 65.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.714 1.206 . . . . 0.0 112.931 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -80.07 -55.63 4.81 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.638 0.654 . . . . 0.0 111.25 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.29 -16.24 63.88 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -168.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.96 -10.63 41.04 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.44 -6.93 0.42 Allowed Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.009 1.164 . . . . 0.0 116.009 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.5 m -96.39 -4.32 42.07 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.879 1.672 . . . . 0.0 114.182 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.298 0 C-N-CA 126.59 1.956 . . . . 0.0 112.083 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 10.0 ptt? 51.67 -178.64 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.813 2.445 . . . . 0.0 115.871 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -82.02 -34.5 29.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.803 1.241 . . . . 0.0 113.512 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.87 39.15 93.56 Favored Glycine 0 CA--C 1.539 1.551 0 N-CA-C 115.855 1.102 . . . . 0.0 115.855 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -138.17 143.5 40.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.335 1.454 . . . . 0.0 111.809 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -105.38 145.8 30.29 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.255 1.422 . . . . 0.0 109.052 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -65.3 161.08 20.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 120.699 -1.251 . . . . 0.0 111.954 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -60.17 -31.64 70.3 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.827 -1.171 . . . . 0.0 112.339 176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.05 -40.92 74.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.986 0.914 . . . . 0.0 112.082 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.48 -43.54 76.71 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.212 1.005 . . . . 0.0 112.031 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -55.02 -39.54 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.585 1.154 . . . . 0.0 111.126 170.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -65.02 -41.54 95.19 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.42 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -36.09 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.861 1.664 . . . . 0.0 111.539 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.63 -32.95 64.3 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.98 80.79 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.249 -0.907 . . . . 0.0 111.978 169.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 66.2 mt -67.33 -33.38 75.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.349 1.06 . . . . 0.0 111.88 174.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -35.1 76.48 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.289 0.949 . . . . 0.0 112.547 173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -68.55 -43.54 76.45 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 118.872 0.76 . . . . 0.0 111.565 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.76 -39.58 93.86 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.642 -0.661 . . . . 0.0 111.785 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.57 -36.78 71.01 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.123 0.969 . . . . 0.0 112.9 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.5 -50.73 72.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.007 0.822 . . . . 0.0 110.751 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.43 -33.47 74.28 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.0 ttt-85 -59.78 -44.6 93.83 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.865 1.266 . . . . 0.0 111.905 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.2 mt -83.73 2.26 38.71 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.921 1.288 . . . . 0.0 114.025 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.92 24.43 74.06 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 121.298 -0.876 . . . . 0.0 114.559 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -93.34 140.51 29.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.777 1.231 . . . . 0.0 110.689 169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -94.62 9.98 36.63 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.206 1.002 . . . . 0.0 113.288 170.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -141.83 156.47 45.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.148 1.379 . . . . 0.0 112.194 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.9 mt -98.21 118.29 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.762 1.625 . . . . 0.0 108.965 171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.35 178.06 30.09 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.779 1.656 . . . . 0.0 111.3 167.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.1 p -56.07 -40.78 74.12 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 121.561 -0.964 . . . . 0.0 111.388 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.86 -47.35 42.92 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 129.415 3.086 . . . . 0.0 113.771 169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -74.65 -32.26 62.21 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.716 -0.615 . . . . 0.0 111.783 -179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -66.92 -42.27 88.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.198 0.599 . . . . 0.0 110.259 172.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.49 -43.48 90.05 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.243 0.929 . . . . 0.0 111.772 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.1 tp -67.64 -35.34 78.71 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.694 0.797 . . . . 0.0 112.052 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.62 94.6 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.801 1.191 . . . . 0.0 113.001 170.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.17 -53.5 57.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.89 1.276 . . . . 0.0 112.954 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -22.99 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -73.21 -20.64 60.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.967 0.907 . . . . 0.0 113.182 170.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.67 -52.65 12.61 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.744 0.818 . . . . 0.0 108.847 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.5 -22.53 2.13 Favored Glycine 0 CA--C 1.537 1.435 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 168.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -108.14 -26.69 10.49 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.615 1.708 . . . . 0.0 113.548 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 156.81 11.98 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.798 1.189 . . . . 0.0 113.54 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.5 mm -52.97 -44.38 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.682 1.193 . . . . 0.0 112.191 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.67 90.33 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.0 -36.5 83.46 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.364 -0.835 . . . . 0.0 111.811 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -70.45 -35.36 73.3 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.776 0.83 . . . . 0.0 112.037 174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.27 94.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.413 1.085 . . . . 0.0 111.869 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -61.05 -46.23 91.56 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.201 0.91 . . . . 0.0 111.188 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -61.45 -37.94 85.4 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.49 -33.25 75.49 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.999 -1.063 . . . . 0.0 113.07 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 69.8 mt -75.43 7.45 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.749 1.619 . . . . 0.0 113.672 173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.51 10.51 76.78 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.898 1.237 . . . . 0.0 114.584 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.25 -166.86 1.63 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.211 1.004 . . . . 0.0 110.885 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.01 172.8 38.26 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 125.705 1.622 . . . . 0.0 110.315 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.1 p -59.57 -45.62 91.3 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 117.419 0.609 . . . . 0.0 112.475 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.62 -42.68 95.34 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.975 0.807 . . . . 0.0 112.366 176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -58.27 -45.91 86.99 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.617 1.167 . . . . 0.0 111.312 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.8 mt -79.0 -46.04 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.404 1.081 . . . . 0.0 111.043 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -58.24 -38.52 77.04 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.993 0.917 . . . . 0.0 112.429 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -58.88 -44.02 91.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.506 0.722 . . . . 0.0 112.253 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -80.5 -24.53 39.33 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.7 t -71.28 -55.21 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 121.604 -0.685 . . . . 0.0 110.065 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -69.68 -24.87 63.66 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.5 p -68.83 -16.12 63.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.357 0.98 . . . . 0.0 113.414 171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.9 -43.47 5.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.318 1.447 . . . . 0.0 112.478 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.4 pt -111.12 8.71 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.39 138.47 47.97 Favored Glycine 0 CA--C 1.544 1.85 0 O-C-N 120.688 -1.257 . . . . 0.0 114.71 -175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.61 74.56 0.19 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.574 2.35 . . . . 0.0 112.627 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -73.07 -176.02 30.34 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.231 1.396 . . . . 0.0 116.377 -173.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.9 131.1 37.34 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.409 1.884 . . . . 0.0 112.426 174.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -129.96 117.22 19.76 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.379 1.071 . . . . 0.0 112.663 -168.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -132.77 -22.65 2.09 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.802 1.241 . . . . 0.0 113.982 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.1 t -157.81 159.03 36.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.459 1.503 . . . . 0.0 111.852 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.25 -18.09 40.36 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.352 1.061 . . . . 0.0 112.09 169.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 61.5 m -80.65 125.19 29.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.133 0.973 . . . . 0.0 109.999 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.25 153.26 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.019 0.928 . . . . 0.0 113.292 -175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.39 156.76 47.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.452 1.901 . . . . 0.0 110.207 170.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -95.66 133.4 39.77 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.104 -0.997 . . . . 0.0 110.898 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.2 p -64.56 161.3 45.0 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 121.695 -0.628 . . . . 0.0 111.512 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.42 -33.86 87.19 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.492 2.128 . . . . 0.0 113.505 174.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 68.9 mtt85 -77.93 -34.09 51.43 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.34 -39.86 85.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.816 1.189 . . . . 0.0 111.829 170.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -58.68 -45.02 90.37 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.697 1.199 . . . . 0.0 111.51 170.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -62.91 -41.9 99.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.013 0.925 . . . . 0.0 112.13 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.75 -47.5 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.204 1.001 . . . . 0.0 112.113 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -60.62 -43.55 94.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.619 1.099 . . . . 0.0 111.001 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -67.94 -37.97 82.28 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.38 -31.63 71.13 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.33 -0.856 . . . . 0.0 112.152 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 40.7 m -65.44 -45.91 81.98 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.927 0.891 . . . . 0.0 111.023 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 17.8 ptp -69.06 -32.1 71.32 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.99 -42.3 89.96 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.729 1.149 . . . . 0.0 113.034 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -61.81 -40.17 94.31 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.137 -0.977 . . . . 0.0 111.258 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.59 -36.26 83.22 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.365 -0.835 . . . . 0.0 112.664 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.3 mtm-85 -68.22 -40.64 82.04 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.713 1.205 . . . . 0.0 112.394 172.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -62.69 -36.1 81.83 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.791 0.836 . . . . 0.0 112.481 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.42 -14.68 42.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.94 35.31 84.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.219 0.914 . . . . 0.0 113.51 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -75.05 -5.85 46.3 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -169.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.0 m 62.31 -0.84 0.46 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.382 2.273 . . . . 0.0 116.463 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -163.74 156.12 17.62 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.33 2.252 . . . . 0.0 109.495 169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 t -79.65 106.26 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -81.14 173.42 54.47 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 122.931 0.301 . . . . 0.0 112.787 173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 55.8 p -55.97 -39.34 71.65 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 122.049 -0.677 . . . . 0.0 110.399 169.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -45.22 -55.59 5.67 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.791 2.437 . . . . 0.0 112.026 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.82 -25.86 59.31 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -61.83 -47.27 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 119.248 0.931 . . . . 0.0 109.958 168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.46 -43.99 97.48 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.395 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.9 mt -57.64 -39.3 76.67 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.184 0.902 . . . . 0.0 112.281 174.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.68 -43.01 99.54 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.015 0.817 . . . . 0.0 113.529 171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.5 -38.61 90.59 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 118.499 1.149 . . . . 0.0 113.149 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -39.94 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 CA-C-N 119.304 0.956 . . . . 0.0 112.183 176.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -66.73 -26.12 66.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.189 0.995 . . . . 0.0 112.707 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.3 tp10 -60.75 -45.79 92.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.335 1.054 . . . . 0.0 112.856 172.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.96 -28.95 0.3 Allowed Glycine 0 CA--C 1.542 1.729 0 C-N-CA 125.882 1.706 . . . . 0.0 116.923 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -87.23 -35.87 18.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.262 1.425 . . . . 0.0 113.403 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.67 161.32 53.78 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.297 0.951 . . . . 0.0 114.044 -171.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.67 -34.81 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.239 1.016 . . . . 0.0 111.411 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.06 -45.96 82.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.058 0.844 . . . . 0.0 113.253 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.86 84.4 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.331 -0.855 . . . . 0.0 112.079 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -62.95 -47.22 84.12 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.154 0.982 . . . . 0.0 111.301 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.0 t -56.19 -51.83 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.438 . . . . 0.0 111.367 175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.15 -40.41 95.9 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.144 0.429 . . . . 0.0 112.066 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -69.85 -34.85 74.17 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.49 -34.81 72.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.023 0.929 . . . . 0.0 112.257 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 60.1 mt -72.56 -31.4 65.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.457 1.103 . . . . 0.0 112.332 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.72 9.23 7.74 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.401 1.477 . . . . 0.0 115.782 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 80.1 t -80.3 146.25 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.212 1.405 . . . . 0.0 110.904 176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.3 m -125.75 152.96 44.66 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.369 1.468 . . . . 0.0 111.327 -178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.355 1.462 . . . . 0.0 112.59 -171.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -73.82 -29.18 62.0 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.65 -45.07 39.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.124 0.97 . . . . 0.0 111.095 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.45 95.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.306 0.642 . . . . 0.0 112.007 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.7 mtt180 -53.61 -50.59 65.35 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 118.726 0.694 . . . . 0.0 111.562 172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.81 -38.47 90.81 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.268 0.94 . . . . 0.0 113.182 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -66.88 -47.85 70.59 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.98 1.264 . . . . 0.0 112.171 174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.77 -44.0 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.76 0.824 . . . . 0.0 111.29 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 85.5 mt -71.82 -23.56 61.57 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.468 1.107 . . . . 0.0 113.213 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -79.24 -48.67 13.76 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.063 0.847 . . . . 0.0 111.179 167.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.1 tp -72.0 -20.71 61.67 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.54 -3.16 4.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 148.39 -10.25 1.12 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.057 1.313 . . . . 0.0 114.841 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.7 m -87.53 -15.09 38.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.957 1.303 . . . . 0.0 114.273 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.102 1.761 . . . . 0.0 111.04 176.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.2 ptm -150.08 151.19 32.81 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.952 1.301 . . . . 0.0 111.998 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -90.25 -32.38 16.59 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.897 0.879 . . . . 0.0 113.179 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.02 51.11 60.56 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.227 0.918 . . . . 0.0 114.899 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -138.9 143.58 38.75 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.5 1.52 . . . . 0.0 111.536 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.18 147.2 47.11 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.02 1.728 . . . . 0.0 109.842 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.9 p -65.79 165.3 13.05 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.13 -0.981 . . . . 0.0 112.117 178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.8 -33.95 75.03 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.719 -1.238 . . . . 0.0 112.961 178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.99 -36.84 67.14 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.632 -0.668 . . . . 0.0 112.18 172.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.78 -42.1 77.86 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.937 0.79 . . . . 0.0 111.576 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.19 -38.93 77.67 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.7 0.8 . . . . 0.0 111.576 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -63.13 -42.72 99.55 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 117.931 -1.033 . . . . 0.0 112.41 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.43 -36.69 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 120.709 1.595 . . . . 0.0 111.658 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.96 -32.54 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.05 -39.14 79.33 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.113 -0.992 . . . . 0.0 112.204 170.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.1 mt -67.37 -36.21 80.91 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.24 -36.37 77.6 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.849 0.86 . . . . 0.0 112.54 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -66.05 -44.28 85.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.823 0.849 . . . . 0.0 111.663 172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.06 -38.84 92.11 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.542 -0.724 . . . . 0.0 112.331 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.37 -39.34 81.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.353 -0.842 . . . . 0.0 111.883 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.12 82.57 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.212 -0.93 . . . . 0.0 112.848 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.95 -42.5 66.53 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.402 0.681 . . . . 0.0 112.661 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -61.65 -45.55 93.57 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.787 1.235 . . . . 0.0 112.635 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.76 -2.07 41.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.479 1.111 . . . . 0.0 113.562 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.15 41.71 85.93 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 121.577 -0.702 . . . . 0.0 112.587 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -101.28 -30.95 11.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.404 1.082 . . . . 0.0 113.772 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m120 53.28 13.24 0.4 Allowed 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.77 147.23 28.57 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.926 1.69 . . . . 0.0 111.43 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -89.81 118.19 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.547 1.139 . . . . 0.0 109.521 174.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 177.8 27.27 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.991 1.757 . . . . 0.0 111.619 167.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.9 p -56.06 -41.52 75.21 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.437 -1.037 . . . . 0.0 111.206 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -48.29 -49.12 34.98 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 128.3 2.64 . . . . 0.0 113.838 169.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -71.78 -33.13 68.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.156 0.583 . . . . 0.0 111.58 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.84 -42.82 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.371 0.668 . . . . 0.0 110.684 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.57 -40.65 95.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.163 0.892 . . . . 0.0 111.479 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.7 tp -68.87 -36.62 78.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.456 0.702 . . . . 0.0 112.22 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.54 -36.87 93.93 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.775 1.178 . . . . 0.0 112.858 171.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 mt -58.12 -50.53 73.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.215 1.006 . . . . 0.0 112.663 171.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -23.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -68.89 -32.12 71.55 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.321 0.964 . . . . 0.0 112.191 168.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -70.03 -51.6 30.85 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.727 0.811 . . . . 0.0 110.025 169.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.26 -26.73 0.56 Allowed Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.197 1.38 . . . . 0.0 116.429 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -102.84 -21.52 14.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.073 1.749 . . . . 0.0 113.539 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.32 159.33 37.57 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.287 0.946 . . . . 0.0 113.118 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -55.5 -45.26 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.309 1.043 . . . . 0.0 111.91 -173.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.74 93.38 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.5 -37.81 85.87 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.205 -0.934 . . . . 0.0 111.949 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -68.34 -34.39 76.01 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.669 0.787 . . . . 0.0 111.64 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.65 91.52 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.061 0.944 . . . . 0.0 112.45 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.48 -46.86 87.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.003 0.82 . . . . 0.0 111.219 172.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -66.66 -34.89 78.87 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.73 -32.84 74.61 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.351 1.06 . . . . 0.0 112.79 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -76.05 9.75 2.3 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.269 1.427 . . . . 0.0 113.54 169.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.55 6.65 73.21 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.271 1.415 . . . . 0.0 115.174 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.0 mt -84.16 -174.85 5.51 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.603 1.201 . . . . 0.0 111.835 176.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.6 164.95 38.48 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.134 1.349 . . . . 0.0 111.361 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -60.74 -42.56 97.6 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.178 0.591 . . . . 0.0 112.556 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -37.51 86.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.4 mttp -67.57 -46.73 71.85 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.039 0.936 . . . . 0.0 111.613 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.36 -43.38 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.545 0.738 . . . . 0.0 110.466 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -61.66 -39.52 91.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.129 0.877 . . . . 0.0 112.17 176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -60.34 -48.65 80.83 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.925 0.784 . . . . 0.0 111.608 173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -71.19 -32.74 69.24 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -64.29 -57.82 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 119.159 0.89 . . . . 0.0 110.077 170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -69.66 -23.3 63.45 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.02 -1.05 . . . . 0.0 113.39 -173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.8 m -66.57 -20.65 66.06 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.246 -0.909 . . . . 0.0 113.233 169.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -101.68 -41.78 6.44 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.924 1.29 . . . . 0.0 112.43 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -105.03 0.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.52 -4.6 5.43 Favored Glycine 0 CA--C 1.542 1.771 0 CA-C-N 119.905 1.229 . . . . 0.0 115.844 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -69.37 -22.61 63.71 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.309 2.243 . . . . 0.0 113.968 174.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.39 165.14 15.39 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 124.346 0.974 . . . . 0.0 114.938 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -144.53 43.59 1.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.296 2.239 . . . . 0.0 109.663 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -59.92 126.38 27.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -167.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.08 -1.48 2.95 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.384 1.874 . . . . 0.0 113.309 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m 53.19 45.98 27.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.645 1.578 . . . . 0.0 114.412 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -139.3 169.98 16.78 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.511 1.524 . . . . 0.0 112.999 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -67.62 161.63 25.34 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.676 0.791 . . . . 0.0 111.874 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -69.6 146.52 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -136.95 160.6 38.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.622 2.369 . . . . 0.0 109.007 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -98.65 134.23 41.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.307 -0.871 . . . . 0.0 111.057 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.4 p -65.39 162.31 42.65 Favored Pre-proline 0 N--CA 1.479 0.99 0 O-C-N 121.725 -0.609 . . . . 0.0 111.316 173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.33 -34.55 89.06 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.471 2.114 . . . . 0.0 113.336 173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtm-85 -70.61 -42.69 70.61 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.263 0.625 . . . . 0.0 112.375 174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.17 -41.09 86.56 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.025 0.83 . . . . 0.0 111.554 177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -55.48 -45.22 77.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.586 1.154 . . . . 0.0 111.114 169.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.99 -37.8 88.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.392 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.5 t -66.49 -37.43 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.088 1.313 . . . . 0.0 112.648 172.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.1 mm -63.36 -40.14 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.011 1.278 . . . . 0.0 110.967 173.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -69.22 -42.75 75.31 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.241 -0.912 . . . . 0.0 112.751 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -75.4 -38.28 60.01 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.994 0.918 . . . . 0.0 112.45 -177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.1 p -61.65 -35.63 78.5 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.888 1.222 . . . . 0.0 111.867 172.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 31.8 ttm -67.84 -36.3 80.1 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.39 0.676 . . . . 0.0 112.111 170.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -67.13 -29.87 69.71 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -78.71 -35.62 44.68 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.101 -0.999 . . . . 0.0 111.702 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.4 -36.82 83.53 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.983 -1.073 . . . . 0.0 112.32 171.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 86.3 mtm-85 -60.42 -32.8 71.7 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.013 0.925 . . . . 0.0 113.307 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -72.07 -27.07 62.43 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 119.298 0.954 . . . . 0.0 113.393 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.73 -9.01 58.62 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.025 0.93 . . . . 0.0 112.497 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.2 18.96 79.48 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.752 1.167 . . . . 0.0 114.254 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.1 m170 -83.03 142.36 31.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.358 1.079 . . . . 0.0 111.548 -177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.5 m -84.53 13.88 5.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.057 1.343 . . . . 0.0 113.449 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -157.36 152.03 25.4 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.793 2.037 . . . . 0.0 110.64 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.06 116.57 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.271 1.429 . . . . 0.0 109.766 175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.12 174.23 50.82 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.06 0.838 . . . . 0.0 113.672 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.5 p -58.41 -40.46 82.54 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.601 -0.941 . . . . 0.0 110.669 170.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.06 -54.4 13.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.268 2.227 . . . . 0.0 111.427 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.38 -32.14 69.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.348 -0.834 . . . . 0.0 112.863 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.74 -49.83 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.415 1.007 . . . . 0.0 110.268 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.5 tp -63.28 -43.97 96.39 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 118.527 -0.749 . . . . 0.0 111.516 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 33.1 mt -56.54 -36.5 69.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.791 0.723 . . . . 0.0 111.69 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.94 97.46 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.652 1.12 . . . . 0.0 114.073 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.2 mt -59.68 -46.9 87.67 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 118.794 1.297 . . . . 0.0 111.828 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -74.29 -32.71 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 175.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -64.38 -33.68 76.43 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.642 1.177 . . . . 0.0 112.24 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -68.03 -47.43 68.44 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.518 0.727 . . . . 0.0 109.928 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.32 2.97 44.53 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 119.489 2.555 . . . . 0.0 119.489 165.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -131.52 -23.93 2.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.784 2.292 . . . . 0.0 113.941 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.98 171.28 23.28 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.005 1.288 . . . . 0.0 113.896 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.4 t -58.55 -36.35 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.614 0.766 . . . . 0.0 111.515 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.37 77.89 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.277 0.944 . . . . 0.0 113.164 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.702 -0.624 . . . . 0.0 111.569 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -67.76 -43.95 78.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.201 1.001 . . . . 0.0 112.881 177.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.1 t -56.73 -47.34 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.044 1.338 . . . . 0.0 111.223 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.75 -43.31 99.1 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.823 0.449 . . . . 0.0 111.398 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.33 -33.87 75.08 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -65.17 -41.51 94.59 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.1 0.864 . . . . 0.0 111.855 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.3 mt -74.36 -31.83 62.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.382 1.073 . . . . 0.0 112.528 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.46 3.36 7.94 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.505 1.526 . . . . 0.0 115.484 171.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.9 t -80.26 143.97 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.027 1.331 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 86.0 p -117.76 165.22 13.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.27 1.428 . . . . 0.0 111.587 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.0 -44.83 61.0 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.608 1.163 . . . . 0.0 111.068 173.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -69.71 -47.22 63.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.309 1.044 . . . . 0.0 112.608 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -68.18 -40.55 82.25 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.131 0.878 . . . . 0.0 112.145 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.64 -42.71 91.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 118.517 -0.754 . . . . 0.0 111.844 173.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -55.21 -53.36 57.02 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 119.507 1.049 . . . . 0.0 111.605 171.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -61.12 -43.04 99.5 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.866 0.757 . . . . 0.0 112.857 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -72.63 -37.02 68.16 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.82 1.191 . . . . 0.0 113.181 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.85 -45.55 76.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.163 0.892 . . . . 0.0 111.199 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.08 -26.83 66.92 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.134 0.974 . . . . 0.0 112.705 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -74.27 -53.83 8.94 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.482 0.713 . . . . 0.0 111.386 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.54 -19.81 60.81 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.42 -7.53 25.88 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.26 -9.47 0.34 Allowed Glycine 0 CA--C 1.535 1.342 0 N-CA-C 115.694 1.038 . . . . 0.0 115.694 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.3 t -81.6 -25.79 35.44 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.617 1.208 . . . . 0.0 112.95 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.1 t30 . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.855 2.062 . . . . 0.0 112.932 176.248 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.9 ptm -144.63 157.17 44.32 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.33 1.452 . . . . 0.0 112.08 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -88.74 -51.65 5.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 112.805 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.0 6.14 51.11 Favored Glycine 0 CA--C 1.542 1.745 0 N-CA-C 116.631 1.412 . . . . 0.0 116.631 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -88.21 147.21 24.96 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.59 1.556 . . . . 0.0 111.089 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.1 148.67 45.4 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.492 1.917 . . . . 0.0 109.536 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.81 162.08 14.19 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 119.807 1.185 . . . . 0.0 111.805 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -60.93 -33.34 73.01 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.681 -1.262 . . . . 0.0 111.898 174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -66.65 -40.5 88.7 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.747 0.819 . . . . 0.0 112.207 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.12 -41.19 70.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.814 0.846 . . . . 0.0 112.091 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -56.56 -41.43 76.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.303 1.041 . . . . 0.0 111.078 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.59 -43.29 99.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 117.365 -1.303 . . . . 0.0 112.707 173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -37.62 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 CA-C-N 121.257 1.844 . . . . 0.0 111.723 177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.65 -34.07 60.48 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.49 -41.22 89.27 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.461 -0.775 . . . . 0.0 111.492 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -68.71 -33.61 74.24 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.992 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.73 -35.62 72.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 120.177 1.353 . . . . 0.0 112.946 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.37 -44.2 88.33 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.724 -0.61 . . . . 0.0 111.268 171.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.89 -40.39 87.73 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.594 -0.691 . . . . 0.0 112.448 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -65.5 -39.44 91.89 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.575 1.08 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.36 65.72 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.443 0.565 . . . . 0.0 110.88 170.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.07 -33.69 76.36 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -69.36 -33.04 72.48 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.827 1.251 . . . . 0.0 112.972 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.73 0.85 49.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.564 1.145 . . . . 0.0 113.603 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.55 27.46 69.42 Favored Glycine 0 CA--C 1.534 1.229 0 O-C-N 121.321 -0.862 . . . . 0.0 114.11 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -99.97 139.87 35.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.586 1.554 . . . . 0.0 110.624 169.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -92.24 10.35 29.96 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -144.4 150.54 37.89 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.528 1.131 . . . . 0.0 111.858 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.28 117.58 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.143 1.377 . . . . 0.0 109.435 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.31 172.42 26.47 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.873 1.225 . . . . 0.0 111.53 167.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.4 p -53.15 -38.55 62.84 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 121.796 -0.826 . . . . 0.0 111.125 168.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -50.67 -46.35 58.55 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 128.392 2.677 . . . . 0.0 113.352 169.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.3 m80 -78.09 -31.15 49.93 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.712 0.805 . . . . 0.0 111.891 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 84.9 mt -65.17 -43.43 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 118.67 0.668 . . . . 0.0 110.279 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.7 tp -66.52 -45.55 79.1 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.128 0.876 . . . . 0.0 111.502 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.8 tp -66.67 -33.79 76.43 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 111.95 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.53 -38.77 95.09 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.814 1.197 . . . . 0.0 112.409 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mt -56.47 -50.1 72.71 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.805 1.242 . . . . 0.0 112.588 172.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -24.93 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -67.85 -32.14 72.45 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 119.605 1.093 . . . . 0.0 111.543 169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -71.4 -51.22 25.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.154 0.982 . . . . 0.0 110.295 170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.44 -11.65 3.97 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -114.93 -21.61 10.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.913 1.856 . . . . 0.0 114.29 -172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.04 159.75 17.62 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.351 0.977 . . . . 0.0 113.607 174.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.2 mm -55.91 -42.32 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.233 1.013 . . . . 0.0 111.777 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.3 90.89 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.73 0.695 . . . . 0.0 112.768 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.2 86.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.068 -1.02 . . . . 0.0 111.91 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -69.02 -33.87 74.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.613 0.765 . . . . 0.0 111.78 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.61 81.53 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.4 1.08 . . . . 0.0 112.471 172.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.72 -48.83 79.82 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.035 0.834 . . . . 0.0 110.596 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -64.71 -34.24 77.85 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 176.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.63 76.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.502 1.121 . . . . 0.0 112.852 173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.16 8.8 2.37 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.338 1.455 . . . . 0.0 113.469 170.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.55 81.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.224 1.393 . . . . 0.0 114.608 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -82.47 -174.56 5.25 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.297 1.048 . . . . 0.0 111.547 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.09 166.3 38.79 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.656 1.598 . . . . 0.0 110.914 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 p -60.87 -43.14 98.8 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -39.49 85.69 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.971 0.908 . . . . 0.0 113.107 176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.56 -45.69 91.76 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.671 0.788 . . . . 0.0 111.697 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 mt -71.36 -43.89 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.565 0.746 . . . . 0.0 110.701 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.63 -39.2 83.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.218 1.007 . . . . 0.0 112.923 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -54.97 -53.05 60.64 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.191 0.996 . . . . 0.0 111.569 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -73.41 -31.26 63.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.7 -57.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 118.846 0.748 . . . . 0.0 110.064 170.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.83 -29.44 70.63 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.959 -1.088 . . . . 0.0 113.447 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -62.12 -28.21 69.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.605 0.762 . . . . 0.0 112.682 172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.81 -31.65 11.41 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.874 1.27 . . . . 0.0 113.726 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.2 pt -118.96 10.63 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.36 13.37 0.26 Allowed Glycine 0 CA--C 1.545 1.933 0 N-CA-C 117.662 1.825 . . . . 0.0 117.662 -174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -80.86 -36.35 31.49 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.959 1.703 . . . . 0.0 113.892 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.75 103.66 0.04 OUTLIER Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.813 1.196 . . . . 0.0 114.556 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -78.08 74.51 4.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.649 1.18 . . . . 0.0 109.903 169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -81.51 72.68 8.55 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.062 1.345 . . . . 0.0 114.178 -167.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.8 mtm -131.24 47.33 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.061 2.145 . . . . 0.0 108.483 169.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.7 m -65.62 67.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 129.58 3.152 . . . . 0.0 116.58 -166.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -135.01 121.21 20.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.774 1.63 . . . . 0.0 109.67 169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 m 54.76 102.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 127.547 2.339 . . . . 0.0 114.517 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.37 146.22 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.319 -0.863 . . . . 0.0 113.012 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -136.85 164.13 29.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.023 1.729 . . . . 0.0 110.266 169.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -98.17 135.8 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.136 0.974 . . . . 0.0 111.25 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.9 p -63.46 158.79 55.83 Favored Pre-proline 0 N--CA 1.484 1.244 0 CA-C-O 118.957 -0.544 . . . . 0.0 111.062 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -55.6 -33.07 85.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.574 2.183 . . . . 0.0 113.58 173.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -43.73 76.64 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.734 0.814 . . . . 0.0 111.253 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.49 78.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.429 0.692 . . . . 0.0 112.508 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -57.97 -46.95 84.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.789 1.235 . . . . 0.0 111.271 171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -60.69 -43.23 97.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 118.231 -0.89 . . . . 0.0 112.407 173.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.98 -46.47 91.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 120.055 1.298 . . . . 0.0 112.048 172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.93 -45.02 99.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.538 1.063 . . . . 0.0 111.181 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -67.69 -37.84 82.85 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.691 -0.631 . . . . 0.0 112.517 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 65.3 mt -68.73 -27.43 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.343 -0.848 . . . . 0.0 112.445 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.4 m -68.34 -42.53 79.16 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.481 1.037 . . . . 0.0 111.29 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.3 ptp -73.6 -30.82 63.23 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 171.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.38 -40.18 89.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.514 1.052 . . . . 0.0 112.673 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -66.62 -40.34 88.74 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.887 -1.133 . . . . 0.0 111.947 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.98 97.87 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.255 -0.903 . . . . 0.0 111.714 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -63.96 -37.94 89.26 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.887 1.275 . . . . 0.0 112.63 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -65.67 -30.35 71.04 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.06 1.344 . . . . 0.0 112.93 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.36 -4.13 43.6 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.569 1.148 . . . . 0.0 113.33 169.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.2 18.58 76.74 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.529 1.061 . . . . 0.0 113.757 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.96 146.49 23.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.833 1.653 . . . . 0.0 111.784 -172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.8 p -95.87 3.92 53.24 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -170.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -156.83 159.77 38.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.698 1.599 . . . . 0.0 111.009 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -87.08 117.17 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.841 1.257 . . . . 0.0 110.64 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.79 169.54 42.78 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 123.479 0.561 . . . . 0.0 112.95 169.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -57.15 -38.66 73.87 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.688 -0.89 . . . . 0.0 111.005 170.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.31 -55.38 8.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.842 2.057 . . . . 0.0 111.434 169.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -68.57 -27.36 66.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.916 0.886 . . . . 0.0 113.128 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.19 -46.27 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.167 0.894 . . . . 0.0 110.616 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.1 tp -67.07 -37.34 83.85 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.22 0.918 . . . . 0.0 112.201 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.4 mt -60.29 -33.48 72.41 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.71 0.686 . . . . 0.0 112.329 169.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.03 -47.8 63.38 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.051 0.834 . . . . 0.0 112.874 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.69 -44.27 85.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.761 1.224 . . . . 0.0 112.507 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -71.99 -41.34 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.6 tpt85 -68.18 -27.54 66.5 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -71.49 -48.17 50.79 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.073 0.851 . . . . 0.0 112.481 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.67 -3.42 12.29 Favored Glycine 0 CA--C 1.542 1.776 0 N-CA-C 119.151 2.42 . . . . 0.0 119.151 168.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -99.38 -33.12 10.83 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.688 2.244 . . . . 0.0 111.508 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.74 169.24 12.26 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.903 1.239 . . . . 0.0 115.095 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 50.5 t -70.06 -34.24 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.102 1.361 . . . . 0.0 111.703 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.94 80.3 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.32 80.86 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.419 -0.801 . . . . 0.0 112.375 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -73.35 -38.4 65.74 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.598 1.159 . . . . 0.0 112.512 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.4 t -57.09 -49.94 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.74 1.216 . . . . 0.0 111.017 170.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.47 -43.49 96.88 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 122.63 0.372 . . . . 0.0 111.519 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -69.25 -30.62 68.79 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -65.54 -41.25 93.25 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.649 171.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.5 mt -73.68 -31.16 63.31 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.371 1.068 . . . . 0.0 112.588 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.05 0.46 9.69 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.005 1.764 . . . . 0.0 115.244 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 71.0 t -82.58 141.23 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.277 1.431 . . . . 0.0 110.709 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.5 p -116.71 169.04 9.67 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.912 1.285 . . . . 0.0 111.917 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.8 -45.45 29.59 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.125 1.37 . . . . 0.0 111.018 169.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -68.51 -46.43 69.66 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.414 1.086 . . . . 0.0 112.86 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -74.5 -35.67 63.21 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 118.812 0.733 . . . . 0.0 112.427 -176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.86 86.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.451 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -55.43 -54.49 43.12 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 119.567 1.076 . . . . 0.0 111.27 172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.59 -42.46 96.79 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.16 0.891 . . . . 0.0 113.003 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -72.68 -36.78 67.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.059 1.3 . . . . 0.0 113.703 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.8 t -70.12 -44.33 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.497 1.044 . . . . 0.0 111.126 177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.4 mt -67.97 -27.6 66.72 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.466 1.106 . . . . 0.0 112.582 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -72.01 -57.34 4.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.828 0.851 . . . . 0.0 110.83 168.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -72.17 -16.47 61.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.72 -7.25 46.91 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.9 -5.46 0.09 OUTLIER Glycine 0 CA--C 1.538 1.516 0 N-CA-C 117.554 1.781 . . . . 0.0 117.554 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.7 m -101.66 -0.14 35.16 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 119.218 1.509 . . . . 0.0 114.033 -177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.544 1.938 . . . . 0.0 113.566 174.869 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.6 tpt -143.55 144.79 32.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.788 1.235 . . . . 0.0 110.66 171.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -75.22 -44.97 43.29 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -171.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.32 3.63 13.66 Favored Glycine 0 CA--C 1.544 1.853 0 N-CA-C 117.023 1.569 . . . . 0.0 117.023 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.0 ttt85 -80.08 137.95 36.87 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -117.11 148.69 41.33 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.796 1.638 . . . . 0.0 109.673 170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.1 p -67.14 166.78 13.31 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.969 -1.082 . . . . 0.0 112.024 175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.46 -39.78 94.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.699 -1.251 . . . . 0.0 111.712 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.39 -37.44 87.0 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.273 1.029 . . . . 0.0 112.196 173.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.68 68.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.22 0.918 . . . . 0.0 111.975 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -59.47 -36.74 76.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.526 0.731 . . . . 0.0 111.489 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -61.07 -46.19 91.67 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 117.149 -1.405 . . . . 0.0 112.811 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -61.92 -37.53 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 CA-C-N 121.541 1.973 . . . . 0.0 111.724 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -74.52 -34.59 63.06 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.11 81.69 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.305 -0.872 . . . . 0.0 111.948 171.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.96 -36.0 79.34 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.291 -0.881 . . . . 0.0 111.427 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.14 -34.39 72.01 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.068 0.849 . . . . 0.0 113.133 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -39.58 75.13 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.123 0.874 . . . . 0.0 111.181 177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -74.85 -36.37 62.36 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 122.207 -0.308 . . . . 0.0 111.262 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -65.19 -37.67 88.07 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.45 -0.781 . . . . 0.0 112.275 171.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.36 -50.13 74.82 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.894 0.77 . . . . 0.0 110.929 170.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.3 -35.64 81.02 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -64.45 -37.76 88.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.054 1.342 . . . . 0.0 112.146 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.2 mt -81.0 -6.61 58.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.084 1.353 . . . . 0.0 114.287 175.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.63 38.7 61.29 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.055 0.843 . . . . 0.0 113.057 -173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -109.22 130.61 55.49 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.214 1.806 . . . . 0.0 109.788 171.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.81 7.57 36.33 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.57 139.27 33.12 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.988 -1.07 . . . . 0.0 112.822 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -76.98 130.09 36.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.928 1.291 . . . . 0.0 110.322 172.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.04 176.39 19.14 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.831 2.158 . . . . 0.0 111.064 167.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.2 p -53.59 -38.79 64.29 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.987 0.899 . . . . 0.0 111.454 171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.93 -49.01 60.59 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.824 2.85 . . . . 0.0 114.07 170.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -73.63 -32.69 64.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.98 0.809 . . . . 0.0 111.556 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.2 mt -65.19 -42.8 95.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.494 0.717 . . . . 0.0 110.062 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.2 tp -66.64 -42.02 87.35 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.876 0.762 . . . . 0.0 112.15 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.2 tp -68.22 -35.69 78.36 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.116 0.966 . . . . 0.0 111.963 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -38.26 93.98 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.849 1.214 . . . . 0.0 112.745 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.18 -52.96 61.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.606 1.163 . . . . 0.0 112.458 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.49 -25.53 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -71.83 -28.82 63.83 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.507 1.048 . . . . 0.0 112.47 171.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -72.26 -45.78 58.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.874 0.761 . . . . 0.0 110.388 169.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 -25.52 0.43 Allowed Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.175 1.845 . . . . 0.0 117.372 169.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -99.63 -17.23 17.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.861 1.664 . . . . 0.0 113.724 -173.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.64 155.38 44.58 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.853 0.74 . . . . 0.0 112.629 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.82 -42.36 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.081 0.952 . . . . 0.0 111.579 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.82 -42.82 90.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.704 0.684 . . . . 0.0 112.731 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -37.35 85.45 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.041 -1.037 . . . . 0.0 111.83 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.28 -34.35 76.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.949 0.899 . . . . 0.0 111.707 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.43 -40.79 81.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.297 1.039 . . . . 0.0 112.59 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -59.0 -48.27 82.2 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.067 0.849 . . . . 0.0 110.63 172.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.68 -34.38 78.16 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.05 -33.08 74.98 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.947 -1.096 . . . . 0.0 112.928 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.7 mt -75.14 9.46 2.0 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.343 1.457 . . . . 0.0 113.484 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.58 6.22 80.75 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.329 1.442 . . . . 0.0 114.781 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.7 mt -82.82 -175.5 5.83 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 118.453 1.126 . . . . 0.0 111.785 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.51 165.44 37.44 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.344 1.449 . . . . 0.0 111.122 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 p -58.07 -44.77 87.68 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.442 0.697 . . . . 0.0 112.753 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -67.27 -33.98 76.45 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -69.82 -44.91 69.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.026 0.93 . . . . 0.0 111.257 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.71 -43.6 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 110.39 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.84 -40.27 94.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.831 0.852 . . . . 0.0 112.437 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -54.43 -53.89 48.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.025 0.93 . . . . 0.0 111.417 172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -71.9 -33.38 68.28 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.27 -58.6 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 118.885 0.766 . . . . 0.0 110.245 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -68.77 -27.64 66.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.299 -0.876 . . . . 0.0 113.292 -172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.9 t -60.99 -28.93 69.38 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.642 0.777 . . . . 0.0 112.547 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 98.2 mt -95.2 -35.77 11.72 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.718 1.207 . . . . 0.0 113.459 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.23 0.43 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.97 0.99 5.14 Favored Glycine 0 CA--C 1.541 1.686 0 N-CA-C 117.494 1.757 . . . . 0.0 117.494 -169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -70.94 -28.61 64.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.405 1.482 . . . . 0.0 113.802 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.32 155.7 8.4 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.362 0.982 . . . . 0.0 114.146 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.75 81.6 0.38 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.303 2.241 . . . . 0.0 109.391 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -120.44 120.76 36.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.043 0.937 . . . . 0.0 112.641 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -111.23 -27.43 8.69 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.694 1.598 . . . . 0.0 112.289 171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.7 p -160.23 178.4 9.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.115 1.766 . . . . 0.0 111.612 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -86.54 -0.43 56.1 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.418 1.487 . . . . 0.0 113.142 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.4 m -82.82 121.34 26.79 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.032 -1.043 . . . . 0.0 109.636 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.9 mm -82.76 127.82 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 123.206 0.603 . . . . 0.0 112.179 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -105.91 175.54 5.46 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.257 1.823 . . . . 0.0 110.919 170.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -115.03 134.68 54.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 110.188 171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.5 p -67.52 161.69 63.19 Favored Pre-proline 0 N--CA 1.477 0.883 0 C-N-CA 123.39 0.676 . . . . 0.0 111.813 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.99 -34.67 92.91 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.411 2.074 . . . . 0.0 112.82 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -68.88 -43.07 76.05 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.494 0.718 . . . . 0.0 112.012 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.79 83.41 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.855 0.752 . . . . 0.0 112.376 173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -58.92 -44.91 91.4 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.097 0.959 . . . . 0.0 111.42 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -57.16 -49.2 76.68 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.897 0.879 . . . . 0.0 111.597 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.69 -45.11 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-N 119.834 1.197 . . . . 0.0 111.836 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.88 -45.79 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 119.554 1.07 . . . . 0.0 111.663 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.88 -39.28 83.72 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.534 -0.729 . . . . 0.0 112.653 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.5 mt -68.43 -31.96 71.66 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.95 0.9 . . . . 0.0 111.892 175.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 m -63.96 -43.21 96.47 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.104 0.865 . . . . 0.0 111.4 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -75.55 -28.59 59.09 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.11 -36.93 80.54 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.226 0.921 . . . . 0.0 112.726 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -66.48 -43.21 86.03 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.336 1.054 . . . . 0.0 111.366 171.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -39.01 86.58 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.26 -0.9 . . . . 0.0 112.27 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -68.26 -40.4 81.9 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.409 1.484 . . . . 0.0 112.385 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -62.39 -35.7 79.99 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.776 1.23 . . . . 0.0 112.159 174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.35 -10.15 59.56 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.896 1.279 . . . . 0.0 113.992 172.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.84 26.75 73.14 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.089 0.852 . . . . 0.0 113.643 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -81.86 -20.64 38.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.829 1.252 . . . . 0.0 113.686 -170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.3 m 60.22 7.6 1.3 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -160.94 156.42 24.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.245 1.818 . . . . 0.0 110.577 168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.6 t -93.14 111.57 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.497 1.519 . . . . 0.0 110.582 -175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 173.59 47.48 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.503 0.573 . . . . 0.0 112.417 169.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 p -56.7 -38.59 72.51 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 121.675 -0.897 . . . . 0.0 111.115 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.43 -57.36 4.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.287 2.235 . . . . 0.0 111.737 169.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.8 -28.52 68.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.379 1.072 . . . . 0.0 113.258 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.41 -45.3 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 119.294 0.952 . . . . 0.0 110.874 170.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.62 -35.99 82.41 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.195 -0.94 . . . . 0.0 111.968 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.4 mt -61.89 -33.74 74.75 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 118.495 0.589 . . . . 0.0 112.368 171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.34 -44.68 73.36 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.082 0.848 . . . . 0.0 113.417 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.42 -44.88 92.8 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.74 1.216 . . . . 0.0 112.641 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.4 pt -69.75 -42.4 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.848 0.749 . . . . 0.0 112.892 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 tpp180 -61.53 -32.98 73.06 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.277 1.031 . . . . 0.0 113.371 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.94 -43.95 97.77 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 118.887 0.767 . . . . 0.0 111.287 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.28 -9.39 20.48 Favored Glycine 0 CA--C 1.538 1.511 0 N-CA-C 119.004 2.362 . . . . 0.0 119.004 167.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -123.33 -24.55 4.61 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 120.871 2.336 . . . . 0.0 113.776 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.97 159.86 13.02 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.539 1.066 . . . . 0.0 113.636 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 73.7 t -56.33 -36.1 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.097 0.959 . . . . 0.0 111.76 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.89 -45.79 82.33 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.461 1.028 . . . . 0.0 113.206 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.13 86.26 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.61 -0.681 . . . . 0.0 111.925 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 43.2 mtm180 -70.3 -40.73 74.08 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.301 1.041 . . . . 0.0 112.881 176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 39.4 t -57.12 -50.3 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.995 1.318 . . . . 0.0 111.127 172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.45 -44.75 92.9 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.807 0.443 . . . . 0.0 111.339 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -69.95 -30.36 67.71 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -65.76 -40.28 91.9 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.413 1.006 . . . . 0.0 111.784 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.4 mt -77.09 -33.08 57.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.273 1.029 . . . . 0.0 112.661 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.08 0.05 5.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.594 1.569 . . . . 0.0 115.437 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.2 t -83.86 145.05 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.424 1.49 . . . . 0.0 110.829 175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.8 t -136.33 170.76 15.51 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.502 1.521 . . . . 0.0 109.725 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 mp -52.67 -45.36 66.75 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.262 1.025 . . . . 0.0 111.924 -172.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -70.12 -36.43 74.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -67.4 -46.85 72.02 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.728 0.811 . . . . 0.0 111.064 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.72 -47.38 83.81 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.62 0.768 . . . . 0.0 111.251 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -55.69 -52.1 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.672 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -62.16 -41.49 98.36 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.646 1.112 . . . . 0.0 112.502 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -70.4 -42.56 71.52 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.106 -0.996 . . . . 0.0 112.829 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.1 -44.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.334 0.97 . . . . 0.0 111.247 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.9 mt -67.2 -27.56 67.36 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.814 1.246 . . . . 0.0 112.635 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -77.1 -56.04 4.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.79 0.723 . . . . 0.0 110.997 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.9 tp -67.25 -19.86 65.58 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -168.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.99 -10.84 43.25 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.55 -5.68 0.17 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.197 1.239 . . . . 0.0 116.197 175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -100.44 -5.2 27.48 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.856 1.662 . . . . 0.0 114.214 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.442 1.897 . . . . 0.0 112.123 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.7 ptm -143.66 172.99 12.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.854 1.261 . . . . 0.0 112.015 173.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -60.26 -47.99 83.64 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.15 1.38 . . . . 0.0 114.416 -171.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.14 -0.26 3.72 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.2 ttp180 -86.83 154.93 20.5 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.074 1.749 . . . . 0.0 112.183 -175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -118.59 164.49 15.25 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.297 1.839 . . . . 0.0 111.083 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.6 p -77.66 169.35 18.45 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.483 -1.386 . . . . 0.0 111.669 169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -65.84 -37.73 86.99 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.916 -1.115 . . . . 0.0 112.315 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -72.4 -33.29 67.06 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 119.006 0.821 . . . . 0.0 112.514 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.39 74.7 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.269 0.94 . . . . 0.0 111.255 175.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -61.09 -34.09 74.38 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.661 -0.65 . . . . 0.0 111.776 171.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -65.47 -41.8 92.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 117.577 -1.202 . . . . 0.0 112.56 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.7 -38.29 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 121.218 1.826 . . . . 0.0 111.727 173.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.79 -33.76 66.47 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.65 86.02 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.483 -0.761 . . . . 0.0 111.598 170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.6 -31.16 69.13 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.574 -0.704 . . . . 0.0 112.379 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -36.04 72.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.743 1.156 . . . . 0.0 112.798 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -66.83 -44.58 80.72 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.546 0.738 . . . . 0.0 111.406 172.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.27 -40.92 90.46 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.77 -0.581 . . . . 0.0 111.802 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -67.62 -38.11 83.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.823 0.849 . . . . 0.0 112.262 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.86 -52.5 65.48 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.614 0.643 . . . . 0.0 111.056 171.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.3 mt -64.85 -34.31 78.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.402 0.681 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.7 ttm-85 -62.24 -40.08 94.99 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.614 1.166 . . . . 0.0 111.854 173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.26 4.45 23.55 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.706 1.202 . . . . 0.0 113.339 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.42 17.04 75.89 Favored Glycine 0 CA--C 1.536 1.399 0 O-C-N 120.707 -1.246 . . . . 0.0 114.917 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -89.81 136.95 32.74 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 0.0 109.501 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -101.64 23.69 10.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.759 0.824 . . . . 0.0 113.016 176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -143.85 153.25 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.911 1.684 . . . . 0.0 111.127 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.4 mt -99.09 116.32 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.79 1.236 . . . . 0.0 109.429 170.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.25 177.3 32.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.128 1.347 . . . . 0.0 110.693 166.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.3 p -55.94 -38.56 70.48 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 121.291 -1.123 . . . . 0.0 111.373 171.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.32 -46.51 46.82 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 128.702 2.801 . . . . 0.0 113.481 169.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -77.61 -30.93 52.63 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.46 0.704 . . . . 0.0 111.653 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.22 -43.89 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 118.765 0.711 . . . . 0.0 110.208 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.9 tp -65.3 -43.14 92.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.023 0.829 . . . . 0.0 111.566 175.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 24.1 tp -67.21 -35.91 80.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.36 0.664 . . . . 0.0 111.949 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.86 -38.29 96.29 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.764 1.173 . . . . 0.0 112.678 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.98 -50.8 72.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.653 1.181 . . . . 0.0 112.692 172.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -24.63 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -69.81 -31.47 69.38 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.3 0.955 . . . . 0.0 111.882 169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -69.54 -50.62 43.23 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.73 0.812 . . . . 0.0 110.121 171.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.62 -4.79 4.89 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 118.572 2.189 . . . . 0.0 118.572 167.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -116.99 -26.45 6.86 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.026 1.913 . . . . 0.0 113.765 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.55 162.7 33.22 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.17 1.366 . . . . 0.0 113.869 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.2 mm -55.47 -43.45 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.767 1.227 . . . . 0.0 112.133 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.42 90.35 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.773 0.715 . . . . 0.0 112.773 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.46 97.49 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.181 0.901 . . . . 0.0 111.59 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -64.06 -36.63 84.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.426 0.69 . . . . 0.0 111.78 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.93 86.29 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.353 1.061 . . . . 0.0 112.789 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.44 -48.82 80.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 119.036 0.835 . . . . 0.0 110.784 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.87 -33.68 76.12 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.82 -33.29 75.35 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.997 -1.064 . . . . 0.0 112.863 173.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -76.38 8.95 2.95 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.262 1.425 . . . . 0.0 113.717 171.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.26 6.79 74.06 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.274 1.416 . . . . 0.0 114.731 175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -80.6 -176.32 5.69 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 118.277 1.038 . . . . 0.0 111.691 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.4 161.09 34.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 125.241 1.4 . . . . 0.0 111.031 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 p -57.8 -44.83 86.56 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.492 0.717 . . . . 0.0 112.31 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -65.37 -43.71 89.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.64 0.776 . . . . 0.0 112.148 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -58.76 -47.4 84.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.932 0.893 . . . . 0.0 111.599 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.0 mt -69.74 -43.14 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.188 0.995 . . . . 0.0 110.737 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.44 -43.75 96.51 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.066 0.946 . . . . 0.0 112.859 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -63.5 -42.23 98.52 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.652 0.781 . . . . 0.0 112.083 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -69.38 -37.66 77.66 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.53 -56.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.032 0.833 . . . . 0.0 110.154 171.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -58.91 -37.57 76.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 71.2 m -67.03 -18.27 65.29 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -102.82 -25.06 13.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.64 1.176 . . . . 0.0 113.667 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.2 pt -114.55 -17.06 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.3 -164.13 41.39 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 123.922 0.772 . . . . 0.0 114.455 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -131.39 137.45 48.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.557 1.543 . . . . 0.0 110.156 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.75 33.33 6.76 Favored Glycine 0 CA--C 1.535 1.289 0 N-CA-C 116.771 1.469 . . . . 0.0 116.771 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -75.6 61.48 1.34 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.353 1.576 . . . . 0.0 110.775 168.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -80.98 127.64 32.8 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.996 1.318 . . . . 0.0 113.058 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.3 mmt -125.43 -1.04 7.55 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.56 1.944 . . . . 0.0 112.616 173.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.9 m 53.18 51.81 14.88 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.41 1.884 . . . . 0.0 114.461 176.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -147.45 166.67 26.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.799 1.24 . . . . 0.0 114.216 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.8 m -61.05 148.66 39.52 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.176 1.391 . . . . 0.0 110.055 167.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -68.14 143.01 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -125.1 155.14 40.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.619 1.967 . . . . 0.0 109.837 168.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -91.88 140.71 29.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.818 0.847 . . . . 0.0 111.097 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.0 p -70.66 163.79 60.81 Favored Pre-proline 0 N--CA 1.481 1.1 0 O-C-N 121.77 -0.581 . . . . 0.0 111.319 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -57.34 -34.1 97.32 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.506 2.137 . . . . 0.0 113.611 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -73.27 -37.9 66.13 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.689 -0.632 . . . . 0.0 111.351 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.68 80.58 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.21 0.914 . . . . 0.0 112.334 173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -58.42 -45.89 87.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.002 1.321 . . . . 0.0 111.547 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -58.31 -46.46 86.09 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.036 0.934 . . . . 0.0 112.007 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.7 t -58.18 -46.14 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.782 1.173 . . . . 0.0 112.011 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 mm -61.01 -44.59 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 119.544 1.066 . . . . 0.0 111.468 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -70.24 -35.26 73.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.502 -0.748 . . . . 0.0 112.763 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.67 -29.67 64.87 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.268 -0.895 . . . . 0.0 112.017 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.1 m -64.34 -40.51 96.03 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.473 1.033 . . . . 0.0 111.358 177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.1 ptp -75.12 -32.34 61.36 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 172.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.53 -31.01 70.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.411 1.005 . . . . 0.0 113.181 172.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.36 -41.78 60.47 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.772 1.229 . . . . 0.0 111.416 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.48 75.94 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.169 -0.957 . . . . 0.0 111.946 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -69.47 -35.52 75.68 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.02 1.328 . . . . 0.0 112.178 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -38.75 90.91 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.807 1.243 . . . . 0.0 112.342 175.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.37 -4.97 59.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.552 1.141 . . . . 0.0 113.663 173.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.8 30.31 76.0 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 124.204 0.907 . . . . 0.0 114.0 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -82.58 -14.79 54.23 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.012 1.325 . . . . 0.0 114.056 -170.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.5 m 61.26 4.27 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 116.877 2.177 . . . . 0.0 116.877 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -164.48 155.42 15.11 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.401 1.88 . . . . 0.0 110.759 168.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.59 111.12 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.36 1.464 . . . . 0.0 111.121 -174.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.82 173.81 52.63 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 123.746 0.689 . . . . 0.0 113.051 169.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.9 p -57.33 -38.62 74.37 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 121.675 -0.897 . . . . 0.0 110.848 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.88 -51.46 40.3 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.623 2.369 . . . . 0.0 112.193 169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -72.61 -28.09 62.56 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.85 0.86 . . . . 0.0 112.823 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 71.2 mt -62.07 -46.79 95.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 118.917 0.78 . . . . 0.0 110.242 168.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.0 tp -62.82 -42.39 99.71 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.471 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 23.2 mt -56.9 -39.82 75.15 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.846 0.748 . . . . 0.0 112.196 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.05 -43.07 99.66 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 123.965 0.793 . . . . 0.0 113.392 173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.51 -42.65 96.83 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.267 1.027 . . . . 0.0 112.315 177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -40.86 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.074 0.852 . . . . 0.0 112.441 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -62.53 -33.41 74.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.715 1.206 . . . . 0.0 112.979 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -69.44 -43.88 72.43 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.683 0.674 . . . . 0.0 111.488 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.82 -2.9 10.67 Favored Glycine 0 CA--C 1.54 1.609 0 N-CA-C 118.998 2.359 . . . . 0.0 118.998 167.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -111.73 -34.6 5.99 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.504 2.152 . . . . 0.0 112.348 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.06 162.87 16.85 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.939 1.257 . . . . 0.0 114.205 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.45 -36.45 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.58 1.152 . . . . 0.0 111.835 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.94 -44.36 82.44 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.526 1.057 . . . . 0.0 113.569 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.52 80.89 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.506 -0.746 . . . . 0.0 112.09 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 42.0 mtm180 -72.98 -37.38 67.06 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.534 1.134 . . . . 0.0 112.84 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -57.9 -49.63 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.881 1.272 . . . . 0.0 110.848 171.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.48 -44.68 95.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.051 0.541 . . . . 0.0 111.707 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -66.96 -33.8 76.36 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.35 -40.52 85.85 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.081 0.855 . . . . 0.0 112.104 174.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -73.98 -31.67 63.08 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.176 0.99 . . . . 0.0 112.782 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.15 9.97 5.85 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.308 1.432 . . . . 0.0 115.532 172.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.93 142.72 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.233 1.413 . . . . 0.0 110.957 174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.7 m -131.46 165.99 22.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.061 1.745 . . . . 0.0 110.518 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.8 mt -45.31 -53.88 7.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.209 1.404 . . . . 0.0 113.139 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -69.77 -39.2 76.81 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -63.28 -45.15 92.79 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.396 1.079 . . . . 0.0 111.251 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.52 -51.25 58.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.301 1.04 . . . . 0.0 111.699 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -58.63 -47.29 84.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.43 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -66.42 -36.79 83.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.852 1.205 . . . . 0.0 112.537 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -69.14 -46.05 68.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.536 1.062 . . . . 0.0 112.334 174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.65 -44.55 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-N 119.004 0.82 . . . . 0.0 111.241 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.73 -24.68 62.67 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 0.0 113.321 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -79.83 -52.64 7.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.056 0.844 . . . . 0.0 111.037 167.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.47 -20.09 65.43 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -169.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.45 -10.09 31.05 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 153.86 2.86 0.14 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.384 1.314 . . . . 0.0 116.384 175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.3 m -115.33 -3.43 12.46 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.0 1.72 . . . . 0.0 114.407 -172.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 125.278 1.431 . . . . 0.0 112.682 174.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.756 -0.09 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.39 138.29 39.73 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.017 1.327 . . . . 0.0 109.026 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -108.23 20.01 19.19 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.244 1.417 . . . . 0.0 113.583 -167.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.24 37.23 1.13 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.604 2.526 . . . . 0.0 115.599 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -134.57 146.35 49.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.564 1.946 . . . . 0.0 109.751 174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -115.44 146.89 41.21 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.86 1.264 . . . . 0.0 109.922 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.5 p -66.15 165.74 13.11 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.242 -0.911 . . . . 0.0 112.082 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.33 -33.01 72.9 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.751 -1.218 . . . . 0.0 111.76 172.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -64.73 -44.72 89.27 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.729 0.812 . . . . 0.0 111.554 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -39.39 67.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.398 1.079 . . . . 0.0 112.219 -176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.66 -35.13 75.48 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.758 0.823 . . . . 0.0 112.039 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -61.13 -46.49 90.34 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.44 1.018 . . . . 0.0 112.404 170.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.65 -39.23 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 119.943 1.247 . . . . 0.0 111.439 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.4 mt -74.56 -30.99 61.95 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.1 -39.5 75.48 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.324 -0.86 . . . . 0.0 112.165 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.3 -31.9 68.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.93 0.892 . . . . 0.0 112.235 176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.12 -32.65 66.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.935 0.894 . . . . 0.0 113.191 175.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -65.79 -48.32 72.18 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.722 0.692 . . . . 0.0 111.408 172.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -65.55 -42.6 91.72 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.638 0.654 . . . . 0.0 110.944 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.53 -38.76 91.23 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.666 -0.646 . . . . 0.0 112.535 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.16 85.4 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.08 0.854 . . . . 0.0 111.834 172.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.07 -33.77 76.22 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.421 0.688 . . . . 0.0 112.692 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 28.1 mtm105 -62.58 -35.93 81.08 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.525 1.057 . . . . 0.0 112.512 170.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.31 -4.65 56.29 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.387 1.475 . . . . 0.0 113.125 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.48 24.78 71.99 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.877 -1.139 . . . . 0.0 114.129 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -102.53 123.28 45.98 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.251 1.42 . . . . 0.0 109.897 171.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -92.36 32.0 1.25 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.221 1.009 . . . . 0.0 112.655 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.421 HD21 ' NE2' ' A' ' 72' ' ' GLN . 2.8 p-10 -154.42 156.61 37.11 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.03 2.132 . . . . 0.0 110.433 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.0 mt -103.11 122.36 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.202 1.401 . . . . 0.0 110.241 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.72 179.96 25.49 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.235 1.874 . . . . 0.0 111.345 167.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -55.27 -39.58 70.0 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.459 -1.024 . . . . 0.0 111.54 172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.71 -47.5 59.04 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 129.602 3.161 . . . . 0.0 113.202 169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -76.76 -31.18 56.89 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.389 -0.82 . . . . 0.0 112.023 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.91 -40.88 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.501 0.592 . . . . 0.0 110.307 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.28 -42.47 93.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.85 0.75 . . . . 0.0 111.82 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 mp -60.7 -41.88 96.08 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.359 -0.838 . . . . 0.0 111.799 171.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.42 -41.34 93.2 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.122 0.868 . . . . 0.0 112.851 173.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.6 mt -58.61 -55.55 33.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.216 1.006 . . . . 0.0 112.41 172.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -22.37 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -70.41 -32.81 70.59 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.408 1.083 . . . . 0.0 111.808 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -71.99 -49.36 37.75 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.491 0.716 . . . . 0.0 109.678 169.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 -10.49 6.21 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 117.881 1.913 . . . . 0.0 117.881 167.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -118.85 -29.0 5.44 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.085 1.942 . . . . 0.0 114.787 -171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.56 161.17 16.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.946 1.26 . . . . 0.0 113.644 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.1 mm -51.52 -45.75 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.881 1.273 . . . . 0.0 112.92 -169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -42.0 80.5 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.34 86.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.067 -1.021 . . . . 0.0 111.773 176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -66.91 -36.64 82.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.513 1.125 . . . . 0.0 111.333 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.54 85.47 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.683 1.193 . . . . 0.0 112.748 173.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.6 mt -58.58 -48.66 80.18 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.157 0.89 . . . . 0.0 110.936 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -68.0 -32.92 73.64 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -33.07 75.04 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.931 -1.106 . . . . 0.0 113.091 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -73.97 8.01 2.29 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.941 1.297 . . . . 0.0 113.503 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.27 68.77 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.26 1.409 . . . . 0.0 114.813 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 mt -83.79 179.09 7.66 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.357 1.079 . . . . 0.0 112.042 177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -159.53 154.98 26.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.625 1.583 . . . . 0.0 111.315 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m -58.75 -41.22 85.99 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.09 -31.29 68.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -73.9 -41.66 61.8 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.711 1.141 . . . . 0.0 110.689 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.68 -47.3 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.227 1.011 . . . . 0.0 110.341 170.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.22 -38.52 85.42 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.471 -0.768 . . . . 0.0 112.894 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.61 -39.66 91.78 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.302 1.041 . . . . 0.0 112.567 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -66.79 -39.07 87.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.108 0.867 . . . . 0.0 112.654 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.5 t -62.97 -52.62 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 118.694 0.679 . . . . 0.0 110.921 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.31 -28.07 69.76 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.429 -0.794 . . . . 0.0 112.808 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.6 m -68.12 -14.02 62.66 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.7 mt -107.81 -35.88 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.557 1.543 . . . . 0.0 112.696 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.1 pt -118.58 8.06 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.16 -2.51 5.27 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 117.204 1.642 . . . . 0.0 117.204 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -73.92 -17.04 61.08 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.347 . . . . 0.0 113.74 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.89 165.24 25.58 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.118 0.866 . . . . 0.0 114.249 -177.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' NE2' HD21 ' A' ' 28' ' ' ASN . 38.6 mt-30 -140.3 71.61 1.38 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.601 1.96 . . . . 0.0 108.158 171.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.57 114.67 23.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.719 0.808 . . . . 0.0 111.768 -171.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -127.48 1.82 6.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.836 1.655 . . . . 0.0 113.032 175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 m 52.16 48.65 22.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.819 1.647 . . . . 0.0 113.681 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -136.92 167.82 20.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.457 1.503 . . . . 0.0 113.776 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 27.2 m -67.04 146.24 54.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.757 1.623 . . . . 0.0 109.38 167.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.62 139.6 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -169.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -117.41 152.72 34.41 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.975 2.11 . . . . 0.0 109.115 167.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -93.91 137.07 33.54 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.181 -0.95 . . . . 0.0 110.105 175.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.3 p -68.41 162.4 61.96 Favored Pre-proline 0 N--CA 1.478 0.96 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.39 -34.98 90.86 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.316 2.011 . . . . 0.0 113.065 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.0 mtm105 -68.9 -41.79 77.78 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.593 0.757 . . . . 0.0 111.884 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.68 81.39 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.825 0.739 . . . . 0.0 112.118 174.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -60.39 -41.79 94.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.259 1.024 . . . . 0.0 111.773 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -61.26 -45.19 95.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.967 170.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.7 t -58.48 -42.62 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 119.931 1.241 . . . . 0.0 112.098 173.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.5 mm -60.4 -44.73 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 119.736 1.153 . . . . 0.0 111.545 177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.83 -37.51 79.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.366 -0.834 . . . . 0.0 112.892 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.9 mt -67.06 -36.82 82.89 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.211 -0.931 . . . . 0.0 111.781 175.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m -64.43 -40.49 95.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.126 0.97 . . . . 0.0 111.098 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 34.8 ttm -65.83 -35.66 81.29 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.949 0.9 . . . . 0.0 112.238 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.64 -36.51 70.76 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.733 0.813 . . . . 0.0 113.002 175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -64.42 -44.42 91.26 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.817 -1.177 . . . . 0.0 111.625 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.22 -36.44 81.97 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.547 -0.721 . . . . 0.0 112.626 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -63.06 -50.72 69.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.769 1.628 . . . . 0.0 111.934 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.3 -34.74 77.18 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.71 0.804 . . . . 0.0 112.914 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 -10.07 59.74 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.12 31.05 79.49 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 119.166 0.894 . . . . 0.0 113.748 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.67 0.01 51.88 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -169.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.0 m 61.38 -21.07 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 128.197 2.599 . . . . 0.0 116.676 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -151.71 160.55 43.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.508 1.923 . . . . 0.0 111.616 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.49 114.63 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.81 1.644 . . . . 0.0 110.5 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.27 175.48 46.19 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.329 0.966 . . . . 0.0 113.498 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.3 p -58.1 -39.92 79.86 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.729 -0.865 . . . . 0.0 110.927 171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -48.03 -57.39 5.85 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.777 2.031 . . . . 0.0 111.481 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -65.46 -32.0 73.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.0 0.92 . . . . 0.0 113.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.76 -49.31 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 119.136 0.88 . . . . 0.0 110.941 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.21 -42.39 96.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 118.322 -0.847 . . . . 0.0 111.368 177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.03 -33.83 67.6 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 119.044 0.838 . . . . 0.0 112.184 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.71 -45.08 87.43 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.188 0.899 . . . . 0.0 113.729 170.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.9 mt -59.5 -46.15 89.67 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.694 1.198 . . . . 0.0 112.852 178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -70.01 -36.09 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.551 0.614 . . . . 0.0 112.488 175.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -71.05 -29.0 64.79 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.38 -38.86 91.24 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.695 0.679 . . . . 0.0 111.833 171.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.16 -29.02 0.32 Allowed Glycine 0 CA--C 1.54 1.641 0 C-N-CA 126.261 1.886 . . . . 0.0 117.713 169.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -103.11 -21.68 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.827 1.314 . . . . 0.0 112.829 -176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.45 155.88 49.14 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.453 -0.78 . . . . 0.0 113.221 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 72.7 t -53.28 -35.9 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.656 1.182 . . . . 0.0 111.963 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.95 -44.47 78.46 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.91 -36.19 79.76 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.372 -0.83 . . . . 0.0 112.328 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.1 mtt180 -63.24 -45.79 89.92 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.143 0.977 . . . . 0.0 111.199 176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.83 -49.96 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.454 1.502 . . . . 0.0 111.306 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.3 mt -60.04 -43.4 95.38 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.202 -0.427 . . . . 0.0 111.6 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.26 -33.59 75.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -67.05 -38.52 85.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.035 0.834 . . . . 0.0 112.101 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.2 mt -76.89 -32.38 57.4 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.324 1.049 . . . . 0.0 112.76 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.27 -0.44 6.49 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 125.687 1.613 . . . . 0.0 115.604 173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.4 t -81.84 147.48 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.408 1.483 . . . . 0.0 110.772 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.1 t -135.84 167.31 21.42 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.381 1.472 . . . . 0.0 110.759 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.15 -48.71 44.61 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.322 1.849 . . . . 0.0 111.974 -175.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -75.24 -30.23 60.46 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.95 -48.57 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 119.132 0.878 . . . . 0.0 110.714 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.75 -42.52 90.81 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.912 0.885 . . . . 0.0 111.62 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.5 mtt-85 -54.33 -54.22 43.35 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.663 1.12 . . . . 0.0 111.948 171.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -62.74 -41.72 99.32 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.323 0.965 . . . . 0.0 113.057 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -70.06 -40.57 75.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.596 1.089 . . . . 0.0 112.5 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.17 -45.46 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.055 0.843 . . . . 0.0 111.329 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.37 -25.14 66.65 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.28 1.032 . . . . 0.0 112.835 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -79.57 -55.96 4.65 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.675 0.671 . . . . 0.0 111.123 168.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.3 tp -66.62 -19.4 65.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.03 -10.12 36.88 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 155.13 -2.32 0.19 Allowed Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.259 1.264 . . . . 0.0 116.259 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.4 m -106.76 -1.0 23.08 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.11 1.764 . . . . 0.0 114.201 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.413 1.885 . . . . 0.0 111.872 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.586 -0.154 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.37 165.86 30.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.112 1.365 . . . . 0.0 112.275 172.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -98.53 -27.56 13.98 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.405 1.482 . . . . 0.0 114.266 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.92 -1.91 15.01 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -78.63 139.26 38.57 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.661 1.984 . . . . 0.0 111.544 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -120.13 146.57 45.85 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.085 1.754 . . . . 0.0 109.479 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -64.8 163.24 14.54 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 121.106 -0.996 . . . . 0.0 111.914 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.19 -32.74 72.49 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.874 -1.141 . . . . 0.0 112.714 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -74.13 -36.29 64.17 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.186 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.02 77.57 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.433 1.015 . . . . 0.0 111.781 177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -57.13 -39.94 76.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.607 0.763 . . . . 0.0 111.476 170.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -65.02 -40.25 94.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.724 175.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.05 -36.05 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 120.903 1.683 . . . . 0.0 111.763 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.33 -33.33 63.13 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.615 0.643 . . . . 0.0 112.62 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.69 -40.12 88.38 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.295 -0.878 . . . . 0.0 111.71 169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.1 mt -69.36 -31.24 69.53 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.582 0.753 . . . . 0.0 112.242 174.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -37.56 84.05 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.459 1.027 . . . . 0.0 112.016 171.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -68.99 -42.2 76.83 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.215 0.606 . . . . 0.0 111.825 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.48 -39.94 95.08 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.632 -0.667 . . . . 0.0 112.041 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.45 -36.11 65.85 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.192 0.997 . . . . 0.0 112.768 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.75 -48.39 81.34 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.587 0.63 . . . . 0.0 110.676 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.1 -40.57 98.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.004 0.922 . . . . 0.0 113.109 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -58.93 -40.25 84.01 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 119.118 0.872 . . . . 0.0 112.064 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.11 -0.02 57.09 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.966 1.306 . . . . 0.0 114.118 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.78 17.19 80.09 Favored Glycine 0 CA--C 1.536 1.381 0 O-C-N 121.112 -0.993 . . . . 0.0 115.043 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -85.73 120.89 27.65 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.127 1.463 . . . . 0.0 109.378 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -83.83 24.0 0.94 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.369 -0.832 . . . . 0.0 112.25 169.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.07 153.66 40.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.721 1.609 . . . . 0.0 110.825 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.7 mt -99.18 123.51 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.201 1.4 . . . . 0.0 109.907 170.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.17 176.64 25.8 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.315 1.912 . . . . 0.0 111.771 168.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -54.66 -40.32 68.92 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.838 0.828 . . . . 0.0 111.191 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.37 -50.16 41.33 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 128.788 2.835 . . . . 0.0 113.597 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -71.66 -31.17 66.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.488 0.586 . . . . 0.0 111.658 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.4 mt -69.73 -42.91 80.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 118.606 0.639 . . . . 0.0 110.66 173.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.7 tp -64.73 -39.9 94.41 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.243 0.929 . . . . 0.0 111.678 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.1 tp -69.96 -37.18 75.73 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.967 0.907 . . . . 0.0 112.074 177.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.77 -38.02 95.81 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.643 1.116 . . . . 0.0 112.799 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.99 -56.07 25.15 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.615 1.166 . . . . 0.0 112.58 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.9 -29.37 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 119.424 1.011 . . . . 0.0 113.454 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -68.26 -24.63 64.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.686 0.794 . . . . 0.0 112.786 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -77.2 -53.82 7.26 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.721 0.808 . . . . 0.0 109.655 169.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.52 -9.44 10.48 Favored Glycine 0 CA--C 1.539 1.552 0 N-CA-C 117.936 1.935 . . . . 0.0 117.936 168.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -116.28 -26.48 7.16 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.962 1.881 . . . . 0.0 113.176 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.34 154.3 25.66 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.307 1.432 . . . . 0.0 113.342 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 -44.14 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.162 1.385 . . . . 0.0 112.512 -173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.99 82.19 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.908 0.777 . . . . 0.0 112.863 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.91 -35.93 81.98 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.168 -0.957 . . . . 0.0 111.907 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -67.96 -36.37 79.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.084 0.954 . . . . 0.0 111.665 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.62 -42.12 91.89 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.363 1.065 . . . . 0.0 112.356 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.5 mt -60.82 -48.34 82.24 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.885 0.766 . . . . 0.0 111.359 173.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -64.34 -36.16 83.23 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -32.51 74.28 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.324 1.049 . . . . 0.0 113.039 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.18 1.392 . . . . 0.0 113.852 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 8.01 73.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.037 1.303 . . . . 0.0 114.766 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.5 mt -83.88 -175.89 6.02 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 118.299 1.05 . . . . 0.0 111.569 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.83 164.56 36.7 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.965 1.269 . . . . 0.0 111.648 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.0 t -58.69 -42.06 87.68 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.135 0.574 . . . . 0.0 112.429 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -60.77 -43.53 97.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.403 1.081 . . . . 0.0 112.625 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.74 -47.72 68.48 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.236 1.014 . . . . 0.0 111.456 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.92 -41.77 82.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.017 0.927 . . . . 0.0 110.645 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -63.69 -45.44 90.03 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.731 0.812 . . . . 0.0 112.24 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -64.54 -38.11 89.88 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.936 0.789 . . . . 0.0 112.957 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -67.27 -42.34 84.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.25 0.932 . . . . 0.0 112.764 173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.9 t -60.32 -55.33 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 119.131 0.878 . . . . 0.0 110.66 174.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.78 -33.79 76.45 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.666 0.787 . . . . 0.0 112.918 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.0 t -64.93 -33.33 75.77 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.562 0.745 . . . . 0.0 112.474 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.1 mt -84.61 -35.63 22.59 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.7 pt -107.25 -25.34 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -172.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.48 -158.73 12.53 Favored Glycine 0 CA--C 1.54 1.639 0 C-N-CA 124.408 1.004 . . . . 0.0 115.301 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -67.51 132.91 48.5 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.262 1.025 . . . . 0.0 109.945 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.15 -167.79 42.04 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 119.04 2.376 . . . . 0.0 119.04 -167.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -75.27 75.84 2.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.791 2.436 . . . . 0.0 108.771 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -85.37 65.75 9.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.885 1.326 . . . . 0.0 112.509 -168.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.3 mmt -92.27 -44.24 8.86 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.33 -1.305 . . . . 0.0 112.828 -170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.5 t -167.38 -165.06 0.64 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.211 1.804 . . . . 0.0 110.317 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -99.35 -177.51 3.62 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.804 2.042 . . . . 0.0 110.66 169.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.8 m 63.69 91.38 0.07 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.555 1.942 . . . . 0.0 112.71 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.44 146.22 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 125.522 1.529 . . . . 0.0 112.213 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -121.95 163.59 19.06 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.269 1.428 . . . . 0.0 110.734 167.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -93.78 132.56 38.05 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 120.757 -1.214 . . . . 0.0 110.692 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.6 p -65.28 161.04 53.31 Favored Pre-proline 0 N--CA 1.477 0.906 0 C-N-CA 123.34 0.656 . . . . 0.0 111.544 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -55.28 -36.02 92.64 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.665 2.243 . . . . 0.0 113.362 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -71.5 -42.79 67.59 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.292 0.637 . . . . 0.0 112.573 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.53 93.6 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.292 0.951 . . . . 0.0 111.771 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -59.77 -44.48 93.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.058 0.943 . . . . 0.0 111.552 172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -61.49 -44.98 96.11 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.987 0.915 . . . . 0.0 111.644 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 36.5 t -57.61 -46.8 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.088 0.955 . . . . 0.0 111.768 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.9 mm -61.06 -45.05 99.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 119.604 1.093 . . . . 0.0 111.558 178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.12 -37.01 83.15 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.547 -0.721 . . . . 0.0 112.843 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.57 -41.96 78.97 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.578 -0.701 . . . . 0.0 111.51 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.8 m -58.52 -40.82 83.96 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.405 1.082 . . . . 0.0 111.472 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 39.4 ttm -69.16 -25.03 64.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.986 0.914 . . . . 0.0 112.962 175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.64 -38.23 29.56 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.79 -1.194 . . . . 0.0 112.671 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.02 -39.43 89.73 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.023 -1.048 . . . . 0.0 111.629 172.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.35 -39.66 87.93 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.634 -0.666 . . . . 0.0 112.238 173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -71.13 -34.11 70.74 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.648 1.179 . . . . 0.0 113.175 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -60.95 -40.7 94.28 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 119.988 1.267 . . . . 0.0 112.145 170.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.67 -9.73 59.5 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.312 1.045 . . . . 0.0 113.468 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.19 19.25 79.83 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.452 1.025 . . . . 0.0 114.713 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -78.12 148.73 34.03 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.348 1.074 . . . . 0.0 110.524 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.2 m -86.86 9.6 18.71 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.563 1.145 . . . . 0.0 113.716 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -161.13 155.35 22.83 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.254 2.221 . . . . 0.0 110.464 -173.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.4 t -84.93 115.74 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.01 1.324 . . . . 0.0 109.931 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.33 172.1 46.7 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.074 0.845 . . . . 0.0 113.528 173.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -58.93 -39.01 80.3 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.729 -0.865 . . . . 0.0 111.035 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.9 -51.74 38.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.811 2.044 . . . . 0.0 111.754 169.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -70.38 -31.35 68.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.922 0.889 . . . . 0.0 112.763 -178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.19 -48.44 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.771 0.714 . . . . 0.0 110.582 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 tp -64.2 -43.25 95.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.565 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.7 mt -58.36 -32.86 68.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.024 0.829 . . . . 0.0 112.633 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.0 83.73 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.172 0.892 . . . . 0.0 113.63 170.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.19 -47.44 83.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.575 1.187 . . . . 0.0 112.24 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.13 -31.36 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 176.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -69.25 -30.88 69.11 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.262 1.392 . . . . 0.0 112.796 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -66.05 -40.92 91.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.06 0.845 . . . . 0.0 110.084 173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.81 6.69 25.26 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 119.35 2.5 . . . . 0.0 119.35 165.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -135.74 -29.18 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 120.361 2.08 . . . . 0.0 113.737 -172.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.31 169.38 32.57 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.203 1.382 . . . . 0.0 112.886 169.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.4 t -57.24 -36.37 51.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.227 1.011 . . . . 0.0 112.47 -171.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.11 79.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.398 0.999 . . . . 0.0 113.331 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.08 -34.79 78.87 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.68 -0.637 . . . . 0.0 112.02 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -67.68 -47.19 70.18 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.449 1.1 . . . . 0.0 111.694 176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -55.54 -49.39 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.151 1.381 . . . . 0.0 111.161 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.28 -43.12 99.4 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.765 0.426 . . . . 0.0 111.747 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -71.39 -31.33 67.17 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -65.86 -40.14 91.38 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.87 0.868 . . . . 0.0 111.712 172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.2 mt -74.58 -33.76 62.73 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.19 0.996 . . . . 0.0 112.498 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.33 2.09 4.64 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.211 1.386 . . . . 0.0 115.65 170.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 98.2 t -88.53 135.54 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.268 1.427 . . . . 0.0 110.829 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.8 p -105.64 170.18 8.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.953 1.301 . . . . 0.0 111.714 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.07 -47.02 61.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.837 1.255 . . . . 0.0 111.231 173.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -75.55 -39.04 58.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.14 0.976 . . . . 0.0 112.648 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -67.12 -40.06 86.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.707 0.803 . . . . 0.0 111.911 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.23 -46.39 77.36 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.478 0.711 . . . . 0.0 111.404 169.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -56.0 -50.11 71.78 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.085 0.857 . . . . 0.0 112.88 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.36 -38.0 87.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.134 0.879 . . . . 0.0 112.558 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -73.37 -42.13 62.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.224 0.92 . . . . 0.0 112.813 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 77.9 t -66.71 -44.31 89.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 119.173 0.897 . . . . 0.0 111.265 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.32 -24.99 64.0 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.531 1.132 . . . . 0.0 112.79 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -76.84 -52.02 10.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.709 0.686 . . . . 0.0 111.823 168.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.0 tp -73.23 -17.91 61.29 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -66.52 -5.53 11.62 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.45 2.88 0.56 Allowed Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.788 1.185 . . . . 0.0 115.666 174.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.7 m -102.84 -16.66 15.84 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 171.132 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 168.16 16.98 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.198 0.999 . . . . 0.0 113.049 178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -63.9 -43.2 96.71 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.218 1.007 . . . . 0.0 113.056 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.91 3.96 18.65 Favored Glycine 0 CA--C 1.542 1.754 0 N-CA-C 116.491 1.356 . . . . 0.0 116.491 175.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.43 143.19 31.35 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.982 1.713 . . . . 0.0 111.647 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -121.43 147.86 45.18 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.365 1.866 . . . . 0.0 109.415 173.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -65.15 164.43 13.15 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.915 -1.115 . . . . 0.0 112.178 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -60.2 -39.03 85.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.826 -1.171 . . . . 0.0 111.472 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -60.84 -45.46 94.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.247 1.019 . . . . 0.0 112.009 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.61 -44.29 78.39 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 111.718 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -57.68 -36.69 72.28 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.557 0.743 . . . . 0.0 111.544 171.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -67.93 -39.0 83.57 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 117.708 -1.139 . . . . 0.0 113.05 174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.43 79.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 120.736 1.607 . . . . 0.0 111.384 173.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.5 mt -73.79 -34.85 64.82 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.87 -40.33 91.56 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.28 -0.887 . . . . 0.0 111.908 170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.5 mt -73.92 -24.4 59.68 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.313 -0.867 . . . . 0.0 112.96 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -36.12 82.59 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.382 0.992 . . . . 0.0 111.814 169.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -67.95 -46.33 71.74 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.62 0.768 . . . . 0.0 111.067 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -61.59 -43.23 99.25 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.094 0.406 . . . . 0.0 111.49 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -70.3 -34.21 72.47 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.56 -52.41 65.78 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.586 1.085 . . . . 0.0 110.248 169.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.89 -34.16 77.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -63.78 -36.2 83.11 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.674 1.59 . . . . 0.0 112.307 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -80.03 -4.77 54.03 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.064 1.346 . . . . 0.0 113.654 173.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.11 18.92 79.09 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.03 -1.044 . . . . 0.0 114.15 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -93.28 154.2 18.14 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.069 1.348 . . . . 0.0 109.445 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.254 0.4 OUTLIER -127.3 36.61 4.38 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.176 -0.953 . . . . 0.0 113.229 169.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.94 140.27 26.81 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.689 1.196 . . . . 0.0 111.002 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.38 118.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.424 1.09 . . . . 0.0 109.453 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.06 177.78 31.55 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.542 1.544 . . . . 0.0 111.046 167.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.2 p -56.31 -39.56 72.95 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.304 1.049 . . . . 0.0 111.346 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.87 -49.38 49.59 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 130.106 3.362 . . . . 0.0 113.182 169.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -73.25 -30.19 63.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.688 -0.672 . . . . 0.0 111.844 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.4 mt -69.3 -42.54 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 172.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.46 -40.91 93.74 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.817 0.735 . . . . 0.0 111.436 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.68 -36.83 84.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.448 0.699 . . . . 0.0 111.659 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.75 -40.01 98.21 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.948 1.261 . . . . 0.0 113.108 172.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.86 -51.89 67.27 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.456 1.128 . . . . 0.0 112.413 172.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -28.26 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -32.23 73.2 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.14 0.976 . . . . 0.0 111.935 172.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -77.1 -46.77 22.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.58 1.152 . . . . 0.0 111.335 175.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.11 -0.45 6.14 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 167.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.84 -7.63 9.51 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 120.146 1.973 . . . . 0.0 114.093 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.86 158.29 51.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.338 1.447 . . . . 0.0 113.686 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.7 mm -58.19 -41.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.25 1.02 . . . . 0.0 110.962 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.69 95.06 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.57 94.3 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.26 -0.9 . . . . 0.0 111.617 175.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.4 tttp -62.27 -37.84 87.02 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.736 -0.602 . . . . 0.0 111.773 173.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.0 -41.54 86.54 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.454 1.102 . . . . 0.0 112.888 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.2 mt -59.4 -48.04 83.14 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.091 0.859 . . . . 0.0 110.931 173.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.65 -32.64 72.63 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.11 74.91 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.036 -1.04 . . . . 0.0 112.868 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.7 mt -77.0 9.03 3.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.389 1.476 . . . . 0.0 113.646 171.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.94 6.05 76.38 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.022 1.296 . . . . 0.0 114.758 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 mt -79.67 -176.91 5.6 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.355 1.078 . . . . 0.0 111.662 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.71 161.06 34.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.073 1.321 . . . . 0.0 111.253 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -57.87 -43.8 86.23 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.427 0.691 . . . . 0.0 112.531 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.38 -39.69 92.56 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.979 0.912 . . . . 0.0 112.541 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -64.52 -48.98 73.09 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 111.464 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.5 mt -69.21 -42.64 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 0.0 110.506 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.07 -42.05 97.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.729 0.695 . . . . 0.0 112.168 176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -60.85 -47.37 86.68 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.803 0.728 . . . . 0.0 111.751 176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.92 -28.98 64.91 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -66.49 -56.32 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.55 1.068 . . . . 0.0 109.393 169.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.76 -32.22 73.8 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -71.34 -18.93 62.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 175.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -96.04 -32.67 12.44 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.419 1.088 . . . . 0.0 113.361 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 pt -109.86 -17.97 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.34 -167.0 24.39 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.396 0.998 . . . . 0.0 115.055 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 85.4 mtm180 -123.09 153.86 39.36 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.832 1.653 . . . . 0.0 111.935 178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.12 92.43 0.24 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.893 1.235 . . . . 0.0 112.868 -177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -140.03 53.54 1.66 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 108.533 175.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -83.7 136.76 34.07 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.687 1.195 . . . . 0.0 113.893 -169.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 mtt -134.55 7.21 3.55 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 127.661 2.384 . . . . 0.0 111.565 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m 58.34 55.44 5.0 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.794 2.037 . . . . 0.0 114.541 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -150.06 173.3 14.02 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.977 1.311 . . . . 0.0 113.467 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.1 t -75.21 173.15 11.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.426 1.091 . . . . 0.0 110.907 167.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.84 142.03 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -169.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -126.95 158.43 36.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.559 2.344 . . . . 0.0 108.483 167.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -93.88 139.4 30.94 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.3 p -68.01 162.54 58.54 Favored Pre-proline 0 N--CA 1.479 1.002 0 O-C-N 121.727 -0.608 . . . . 0.0 110.806 170.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.34 -33.86 92.61 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.188 1.925 . . . . 0.0 113.178 173.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 mtm105 -68.64 -46.09 70.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.74 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -39.0 84.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.528 -0.733 . . . . 0.0 112.392 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -58.65 -43.65 89.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.198 0.999 . . . . 0.0 111.147 171.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -67.17 -37.9 84.54 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 118.318 -0.848 . . . . 0.0 112.274 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.1 t -58.86 -46.27 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 119.956 1.253 . . . . 0.0 111.717 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.7 mm -61.69 -42.8 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.414 1.007 . . . . 0.0 111.169 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -68.62 -35.19 76.97 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.08 -31.87 66.5 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.219 -0.926 . . . . 0.0 111.793 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.3 m -62.53 -41.6 98.97 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.642 1.11 . . . . 0.0 111.736 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.8 ptp -74.02 -24.17 59.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 172.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -72.66 -41.1 65.78 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.562 -0.711 . . . . 0.0 112.694 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -64.37 -33.62 76.28 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.435 -1.416 . . . . 0.0 111.496 171.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -46.85 81.09 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.572 -0.705 . . . . 0.0 112.368 170.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -72.02 -25.36 61.78 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.004 -1.06 . . . . 0.0 113.748 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -59.65 -35.05 73.63 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 119.558 1.072 . . . . 0.0 111.643 168.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mp -84.89 -4.46 59.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.732 1.613 . . . . 0.0 113.625 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.78 18.51 72.39 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.235 0.921 . . . . 0.0 113.971 -172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.82 133.96 37.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.888 1.275 . . . . 0.0 111.236 -174.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -77.74 -1.78 32.98 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -160.27 164.22 32.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.7 2.0 . . . . 0.0 110.579 -177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.6 t -90.79 115.35 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.43 1.492 . . . . 0.0 110.629 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.77 173.12 45.02 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.977 0.798 . . . . 0.0 112.984 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.3 p -58.3 -38.39 76.95 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 121.469 -1.018 . . . . 0.0 111.278 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -49.83 -52.0 35.75 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.135 2.174 . . . . 0.0 111.572 169.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -70.9 -30.24 66.54 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.083 0.953 . . . . 0.0 112.92 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.4 mt -61.23 -47.42 93.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.978 0.808 . . . . 0.0 110.418 169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 tp -64.07 -41.63 97.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.84 -0.6 . . . . 0.0 111.393 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.7 mt -57.41 -38.07 73.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.665 0.666 . . . . 0.0 112.296 172.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.33 -40.8 99.37 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.091 0.853 . . . . 0.0 113.404 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.0 mt -64.36 -38.41 90.92 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.452 1.126 . . . . 0.0 112.825 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -41.19 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 119.233 0.924 . . . . 0.0 112.194 174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.18 -32.09 70.74 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.268 1.027 . . . . 0.0 112.406 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.06 -44.17 97.26 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.247 1.019 . . . . 0.0 112.542 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.87 -29.19 0.29 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.059 1.79 . . . . 0.0 117.031 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -99.09 -13.05 19.99 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.648 1.579 . . . . 0.0 113.733 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.78 167.52 48.01 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.37 -0.832 . . . . 0.0 113.596 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.55 -37.79 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.241 0.616 . . . . 0.0 109.696 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.09 -43.54 82.29 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.42 -36.96 85.48 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.671 -0.643 . . . . 0.0 112.175 175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -42.56 77.75 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.902 0.881 . . . . 0.0 112.721 174.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.6 t -56.48 -49.0 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.599 1.159 . . . . 0.0 110.918 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.1 -44.13 97.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.058 0.543 . . . . 0.0 111.755 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -70.08 -32.42 70.49 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -67.11 -40.91 86.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.944 0.898 . . . . 0.0 111.651 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.02 -31.93 64.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.207 1.003 . . . . 0.0 112.427 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.15 4.74 7.65 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.471 1.51 . . . . 0.0 115.528 170.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.1 t -82.93 144.18 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.212 1.405 . . . . 0.0 110.89 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 92.3 p -130.16 167.71 17.96 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.939 1.696 . . . . 0.0 111.395 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 10.4 mt -48.09 -52.4 20.47 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.882 1.273 . . . . 0.0 112.915 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -72.8 -36.25 67.53 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -70.08 -42.88 72.18 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.981 0.81 . . . . 0.0 111.653 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.03 -50.42 70.75 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.029 0.931 . . . . 0.0 111.621 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 81.9 mtt-85 -59.93 -47.38 86.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.129 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.97 -39.51 94.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.686 1.13 . . . . 0.0 112.567 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -69.37 -45.97 68.06 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.561 1.073 . . . . 0.0 112.419 176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 99.4 t -65.89 -43.52 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 118.881 0.764 . . . . 0.0 111.267 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.79 -25.52 62.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.541 1.136 . . . . 0.0 113.247 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -78.99 -50.14 11.59 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.023 0.829 . . . . 0.0 111.617 168.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.03 -17.27 61.46 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -168.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.8 -5.3 11.68 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 147.53 -6.81 1.08 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.856 1.217 . . . . 0.0 115.015 175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -89.37 -9.4 50.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.323 1.449 . . . . 0.0 114.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.135 1.774 . . . . 0.0 111.99 174.093 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 110.716 -0.105 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.5 mmm -67.88 153.27 44.09 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.348 1.059 . . . . 0.0 112.623 177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -77.37 3.6 12.8 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.521 1.128 . . . . 0.0 113.713 173.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.53 8.47 58.81 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 126.396 1.95 . . . . 0.0 116.536 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.87 149.65 46.56 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.772 1.229 . . . . 0.0 109.127 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -113.79 143.39 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.17 0.988 . . . . 0.0 109.887 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -64.49 164.86 10.85 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 121.287 -0.883 . . . . 0.0 112.394 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -64.9 -15.46 62.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.909 -1.12 . . . . 0.0 113.346 177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.35 -40.56 13.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.835 1.254 . . . . 0.0 111.838 169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.54 82.85 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.778 0.831 . . . . 0.0 112.054 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -58.9 -36.74 75.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.618 0.767 . . . . 0.0 112.064 171.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -66.99 -40.69 87.45 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.315 -0.85 . . . . 0.0 112.399 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -40.4 88.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.826 1.194 . . . . 0.0 111.05 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.43 -29.76 62.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.33 -42.29 72.09 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.367 -0.833 . . . . 0.0 112.126 170.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.7 -36.13 82.76 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.621 0.768 . . . . 0.0 111.823 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.46 -32.43 64.95 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.42 -45.62 68.74 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.448 -0.782 . . . . 0.0 111.673 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -68.62 -35.71 77.66 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.569 -0.707 . . . . 0.0 111.304 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -64.79 -37.45 87.66 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.211 1.004 . . . . 0.0 112.49 174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.92 -49.09 76.16 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.696 0.68 . . . . 0.0 111.578 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.5 mt -66.89 -32.77 74.25 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -61.06 -36.73 80.4 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.676 1.59 . . . . 0.0 112.27 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.3 5.17 52.47 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.3 36.76 49.55 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.637 -0.665 . . . . 0.0 113.491 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -116.87 143.19 45.98 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.262 1.425 . . . . 0.0 111.199 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.6 p-10 -100.76 15.85 26.98 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.768 1.227 . . . . 0.0 113.896 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -149.02 153.55 38.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.093 0.957 . . . . 0.0 112.545 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.7 mt -98.11 121.68 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.032 1.733 . . . . 0.0 109.664 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.03 -178.17 25.48 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.815 2.15 . . . . 0.0 111.889 168.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 p -55.97 -41.62 75.01 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.157 0.98 . . . . 0.0 111.156 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.57 -45.82 57.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.471 3.108 . . . . 0.0 113.7 171.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -76.22 -34.96 59.25 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.74 -0.6 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -63.23 -40.4 88.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 123.107 0.563 . . . . 0.0 110.178 170.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.12 -43.32 82.73 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.784 0.72 . . . . 0.0 111.963 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.83 -41.57 87.2 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.178 0.899 . . . . 0.0 112.052 171.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.92 93.71 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.055 0.836 . . . . 0.0 112.368 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.29 -57.81 11.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.376 1.07 . . . . 0.0 112.599 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.24 -21.0 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -77.45 -27.95 52.28 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.262 0.937 . . . . 0.0 112.66 169.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -70.67 -47.59 59.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.835 0.743 . . . . 0.0 109.338 169.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.56 -6.13 4.96 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 166.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -124.12 -24.71 4.3 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.005 1.903 . . . . 0.0 114.102 -169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.57 29.66 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.858 1.218 . . . . 0.0 113.313 170.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.91 -43.32 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.662 1.185 . . . . 0.0 112.704 -170.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.48 85.55 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.182 0.901 . . . . 0.0 113.079 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.83 -35.47 80.12 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.345 -0.847 . . . . 0.0 111.753 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -68.16 -35.44 78.06 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.289 1.036 . . . . 0.0 111.822 173.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.4 -40.53 81.26 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.595 1.158 . . . . 0.0 112.515 172.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -60.16 -46.62 89.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.86 0.755 . . . . 0.0 111.14 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -65.19 -34.69 78.97 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.19 77.55 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.388 0.995 . . . . 0.0 112.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.05 7.19 4.32 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.309 1.444 . . . . 0.0 113.2 169.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.01 4.71 86.75 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.449 1.5 . . . . 0.0 115.093 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -91.22 99.44 12.43 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.055 1.427 . . . . 0.0 111.228 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.62 155.56 52.81 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.333 0.492 . . . . 0.0 112.32 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.5 p -55.23 -45.2 75.98 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.466 1.106 . . . . 0.0 112.562 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -53.18 -42.83 66.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.822 1.249 . . . . 0.0 112.719 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -71.31 -42.52 68.52 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.46 0.704 . . . . 0.0 111.43 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.0 mt -66.81 -47.87 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.112 0.965 . . . . 0.0 110.758 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.35 -39.14 91.98 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.698 -0.626 . . . . 0.0 112.135 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.82 -44.11 97.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.146 0.978 . . . . 0.0 112.462 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -65.08 -38.83 92.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.67 -53.77 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.929 0.786 . . . . 0.0 110.812 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -63.17 -30.73 71.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -62.01 -29.07 70.02 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.441 -0.787 . . . . 0.0 112.599 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.27 -46.78 7.54 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.2 1.4 . . . . 0.0 112.727 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.1 pt -99.97 -7.11 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.89 73.13 0.85 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.897 1.237 . . . . 0.0 113.141 -177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -132.12 -25.02 2.05 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.643 1.977 . . . . 0.0 113.683 -175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.7 134.99 0.78 Allowed Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.187 1.851 . . . . 0.0 113.803 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -151.12 6.68 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -62.44 127.37 31.01 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.763 -1.211 . . . . 0.0 112.897 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.5 mmt -113.48 39.57 2.6 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.82 1.648 . . . . 0.0 112.247 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 m 54.71 49.91 16.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.746 1.619 . . . . 0.0 113.824 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -135.86 150.05 49.25 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.792 1.637 . . . . 0.0 111.449 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -69.82 169.04 13.84 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.846 0.858 . . . . 0.0 111.557 168.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.42 145.04 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -138.18 160.0 40.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.354 2.262 . . . . 0.0 109.53 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -95.96 133.01 40.67 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.169 -0.957 . . . . 0.0 111.018 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.4 p -66.8 163.85 39.3 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.747 -0.596 . . . . 0.0 111.526 174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -55.03 -32.69 80.29 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.362 2.041 . . . . 0.0 113.248 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -67.23 -48.06 68.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.786 0.834 . . . . 0.0 111.323 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.42 -38.62 81.41 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.039 0.536 . . . . 0.0 112.401 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -59.89 -44.87 93.99 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.186 0.994 . . . . 0.0 111.158 173.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -61.6 -44.54 96.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.869 0.868 . . . . 0.0 111.783 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -58.24 -44.32 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.178 0.899 . . . . 0.0 112.066 172.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.1 mm -63.78 -45.39 97.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 119.851 1.205 . . . . 0.0 111.468 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.88 -38.9 92.53 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.559 -0.713 . . . . 0.0 112.372 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.6 -38.31 83.79 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.468 -0.77 . . . . 0.0 112.09 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -61.44 -41.84 97.82 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.315 -0.865 . . . . 0.0 110.908 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.1 ttm -66.94 -38.64 86.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.002 1.321 . . . . 0.0 112.348 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -69.88 -36.74 75.7 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.343 1.057 . . . . 0.0 113.195 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -71.31 -37.05 71.8 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.827 -1.171 . . . . 0.0 112.136 174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.67 -43.82 80.78 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.306 -0.871 . . . . 0.0 113.032 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -70.59 -27.73 64.33 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -69.56 -31.25 69.32 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.145 0.978 . . . . 0.0 112.538 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.93 7.63 33.56 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.688 1.195 . . . . 0.0 112.887 170.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.89 13.95 78.49 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.252 . . . . 0.0 115.991 172.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -89.35 140.4 29.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.113 1.457 . . . . 0.0 111.737 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.4 p -92.68 20.89 5.96 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.252 1.421 . . . . 0.0 112.841 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -161.23 155.66 23.05 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.625 2.37 . . . . 0.0 110.27 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.8 t -94.78 114.76 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.34 1.856 . . . . 0.0 110.227 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.13 173.17 48.28 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.071 0.843 . . . . 0.0 113.593 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.3 p -58.05 -40.13 80.18 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.736 -0.861 . . . . 0.0 110.961 171.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.88 -52.91 17.48 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.222 2.209 . . . . 0.0 111.642 169.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -71.7 -29.48 64.61 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.096 0.958 . . . . 0.0 112.831 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.24 -47.7 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 118.921 0.782 . . . . 0.0 110.438 169.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -63.8 -42.3 97.74 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.377 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -56.57 -36.71 69.64 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 119.224 0.92 . . . . 0.0 112.105 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.93 -45.59 95.34 Favored Glycine 0 CA--C 1.538 1.505 0 CA-C-N 119.122 0.874 . . . . 0.0 113.929 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.89 -48.36 81.72 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.529 1.165 . . . . 0.0 112.428 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -73.11 -33.94 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 176.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -68.59 -30.76 69.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.721 1.146 . . . . 0.0 112.659 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -65.14 -46.79 79.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 119.17 0.895 . . . . 0.0 109.927 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.7 1.26 37.11 Favored Glycine 0 CA--C 1.538 1.526 0 N-CA-C 119.26 2.464 . . . . 0.0 119.26 166.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -127.44 -28.75 2.76 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.76 2.28 . . . . 0.0 113.604 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.19 169.61 13.35 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.19 1.376 . . . . 0.0 113.926 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.6 t -57.66 -37.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.825 0.85 . . . . 0.0 111.579 -174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.32 77.98 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.349 0.977 . . . . 0.0 113.002 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.11 89.27 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.653 -0.655 . . . . 0.0 111.604 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -61.81 -47.05 86.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.891 1.276 . . . . 0.0 112.325 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.14 -47.05 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.992 1.717 . . . . 0.0 111.563 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.01 -42.74 99.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 119.389 -0.338 . . . . 0.0 111.199 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -68.14 -33.61 74.8 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -64.5 -40.69 96.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.329 0.968 . . . . 0.0 111.745 172.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.5 mt -77.83 -33.84 52.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.458 1.103 . . . . 0.0 112.82 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.85 -1.89 5.14 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.299 1.428 . . . . 0.0 115.697 171.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.6 t -80.18 146.56 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.158 1.383 . . . . 0.0 110.73 173.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.9 t -134.79 168.36 19.19 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.083 1.353 . . . . 0.0 110.75 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.38 -48.41 36.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.598 1.959 . . . . 0.0 111.902 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 p30 -73.02 -39.86 65.64 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.715 1.206 . . . . 0.0 113.783 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -61.36 -47.56 85.3 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.086 0.955 . . . . 0.0 111.211 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.19 -45.53 80.52 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.998 0.919 . . . . 0.0 111.661 177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -54.35 -52.66 60.88 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.463 1.029 . . . . 0.0 111.961 173.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -62.86 -40.64 98.12 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.095 0.862 . . . . 0.0 112.644 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -70.69 -42.11 71.1 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.407 1.003 . . . . 0.0 112.502 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.1 -44.89 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.155 0.889 . . . . 0.0 111.26 178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.06 -27.34 65.55 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.572 1.149 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.42 -49.73 15.95 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.789 0.722 . . . . 0.0 111.478 168.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.1 tp -73.44 -20.22 60.77 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.73 -8.53 28.72 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.35 -6.72 0.23 Allowed Glycine 0 CA--C 1.536 1.393 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.4 t -84.15 -28.9 27.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.687 1.243 . . . . 0.0 112.95 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--O 1.254 1.318 0 C-N-CA 125.725 1.61 . . . . 0.0 112.337 175.465 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.5 tpp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.324 -0.37 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . 0.261 22.7 ptt? 52.29 177.2 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 128.336 2.654 . . . . 0.0 116.219 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -84.19 54.69 3.04 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.833 1.253 . . . . 0.0 112.284 -174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.53 36.06 0.69 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.795 2.14 . . . . 0.0 115.252 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -140.16 146.17 38.44 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.141 2.176 . . . . 0.0 110.777 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -119.87 149.0 42.8 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.827 1.651 . . . . 0.0 110.259 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.8 p -64.69 165.46 10.3 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.224 -0.923 . . . . 0.0 112.256 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -59.62 -41.68 90.96 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.818 -1.176 . . . . 0.0 111.464 174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 13' ' ' VAL . 31.0 mmt180 -62.32 -41.93 98.96 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.545 0.738 . . . . 0.0 111.925 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.83 -40.15 76.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.61 0.764 . . . . 0.0 112.054 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -59.8 -40.5 88.57 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.759 0.824 . . . . 0.0 111.587 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -61.96 -41.66 98.25 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.458 172.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -65.75 -35.22 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 121.097 1.771 . . . . 0.0 112.058 177.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.77 -32.41 65.6 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.745 0.702 . . . . 0.0 112.461 175.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -38.97 76.01 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.204 -0.935 . . . . 0.0 112.103 171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.09 -23.93 59.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.397 1.079 . . . . 0.0 112.641 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.8 -34.66 78.41 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.079 0.854 . . . . 0.0 112.002 169.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -68.42 -42.24 79.22 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.4 0.68 . . . . 0.0 111.584 171.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.09 -46.18 88.62 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.534 -0.729 . . . . 0.0 111.543 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -66.57 -31.55 72.33 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.141 0.976 . . . . 0.0 113.136 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.78 -54.33 28.45 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.56 0.618 . . . . 0.0 110.775 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.5 -39.47 91.91 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -67.13 -20.63 65.8 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 119.008 0.822 . . . . 0.0 113.179 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.28 2.78 48.52 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.51 1.924 . . . . 0.0 112.501 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.48 7.75 88.23 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.105 1.336 . . . . 0.0 115.368 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -83.36 125.58 31.81 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.369 1.585 . . . . 0.0 110.064 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -90.78 29.57 1.31 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.837 1.255 . . . . 0.0 111.765 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -153.6 150.23 28.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.886 1.674 . . . . 0.0 111.106 -168.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.4 mt -109.47 117.11 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.834 1.254 . . . . 0.0 108.854 170.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.89 -176.62 29.39 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.023 1.773 . . . . 0.0 111.705 168.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.7 p -57.16 -40.95 78.27 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.566 -0.961 . . . . 0.0 111.022 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -49.47 -48.71 47.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.966 2.906 . . . . 0.0 113.205 169.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -74.29 -31.59 62.57 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.696 -0.628 . . . . 0.0 111.935 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.6 mt -68.33 -39.81 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-N 118.783 0.719 . . . . 0.0 110.733 170.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.76 -44.58 95.83 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 119.358 0.981 . . . . 0.0 111.276 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.82 -42.34 79.41 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.785 0.834 . . . . 0.0 111.628 170.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.16 -45.1 88.52 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.266 0.936 . . . . 0.0 113.202 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.3 mt -57.64 -54.52 45.99 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.319 1.059 . . . . 0.0 111.748 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.78 -22.1 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -71.38 -31.95 67.91 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.803 1.241 . . . . 0.0 111.931 170.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.8 -43.56 62.6 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.425 0.557 . . . . 0.0 110.574 169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.86 -24.58 0.41 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 126.492 1.996 . . . . 0.0 117.561 168.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -100.83 -15.86 17.47 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.797 1.639 . . . . 0.0 113.442 -177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.72 154.84 38.53 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.798 0.713 . . . . 0.0 112.537 178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -54.62 -42.58 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.095 0.958 . . . . 0.0 111.281 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -63.61 -45.85 88.43 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 176.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.71 94.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.219 0.918 . . . . 0.0 111.676 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -72.4 -25.75 61.61 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.68 -40.47 76.37 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.134 0.879 . . . . 0.0 111.93 169.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.78 -46.84 88.92 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 118.966 0.803 . . . . 0.0 111.11 171.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -61.73 -39.65 92.32 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.218 1.007 . . . . 0.0 112.2 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.88 74.82 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.556 1.142 . . . . 0.0 113.257 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.3 mt -74.48 7.88 2.64 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.949 1.3 . . . . 0.0 113.808 170.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.09 71.66 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.131 1.348 . . . . 0.0 114.729 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -85.44 -172.5 4.17 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 118.372 1.086 . . . . 0.0 111.606 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.6 156.27 24.77 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 126.774 2.13 . . . . 0.0 110.192 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.5 m -56.25 -47.75 77.91 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.785 0.834 . . . . 0.0 113.064 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -58.68 -45.23 89.9 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.683 0.793 . . . . 0.0 112.209 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -63.31 -43.97 96.3 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.586 0.754 . . . . 0.0 111.707 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.2 mt -65.07 -48.08 85.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.611 0.764 . . . . 0.0 110.587 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -65.59 -40.01 92.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.337 0.655 . . . . 0.0 112.576 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -67.34 -38.18 84.45 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.366 0.984 . . . . 0.0 113.143 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -69.97 -33.81 72.57 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.758 1.163 . . . . 0.0 112.595 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.82 -53.36 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.072 0.851 . . . . 0.0 110.487 169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -59.27 -34.73 72.61 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.808 0.843 . . . . 0.0 112.746 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 61.2 m -68.1 -18.14 64.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.247 1.019 . . . . 0.0 113.726 174.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.6 mt -100.32 -32.92 10.61 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.183 1.393 . . . . 0.0 113.183 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.9 pt -108.02 -17.04 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.79 -171.9 37.35 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -86.58 33.31 0.64 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.284 1.834 . . . . 0.0 115.024 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.76 -170.56 52.73 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 117.816 1.887 . . . . 0.0 117.816 168.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -120.01 -28.27 5.18 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.756 2.022 . . . . 0.0 113.19 -169.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 42.14 65.86 0.82 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.542 2.737 . . . . 0.0 115.888 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 62.5 mtt -98.6 -37.41 9.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.623 1.169 . . . . 0.0 113.305 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -159.97 161.84 34.25 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.48 1.512 . . . . 0.0 112.095 -176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -81.39 -13.88 57.8 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.524 0.73 . . . . 0.0 112.422 168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.8 m -78.81 121.01 24.26 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.921 0.888 . . . . 0.0 109.991 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -82.5 150.98 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.375 1.07 . . . . 0.0 112.951 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -131.16 138.34 49.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.089 1.755 . . . . 0.0 110.586 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -83.85 129.03 34.94 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.586 -0.696 . . . . 0.0 110.46 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.7 p -65.45 161.89 46.89 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.449 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -55.46 -34.22 88.65 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.424 2.083 . . . . 0.0 113.059 172.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -71.11 -39.48 72.05 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.067 0.947 . . . . 0.0 112.228 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.73 80.57 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.704 1.138 . . . . 0.0 111.829 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -59.04 -41.96 89.12 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.193 0.997 . . . . 0.0 111.237 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -62.24 -40.93 97.79 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.167 0.987 . . . . 0.0 112.158 172.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.46 -42.12 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.111 1.323 . . . . 0.0 111.839 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.2 mm -59.07 -45.66 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.865 1.211 . . . . 0.0 111.033 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.96 -41.24 91.47 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.659 -0.651 . . . . 0.0 112.682 175.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.1 mt -67.28 -36.19 81.06 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.004 0.922 . . . . 0.0 112.279 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m -61.84 -39.91 93.5 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.556 0.742 . . . . 0.0 110.872 175.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 33.2 ttm -72.15 -35.01 68.94 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.397 1.079 . . . . 0.0 112.343 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -67.0 -28.7 68.47 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.994 1.317 . . . . 0.0 113.199 172.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.66 -41.36 21.5 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.142 -0.973 . . . . 0.0 111.894 172.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -36.49 73.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.083 -1.01 . . . . 0.0 112.119 172.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -67.02 -32.63 73.97 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.301 1.44 . . . . 0.0 113.516 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -70.46 -35.41 73.3 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 119.498 1.045 . . . . 0.0 112.803 171.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.5 mm? -76.22 -16.66 59.78 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 173.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.19 30.77 77.44 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 118.782 0.719 . . . . 0.0 112.539 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -78.62 -2.79 40.71 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t 65.27 -27.25 0.1 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 127.754 2.422 . . . . 0.0 116.115 -176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -149.67 160.62 43.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.997 2.119 . . . . 0.0 111.076 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.46 116.53 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.154 1.382 . . . . 0.0 110.689 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.23 174.6 42.12 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.441 1.02 . . . . 0.0 113.472 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.4 p -59.08 -39.46 82.2 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.588 -0.948 . . . . 0.0 111.187 173.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.11 -52.37 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.011 2.124 . . . . 0.0 111.572 169.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 48.2 m80 -71.0 -29.14 65.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.002 0.921 . . . . 0.0 112.909 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.2 mt -60.89 -46.99 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.183 0.901 . . . . 0.0 110.629 169.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.422 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -63.92 -43.42 95.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 118.439 -0.791 . . . . 0.0 111.599 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 22.2 mt -57.09 -37.0 71.28 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.057 0.844 . . . . 0.0 111.939 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.32 -41.37 99.5 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.654 1.121 . . . . 0.0 114.023 172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.0 mt -63.54 -46.14 87.35 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.494 1.147 . . . . 0.0 112.285 176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.0 -33.57 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.958 0.799 . . . . 0.0 112.926 175.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -59.49 -33.64 71.6 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.43 1.014 . . . . 0.0 113.233 170.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -67.03 -50.07 63.22 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.296 0.638 . . . . 0.0 110.774 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.52 -27.73 1.83 Allowed Glycine 0 CA--C 1.537 1.457 0 N-CA-C 117.569 1.787 . . . . 0.0 117.569 168.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.16 -30.41 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.19 1.995 . . . . 0.0 113.08 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.55 159.55 30.16 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.047 1.308 . . . . 0.0 113.574 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.6 t -55.3 -35.33 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.708 1.203 . . . . 0.0 112.373 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.44 83.17 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.594 -0.691 . . . . 0.0 112.131 175.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -64.84 -44.28 90.29 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.896 0.878 . . . . 0.0 112.115 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.32 -44.78 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.218 1.407 . . . . 0.0 111.469 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.85 -45.88 91.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 119.168 -0.444 . . . . 0.0 111.056 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -66.67 -35.16 79.49 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -64.85 -43.81 91.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.793 1.637 . . . . 0.0 111.647 175.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.1 mt -73.55 -34.58 65.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.004 0.922 . . . . 0.0 113.104 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 131.42 -0.3 5.1 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.315 1.436 . . . . 0.0 115.732 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 73.3 t -80.01 148.35 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.602 1.561 . . . . 0.0 110.966 173.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.4 m -136.41 162.81 32.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.938 1.695 . . . . 0.0 109.903 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.02 -47.85 64.8 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.454 1.102 . . . . 0.0 112.242 -174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -69.46 -37.72 77.44 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -64.58 -48.2 75.87 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 111.031 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.41 84.96 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.074 0.95 . . . . 0.0 111.537 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -54.01 -52.17 61.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.326 0.967 . . . . 0.0 111.576 172.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -62.9 -41.03 99.29 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.202 0.91 . . . . 0.0 112.668 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -71.97 -39.37 69.37 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.982 -1.073 . . . . 0.0 113.023 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.25 -45.12 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.567 1.076 . . . . 0.0 111.216 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -67.47 -26.96 66.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.905 1.282 . . . . 0.0 112.795 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.09 -55.62 5.14 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.83 0.741 . . . . 0.0 111.256 167.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.4 tp -66.95 -18.9 65.6 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -168.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.6 -10.79 49.22 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.06 3.58 0.08 OUTLIER Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.757 1.463 . . . . 0.0 116.757 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -122.24 11.04 10.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.515 1.926 . . . . 0.0 113.824 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.109 0 C-N-CA 126.298 1.839 . . . . 0.0 111.704 177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 8.2 tpt -153.91 143.99 22.03 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.984 1.313 . . . . 0.0 109.939 172.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -126.8 -43.75 1.69 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 20.91 74.12 Favored Glycine 0 CA--C 1.541 1.69 0 N-CA-C 115.027 0.771 . . . . 0.0 115.027 -178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -116.54 146.69 42.45 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.458 1.903 . . . . 0.0 111.528 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -130.03 145.96 51.69 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.582 1.553 . . . . 0.0 109.309 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.3 p -63.74 164.85 9.25 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.134 -0.979 . . . . 0.0 111.883 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -58.82 -39.73 82.03 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 120.801 -1.187 . . . . 0.0 111.525 175.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 13' ' ' VAL . 38.3 mmt180 -62.95 -44.66 95.45 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.575 0.75 . . . . 0.0 111.776 172.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -42.15 91.49 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.849 0.859 . . . . 0.0 111.942 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -58.54 -41.3 85.24 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.571 0.748 . . . . 0.0 111.375 172.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -65.12 -40.64 94.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 117.513 -1.232 . . . . 0.0 112.494 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -64.6 -37.34 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 121.367 1.894 . . . . 0.0 111.666 177.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -72.06 -30.25 64.97 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.87 69.21 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.497 -0.752 . . . . 0.0 112.305 170.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -68.06 -31.31 70.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.171 0.988 . . . . 0.0 112.19 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.76 69.3 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.31 1.044 . . . . 0.0 113.242 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -69.03 -44.38 72.85 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.5 -0.75 . . . . 0.0 111.641 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -68.47 -36.94 79.7 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.525 -0.734 . . . . 0.0 111.399 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -65.09 -34.56 78.7 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 113.032 173.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.79 -50.09 58.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.999 0.818 . . . . 0.0 111.317 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -33.1 74.48 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ptt85 -64.82 -24.79 67.66 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.82 1.191 . . . . 0.0 113.058 173.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -92.45 1.74 57.07 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.829 1.651 . . . . 0.0 112.349 174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.88 -5.32 58.51 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.52 1.534 . . . . 0.0 115.045 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -70.05 125.22 26.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.548 1.674 . . . . 0.0 110.574 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -83.78 11.43 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -146.38 154.93 42.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.867 1.267 . . . . 0.0 111.704 -172.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.5 mt -100.9 114.28 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.958 1.303 . . . . 0.0 109.331 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.69 -179.87 37.48 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.337 1.446 . . . . 0.0 111.651 167.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.5 p -56.2 -40.78 74.55 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.485 -1.009 . . . . 0.0 111.071 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.5 -49.15 46.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.061 2.944 . . . . 0.0 113.225 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -74.22 -31.33 62.58 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.472 -0.767 . . . . 0.0 112.154 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.24 -41.44 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 CA-C-N 118.49 0.587 . . . . 0.0 110.427 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.73 -40.91 97.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.28 0.945 . . . . 0.0 111.698 174.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.41 -42.5 87.33 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.904 0.882 . . . . 0.0 112.278 170.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.59 -44.26 93.95 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.184 0.897 . . . . 0.0 113.037 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.4 mt -58.33 -54.11 50.75 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.292 1.046 . . . . 0.0 111.86 174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -24.55 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.73 1.15 . . . . 0.0 113.818 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 -74.0 -28.72 61.6 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.518 1.054 . . . . 0.0 112.538 169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -67.62 -43.55 80.15 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.326 0.967 . . . . 0.0 110.998 170.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.68 -39.25 0.62 Allowed Glycine 0 CA--C 1.539 1.534 0 C-N-CA 126.343 1.925 . . . . 0.0 117.314 168.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.8 -14.81 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.577 1.551 . . . . 0.0 113.055 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.31 148.56 43.67 Favored Glycine 0 CA--C 1.535 1.283 0 O-C-N 121.395 -0.815 . . . . 0.0 111.343 169.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -52.02 -40.5 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.388 1.075 . . . . 0.0 112.682 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.31 -47.79 80.76 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.51 -38.0 88.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.274 -0.891 . . . . 0.0 111.533 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -63.55 -38.79 92.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.156 0.983 . . . . 0.0 111.787 174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.33 -41.8 84.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.124 1.37 . . . . 0.0 112.622 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.82 -46.06 92.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.925 0.784 . . . . 0.0 111.399 175.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.84 -34.13 74.98 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.493 -0.755 . . . . 0.0 112.577 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.16 -33.01 74.55 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.095 -1.003 . . . . 0.0 112.912 172.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.77 8.45 3.66 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.416 1.486 . . . . 0.0 114.05 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 11.02 71.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.792 1.187 . . . . 0.0 114.906 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -84.23 -175.83 5.97 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.386 1.093 . . . . 0.0 111.564 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.25 162.57 35.41 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.33 1.443 . . . . 0.0 111.122 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.9 p -56.0 -57.24 12.95 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.062 0.945 . . . . 0.0 112.277 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -64.14 -33.41 75.72 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.279 -0.888 . . . . 0.0 113.051 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.9 mtpt -62.87 -43.28 99.23 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.853 0.861 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.09 -49.03 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.278 1.031 . . . . 0.0 111.018 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -67.16 -37.61 84.06 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.545 -0.722 . . . . 0.0 112.759 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -76.97 -26.32 53.8 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -68.34 -39.15 82.01 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.251 0.932 . . . . 0.0 111.36 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.7 -54.51 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.526 0.603 . . . . 0.0 110.794 169.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -58.73 -34.03 70.9 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.785 0.721 . . . . 0.0 112.807 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.9 m -70.48 -20.46 62.87 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 175.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.8 mt -95.34 -36.22 11.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.918 1.287 . . . . 0.0 113.008 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 pt -99.94 -23.06 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -174.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.75 161.84 10.97 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.282 0.944 . . . . 0.0 113.708 -175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -141.43 152.81 44.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.32 -1.106 . . . . 0.0 113.541 -170.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.5 17.36 62.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 125.402 1.477 . . . . 0.0 113.928 -172.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -90.91 54.98 2.79 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.528 1.531 . . . . 0.0 111.946 -170.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -87.97 140.94 28.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.872 1.269 . . . . 0.0 113.792 -174.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.21 -31.73 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.217 1.407 . . . . 0.0 113.879 172.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 96.3 p -156.17 176.44 12.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.979 1.311 . . . . 0.0 112.826 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -107.15 -172.5 2.09 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.443 1.897 . . . . 0.0 112.466 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.7 m 64.76 100.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.181 2.192 . . . . 0.0 113.086 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.07 147.34 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -169.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -138.11 158.67 43.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.914 2.085 . . . . 0.0 109.798 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -96.56 137.89 34.96 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.154 -0.966 . . . . 0.0 110.841 -176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.5 p -65.72 161.42 53.18 Favored Pre-proline 0 N--CA 1.48 1.075 0 O-C-N 121.646 -0.659 . . . . 0.0 111.586 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.6 -36.73 95.15 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.411 2.074 . . . . 0.0 113.279 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -67.49 -43.59 80.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.849 0.86 . . . . 0.0 111.683 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.3 -42.92 82.92 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.193 0.906 . . . . 0.0 112.367 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -57.88 -43.61 86.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.395 1.078 . . . . 0.0 111.408 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 tttt -64.81 -43.63 92.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.554 0.742 . . . . 0.0 111.993 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.6 t -57.56 -41.7 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 119.516 1.053 . . . . 0.0 112.017 173.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.9 mm -60.99 -43.19 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 119.886 1.221 . . . . 0.0 111.138 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.24 -36.68 82.15 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.264 -0.897 . . . . 0.0 112.74 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.9 mt -71.57 -31.45 66.99 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.087 0.955 . . . . 0.0 112.155 176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -65.1 -39.91 93.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.462 1.105 . . . . 0.0 110.607 172.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.2 ttm -73.97 -30.08 62.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.662 0.785 . . . . 0.0 112.445 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.58 -40.74 84.85 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.856 0.863 . . . . 0.0 112.313 169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -62.27 -45.13 94.68 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 111.535 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.9 -48.03 79.15 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.46 -0.775 . . . . 0.0 112.337 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -70.76 -29.65 65.94 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.87 -37.84 87.22 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.291 1.036 . . . . 0.0 112.018 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.84 2.9 40.37 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.323 1.049 . . . . 0.0 113.574 170.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.91 17.98 77.68 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 116.022 1.169 . . . . 0.0 116.022 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.35 139.22 31.74 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.77 1.285 . . . . 0.0 111.556 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 m -81.12 8.68 8.15 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.899 1.279 . . . . 0.0 113.758 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -160.87 154.21 21.78 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.291 2.236 . . . . 0.0 110.552 -177.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.1 117.14 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.047 1.339 . . . . 0.0 110.186 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.04 171.15 44.19 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.912 0.767 . . . . 0.0 112.91 169.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.7 p -59.11 -37.5 77.33 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 121.346 -1.09 . . . . 0.0 111.297 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.09 -50.15 49.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.813 2.045 . . . . 0.0 111.452 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -72.63 -31.02 64.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.755 0.822 . . . . 0.0 112.741 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 75.4 mt -60.29 -48.34 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.036 0.835 . . . . 0.0 110.664 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.23 -45.68 92.24 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.565 -0.709 . . . . 0.0 111.404 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.66 -35.87 73.24 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 118.784 0.72 . . . . 0.0 112.674 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.17 -39.89 97.53 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 119.652 1.114 . . . . 0.0 113.963 170.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.4 mt -62.57 -43.3 99.16 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.507 1.153 . . . . 0.0 112.162 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -30.33 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 CA-C-N 118.918 0.781 . . . . 0.0 113.053 177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 7.4 tpp85 -57.66 -41.02 80.64 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.743 1.217 . . . . 0.0 111.632 172.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -70.66 -38.97 73.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.28 -27.59 0.56 Allowed Glycine 0 CA--C 1.541 1.673 0 N-CA-C 117.074 1.59 . . . . 0.0 117.074 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -94.2 -23.06 18.05 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.903 1.351 . . . . 0.0 113.054 -175.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.68 154.56 52.3 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.929 0.776 . . . . 0.0 112.62 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -53.46 -35.32 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.549 1.14 . . . . 0.0 111.688 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.49 -45.21 73.18 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -69.08 -34.28 74.87 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.443 -0.786 . . . . 0.0 112.623 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -65.02 -43.21 93.16 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.708 0.803 . . . . 0.0 111.942 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.43 -45.51 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.953 1.301 . . . . 0.0 111.598 178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.49 -43.05 99.56 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.938 0.495 . . . . 0.0 111.344 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.65 -34.45 76.97 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -64.71 -41.67 95.82 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.149 0.886 . . . . 0.0 112.042 173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.1 mt -76.48 -33.49 58.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.16 0.984 . . . . 0.0 113.111 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.58 18.04 1.84 Allowed Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.588 1.09 . . . . 0.0 115.707 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 55.0 t -106.11 139.44 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.86 1.664 . . . . 0.0 111.008 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 59.4 p -111.62 168.51 9.5 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.507 1.523 . . . . 0.0 111.328 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -45.42 67.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.106 0.962 . . . . 0.0 111.543 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.18 -37.5 61.2 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.787 1.235 . . . . 0.0 113.058 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.69 -41.66 83.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.694 1.198 . . . . 0.0 111.78 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.27 -46.28 70.83 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.831 0.852 . . . . 0.0 112.022 171.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 mtt-85 -53.74 -50.17 66.56 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.735 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -60.58 -42.66 97.11 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.155 0.889 . . . . 0.0 112.862 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -71.56 -38.7 70.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.452 1.023 . . . . 0.0 113.14 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.54 -44.09 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.037 0.835 . . . . 0.0 111.351 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.3 mt -69.56 -24.77 63.75 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.628 1.171 . . . . 0.0 112.94 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -77.41 -50.69 12.19 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.783 0.833 . . . . 0.0 111.506 169.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.22 -17.17 59.63 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.4 -5.38 10.7 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 145.62 -2.32 1.06 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 124.889 1.233 . . . . 0.0 115.079 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 58.0 m -86.48 -35.52 19.58 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.385 1.074 . . . . 0.0 113.089 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.433 2.693 . . . . 0.0 115.816 171.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -71.6 133.12 45.51 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.627 0.771 . . . . 0.0 110.583 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -108.2 -46.36 3.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.573 1.149 . . . . 0.0 113.857 -175.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.05 7.49 44.14 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 115.801 1.08 . . . . 0.0 115.801 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -80.62 138.44 36.43 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.718 2.007 . . . . 0.0 110.875 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -121.59 144.65 48.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.405 1.482 . . . . 0.0 109.8 173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.6 p -62.54 163.3 9.09 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.534 -0.729 . . . . 0.0 111.947 175.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.64 -35.93 77.42 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.876 -1.14 . . . . 0.0 111.774 173.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.4 mtm-85 -61.95 -46.31 89.86 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.707 0.803 . . . . 0.0 111.61 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.89 70.72 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.813 0.845 . . . . 0.0 111.586 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -58.68 -38.19 77.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.459 0.703 . . . . 0.0 111.703 171.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.13 -42.6 96.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 117.61 -1.186 . . . . 0.0 112.747 172.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.72 -35.47 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 121.186 1.812 . . . . 0.0 112.096 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -74.79 -32.5 62.04 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 177.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.59 -40.55 84.79 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.407 -0.808 . . . . 0.0 111.776 169.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.3 mt -66.24 -36.62 83.5 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.715 0.806 . . . . 0.0 111.744 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.84 -33.53 70.53 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.538 1.063 . . . . 0.0 112.893 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -67.32 -46.39 73.65 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.837 0.744 . . . . 0.0 111.6 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -64.34 -38.97 92.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.596 -0.69 . . . . 0.0 112.087 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -69.58 -36.75 76.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.869 0.868 . . . . 0.0 112.164 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.26 -50.64 72.85 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.64 0.655 . . . . 0.0 110.881 169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.61 -34.98 79.5 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -61.05 -39.58 90.38 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.198 1.399 . . . . 0.0 111.973 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.0 mt -84.79 1.46 46.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.912 1.285 . . . . 0.0 113.539 176.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.96 66.92 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.181 0.896 . . . . 0.0 114.627 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -100.64 133.07 45.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.481 1.512 . . . . 0.0 111.357 174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -84.75 6.1 25.77 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 173.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -144.82 153.83 42.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.849 0.86 . . . . 0.0 113.132 -178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.6 mt -93.13 120.39 42.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 C-N-CA 126.282 1.833 . . . . 0.0 109.75 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.45 177.97 28.68 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.955 1.741 . . . . 0.0 111.325 167.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.0 p -54.97 -40.28 69.86 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.508 -0.995 . . . . 0.0 111.503 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -49.6 -50.07 44.14 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 129.78 3.232 . . . . 0.0 113.329 170.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -73.13 -32.13 64.73 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.319 0.648 . . . . 0.0 111.73 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -66.91 -44.92 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 123.199 0.6 . . . . 0.0 110.545 172.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.6 tp -63.03 -44.57 95.55 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.27 0.941 . . . . 0.0 111.058 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.0 -38.72 92.12 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.403 1.081 . . . . 0.0 112.175 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.55 -38.37 96.26 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.029 0.823 . . . . 0.0 112.728 169.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.63 -49.93 75.83 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.791 1.237 . . . . 0.0 112.699 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -23.46 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.4 ttt180 -71.03 -30.02 66.11 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 119.542 1.064 . . . . 0.0 112.066 169.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -70.93 -44.0 67.07 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.828 0.74 . . . . 0.0 110.304 168.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.94 -23.04 0.55 Allowed Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.13 1.824 . . . . 0.0 117.557 168.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -113.71 -3.26 13.57 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.094 1.357 . . . . 0.0 114.374 -173.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.88 159.6 46.06 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 121.381 -0.825 . . . . 0.0 112.185 169.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.4 mm -58.11 -41.62 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.519 -0.989 . . . . 0.0 111.565 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.84 95.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.26 -36.43 84.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.422 -0.799 . . . . 0.0 111.952 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -68.02 -37.39 81.35 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.41 0.684 . . . . 0.0 111.912 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.53 -40.95 93.53 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.416 1.086 . . . . 0.0 112.413 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.57 -48.87 79.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.824 0.85 . . . . 0.0 110.892 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -67.45 -34.68 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.47 75.88 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.371 1.068 . . . . 0.0 112.739 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.11 9.5 2.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.323 1.449 . . . . 0.0 113.839 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.25 7.96 75.77 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.971 1.272 . . . . 0.0 114.854 173.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.1 mt -83.59 -175.43 5.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.24 1.02 . . . . 0.0 111.201 173.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.7 157.89 30.54 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.019 1.295 . . . . 0.0 111.295 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.0 m -60.54 -38.11 83.41 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.94 -39.24 87.27 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.693 0.797 . . . . 0.0 112.376 176.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -66.35 -45.39 80.33 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.894 0.878 . . . . 0.0 111.418 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.3 mt -69.3 -43.72 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.831 0.852 . . . . 0.0 110.274 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -60.38 -41.58 94.06 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.909 0.777 . . . . 0.0 112.219 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -44.0 97.23 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.918 0.781 . . . . 0.0 111.72 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -68.65 -37.75 79.91 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 56.0 t -61.31 -55.26 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 119.114 0.87 . . . . 0.0 110.167 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -68.01 -26.39 65.87 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.172 -0.955 . . . . 0.0 113.46 -176.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -63.56 -29.96 71.14 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.407 -0.808 . . . . 0.0 112.369 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -94.11 -38.34 11.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.647 1.179 . . . . 0.0 113.321 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 pt -115.93 11.71 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.39 47.68 0.7 Allowed Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.359 1.457 . . . . 0.0 114.809 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -122.3 -27.81 4.42 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.457 2.303 . . . . 0.0 113.345 -169.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.71 160.73 11.06 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.584 1.564 . . . . 0.0 114.818 -175.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -143.78 95.08 2.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.268 2.227 . . . . 0.0 107.963 169.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -60.1 -179.86 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.895 2.078 . . . . 0.0 114.825 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mpp? 68.58 47.33 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.883 2.073 . . . . 0.0 111.219 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 m -82.47 127.99 33.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.285 1.434 . . . . 0.0 113.293 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.32 -38.25 0.09 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.864 1.666 . . . . 0.0 111.757 169.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.6 t -149.52 157.26 43.12 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.356 1.862 . . . . 0.0 110.078 169.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -94.37 149.14 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -170.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -132.82 169.15 17.15 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.495 1.918 . . . . 0.0 110.411 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -102.61 139.69 37.86 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.332 1.053 . . . . 0.0 110.863 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 p -69.95 162.98 64.91 Favored Pre-proline 0 N--CA 1.478 0.962 0 O-C-N 121.866 -0.521 . . . . 0.0 111.446 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.64 -32.41 90.43 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.481 2.121 . . . . 0.0 113.233 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -70.41 -43.93 68.99 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.328 1.051 . . . . 0.0 111.933 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.02 -40.4 91.03 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.617 -0.677 . . . . 0.0 111.961 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -58.1 -44.85 87.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.235 1.014 . . . . 0.0 111.97 171.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -60.96 -43.53 98.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.194 0.998 . . . . 0.0 111.928 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.9 t -59.2 -46.57 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.622 0.769 . . . . 0.0 112.241 170.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.4 mm -61.67 -43.08 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.546 1.066 . . . . 0.0 111.36 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.03 -38.79 86.53 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.595 -0.69 . . . . 0.0 112.704 174.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.4 mt -71.06 -26.67 63.18 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.268 -0.895 . . . . 0.0 112.632 174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.1 m -67.01 -42.61 84.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.159 0.89 . . . . 0.0 111.255 176.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.5 ptp -74.14 -28.52 61.37 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 172.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -69.08 -34.37 75.02 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -70.36 -37.7 74.64 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.935 -1.103 . . . . 0.0 111.344 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.88 96.04 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.055 -1.028 . . . . 0.0 113.081 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -68.12 -18.35 64.61 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.147 -0.971 . . . . 0.0 113.399 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -27.7 66.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.464 1.105 . . . . 0.0 112.923 169.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.92 -5.76 59.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.906 1.282 . . . . 0.0 112.223 168.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.53 81.3 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.642 1.115 . . . . 0.0 114.192 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -80.71 140.94 35.32 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.729 1.264 . . . . 0.0 111.302 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 75.1 p -93.16 18.07 9.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.804 1.642 . . . . 0.0 113.279 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -158.32 154.39 27.01 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.582 1.953 . . . . 0.0 111.17 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -94.79 114.86 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.596 1.558 . . . . 0.0 110.593 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.18 167.09 44.96 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.527 1.06 . . . . 0.0 113.044 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 p -53.14 -38.85 63.06 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.597 -0.943 . . . . 0.0 112.686 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -51.19 -54.24 27.35 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.983 2.113 . . . . 0.0 111.454 169.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -68.28 -29.44 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.296 1.038 . . . . 0.0 112.979 -177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.0 mt -59.03 -50.07 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 118.888 0.767 . . . . 0.0 110.293 169.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 52.4 tp -64.68 -44.6 89.84 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.59 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.06 -43.39 60.98 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 118.942 0.792 . . . . 0.0 111.228 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -38.98 95.12 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.465 1.031 . . . . 0.0 114.663 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 mt -63.02 -41.12 99.46 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.082 1.441 . . . . 0.0 111.737 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mt -81.15 -40.89 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-N 117.844 0.293 . . . . 0.0 110.967 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -64.94 -27.04 68.57 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.487 1.115 . . . . 0.0 113.366 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -65.54 -36.31 83.43 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 118.766 0.712 . . . . 0.0 111.977 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.25 6.89 22.51 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.124 2.41 . . . . 0.0 119.124 167.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.8 -35.04 3.11 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.157 1.979 . . . . 0.0 112.797 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -71.65 165.49 53.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.344 1.449 . . . . 0.0 114.427 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.8 t -56.41 -34.75 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.077 1.351 . . . . 0.0 112.296 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.82 78.75 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.351 0.978 . . . . 0.0 113.247 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.52 79.51 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.548 -0.72 . . . . 0.0 112.293 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -66.38 -45.57 79.63 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.404 1.082 . . . . 0.0 111.554 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.42 -49.84 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.038 1.335 . . . . 0.0 111.252 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.77 -39.87 95.32 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.931 -0.481 . . . . 0.0 111.818 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -68.18 -33.22 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -66.42 -39.91 89.24 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.089 0.859 . . . . 0.0 111.803 173.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.0 mt -73.05 -31.35 64.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.322 1.049 . . . . 0.0 112.386 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.09 5.85 6.07 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.656 1.598 . . . . 0.0 115.816 169.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 62.9 t -96.99 146.83 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.07 1.748 . . . . 0.0 111.16 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.7 t -141.78 174.86 10.18 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.12 1.368 . . . . 0.0 111.627 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 24.0 mt -40.67 -66.38 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.401 2.28 . . . . 0.0 113.67 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 p30 -64.82 -37.01 86.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -71.23 -38.62 71.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.844 1.257 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.02 -52.38 14.6 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.092 0.957 . . . . 0.0 112.019 173.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -62.87 -38.84 92.44 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.559 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -64.19 -38.1 89.84 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.617 1.553 . . . . 0.0 113.047 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -69.42 -44.43 71.37 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.261 -0.9 . . . . 0.0 111.763 175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 98.6 t -64.99 -45.02 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.8 0.727 . . . . 0.0 111.416 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 90.7 mt -68.45 -26.61 65.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.47 1.108 . . . . 0.0 113.207 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -79.48 -51.14 9.73 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.03 0.832 . . . . 0.0 111.819 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.42 -21.28 65.58 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -69.02 -7.51 36.26 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 166.4 -13.48 0.07 OUTLIER Glycine 0 CA--C 1.538 1.474 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -95.65 -12.5 25.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.06 1.43 . . . . 0.0 114.387 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 126.24 1.816 . . . . 0.0 112.244 177.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 20.1 ttt 63.57 158.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.82 2.048 . . . . 0.0 114.417 -173.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -69.29 -43.4 73.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.4 2.64 7.59 Favored Glycine 0 CA--C 1.541 1.683 0 N-CA-C 116.782 1.473 . . . . 0.0 116.782 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.8 mmt-85 -84.08 143.57 29.63 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.677 1.591 . . . . 0.0 111.776 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -113.36 146.46 39.43 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.728 1.611 . . . . 0.0 109.072 169.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -65.23 162.32 17.5 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.17 -0.956 . . . . 0.0 111.341 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.06 -29.53 68.61 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.874 -1.141 . . . . 0.0 112.235 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -69.81 -43.74 71.44 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.089 1.356 . . . . 0.0 111.699 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.97 -40.59 68.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.355 1.062 . . . . 0.0 112.152 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -57.81 -34.45 69.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -63.7 -45.15 91.31 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.836 0.854 . . . . 0.0 112.142 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.75 -35.6 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.534 1.061 . . . . 0.0 111.684 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.07 -34.07 66.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.57 -38.31 86.8 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.325 -0.859 . . . . 0.0 111.996 170.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.08 -36.85 78.05 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.506 -0.746 . . . . 0.0 112.183 173.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.51 -30.75 67.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.332 0.969 . . . . 0.0 113.075 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -67.99 -40.78 83.0 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.565 0.746 . . . . 0.0 111.904 171.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.99 -35.02 76.23 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.208 -0.932 . . . . 0.0 111.812 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -62.06 -46.32 89.63 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.503 -0.748 . . . . 0.0 111.358 170.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -38.55 84.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.274 -0.891 . . . . 0.0 113.014 176.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.35 -43.8 39.31 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -66.02 -31.18 71.92 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 120.109 1.322 . . . . 0.0 112.604 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.17 -10.1 58.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.662 1.185 . . . . 0.0 112.803 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.87 30.55 65.69 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 119.186 0.903 . . . . 0.0 114.258 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.441 ' CE1' HE22 ' A' ' 72' ' ' GLN . 11.8 m-70 -87.15 -27.8 22.84 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.442 1.121 . . . . 0.0 113.508 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.6 m120 54.66 10.08 0.33 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -143.72 150.8 39.19 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.4 1.48 . . . . 0.0 111.543 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.9 mt -98.16 115.64 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 124.576 1.151 . . . . 0.0 109.568 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.8 177.64 31.79 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.611 1.577 . . . . 0.0 111.333 167.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.3 p -56.03 -39.2 71.6 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.416 -1.049 . . . . 0.0 111.359 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -50.5 -49.17 56.23 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 129.556 3.142 . . . . 0.0 113.304 170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -72.76 -29.22 63.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 118.778 0.717 . . . . 0.0 112.096 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.59 -42.77 71.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 118.746 0.703 . . . . 0.0 110.611 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.03 -40.03 96.53 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.09 0.859 . . . . 0.0 111.257 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.5 tp -71.32 -34.42 70.55 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.536 -0.727 . . . . 0.0 111.871 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.58 -37.57 94.96 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.0 1.286 . . . . 0.0 113.105 170.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.8 mt -57.57 -54.91 41.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.271 1.028 . . . . 0.0 112.232 170.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.63 -24.3 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.655 1.116 . . . . 0.0 113.696 177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -66.59 -32.76 74.3 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.867 0.867 . . . . 0.0 111.708 170.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -73.78 -44.79 55.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.187 0.595 . . . . 0.0 111.047 169.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.71 -24.43 0.64 Allowed Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.856 1.693 . . . . 0.0 117.015 169.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.15 -4.79 13.74 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.22 1.408 . . . . 0.0 113.983 -174.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.88 159.34 43.39 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 121.579 -0.7 . . . . 0.0 112.307 170.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.7 mm -56.7 -45.51 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.736 0.814 . . . . 0.0 111.2 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.41 92.53 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.16 88.98 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.996 -1.065 . . . . 0.0 112.146 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -71.15 -31.05 67.21 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.711 0.804 . . . . 0.0 111.84 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.08 -41.16 86.83 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.092 0.957 . . . . 0.0 112.62 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.95 -47.92 83.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.028 0.831 . . . . 0.0 110.789 172.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -65.23 -34.1 77.56 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.59 -32.31 73.9 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 121.088 -1.007 . . . . 0.0 112.937 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.68 7.31 3.9 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.2 1.4 . . . . 0.0 113.701 170.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.43 6.78 77.14 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.16 1.362 . . . . 0.0 114.699 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.83 -177.42 6.35 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.436 1.118 . . . . 0.0 111.537 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.3 163.37 37.11 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.784 1.183 . . . . 0.0 111.317 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -58.78 -42.16 88.34 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.418 0.687 . . . . 0.0 112.52 -177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.65 -44.26 91.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.607 0.763 . . . . 0.0 112.26 176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -62.08 -46.91 86.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 111.41 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -69.56 -42.56 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.595 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -62.13 -42.92 99.72 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.176 0.898 . . . . 0.0 112.613 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.57 -45.23 95.04 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.476 0.711 . . . . 0.0 111.937 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -68.53 -40.66 80.67 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.09 -58.77 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.178 0.899 . . . . 0.0 110.536 174.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -69.13 -28.23 66.27 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 29.4 t -65.89 -33.88 76.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.834 0.743 . . . . 0.0 112.399 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -81.55 -36.69 28.82 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.6 pt -105.99 -17.41 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.31 -162.53 49.51 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 119.329 0.968 . . . . 0.0 114.673 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -147.66 164.68 32.77 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.909 1.683 . . . . 0.0 113.282 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.14 31.85 50.91 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 165.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.441 HE22 ' CE1' ' A' ' 26' ' ' HIS . 2.2 mp0 -66.15 -43.94 85.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.671 1.736 . . . . 0.0 111.818 171.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 37.26 70.77 0.16 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.599 2.76 . . . . 0.0 113.94 169.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -1.09 2.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -168.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -146.29 175.29 10.63 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.437 1.095 . . . . 0.0 112.203 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -136.56 142.97 43.42 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.689 1.996 . . . . 0.0 109.784 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.8 m 64.32 130.92 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.506 1.922 . . . . 0.0 112.57 -168.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.67 150.1 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.248 -0.908 . . . . 0.0 113.241 -172.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -136.29 152.68 50.97 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.107 1.763 . . . . 0.0 110.418 170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -92.65 134.3 35.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.378 1.071 . . . . 0.0 110.791 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.4 p -66.38 162.92 44.59 Favored Pre-proline 0 N--CA 1.478 0.955 0 O-C-N 121.643 -0.661 . . . . 0.0 111.467 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -55.8 -35.43 93.61 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.288 1.992 . . . . 0.0 113.061 171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 mtm105 -67.46 -42.53 82.88 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.838 0.855 . . . . 0.0 111.574 175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.46 -39.84 77.51 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.648 -0.658 . . . . 0.0 112.476 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -61.53 -42.63 99.11 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.37 -0.831 . . . . 0.0 111.223 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -60.53 -42.72 97.07 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.378 -0.82 . . . . 0.0 111.813 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 t -59.78 -44.22 93.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 119.885 1.22 . . . . 0.0 112.188 171.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 mm -60.69 -45.99 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 120.178 1.354 . . . . 0.0 111.231 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -65.69 -39.55 91.4 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.447 0.699 . . . . 0.0 112.402 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.66 -31.12 66.48 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.832 0.853 . . . . 0.0 112.483 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 m -64.42 -39.14 93.27 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.426 1.012 . . . . 0.0 110.683 173.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.9 ttm -67.87 -41.4 82.9 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.888 1.275 . . . . 0.0 112.003 174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.69 -39.89 91.75 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.485 1.114 . . . . 0.0 112.754 175.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -74.39 -32.38 62.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.047 0.939 . . . . 0.0 112.273 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.37 97.52 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.039 -1.038 . . . . 0.0 111.439 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.9 ttm105 -62.03 -38.15 87.6 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.771 0.828 . . . . 0.0 112.057 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -34.99 75.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.611 1.564 . . . . 0.0 113.099 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -93.38 4.96 53.12 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.911 1.284 . . . . 0.0 113.551 172.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.26 18.58 79.18 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 124.631 1.11 . . . . 0.0 115.673 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -81.37 146.94 30.06 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 118.901 1.351 . . . . 0.0 111.595 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 61.1 p -93.22 12.21 25.28 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.64 1.576 . . . . 0.0 113.475 173.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -156.9 155.15 30.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.547 1.939 . . . . 0.0 111.074 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.96 112.87 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.375 1.47 . . . . 0.0 110.043 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.72 176.48 49.45 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 123.988 0.804 . . . . 0.0 113.671 173.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.1 p -57.86 -40.45 80.22 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.619 -0.93 . . . . 0.0 110.774 171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -49.23 -51.85 30.66 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 129.298 3.039 . . . . 0.0 111.525 169.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -74.28 -28.96 61.44 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.875 0.87 . . . . 0.0 112.979 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.53 -47.69 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.115 0.87 . . . . 0.0 109.797 168.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.16 -42.92 99.51 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 117.887 -1.054 . . . . 0.0 111.377 176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.71 -38.0 71.7 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.683 1.129 . . . . 0.0 112.242 173.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.62 -42.1 98.89 Favored Glycine 0 CA--C 1.537 1.453 0 CA-C-N 119.125 0.875 . . . . 0.0 113.796 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.34 -45.74 91.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.574 1.15 . . . . 0.0 112.545 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.1 OUTLIER -71.92 -34.37 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 118.541 0.61 . . . . 0.0 112.635 175.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -67.51 -32.42 73.2 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.233 0.924 . . . . 0.0 112.873 177.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -63.4 -41.01 98.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.763 0.71 . . . . 0.0 112.18 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.88 -28.02 0.4 Allowed Glycine 0 CA--C 1.54 1.647 0 N-CA-C 117.424 1.729 . . . . 0.0 117.424 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -100.91 -25.56 14.05 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.953 1.377 . . . . 0.0 112.883 -175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.09 158.11 48.34 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 121.462 -0.774 . . . . 0.0 113.458 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.1 t -52.69 -37.11 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.237 1.015 . . . . 0.0 111.927 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.81 -44.57 77.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.01 -36.32 82.96 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.523 -0.735 . . . . 0.0 111.958 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -65.4 -46.07 81.51 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.243 1.017 . . . . 0.0 111.565 176.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.4 t -55.8 -50.58 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.218 1.407 . . . . 0.0 110.948 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.78 -43.63 97.82 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.24 -0.409 . . . . 0.0 111.721 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -69.14 -32.93 72.63 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -66.34 -39.57 89.29 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.767 0.827 . . . . 0.0 111.915 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.7 mt -75.03 -32.88 61.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.205 1.002 . . . . 0.0 112.523 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.84 2.17 5.74 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 125.649 1.595 . . . . 0.0 115.787 170.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.99 140.1 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 111.243 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.7 p -112.7 173.63 6.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.553 1.541 . . . . 0.0 112.128 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.84 -44.03 49.21 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.745 1.218 . . . . 0.0 111.132 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -79.24 -36.02 40.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.247 1.019 . . . . 0.0 113.21 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.48 -46.61 72.47 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.648 1.113 . . . . 0.0 111.323 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -64.14 -44.76 91.19 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 118.707 -0.664 . . . . 0.0 111.387 174.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -56.24 -51.85 66.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.435 1.016 . . . . 0.0 112.737 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -61.66 -40.63 95.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.505 1.048 . . . . 0.0 112.593 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.81 -40.63 69.01 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.463 1.029 . . . . 0.0 112.856 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.69 -44.71 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.402 1.001 . . . . 0.0 111.27 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.1 mt -68.82 -27.99 66.35 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.553 1.141 . . . . 0.0 112.843 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -75.66 -50.55 15.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.709 0.686 . . . . 0.0 111.35 168.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.5 tp -73.91 -19.93 60.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.48 -9.29 32.91 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 163.54 -23.94 0.18 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.058 0.837 . . . . 0.0 114.883 173.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -68.03 -35.12 77.74 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 118.232 1.016 . . . . 0.0 113.389 -176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 127.058 2.143 . . . . 0.0 113.73 178.787 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.374 0.131 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 97.4 mmm -74.94 157.56 34.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.759 0.823 . . . . 0.0 112.644 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -66.77 -35.57 80.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.537 1.135 . . . . 0.0 113.588 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.48 26.84 68.64 Favored Glycine 0 CA--C 1.538 1.47 0 N-CA-C 115.475 0.95 . . . . 0.0 115.475 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -110.73 145.5 37.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.246 1.818 . . . . 0.0 110.957 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.18 152.66 47.78 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.009 1.724 . . . . 0.0 110.009 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.4 p -68.21 169.16 10.87 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.193 -0.942 . . . . 0.0 112.178 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -60.9 -45.13 95.85 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 120.678 -1.264 . . . . 0.0 111.413 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -67.88 -34.35 76.5 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.655 -0.653 . . . . 0.0 111.844 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.71 78.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 119.006 0.821 . . . . 0.0 111.968 174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.75 -36.16 78.23 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.813 -0.555 . . . . 0.0 111.546 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -65.21 -41.08 94.83 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 117.336 -1.316 . . . . 0.0 112.856 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -37.97 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 121.41 1.914 . . . . 0.0 111.757 174.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.0 mt -74.62 -34.19 62.74 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.727 0.694 . . . . 0.0 112.704 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.55 85.95 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.281 -0.887 . . . . 0.0 111.913 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.32 -27.37 60.67 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.393 -0.817 . . . . 0.0 112.304 175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.15 88.9 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.83 1.196 . . . . 0.0 111.949 169.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.34 -44.83 86.51 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.243 0.617 . . . . 0.0 111.444 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -64.7 -44.83 89.0 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.572 0.624 . . . . 0.0 111.845 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -65.53 -38.37 89.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.992 0.917 . . . . 0.0 112.326 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.95 71.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.577 0.626 . . . . 0.0 111.09 172.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.8 -37.61 88.2 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 -62.09 -34.55 76.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.264 1.026 . . . . 0.0 112.051 175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 tp -89.53 1.19 56.25 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.705 1.602 . . . . 0.0 113.153 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.3 11.75 84.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.732 1.158 . . . . 0.0 115.365 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -85.89 126.09 33.81 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.041 1.42 . . . . 0.0 111.566 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -79.48 -0.31 32.64 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.684 1.365 . . . . 0.0 114.684 173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.16 153.62 51.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.9 1.28 . . . . 0.0 111.684 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.5 mt -95.78 116.88 38.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.842 1.657 . . . . 0.0 108.738 169.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.35 179.73 33.56 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.612 1.577 . . . . 0.0 111.605 168.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.69 -41.08 73.22 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.502 -0.999 . . . . 0.0 111.029 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -49.26 -48.51 45.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 129.05 2.94 . . . . 0.0 113.66 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -74.87 -32.38 61.86 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.341 0.657 . . . . 0.0 111.708 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.1 mt -65.42 -43.51 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.934 0.788 . . . . 0.0 110.426 171.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.5 tp -64.6 -44.05 91.86 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.374 0.988 . . . . 0.0 111.474 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -64.98 -37.11 86.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.954 0.902 . . . . 0.0 111.81 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.47 97.67 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.708 1.147 . . . . 0.0 112.829 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.78 -50.49 72.17 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.658 1.183 . . . . 0.0 112.51 173.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -28.19 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 tpp180 -67.45 -31.96 72.48 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 119.248 0.931 . . . . 0.0 111.783 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -72.5 -49.58 31.97 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.076 0.95 . . . . 0.0 110.325 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.5 -7.4 4.99 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 118.524 2.17 . . . . 0.0 118.524 167.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -119.57 -10.76 9.56 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.919 1.86 . . . . 0.0 114.119 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.43 157.89 32.41 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 121.042 -1.036 . . . . 0.0 112.869 169.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mm -56.69 -41.72 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.945 0.898 . . . . 0.0 111.092 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 -44.96 89.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.93 95.92 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.357 -0.839 . . . . 0.0 111.683 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -67.13 -32.93 74.39 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.279 0.632 . . . . 0.0 112.172 174.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.19 80.99 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.341 1.056 . . . . 0.0 112.554 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.05 -47.22 86.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.089 0.859 . . . . 0.0 110.771 172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -61.85 -39.04 90.45 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.291 1.036 . . . . 0.0 112.506 175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.17 -33.19 75.43 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 113.098 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.92 9.39 1.92 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.205 1.402 . . . . 0.0 113.709 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.59 6.36 77.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.31 1.433 . . . . 0.0 114.771 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.7 mt -83.87 -172.9 4.41 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.387 1.093 . . . . 0.0 111.649 176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.53 165.88 36.46 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.766 1.65 . . . . 0.0 110.934 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.3 p -60.35 -42.28 95.41 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.56 -46.41 88.48 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.402 1.081 . . . . 0.0 111.968 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.88 -46.31 89.95 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.878 0.871 . . . . 0.0 111.697 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.9 mt -71.38 -43.78 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.77 0.828 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -61.04 -40.06 92.17 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 119.138 0.881 . . . . 0.0 112.469 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 -49.34 78.24 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.734 0.813 . . . . 0.0 111.125 174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -70.34 -33.59 71.65 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.91 -53.35 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.481 1.037 . . . . 0.0 110.046 171.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.68 -23.02 66.08 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.975 -1.078 . . . . 0.0 113.172 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 63.5 m -65.73 -15.73 63.1 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.788 -1.195 . . . . 0.0 113.224 170.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.8 mt -116.17 -27.89 6.74 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.396 1.479 . . . . 0.0 113.44 -177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.3 pt -125.6 1.88 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 115.934 1.827 . . . . 0.0 115.934 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.15 27.12 0.99 Allowed Glycine 0 N--CA 1.475 1.273 0 C-N-CA 125.65 1.595 . . . . 0.0 116.362 -170.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -103.31 -4.79 23.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.984 1.713 . . . . 0.0 112.868 169.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.83 -165.03 48.81 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.052 0.834 . . . . 0.0 114.687 176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.33 -170.89 3.77 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.964 1.705 . . . . 0.0 110.482 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.88 170.51 8.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.787 1.635 . . . . 0.0 111.229 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 49.45 43.48 23.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.73 2.012 . . . . 0.0 114.509 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 p -66.29 81.96 0.09 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.6 1.96 . . . . 0.0 113.609 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -158.38 167.57 29.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.943 2.497 . . . . 0.0 110.075 174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.7 m 42.77 70.64 0.28 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 126.517 1.927 . . . . 0.0 113.403 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.96 145.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -124.27 169.14 12.07 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.869 1.668 . . . . 0.0 110.011 168.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -104.82 137.41 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.044 0.938 . . . . 0.0 110.044 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.9 p -67.17 162.72 52.16 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.071 -0.393 . . . . 0.0 111.217 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.04 -34.35 92.21 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.313 2.009 . . . . 0.0 113.236 173.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -72.11 -40.09 68.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.096 0.958 . . . . 0.0 112.301 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.03 -39.99 82.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.078 0.854 . . . . 0.0 111.912 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -60.65 -43.74 97.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.168 0.987 . . . . 0.0 111.299 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -59.46 -46.31 89.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 172.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -57.35 -45.88 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.451 1.023 . . . . 0.0 111.872 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.1 mm -60.94 -43.31 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.352 0.978 . . . . 0.0 111.472 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.64 -44.29 86.89 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.418 -0.801 . . . . 0.0 112.463 174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.4 mt -63.24 -31.84 73.1 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 112.035 176.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.2 m -66.89 -45.97 76.35 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.477 1.111 . . . . 0.0 111.624 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.4 ptp -73.87 -30.67 62.76 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.79 -35.22 80.08 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.674 -0.641 . . . . 0.0 112.524 171.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -75.46 -37.09 60.51 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.011 -1.055 . . . . 0.0 113.159 170.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.29 84.08 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.5 1.045 . . . . 0.0 111.653 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 14.3 ttm105 -62.56 -39.24 93.01 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.041 0.937 . . . . 0.0 112.195 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -35.44 79.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.026 1.331 . . . . 0.0 112.836 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -88.99 6.04 41.47 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.914 1.286 . . . . 0.0 113.472 172.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.64 75.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.836 1.208 . . . . 0.0 115.992 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -87.34 146.66 25.82 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.898 1.349 . . . . 0.0 111.92 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.4 p -92.85 9.19 36.41 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.737 1.615 . . . . 0.0 113.436 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -155.02 157.16 37.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.6 1.96 . . . . 0.0 110.931 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 15.2 t -90.22 118.32 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.438 1.495 . . . . 0.0 110.724 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.41 170.67 42.92 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 123.853 0.739 . . . . 0.0 113.189 169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -56.89 -39.72 74.93 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.696 -0.885 . . . . 0.0 111.094 170.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.39 -52.47 16.65 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.541 2.336 . . . . 0.0 111.831 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -72.75 -29.39 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.195 0.998 . . . . 0.0 112.851 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.02 -46.67 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 118.883 0.765 . . . . 0.0 110.47 169.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.41 -42.82 98.77 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.433 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.05 -38.54 70.74 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.248 0.931 . . . . 0.0 111.921 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.94 -44.66 97.52 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-N 119.195 0.907 . . . . 0.0 113.665 172.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.96 -49.69 76.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.495 1.118 . . . . 0.0 112.699 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -68.56 -37.7 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.537 0.608 . . . . 0.0 112.239 176.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -67.65 -27.97 67.32 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -65.92 -47.56 74.31 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.862 0.756 . . . . 0.0 110.139 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.86 -16.88 3.97 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 118.222 2.049 . . . . 0.0 118.222 167.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -115.38 -27.19 7.28 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.352 2.076 . . . . 0.0 113.099 -172.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.05 163.62 24.95 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.455 1.502 . . . . 0.0 113.663 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.12 -36.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.838 1.255 . . . . 0.0 112.225 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -56.55 -45.04 81.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.385 0.993 . . . . 0.0 113.284 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.91 -36.11 82.5 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.472 -0.767 . . . . 0.0 112.001 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -64.62 -44.67 89.78 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.896 0.878 . . . . 0.0 111.992 174.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.08 -51.16 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 110.902 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.24 -44.86 94.88 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.543 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.59 -35.06 79.29 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -65.86 -38.63 89.33 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 112.015 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.3 mt -74.81 -32.4 61.96 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.234 1.014 . . . . 0.0 112.58 177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.01 1.91 6.2 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.725 1.631 . . . . 0.0 115.414 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 90.6 t -86.37 141.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.609 1.563 . . . . 0.0 111.208 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -133.02 167.92 19.43 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.28 1.832 . . . . 0.0 109.844 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 131' ' ' LEU . 5.0 mp -52.31 -46.55 66.03 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.62 0.768 . . . . 0.0 112.398 -173.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -69.19 -38.85 78.88 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -63.62 -48.27 78.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.747 0.819 . . . . 0.0 111.061 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.423 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.11 -47.2 78.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.798 0.839 . . . . 0.0 111.599 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -55.29 -51.54 66.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.246 0.93 . . . . 0.0 112.188 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -65.44 -38.57 90.27 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.606 1.094 . . . . 0.0 112.581 -176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -69.56 -43.86 72.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.667 1.121 . . . . 0.0 112.242 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.3 t -65.08 -45.99 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.124 0.875 . . . . 0.0 111.304 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 93.0 mt -69.61 -27.68 65.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.245 1.018 . . . . 0.0 112.993 -178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -76.33 -50.74 13.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.018 0.826 . . . . 0.0 111.352 168.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.95 -22.09 63.2 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.4 -9.86 51.24 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.7 -17.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.371 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 49.9 m -85.65 -17.11 37.03 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 119.072 1.436 . . . . 0.0 114.132 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.401 1.88 . . . . 0.0 112.179 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.444 0.164 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.1 mmm -77.63 156.18 30.95 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.782 0.833 . . . . 0.0 111.909 174.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -75.8 -40.61 54.78 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.6 18.35 71.86 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.748 1.059 . . . . 0.0 115.748 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -109.37 141.58 41.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.257 1.423 . . . . 0.0 111.726 -178.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -119.24 146.0 45.59 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.394 1.478 . . . . 0.0 109.502 169.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.5 p -65.53 165.04 12.91 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.222 -0.924 . . . . 0.0 111.465 175.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -62.56 -30.55 71.39 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.821 -1.174 . . . . 0.0 111.788 171.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -67.37 -40.94 85.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.412 1.085 . . . . 0.0 111.587 173.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.92 44.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.039 0.936 . . . . 0.0 112.525 -178.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -57.92 -36.75 72.92 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.724 0.809 . . . . 0.0 111.597 171.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -61.24 -44.26 97.55 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.338 172.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.28 -33.98 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 120.128 1.331 . . . . 0.0 111.84 177.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.14 -32.63 65.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.732 0.696 . . . . 0.0 112.773 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.35 85.37 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.243 -0.911 . . . . 0.0 111.804 169.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.9 -29.98 68.37 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 112.491 173.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.4 -36.1 82.59 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.53 1.059 . . . . 0.0 112.313 173.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -66.1 -45.6 80.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.541 0.736 . . . . 0.0 111.438 172.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -62.95 -46.58 87.08 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.81 -0.556 . . . . 0.0 112.059 176.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -62.51 -40.17 95.85 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.197 0.999 . . . . 0.0 112.058 177.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.29 -54.01 50.85 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.18 0.592 . . . . 0.0 111.346 172.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 73.3 mt -60.59 -40.23 91.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.963 0.905 . . . . 0.0 112.912 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -70.4 -30.58 67.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.454 1.102 . . . . 0.0 112.386 178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 28.5 tp -86.03 3.89 40.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.222 1.409 . . . . 0.0 112.777 169.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.96 15.96 81.0 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.302 -1.499 . . . . 0.0 115.609 176.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -91.71 126.24 36.72 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.345 1.573 . . . . 0.0 109.47 170.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.17 21.55 1.99 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.431 -0.793 . . . . 0.0 111.825 176.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -151.09 153.79 35.74 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.799 2.04 . . . . 0.0 110.974 -169.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.8 mt -104.09 116.01 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.733 1.213 . . . . 0.0 109.841 175.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.19 177.53 32.49 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.814 1.673 . . . . 0.0 111.188 167.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.1 p -57.23 -39.52 75.67 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 121.401 -1.058 . . . . 0.0 111.297 172.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -50.34 -46.8 55.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.013 2.925 . . . . 0.0 112.951 169.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -75.4 -32.34 60.72 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.485 -0.759 . . . . 0.0 111.935 -178.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 80.5 mt -65.62 -40.92 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.522 0.601 . . . . 0.0 110.644 170.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.83 -42.92 94.57 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.56 -0.712 . . . . 0.0 111.547 174.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.0 mp -57.08 -42.97 81.66 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.79 0.836 . . . . 0.0 111.687 169.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.39 -42.3 95.63 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.205 0.907 . . . . 0.0 113.54 174.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 46' ' ' ALA . 29.7 mt -59.64 -55.33 35.74 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.256 1.022 . . . . 0.0 111.882 173.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -20.96 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -71.45 -31.8 67.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.302 0.955 . . . . 0.0 111.957 169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -72.94 -43.84 61.87 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.597 0.635 . . . . 0.0 110.952 169.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.24 -24.67 0.57 Allowed Glycine 0 CA--C 1.538 1.491 0 C-N-CA 125.922 1.725 . . . . 0.0 116.97 169.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -113.57 -4.36 13.51 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.347 1.459 . . . . 0.0 114.127 -174.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.17 158.43 45.5 Favored Glycine 0 CA--C 1.535 1.31 0 O-C-N 121.55 -0.719 . . . . 0.0 112.086 169.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.45 -44.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.843 0.857 . . . . 0.0 111.382 -176.417 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 38' ' ' LEU . . . -65.15 -44.48 88.45 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 177.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.9 88.53 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.182 -0.949 . . . . 0.0 111.994 177.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -66.75 -35.79 80.94 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.917 0.887 . . . . 0.0 111.555 173.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.24 -41.47 89.96 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.02 0.928 . . . . 0.0 112.717 172.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.9 mt -59.28 -47.46 85.28 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.962 0.801 . . . . 0.0 111.146 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -68.73 -32.78 72.81 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 178.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.35 -32.95 74.86 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.327 1.051 . . . . 0.0 112.78 172.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -76.37 9.66 2.51 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.116 1.366 . . . . 0.0 113.505 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.57 7.79 71.46 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.196 1.379 . . . . 0.0 115.162 172.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -83.68 -178.93 7.18 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.624 1.212 . . . . 0.0 112.202 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.35 158.27 29.67 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.65 1.595 . . . . 0.0 111.248 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 p -55.78 -49.5 73.0 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.258 1.023 . . . . 0.0 112.559 -175.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -54.82 -45.3 74.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.323 1.049 . . . . 0.0 112.533 177.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -70.51 -41.07 73.12 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.486 0.714 . . . . 0.0 111.968 -175.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.2 -46.5 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 123.665 0.786 . . . . 0.0 110.776 175.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.46 -39.53 88.87 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.646 -0.658 . . . . 0.0 111.773 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -62.27 -43.36 99.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.057 0.943 . . . . 0.0 112.582 173.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -65.09 -38.76 91.78 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.216 0.917 . . . . 0.0 112.676 175.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.47 -53.86 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.9 0.773 . . . . 0.0 110.829 171.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -61.89 -32.1 72.45 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.569 0.748 . . . . 0.0 112.934 -178.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 t -64.67 -29.21 70.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.029 0.932 . . . . 0.0 112.669 173.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.3 mt -91.28 -39.28 12.15 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.707 1.203 . . . . 0.0 113.367 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -107.27 -23.88 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -173.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 60.0 -169.5 7.4 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.809 1.195 . . . . 0.0 115.137 -176.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 44.7 ttm-85 -69.92 132.1 45.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 121.669 -0.901 . . . . 0.0 109.557 169.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.15 -168.45 29.83 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 122.895 1.275 . . . . 0.0 115.793 -169.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -80.83 53.12 1.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.902 2.481 . . . . 0.0 109.665 -176.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -53.89 111.4 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.472 1.909 . . . . 0.0 116.133 -165.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.4 mmt -128.76 -19.44 3.69 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.317 1.847 . . . . 0.0 112.658 170.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t 57.64 83.74 0.11 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.195 2.198 . . . . 0.0 112.727 -175.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -138.28 171.22 14.72 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.179 1.791 . . . . 0.0 110.383 -174.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.0 m -53.51 128.21 28.04 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.134 0.973 . . . . 0.0 111.393 174.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.95 148.46 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.833 0.853 . . . . 0.0 112.647 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -138.1 154.41 49.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.086 1.355 . . . . 0.0 110.684 169.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -89.24 137.94 31.87 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.607 0.763 . . . . 0.0 111.164 -177.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.3 p -69.31 163.05 61.67 Favored Pre-proline 0 N--CA 1.479 1.012 0 O-C-N 121.79 -0.569 . . . . 0.0 111.262 172.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.98 -33.88 96.43 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.499 2.133 . . . . 0.0 113.244 172.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.8 mmp_? -67.34 -46.7 72.65 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.401 1.08 . . . . 0.0 111.142 175.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.78 -38.77 83.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.437 0.695 . . . . 0.0 112.409 177.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -59.11 -41.1 87.32 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.108 0.963 . . . . 0.0 111.213 171.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -68.65 -36.61 78.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.502 174.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.36 -45.09 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.501 1.046 . . . . 0.0 111.115 169.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.0 mm -61.91 -44.71 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.714 1.143 . . . . 0.0 111.427 178.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -59.87 -46.28 89.81 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.606 -0.684 . . . . 0.0 112.219 173.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.54 -31.68 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.423 0.689 . . . . 0.0 112.466 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.1 m -62.14 -38.42 88.94 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.348 0.976 . . . . 0.0 110.989 172.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.4 ttm -70.72 -36.43 73.19 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.288 1.035 . . . . 0.0 112.407 175.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.43 -39.99 85.46 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.78 0.832 . . . . 0.0 112.559 172.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.3 -43.84 93.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 120.788 -1.195 . . . . 0.0 111.537 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.17 -43.53 92.12 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.525 -0.734 . . . . 0.0 112.317 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -60.17 -44.48 94.99 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.721 1.208 . . . . 0.0 112.355 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -67.83 -28.84 67.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.78 -12.03 59.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.07 0.948 . . . . 0.0 113.273 169.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.07 17.3 80.26 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.529 1.061 . . . . 0.0 114.193 -174.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -85.69 133.22 34.03 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.431 1.116 . . . . 0.0 110.561 177.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.7 m -73.36 3.0 6.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.154 1.382 . . . . 0.0 114.363 -179.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.15 154.19 28.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.555 2.342 . . . . 0.0 111.284 -173.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.99 117.47 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 125.977 1.711 . . . . 0.0 110.134 176.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.5 175.68 44.27 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.321 0.963 . . . . 0.0 113.512 171.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.8 p -58.14 -40.34 81.09 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.466 -1.02 . . . . 0.0 110.934 172.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -48.78 -53.86 17.4 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.816 2.846 . . . . 0.0 111.171 169.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -70.1 -30.39 67.58 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 118.219 -0.896 . . . . 0.0 113.122 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 70.8 mt -59.57 -48.15 88.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 119.267 0.94 . . . . 0.0 110.281 169.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 36.9 tp -64.03 -43.42 95.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 118.398 -0.81 . . . . 0.0 111.612 177.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 35.2 mt -56.99 -35.79 69.63 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.021 0.828 . . . . 0.0 111.911 173.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.36 -45.17 94.1 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.362 0.982 . . . . 0.0 113.764 170.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.59 -45.6 88.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.736 1.268 . . . . 0.0 112.126 177.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -35.99 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 175.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -68.43 -31.54 70.94 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.402 1.001 . . . . 0.0 112.899 178.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -70.09 -45.22 67.44 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.151 0.887 . . . . 0.0 111.36 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.36 -12.42 2.51 Favored Glycine 0 CA--C 1.539 1.576 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 167.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -100.68 -34.53 9.83 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.379 2.09 . . . . 0.0 112.37 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.31 158.8 42.01 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.346 0.974 . . . . 0.0 114.138 176.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.3 t -54.26 -35.32 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.552 1.541 . . . . 0.0 112.693 -177.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.03 -43.54 73.81 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.52 80.45 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.484 -0.76 . . . . 0.0 112.331 176.317 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -66.43 -44.96 81.45 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.781 1.232 . . . . 0.0 111.238 177.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 49.5 t -57.24 -48.71 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.482 1.513 . . . . 0.0 111.417 177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.68 -42.1 98.46 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.605 0.362 . . . . 0.0 111.658 178.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -67.94 -35.35 78.27 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 176.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -65.0 -40.72 95.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.964 0.802 . . . . 0.0 112.059 174.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.52 -31.94 62.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.506 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.91 1.38 7.51 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.403 1.478 . . . . 0.0 115.496 171.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.23 147.9 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.017 1.327 . . . . 0.0 110.641 173.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.3 t -130.94 158.72 39.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.228 1.411 . . . . 0.0 110.515 -179.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.41 -47.75 47.68 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.028 1.731 . . . . 0.0 112.083 -174.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -69.08 -38.47 79.02 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -71.85 -42.53 66.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.757 0.823 . . . . 0.0 111.521 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.92 95.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.981 0.912 . . . . 0.0 111.274 170.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -55.98 -54.96 38.49 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.947 0.794 . . . . 0.0 111.918 172.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -59.7 -40.84 89.25 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.572 1.078 . . . . 0.0 113.034 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -69.89 -44.28 70.06 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.536 1.062 . . . . 0.0 112.333 177.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.24 -44.55 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.025 0.83 . . . . 0.0 111.337 179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 98.5 mt -67.94 -28.56 67.59 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.523 1.129 . . . . 0.0 112.963 -179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -76.93 -51.07 11.85 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.806 0.73 . . . . 0.0 111.736 169.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.3 tp -70.29 -20.93 63.0 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.0 -7.66 37.56 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 177.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 167.88 -18.76 0.08 OUTLIER Glycine 0 CA--C 1.536 1.406 0 N-CA-C 116.806 1.483 . . . . 0.0 116.806 172.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -83.94 -19.96 33.76 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 118.976 1.388 . . . . 0.0 113.988 -177.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 126.683 1.993 . . . . 0.0 111.063 177.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 tpp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 110.669 -0.123 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -145.41 131.31 19.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.867 1.667 . . . . 0.0 108.339 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -77.78 -53.46 7.49 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -167.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.73 17.21 68.92 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 123.641 0.638 . . . . 0.0 114.365 -169.275 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 49.9 mtt85 -112.04 138.17 49.06 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.232 1.813 . . . . 0.0 110.66 -177.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -129.45 143.72 50.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.918 1.287 . . . . 0.0 109.079 178.204 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.4 p -61.43 162.98 7.22 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.333 0.969 . . . . 0.0 111.747 176.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -58.86 -33.96 71.06 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 120.725 -1.234 . . . . 0.0 111.647 176.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -69.44 -42.59 74.74 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.332 1.053 . . . . 0.0 112.214 172.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.17 92.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.753 0.821 . . . . 0.0 111.707 178.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -57.49 -40.93 79.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.823 0.849 . . . . 0.0 111.527 171.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -64.51 -40.65 96.04 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 117.566 -1.207 . . . . 0.0 112.913 174.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.33 -38.37 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.935 1.698 . . . . 0.0 111.565 176.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.28 -31.81 62.67 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.55 83.01 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.342 -0.849 . . . . 0.0 111.848 169.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.88 -27.29 63.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.783 0.833 . . . . 0.0 112.608 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.63 -34.28 76.73 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.309 0.959 . . . . 0.0 112.615 172.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -69.79 -45.27 68.34 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.578 -0.701 . . . . 0.0 111.462 172.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.52 -40.01 93.06 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.89 -0.506 . . . . 0.0 111.496 176.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -69.97 -39.25 76.1 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.296 1.039 . . . . 0.0 113.231 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.86 -46.66 88.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.517 1.053 . . . . 0.0 111.066 172.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -66.86 -34.04 76.93 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -63.46 -40.54 97.41 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.459 1.027 . . . . 0.0 112.184 170.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -16.62 64.11 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.538 1.135 . . . . 0.0 112.634 174.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.35 30.27 60.8 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.073 -1.017 . . . . 0.0 112.843 -169.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -103.75 143.13 33.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.858 1.663 . . . . 0.0 110.812 171.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.79 2.65 41.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 177.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -134.88 151.08 50.59 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.353 1.061 . . . . 0.0 111.145 174.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.4 mt -86.3 123.95 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.853 1.261 . . . . 0.0 110.379 176.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.57 25.98 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 126.712 2.101 . . . . 0.0 111.771 168.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.4 p -55.75 -40.73 72.95 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.043 0.925 . . . . 0.0 111.273 173.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -49.74 -47.36 50.84 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.101 2.961 . . . . 0.0 113.802 170.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -74.78 -32.25 61.97 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.695 -0.628 . . . . 0.0 111.822 -177.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.42 -41.16 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.484 0.584 . . . . 0.0 110.458 171.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.48 -40.64 96.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.967 0.803 . . . . 0.0 111.477 174.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.69 -45.25 92.65 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.926 0.89 . . . . 0.0 111.993 171.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.05 -41.9 92.75 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 124.248 0.927 . . . . 0.0 112.867 173.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.41 -56.83 16.72 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.28 1.032 . . . . 0.0 112.516 173.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -24.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.75 -24.28 56.07 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.981 0.912 . . . . 0.0 113.081 172.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -75.5 -48.21 23.6 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 167.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.35 -6.82 5.33 Favored Glycine 0 CA--C 1.536 1.351 0 N-CA-C 118.258 2.063 . . . . 0.0 118.258 166.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -124.39 -23.36 4.48 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.789 1.794 . . . . 0.0 114.276 -169.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.66 160.92 36.48 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.084 1.326 . . . . 0.0 113.415 169.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.9 mm -54.58 -42.68 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.754 1.222 . . . . 0.0 113.309 -169.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -45.11 83.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.525 1.057 . . . . 0.0 112.842 178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.81 -35.84 81.82 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.297 -0.877 . . . . 0.0 111.702 176.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -64.11 -39.81 94.85 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 111.435 172.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.41 -41.88 84.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.229 . . . . 0.0 112.642 174.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 -47.8 84.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.958 0.799 . . . . 0.0 111.151 173.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.34 -35.23 79.82 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 176.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -33.13 75.09 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.085 -1.01 . . . . 0.0 113.03 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -75.52 6.9 4.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.217 1.407 . . . . 0.0 113.76 171.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.76 7.66 74.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.903 1.24 . . . . 0.0 114.837 175.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 mt -82.49 -175.61 5.82 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.341 1.071 . . . . 0.0 111.268 172.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.86 164.22 37.78 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.085 1.326 . . . . 0.0 111.243 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -58.05 -50.52 73.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.639 0.776 . . . . 0.0 112.163 -176.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.42 -43.3 88.61 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.341 0.656 . . . . 0.0 112.323 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -63.8 -45.82 87.97 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.744 1.218 . . . . 0.0 112.284 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 50.9 mt -70.87 -43.27 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.41 . . . . 0.0 110.515 179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -67.26 -39.9 86.17 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.554 -0.716 . . . . 0.0 112.848 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.61 -41.18 93.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 119.458 1.027 . . . . 0.0 113.02 176.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -66.41 -36.9 83.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 175.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.16 -52.16 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 119.003 0.819 . . . . 0.0 110.703 169.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.24 -29.46 69.85 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.883 0.873 . . . . 0.0 113.31 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.6 t -67.52 -14.96 63.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.151 0.981 . . . . 0.0 113.426 172.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -109.77 -36.19 5.98 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.695 1.598 . . . . 0.0 112.782 -179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -110.54 3.22 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 115.589 1.7 . . . . 0.0 115.589 -176.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.13 7.0 0.59 Allowed Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.237 1.875 . . . . 0.0 117.448 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 tpt180 -78.09 -25.93 47.86 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.646 1.579 . . . . 0.0 112.897 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.72 162.29 21.63 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.707 1.146 . . . . 0.0 114.466 -177.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -140.95 64.86 1.41 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.84 2.056 . . . . 0.0 108.315 171.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -83.04 90.35 7.02 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.945 0.898 . . . . 0.0 112.07 -169.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.7 mtt -126.99 -2.85 6.47 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.358 1.463 . . . . 0.0 113.163 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . 0.277 86.5 p 50.8 29.42 4.3 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.759 2.424 . . . . 0.0 116.895 175.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -73.1 150.57 42.16 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.169 1.788 . . . . 0.0 109.949 169.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -54.23 137.79 40.21 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.141 0.976 . . . . 0.0 108.9 167.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -61.29 134.57 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 119.016 0.825 . . . . 0.0 111.522 -174.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -132.74 162.83 30.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.264 1.426 . . . . 0.0 110.096 171.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -93.69 131.97 38.49 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.625 -0.672 . . . . 0.0 110.582 -175.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.2 p -64.29 160.95 45.67 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.615 0.766 . . . . 0.0 111.18 171.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -55.93 -33.52 89.18 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.472 2.115 . . . . 0.0 113.741 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.0 mmm-85 -74.19 -42.1 60.39 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.587 0.755 . . . . 0.0 111.522 178.112 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.3 -40.47 90.01 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.794 0.725 . . . . 0.0 112.309 173.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -58.45 -44.39 89.21 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.219 1.008 . . . . 0.0 111.068 172.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -68.41 -36.85 79.69 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 117.988 -1.006 . . . . 0.0 112.611 175.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.4 t -57.17 -47.41 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 120.193 1.36 . . . . 0.0 111.124 168.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 mm -63.25 -43.52 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.144 0.884 . . . . 0.0 111.395 -179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.05 -37.98 85.01 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.322 -0.862 . . . . 0.0 112.6 175.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.4 mt -65.97 -40.85 91.61 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.026 0.83 . . . . 0.0 111.473 173.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -58.91 -42.75 90.4 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.252 1.021 . . . . 0.0 110.803 175.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 28.7 ttm -72.42 -31.65 65.67 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 176.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -70.29 -34.12 72.36 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 119.298 0.954 . . . . 0.0 112.871 171.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.03 -47.3 74.87 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 120.496 -1.378 . . . . 0.0 110.765 169.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.62 73.57 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 175.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -71.31 -42.65 68.37 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.959 1.704 . . . . 0.0 112.793 177.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -71.85 -31.31 66.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.32 -9.81 59.33 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.144 0.977 . . . . 0.0 113.071 172.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.31 28.21 60.38 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.945 1.259 . . . . 0.0 115.734 170.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -78.37 -15.92 58.19 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.8 m 61.3 0.87 0.47 Allowed 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 -172.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -157.26 157.21 33.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.454 2.302 . . . . 0.0 110.19 173.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.72 118.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.031 1.332 . . . . 0.0 110.379 179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.69 170.6 42.29 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 123.944 0.783 . . . . 0.0 113.276 170.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 p -58.39 -39.05 78.6 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.548 -0.972 . . . . 0.0 111.18 171.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -47.8 -53.94 13.89 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.199 2.2 . . . . 0.0 111.55 169.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -68.98 -31.8 70.9 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.041 0.937 . . . . 0.0 113.025 179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.87 -46.1 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.048 0.84 . . . . 0.0 110.783 171.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 34.5 tp -63.67 -43.84 95.53 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.312 174.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -56.77 -36.36 69.74 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.356 0.98 . . . . 0.0 112.494 175.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -66.83 -42.6 92.88 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.116 0.865 . . . . 0.0 113.997 171.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.54 -43.79 96.81 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.589 1.194 . . . . 0.0 112.845 177.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -36.89 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.481 173.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -64.62 -29.61 70.62 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.894 1.224 . . . . 0.0 112.984 177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -62.86 -32.88 74.2 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.925 0.89 . . . . 0.0 112.578 172.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.43 -28.24 0.27 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 126.986 2.232 . . . . 0.0 118.124 168.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -115.59 -19.76 10.45 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.011 1.405 . . . . 0.0 113.4 -170.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.51 158.04 43.78 Favored Glycine 0 CA--C 1.534 1.254 0 O-C-N 121.4 -0.812 . . . . 0.0 112.772 173.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.5 t -53.12 -36.43 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.475 1.11 . . . . 0.0 112.143 -177.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.29 78.29 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.59 -38.06 86.21 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.77 -0.581 . . . . 0.0 111.985 177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.0 mtt180 -62.15 -48.49 79.84 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.206 1.002 . . . . 0.0 111.281 176.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.02 -51.4 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.055 1.342 . . . . 0.0 111.336 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.2 mt -61.75 -42.57 99.15 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.702 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.71 -29.28 64.39 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 178.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -72.68 -37.3 67.94 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.596 1.159 . . . . 0.0 111.547 175.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.14 -36.15 74.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.298 1.039 . . . . 0.0 112.365 171.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.37 -1.5 4.47 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.35 1.452 . . . . 0.0 116.029 169.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 81.4 t -86.76 132.45 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.283 1.433 . . . . 0.0 110.894 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.5 p -101.71 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.754 1.221 . . . . 0.0 111.257 177.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 131' ' ' LEU . 4.6 mp -53.47 -42.78 67.59 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.169 -0.332 . . . . 0.0 110.455 169.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.62 -42.55 61.33 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.101 0.96 . . . . 0.0 112.955 -175.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.8 -44.7 92.55 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.454 0.702 . . . . 0.0 111.605 177.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.98 -47.45 83.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.018 0.527 . . . . 0.0 111.382 171.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -57.7 -49.77 75.43 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 118.198 -0.906 . . . . 0.0 112.797 -179.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -61.93 -40.9 97.09 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.889 1.222 . . . . 0.0 112.491 -179.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -69.63 -44.86 69.78 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.174 0.897 . . . . 0.0 112.162 177.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 88.3 t -64.06 -45.61 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 119.166 0.894 . . . . 0.0 111.258 179.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.05 -26.16 64.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.328 1.051 . . . . 0.0 113.051 -179.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -79.11 -49.51 12.5 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.851 0.751 . . . . 0.0 111.848 168.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.0 tp -72.51 -18.94 61.61 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -169.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.39 -8.5 40.94 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 115.071 1.508 . . . . 0.0 115.071 176.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.53 -10.14 0.12 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 173.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -32.97 29.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.057 1.429 . . . . 0.0 112.747 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.248 1.819 . . . . 0.0 111.395 174.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tmm? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.03 166.73 30.67 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.436 1.494 . . . . 0.0 110.597 169.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -95.99 141.66 29.14 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.529 1.132 . . . . 0.0 112.149 175.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.18 -2.38 60.69 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.764 1.173 . . . . 0.0 115.199 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 ttt85 -82.53 137.23 34.65 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.81 1.305 . . . . 0.0 111.807 -177.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -110.49 150.32 29.05 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.811 2.044 . . . . 0.0 109.45 169.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.8 p -63.29 165.02 8.01 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 120.854 -1.154 . . . . 0.0 112.026 176.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -63.25 -32.1 73.41 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.965 -1.084 . . . . 0.0 112.103 178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -74.27 -36.11 63.8 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.506 -0.746 . . . . 0.0 112.789 170.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.85 -40.84 79.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.622 1.101 . . . . 0.0 111.75 177.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -57.15 -40.72 77.77 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.909 0.884 . . . . 0.0 111.12 169.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -64.07 -40.5 96.41 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 117.951 -1.024 . . . . 0.0 112.583 175.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -37.74 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 120.63 1.559 . . . . 0.0 111.629 174.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.2 -30.98 62.46 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.763 0.711 . . . . 0.0 112.761 178.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.79 -41.04 83.81 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.197 -0.939 . . . . 0.0 111.771 169.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.57 -34.47 77.12 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.426 0.69 . . . . 0.0 112.04 173.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.44 -36.04 77.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.146 0.885 . . . . 0.0 112.768 175.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.59 -44.86 81.03 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.124 0.57 . . . . 0.0 111.592 173.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.78 -45.08 72.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.626 0.648 . . . . 0.0 111.183 -179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -56.13 -43.46 78.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.043 1.337 . . . . 0.0 112.479 172.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.98 38.66 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.817 0.735 . . . . 0.0 111.013 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.88 -39.26 91.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.6 0.76 . . . . 0.0 112.848 -177.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -64.64 -37.87 89.05 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.291 1.436 . . . . 0.0 112.151 176.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.5 4.65 27.0 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.527 1.531 . . . . 0.0 112.947 173.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.4 14.86 81.97 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 120.361 -1.462 . . . . 0.0 114.811 177.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -89.17 130.93 35.51 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.803 1.301 . . . . 0.0 110.354 170.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -104.58 11.14 34.58 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.231 1.412 . . . . 0.0 112.723 175.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.78 140.83 40.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.447 1.499 . . . . 0.0 111.104 168.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mt -81.95 127.06 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.922 0.889 . . . . 0.0 110.718 177.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.58 173.58 21.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.63 2.062 . . . . 0.0 111.52 167.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -55.57 -37.99 68.76 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.88 0.872 . . . . 0.0 111.521 172.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -50.67 -47.38 58.78 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.875 2.87 . . . . 0.0 113.226 169.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -74.75 -33.82 62.39 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.528 -0.733 . . . . 0.0 111.81 -178.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 79.2 mt -64.08 -41.36 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.266 0.626 . . . . 0.0 110.385 170.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.23 -43.9 85.31 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.586 0.63 . . . . 0.0 111.832 175.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -55.65 -44.94 77.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.14 0.976 . . . . 0.0 111.741 170.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.45 92.37 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.053 0.835 . . . . 0.0 112.783 173.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mt -58.54 -56.47 21.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.521 1.128 . . . . 0.0 112.686 174.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -24.41 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -177.172 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -73.76 -28.55 61.73 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 119.173 0.897 . . . . 0.0 112.482 170.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.99 -52.37 24.85 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.573 0.624 . . . . 0.0 109.857 169.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 -12.65 3.19 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.139 2.016 . . . . 0.0 118.139 168.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -104.27 -35.24 8.05 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.806 1.803 . . . . 0.0 112.619 -175.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.52 154.95 20.03 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.067 1.318 . . . . 0.0 113.821 179.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.2 mm -51.67 -43.43 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.36 1.464 . . . . 0.0 112.509 -172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.67 -45.23 83.69 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.26 -36.29 82.62 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.3 -0.875 . . . . 0.0 111.846 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.58 0.752 . . . . 0.0 111.75 173.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.78 84.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.514 1.126 . . . . 0.0 112.423 173.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.79 -46.9 87.76 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.077 0.853 . . . . 0.0 111.268 172.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.43 -34.46 78.0 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.72 -33.35 75.68 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.978 -1.076 . . . . 0.0 112.969 173.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -74.23 8.24 2.29 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.162 1.385 . . . . 0.0 113.622 170.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 7.81 74.03 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.088 1.328 . . . . 0.0 114.912 173.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -84.77 -175.95 6.0 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.446 1.123 . . . . 0.0 111.751 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -163.57 158.86 31.43 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 125.66 1.6 . . . . 0.0 111.248 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.8 p -57.87 -49.53 76.41 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.966 0.906 . . . . 0.0 112.632 -174.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -55.2 -44.2 75.1 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.31 1.044 . . . . 0.0 112.348 176.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -69.66 -43.89 71.65 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.371 0.668 . . . . 0.0 111.287 -174.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.8 mt -67.33 -45.5 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 123.636 0.774 . . . . 0.0 110.843 176.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -66.69 -41.55 87.87 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.559 -0.713 . . . . 0.0 112.047 -177.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.24 -39.36 93.79 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 174.608 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -67.0 -37.36 84.06 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.293 0.951 . . . . 0.0 112.623 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.41 -53.91 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 118.978 0.808 . . . . 0.0 110.691 170.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.474 0.71 . . . . 0.0 112.73 -177.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.9 t -64.89 -31.09 72.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.25 1.02 . . . . 0.0 112.84 174.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.33 -38.08 16.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.351 1.061 . . . . 0.0 113.292 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.8 pt -105.52 -25.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -172.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.9 -161.45 10.37 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 119.206 0.912 . . . . 0.0 114.321 -174.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -71.26 141.47 50.55 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.52 -0.988 . . . . 0.0 110.862 169.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 -173.65 45.49 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 -169.178 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.441 ' H ' ' CD ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -72.46 66.91 0.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.132 2.173 . . . . 0.0 111.2 172.33 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -68.53 108.58 3.36 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.717 1.607 . . . . 0.0 112.912 -168.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 78.0 mtm -135.88 1.07 2.73 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.106 1.763 . . . . 0.0 113.615 -175.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.2 m 55.88 26.96 10.32 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.761 1.624 . . . . 0.0 114.975 -176.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -82.14 150.54 27.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.533 1.533 . . . . 0.0 111.402 176.45 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.3 m -61.47 144.36 54.33 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.692 1.197 . . . . 0.0 109.625 168.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 mm -66.81 136.81 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -169.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -117.33 156.92 27.01 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.774 2.029 . . . . 0.0 108.894 166.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -95.55 133.87 39.07 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.099 -1.0 . . . . 0.0 110.194 174.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -65.69 160.13 63.32 Favored Pre-proline 0 N--CA 1.477 0.884 0 C-N-CA 123.415 0.686 . . . . 0.0 111.374 171.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -56.38 -34.34 94.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.477 2.118 . . . . 0.0 113.088 172.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -63.58 -50.85 67.86 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.074 1.349 . . . . 0.0 111.123 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.48 83.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.412 0.685 . . . . 0.0 112.756 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.36 -43.84 92.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.025 0.93 . . . . 0.0 111.301 174.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.23 -39.74 93.14 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 118.599 -0.715 . . . . 0.0 112.2 175.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.36 -47.43 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 119.34 0.973 . . . . 0.0 111.719 169.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 19.0 mm -62.2 -43.51 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 119.358 0.981 . . . . 0.0 111.466 -179.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.03 -41.05 95.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.648 -0.658 . . . . 0.0 112.549 174.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.77 -28.94 67.24 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.301 -0.874 . . . . 0.0 112.593 175.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 39.2 m -65.51 -45.69 82.56 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.08 0.855 . . . . 0.0 111.045 177.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 19.8 ptp -71.68 -30.65 65.92 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 173.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.12 -44.99 78.49 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.476 1.034 . . . . 0.0 112.844 173.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -64.43 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.018 -1.051 . . . . 0.0 111.376 175.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.55 -41.58 96.24 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.339 -0.851 . . . . 0.0 112.504 172.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -65.4 -39.73 92.55 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.283 1.433 . . . . 0.0 112.073 177.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -65.26 -28.88 69.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.905 1.282 . . . . 0.0 112.888 173.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.45 -4.73 49.89 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.938 1.295 . . . . 0.0 113.875 169.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.02 23.65 77.89 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -178.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -76.44 177.44 7.37 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.219 1.008 . . . . 0.0 112.627 -178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 49.2 m -111.03 -16.68 13.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.619 1.568 . . . . 0.0 113.582 177.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -156.65 159.08 38.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.3 1.44 . . . . 0.0 112.163 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.9 t -82.91 112.61 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.077 1.351 . . . . 0.0 110.712 -176.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.1 172.76 53.01 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.837 0.732 . . . . 0.0 113.708 173.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.9 p -57.94 -39.83 79.0 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 121.784 -0.833 . . . . 0.0 110.672 170.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.52 -54.71 10.85 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.21 2.204 . . . . 0.0 111.631 169.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -69.25 -28.93 66.76 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.008 0.923 . . . . 0.0 113.131 -178.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.37 -46.67 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.326 0.967 . . . . 0.0 110.238 169.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.8 tp -66.96 -36.97 83.39 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 118.365 -0.826 . . . . 0.0 112.171 177.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.0 mt -59.43 -36.1 75.26 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.155 0.889 . . . . 0.0 112.131 169.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.75 -47.2 85.89 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.888 0.756 . . . . 0.0 113.244 170.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -59.18 -44.23 92.17 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.617 1.167 . . . . 0.0 112.52 179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.2 pt -71.89 -43.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.0 tpt85 -68.87 -26.12 64.97 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -175.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -68.91 -41.92 77.53 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.002 0.819 . . . . 0.0 111.609 176.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.42 -1.25 9.59 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 119.078 2.391 . . . . 0.0 119.078 167.375 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -114.21 -31.5 6.29 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.607 2.203 . . . . 0.0 112.925 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.93 157.87 45.52 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.61 1.1 . . . . 0.0 114.069 174.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 71.7 t -55.29 -34.58 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.549 1.54 . . . . 0.0 112.724 -176.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.96 -44.46 74.39 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.063 0.847 . . . . 0.0 113.042 178.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.31 -36.18 82.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.563 -0.711 . . . . 0.0 112.374 175.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -65.15 -45.68 83.98 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.475 1.11 . . . . 0.0 111.299 177.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.15 -49.41 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.075 1.35 . . . . 0.0 111.324 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.84 -43.72 94.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 119.068 -0.491 . . . . 0.0 111.288 178.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -69.57 -29.72 67.35 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -71.36 -34.92 70.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.082 0.856 . . . . 0.0 112.408 172.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.1 mt -77.48 -35.05 54.05 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.098 0.959 . . . . 0.0 112.712 176.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 133.23 -5.2 4.96 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.716 1.627 . . . . 0.0 115.586 172.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 77.1 t -80.23 145.24 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.244 1.417 . . . . 0.0 111.035 175.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.6 m -133.05 162.78 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.148 1.379 . . . . 0.0 110.405 -176.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 tt -46.17 -49.68 16.58 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.899 1.679 . . . . 0.0 112.407 -178.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -70.76 -38.97 73.52 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.45 -0.781 . . . . 0.0 113.099 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -64.57 -46.3 83.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.243 1.017 . . . . 0.0 110.832 179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.33 80.77 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.979 0.912 . . . . 0.0 111.378 174.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -52.95 -53.21 53.0 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.352 0.978 . . . . 0.0 111.558 173.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.685 1.13 . . . . 0.0 112.43 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -67.29 -34.14 76.77 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.903 1.229 . . . . 0.0 113.06 -177.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.6 t -72.9 -47.16 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 119.268 0.94 . . . . 0.0 111.4 177.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.19 -24.98 67.52 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.512 1.125 . . . . 0.0 112.188 177.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -75.77 -62.05 1.72 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.292 1.037 . . . . 0.0 111.331 168.115 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.2 tp -65.64 -19.68 66.0 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -168.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.35 -11.77 45.38 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.47 -30.96 0.16 Allowed Glycine 0 CA--C 1.536 1.386 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.5 t -72.62 -27.48 62.18 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -176.135 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 127.954 2.502 . . . . 0.0 114.98 177.662 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.4 ttt -74.37 152.97 39.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.971 0.908 . . . . 0.0 111.888 176.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -71.43 8.55 1.03 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.587 1.955 . . . . 0.0 115.172 176.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.21 7.22 61.01 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.47 1.51 . . . . 0.0 116.585 -174.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -73.58 148.62 42.78 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.097 1.359 . . . . 0.0 110.537 175.208 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -111.9 151.75 28.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.222 1.409 . . . . 0.0 110.141 175.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.5 p -70.09 167.67 17.2 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 121.207 -0.933 . . . . 0.0 112.203 175.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.04 -36.48 83.7 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.902 -1.124 . . . . 0.0 111.583 171.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -61.62 -47.02 87.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.472 0.709 . . . . 0.0 111.395 172.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.29 -41.15 73.75 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.844 0.858 . . . . 0.0 111.342 -174.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -61.56 -33.91 74.67 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.637 -0.664 . . . . 0.0 111.851 171.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -66.91 -41.1 87.69 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.586 172.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.57 -34.89 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 120.88 1.673 . . . . 0.0 111.899 175.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.3 -33.24 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.625 0.648 . . . . 0.0 112.576 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.24 -40.25 86.28 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.239 -0.913 . . . . 0.0 111.808 169.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.64 -25.52 61.31 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.726 0.81 . . . . 0.0 112.625 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.55 83.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.46 1.027 . . . . 0.0 112.072 170.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -67.63 -44.2 78.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.715 -0.615 . . . . 0.0 111.428 172.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -62.44 -41.33 98.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.856 -0.527 . . . . 0.0 111.835 177.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -72.6 -34.87 67.68 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.962 0.905 . . . . 0.0 112.77 177.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -46.56 90.17 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.017 0.826 . . . . 0.0 110.912 169.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.19 -32.13 71.21 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.069 0.948 . . . . 0.0 113.313 178.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -58.88 -40.15 83.53 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 119.391 0.996 . . . . 0.0 111.683 170.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.6 mt -85.15 -2.04 57.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.803 1.241 . . . . 0.0 113.424 175.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.74 12.65 78.31 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 115.243 -177.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -77.3 141.06 40.12 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 1.555 . . . . 0.0 110.859 175.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -96.07 15.9 19.46 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -138.99 151.21 46.66 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.0 0.92 . . . . 0.0 112.502 177.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -100.71 115.0 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 C-N-CA 125.782 1.633 . . . . 0.0 106.951 168.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.23 -178.77 34.33 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.265 1.412 . . . . 0.0 111.559 168.249 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 27.7 p -55.35 -40.26 71.03 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.632 -0.922 . . . . 0.0 111.108 171.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.45 -50.41 41.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 129.615 3.166 . . . . 0.0 113.344 169.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.71 -29.99 62.59 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.818 -0.611 . . . . 0.0 111.859 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.4 mt -69.37 -43.35 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.047 0.84 . . . . 0.0 110.641 172.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.9 tp -63.48 -43.46 97.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.341 0.973 . . . . 0.0 111.073 174.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.11 -37.61 86.17 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.151 0.98 . . . . 0.0 111.998 177.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.28 -38.11 95.14 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.657 1.122 . . . . 0.0 112.604 169.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.04 -51.66 68.68 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.591 1.156 . . . . 0.0 112.725 173.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.46 -23.17 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 176.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -69.81 -28.81 66.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.99 0.916 . . . . 0.0 112.166 170.212 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -75.87 -49.26 18.42 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.24 1.016 . . . . 0.0 109.642 168.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.7 -8.81 9.65 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 118.297 2.079 . . . . 0.0 118.297 167.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -122.32 -19.38 6.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.982 1.891 . . . . 0.0 114.911 -172.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.59 163.54 27.67 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.546 1.069 . . . . 0.0 113.504 172.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.0 -43.51 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 121.812 -0.817 . . . . 0.0 112.274 -169.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -64.79 -43.16 94.1 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.27 85.88 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.249 -0.907 . . . . 0.0 111.774 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -67.48 -36.27 80.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.669 0.788 . . . . 0.0 111.662 173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.38 86.72 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.452 1.101 . . . . 0.0 112.433 173.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.1 -47.4 85.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.697 0.799 . . . . 0.0 110.921 172.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.62 -33.68 74.45 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.322 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.24 75.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.394 1.078 . . . . 0.0 112.909 173.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -75.46 8.15 3.06 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.166 1.387 . . . . 0.0 113.641 171.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.15 7.82 72.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.051 1.31 . . . . 0.0 114.822 173.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.66 -176.92 6.52 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.331 1.065 . . . . 0.0 111.651 175.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.87 159.92 31.91 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.381 1.467 . . . . 0.0 111.273 178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 p -58.93 -42.91 90.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 112.705 -175.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.18 -39.1 92.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.108 0.963 . . . . 0.0 112.624 177.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -67.47 -46.11 73.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.903 0.881 . . . . 0.0 111.649 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.03 -42.63 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.992 0.917 . . . . 0.0 110.343 177.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -60.7 -43.71 97.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.858 0.863 . . . . 0.0 112.223 175.56 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -60.62 -48.07 83.43 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.695 0.68 . . . . 0.0 111.176 175.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.26 -34.65 77.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.34 0.973 . . . . 0.0 113.446 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -61.1 -56.17 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.406 1.003 . . . . 0.0 110.037 169.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -63.74 -29.85 71.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.641 0.776 . . . . 0.0 112.956 -176.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 54.2 m -67.94 -22.65 65.04 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.601 1.161 . . . . 0.0 113.165 174.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -101.11 -29.84 11.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.625 1.17 . . . . 0.0 113.552 -178.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.4 pt -112.0 -17.13 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -175.59 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.52 -163.5 31.74 Favored Glycine 0 CA--C 1.538 1.519 0 CA-C-N 119.023 0.828 . . . . 0.0 114.755 -178.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -141.71 165.11 28.38 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.762 1.625 . . . . 0.0 112.546 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.39 20.14 59.21 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.846 1.212 . . . . 0.0 114.869 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -78.84 48.08 0.8 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.681 1.592 . . . . 0.0 112.133 -179.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -93.76 128.45 40.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.841 1.256 . . . . 0.0 113.04 -169.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 72.6 mtm -137.07 -15.76 1.48 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.251 2.221 . . . . 0.0 113.013 178.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.0 t -155.3 -167.91 2.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.821 2.448 . . . . 0.0 109.203 -176.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -119.93 9.13 11.18 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.268 -1.52 . . . . 0.0 112.808 170.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -115.55 154.74 28.82 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.317 1.847 . . . . 0.0 111.161 -177.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -101.59 150.72 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.565 1.546 . . . . 0.0 113.554 177.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -140.49 162.7 34.73 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.687 1.995 . . . . 0.0 110.324 168.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -94.82 135.15 36.65 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.603 -1.311 . . . . 0.0 111.318 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -69.08 162.54 64.55 Favored Pre-proline 0 N--CA 1.479 1.009 0 O-C-N 121.693 -0.629 . . . . 0.0 111.366 173.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -57.05 -32.23 92.55 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.497 2.131 . . . . 0.0 113.447 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -71.46 -40.75 70.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.75 0.82 . . . . 0.0 111.548 175.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.08 -41.8 81.36 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.825 0.739 . . . . 0.0 112.2 174.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -58.33 -44.34 88.66 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.19 0.996 . . . . 0.0 111.305 173.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -60.91 -43.29 98.75 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 112.334 171.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.3 t -59.8 -42.11 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.076 1.307 . . . . 0.0 112.321 172.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 27.6 mm -60.6 -45.7 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.936 176.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -65.7 -36.93 85.05 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.55 -0.719 . . . . 0.0 112.889 175.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.22 -30.29 60.55 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.229 1.012 . . . . 0.0 112.665 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 m -65.6 -40.75 92.99 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.065 0.946 . . . . 0.0 110.487 170.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 36.4 ttm -66.47 -38.86 88.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.592 1.157 . . . . 0.0 111.999 172.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.34 -35.24 77.47 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.823 0.849 . . . . 0.0 112.9 175.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -69.73 -44.14 70.9 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.989 -1.069 . . . . 0.0 111.162 171.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.8 -37.53 73.91 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.01 -1.056 . . . . 0.0 112.371 173.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -66.49 -47.42 73.07 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.714 1.605 . . . . 0.0 112.115 171.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -63.32 -39.61 95.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.119 -178.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.47 -4.07 49.55 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 173.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.65 27.38 73.2 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 121.257 -0.902 . . . . 0.0 113.665 -178.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -83.63 -18.98 36.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.959 1.304 . . . . 0.0 113.214 -172.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 m 61.34 4.94 1.02 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.192 2.197 . . . . 0.0 116.848 177.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -159.09 153.92 24.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.646 1.578 . . . . 0.0 110.783 169.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.0 t -88.51 106.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.774 1.63 . . . . 0.0 110.44 -174.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.45 172.65 50.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 123.398 0.523 . . . . 0.0 112.89 169.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -53.08 -38.61 62.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.006 0.922 . . . . 0.0 112.466 169.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -51.83 -55.15 21.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.092 2.157 . . . . 0.0 111.582 169.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -66.38 -28.8 68.92 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.044 0.938 . . . . 0.0 113.512 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 61.9 mt -60.55 -48.9 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 119.453 1.024 . . . . 0.0 110.613 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.408 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 40.0 tp -64.03 -43.14 96.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.543 178.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -55.01 -41.17 70.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.733 0.697 . . . . 0.0 112.065 172.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -63.02 -40.07 98.83 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.653 1.12 . . . . 0.0 113.927 173.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.09 -40.12 96.72 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.401 1.08 . . . . 0.0 112.207 175.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -39.82 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.987 0.812 . . . . 0.0 112.186 173.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -57.76 -32.67 67.71 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.041 1.336 . . . . 0.0 112.98 176.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -68.11 -41.52 81.65 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.467 0.707 . . . . 0.0 112.324 174.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.36 -32.1 0.45 Allowed Glycine 0 CA--C 1.539 1.565 0 C-N-CA 126.113 1.816 . . . . 0.0 117.415 169.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.5 -24.4 15.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 118.775 1.288 . . . . 0.0 112.535 -173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.81 160.48 50.05 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.219 0.914 . . . . 0.0 113.714 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.02 -37.15 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.464 1.106 . . . . 0.0 111.941 -177.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.12 -44.33 83.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.512 1.051 . . . . 0.0 113.279 178.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.64 81.48 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.599 -0.688 . . . . 0.0 111.986 174.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -66.99 -42.94 84.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.79 0.836 . . . . 0.0 112.234 175.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 51.2 t -56.98 -48.68 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.303 1.441 . . . . 0.0 110.96 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.64 -45.11 95.29 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.062 0.545 . . . . 0.0 111.689 177.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -66.54 -34.36 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 178.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -67.57 -40.45 84.89 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.793 0.837 . . . . 0.0 112.103 175.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.8 mt -75.35 -32.2 60.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.175 0.99 . . . . 0.0 112.725 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.38 10.96 3.91 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.226 1.393 . . . . 0.0 115.741 172.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 85.4 t -92.9 144.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.677 1.591 . . . . 0.0 111.077 176.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.1 m -133.85 166.84 21.74 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.192 1.797 . . . . 0.0 110.427 -176.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.8 mt -46.61 -57.26 4.94 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.717 1.207 . . . . 0.0 113.039 -177.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -64.69 -38.72 91.97 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.074 0.852 . . . . 0.0 112.326 -176.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -63.63 -47.77 80.01 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.508 1.123 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.12 -52.17 30.96 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.298 1.039 . . . . 0.0 112.02 177.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 20.7 mtp-105 -59.34 -45.19 92.04 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.649 0.659 . . . . 0.0 111.686 -177.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.69 -37.56 84.97 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.086 0.857 . . . . 0.0 112.866 -178.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -69.46 -44.25 71.59 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.067 -1.02 . . . . 0.0 112.151 173.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 80.5 t -65.1 -44.32 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.897 0.771 . . . . 0.0 111.353 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.75 -23.13 62.36 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.291 1.036 . . . . 0.0 113.296 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -80.01 -53.56 6.61 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.055 0.843 . . . . 0.0 111.269 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.3 tp -67.73 -18.49 64.92 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -168.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.11 -7.76 19.66 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.19 -0.53 0.33 Allowed Glycine 0 CA--C 1.538 1.515 0 N-CA-C 116.125 1.21 . . . . 0.0 116.125 175.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 74.2 m -107.55 -7.72 16.43 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.82 1.648 . . . . 0.0 114.351 -174.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.324 1.449 . . . . 0.0 112.809 175.753 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 38.0 ttp -148.16 160.52 42.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.907 1.283 . . . . 0.0 111.233 179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -65.08 -4.85 5.3 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.939 1.696 . . . . 0.0 114.944 175.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.11 9.45 32.54 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.016 1.77 . . . . 0.0 116.389 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -65.93 158.63 27.56 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.011 1.406 . . . . 0.0 111.219 169.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -121.85 150.15 42.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.288 1.435 . . . . 0.0 110.472 173.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.2 p -72.66 170.33 14.73 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.957 0.903 . . . . 0.0 112.084 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -60.44 -45.7 92.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.242 -1.537 . . . . 0.0 111.698 174.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -63.68 -39.19 93.7 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.811 -0.556 . . . . 0.0 112.057 177.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -42.1 75.37 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.416 0.686 . . . . 0.0 112.059 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -62.07 -35.65 79.3 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.592 -0.692 . . . . 0.0 111.306 171.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -65.36 -41.08 94.21 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 117.356 -1.307 . . . . 0.0 112.918 172.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.79 -38.41 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 121.451 1.932 . . . . 0.0 111.539 173.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.15 -31.81 64.5 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.23 83.87 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.238 -0.914 . . . . 0.0 111.704 170.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -70.07 -28.74 65.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.713 0.805 . . . . 0.0 112.232 176.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.99 -35.72 81.14 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.153 0.981 . . . . 0.0 112.795 172.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -67.07 -43.0 83.74 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.465 0.706 . . . . 0.0 111.24 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -68.91 -38.05 79.33 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.493 -0.755 . . . . 0.0 112.126 176.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -64.95 -31.96 73.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.121 0.968 . . . . 0.0 113.1 173.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.18 -53.3 20.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.696 0.68 . . . . 0.0 111.113 169.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.5 -38.15 90.03 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -174.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? -70.03 -21.78 63.16 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 176.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.2 tp -86.66 -8.8 57.14 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.389 1.476 . . . . 0.0 112.594 175.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.34 34.17 37.33 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.243 -0.911 . . . . 0.0 113.053 -171.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -111.93 131.91 55.09 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.727 1.611 . . . . 0.0 110.09 170.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -100.15 30.24 3.89 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.947 0.899 . . . . 0.0 112.49 170.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.913 1.685 . . . . 0.0 111.222 -179.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.0 mt -112.48 117.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.593 1.157 . . . . 0.0 109.25 169.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.64 179.42 30.4 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.997 1.761 . . . . 0.0 111.458 167.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -55.81 -39.5 71.42 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.493 -1.004 . . . . 0.0 111.275 171.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -50.21 -49.79 51.65 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 129.734 3.214 . . . . 0.0 113.073 169.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -73.12 -34.63 66.24 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.567 -0.708 . . . . 0.0 111.907 -179.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.3 mt -63.26 -41.26 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.539 0.609 . . . . 0.0 110.483 171.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.3 tp -66.54 -42.63 86.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.712 0.687 . . . . 0.0 111.69 175.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.34 -42.72 87.46 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.999 0.92 . . . . 0.0 112.111 171.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.82 -43.08 96.79 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.053 0.835 . . . . 0.0 112.882 172.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.67 -52.62 64.68 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.664 1.186 . . . . 0.0 112.67 173.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.67 -22.77 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -71.94 -32.14 67.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.713 1.142 . . . . 0.0 111.652 168.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.36 -50.16 41.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.417 0.687 . . . . 0.0 110.455 172.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.95 -6.38 10.02 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 118.485 2.154 . . . . 0.0 118.485 167.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -128.25 -15.09 4.73 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.315 2.057 . . . . 0.0 114.08 -169.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.73 157.87 37.62 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 121.401 -0.812 . . . . 0.0 111.803 167.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -52.63 -41.1 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.753 1.221 . . . . 0.0 112.055 -176.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.84 86.06 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 177.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.79 -41.58 87.4 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.197 -0.94 . . . . 0.0 111.751 178.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -61.15 -38.06 85.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.46 0.704 . . . . 0.0 111.983 170.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.33 86.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.229 1.012 . . . . 0.0 112.938 174.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.7 mt -58.82 -48.74 80.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.881 0.764 . . . . 0.0 111.011 172.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -67.81 -32.48 73.07 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.67 -32.89 74.52 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.016 -1.053 . . . . 0.0 113.019 173.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.99 6.08 4.5 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.048 1.339 . . . . 0.0 113.706 171.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.11 6.82 74.56 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 125.05 1.31 . . . . 0.0 114.414 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -79.59 -175.99 5.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.05 0.925 . . . . 0.0 111.271 174.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.14 156.52 28.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.58 1.562 . . . . 0.0 110.331 179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.3 m -57.14 -45.77 83.25 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.049 0.539 . . . . 0.0 112.076 -175.031 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.18 -44.29 96.92 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.589 -0.695 . . . . 0.0 112.123 177.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -57.19 -47.1 82.1 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.117 0.967 . . . . 0.0 111.604 179.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.9 mt -70.81 -47.62 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.535 1.134 . . . . 0.0 110.945 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.1 -39.65 93.44 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.734 -0.603 . . . . 0.0 111.997 -177.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -60.72 -44.98 95.94 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.89 0.768 . . . . 0.0 112.78 172.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -68.87 -27.88 66.2 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 178.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.2 -53.64 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.945 0.793 . . . . 0.0 110.139 168.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.46 -20.65 61.35 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.2 p -69.7 -15.03 63.09 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.396 0.998 . . . . 0.0 113.019 169.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.5 mt -103.84 -43.94 5.18 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 112.284 177.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.2 pt -102.83 -1.43 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -175.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.75 9.69 2.59 Favored Glycine 0 CA--C 1.539 1.568 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 -170.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.4 ptt180 -66.88 -24.89 66.17 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.583 1.553 . . . . 0.0 114.545 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.32 139.3 0.89 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.914 1.245 . . . . 0.0 113.235 -171.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.57 74.9 0.84 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.184 1.793 . . . . 0.0 108.76 -179.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -99.83 128.57 45.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.668 -171.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -122.85 -2.66 8.74 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 113.009 178.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 t 52.62 57.92 5.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.541 1.536 . . . . 0.0 111.963 -175.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -139.94 151.11 45.3 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.1 m -56.28 143.03 35.45 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.361 1.065 . . . . 0.0 110.029 167.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.18 142.35 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -171.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -120.38 146.14 46.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.042 1.737 . . . . 0.0 110.029 168.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -86.45 137.78 32.28 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.505 0.722 . . . . 0.0 110.366 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.8 p -69.01 163.11 59.81 Favored Pre-proline 0 N--CA 1.479 1.015 0 O-C-N 121.813 -0.555 . . . . 0.0 111.102 172.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.19 -34.41 93.2 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.457 2.105 . . . . 0.0 113.142 171.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -68.94 -42.38 76.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.717 0.807 . . . . 0.0 111.671 175.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.19 -39.8 82.39 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.57 -0.706 . . . . 0.0 112.502 174.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -59.9 -45.25 93.14 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.648 1.179 . . . . 0.0 111.575 173.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -57.62 -45.62 85.15 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.327 1.051 . . . . 0.0 111.959 171.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.6 t -59.55 -45.81 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 119.224 0.92 . . . . 0.0 112.074 173.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.9 mm -62.71 -43.15 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 119.435 1.016 . . . . 0.0 111.542 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.04 -40.32 87.16 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.594 -0.691 . . . . 0.0 112.491 174.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 mt -64.82 -35.65 81.79 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.487 -0.758 . . . . 0.0 111.907 173.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.1 m -61.55 -43.03 99.61 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.255 0.934 . . . . 0.0 111.717 -178.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.6 ptp -76.46 -29.72 57.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 175.201 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.79 -40.21 83.97 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.154 0.581 . . . . 0.0 112.498 172.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.51 -43.7 72.55 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.296 -0.878 . . . . 0.0 111.696 172.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.22 -44.48 71.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.183 0.901 . . . . 0.0 112.42 177.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.4 ttp85 -62.89 -37.06 85.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.548 1.139 . . . . 0.0 113.04 176.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -68.05 -32.26 72.48 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.608 1.095 . . . . 0.0 112.877 176.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -83.43 5.85 22.23 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.303 1.041 . . . . 0.0 113.176 170.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 12.2 81.43 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 124.928 1.251 . . . . 0.0 115.579 173.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -91.1 138.21 31.78 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.872 1.336 . . . . 0.0 111.302 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.2 p -89.02 15.97 7.8 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.735 1.214 . . . . 0.0 112.968 169.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -154.8 148.3 25.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.846 1.658 . . . . 0.0 111.603 -179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.7 t -85.81 114.25 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 126.674 1.989 . . . . 0.0 110.164 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.44 172.44 48.82 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.648 0.642 . . . . 0.0 112.02 168.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 48.6 p -57.62 -38.47 75.03 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -1.08 . . . . 0.0 111.201 172.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -48.9 -50.99 32.47 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.086 2.154 . . . . 0.0 111.906 169.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -72.79 -29.13 63.04 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.046 0.938 . . . . 0.0 112.685 -178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.04 -47.16 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 118.978 0.808 . . . . 0.0 110.107 169.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.9 tp -64.22 -43.51 94.76 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.035 -0.983 . . . . 0.0 111.413 177.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 28.8 mt -56.46 -35.77 68.3 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.62 1.1 . . . . 0.0 112.057 172.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.46 -48.93 78.47 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 118.907 0.776 . . . . 0.0 113.433 170.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.5 mt -56.95 -47.01 81.69 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.954 1.302 . . . . 0.0 112.472 179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.77 -36.94 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 176.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -74.06 -23.57 59.38 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 119.727 1.149 . . . . 0.0 113.743 -177.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -66.02 -42.73 89.26 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 118.997 0.817 . . . . 0.0 110.571 169.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.69 -6.41 9.07 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 119.384 2.513 . . . . 0.0 119.384 166.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -116.33 -26.69 7.06 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 120.519 2.16 . . . . 0.0 112.986 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.53 158.91 31.16 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.343 0.973 . . . . 0.0 114.199 175.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.2 t -54.7 -36.73 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.7 1.2 . . . . 0.0 111.421 -176.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.88 82.23 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.21 81.88 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.375 -0.828 . . . . 0.0 112.035 176.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -68.62 -40.59 80.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.481 1.113 . . . . 0.0 112.442 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.6 t -58.13 -48.0 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.721 1.609 . . . . 0.0 111.779 171.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.52 -41.25 97.03 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.087 -0.383 . . . . 0.0 111.378 178.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -68.15 -33.26 74.16 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 175.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.77 -41.41 92.09 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.402 1.001 . . . . 0.0 111.948 172.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.2 mt -72.96 -31.78 64.78 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.457 1.103 . . . . 0.0 112.569 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 125.95 0.71 7.61 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.697 1.618 . . . . 0.0 115.498 171.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.3 t -82.33 144.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.46 1.504 . . . . 0.0 110.708 174.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 p -112.98 168.64 9.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.699 1.199 . . . . 0.0 111.646 178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.37 -47.26 56.28 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.701 1.2 . . . . 0.0 111.226 172.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.51 -28.1 37.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -177.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -69.02 -44.92 71.76 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 120.293 1.406 . . . . 0.0 111.638 172.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.438 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -65.12 -43.39 92.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.631 174.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -52.83 -54.77 29.56 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 119.111 0.869 . . . . 0.0 111.637 171.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -63.6 -40.72 97.65 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -173.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -70.57 -39.44 73.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.475 1.034 . . . . 0.0 112.497 177.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.54 -45.33 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.887 0.767 . . . . 0.0 111.496 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.3 mt -67.65 -25.41 65.7 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.457 1.103 . . . . 0.0 112.983 179.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -78.51 -54.68 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.68 0.673 . . . . 0.0 111.168 168.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.8 tp -67.7 -19.37 65.15 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -168.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.97 -11.16 45.7 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.84 5.85 0.09 OUTLIER Glycine 0 CA--C 1.538 1.496 0 N-CA-C 116.683 1.433 . . . . 0.0 116.683 175.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 67.8 m -121.7 -0.36 9.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.994 1.717 . . . . 0.0 114.495 -171.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.256 1.422 . . . . 0.0 112.831 175.494 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 92.2 mtp -127.34 162.52 26.08 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.618 1.567 . . . . 0.0 111.062 173.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -62.53 -42.81 99.77 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -169.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.35 23.67 74.97 Favored Glycine 0 CA--C 1.539 1.585 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -176.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -110.47 135.1 51.67 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.497 1.519 . . . . 0.0 111.669 -174.161 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -119.83 149.55 41.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.084 1.353 . . . . 0.0 109.903 172.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.1 p -69.44 166.62 18.35 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.505 -0.747 . . . . 0.0 112.048 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -67.95 -13.09 61.89 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.804 -1.185 . . . . 0.0 113.264 170.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.2 mtm105 -85.77 -41.66 14.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.829 1.252 . . . . 0.0 111.486 170.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.34 -39.83 67.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.719 1.208 . . . . 0.0 112.503 -178.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -61.21 -28.73 69.36 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.754 -0.591 . . . . 0.0 112.312 174.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -69.93 -40.21 75.65 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 118.414 -0.803 . . . . 0.0 112.504 172.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -35.03 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.949 1.249 . . . . 0.0 111.271 174.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -73.19 -35.77 66.44 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.73 90.77 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.08 -1.012 . . . . 0.0 111.854 171.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.71 -25.17 61.13 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.771 0.828 . . . . 0.0 112.521 174.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.23 88.38 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.509 1.05 . . . . 0.0 111.974 169.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -65.19 -46.14 81.96 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.229 0.611 . . . . 0.0 111.035 172.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -63.41 -48.04 79.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.449 0.568 . . . . 0.0 111.445 177.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.34 -31.1 72.05 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.909 1.231 . . . . 0.0 112.778 -179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.55 -52.68 62.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 118.939 0.79 . . . . 0.0 110.699 168.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.79 -37.31 87.18 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -65.4 -31.37 72.45 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.118 1.367 . . . . 0.0 112.347 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.5 mt -88.33 3.33 50.1 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.091 1.356 . . . . 0.0 113.301 171.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.34 21.58 79.5 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 120.833 -1.167 . . . . 0.0 115.137 178.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -97.88 136.37 38.28 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.999 1.319 . . . . 0.0 109.629 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.14 21.96 14.88 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 174.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -135.47 153.41 51.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.901 1.281 . . . . 0.0 110.764 171.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.57 114.12 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.116 1.366 . . . . 0.0 109.068 171.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.88 178.3 36.12 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.142 1.353 . . . . 0.0 111.545 168.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 p -55.38 -41.03 72.07 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.562 -0.964 . . . . 0.0 110.974 172.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -48.02 -49.44 31.05 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 128.954 2.902 . . . . 0.0 113.933 169.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -73.66 -30.95 63.23 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 123.269 0.628 . . . . 0.0 111.547 -177.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.7 mt -68.98 -42.17 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 118.645 0.657 . . . . 0.0 110.639 172.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 60.5 tp -64.68 -42.09 95.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.341 0.973 . . . . 0.0 111.309 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.7 tp -65.99 -36.49 83.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 111.926 176.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.01 -39.71 98.41 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.625 1.107 . . . . 0.0 113.027 170.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.35 -52.74 64.13 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.481 1.113 . . . . 0.0 112.297 172.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -24.87 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 178.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -68.78 -31.9 71.26 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 119.329 0.968 . . . . 0.0 111.971 170.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -71.43 -50.34 32.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.536 0.734 . . . . 0.0 109.942 170.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.4 -10.28 5.04 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 167.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -117.16 -21.2 8.93 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.895 1.848 . . . . 0.0 114.045 -172.345 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.2 162.05 24.29 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.942 1.258 . . . . 0.0 113.749 174.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.1 mm -54.66 -45.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.575 1.15 . . . . 0.0 111.576 -175.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -44.21 90.11 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 178.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.04 93.11 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.351 -0.843 . . . . 0.0 112.138 178.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.273 31.8 mttp -75.89 -20.55 57.96 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 173.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.73 -39.92 73.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 119.577 1.081 . . . . 0.0 110.963 167.504 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.88 -47.61 84.2 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.521 -0.737 . . . . 0.0 111.059 171.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -63.27 -36.6 84.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.671 0.788 . . . . 0.0 112.542 177.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.67 -32.9 74.77 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.42 1.088 . . . . 0.0 113.158 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.16 8.58 2.53 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.087 1.355 . . . . 0.0 113.653 170.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.85 80.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.141 1.353 . . . . 0.0 114.623 176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 mt -83.83 -173.69 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.35 1.075 . . . . 0.0 111.506 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.32 163.33 34.78 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.297 1.427 . . . . 0.0 111.297 -178.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 p -61.43 -41.59 97.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -173.457 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -42.2 92.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.674 0.789 . . . . 0.0 113.075 178.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -66.53 -46.03 77.5 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.051 0.941 . . . . 0.0 111.906 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.56 -43.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.477 0.711 . . . . 0.0 110.656 177.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -61.54 -43.19 99.32 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.744 0.818 . . . . 0.0 112.413 177.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.5 tmpt? -63.39 -42.98 98.84 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.185 0.594 . . . . 0.0 111.729 176.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.43 -38.38 84.46 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 176.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.8 t -60.32 -56.31 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 119.272 0.942 . . . . 0.0 110.28 171.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 -34.29 72.82 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.0 m -67.3 -18.86 65.36 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 176.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -103.33 -30.83 10.37 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.871 1.268 . . . . 0.0 113.424 -179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.7 pt -109.29 -18.29 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -176.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.86 -164.53 35.3 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 122.009 0.783 . . . . 0.0 114.674 -177.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 36.7 ttp-105 -128.47 138.85 52.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.786 1.634 . . . . 0.0 111.118 -176.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.46 96.57 0.25 Allowed Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.528 1.537 . . . . 0.0 114.26 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -133.43 30.83 3.81 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.326 1.85 . . . . 0.0 111.2 169.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -71.84 120.43 17.42 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.838 1.255 . . . . 0.0 113.068 -169.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.6 mtm -133.13 -15.29 2.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.928 2.091 . . . . 0.0 112.88 174.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 t -146.0 176.66 9.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.909 2.084 . . . . 0.0 110.578 176.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -119.82 5.52 10.95 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.545 1.538 . . . . 0.0 113.703 -178.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -123.81 134.43 53.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.366 1.466 . . . . 0.0 110.013 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.31 146.37 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.987 0.899 . . . . 0.0 113.284 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -140.26 163.21 33.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.55 1.94 . . . . 0.0 109.16 167.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -95.46 138.85 32.57 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.307 -0.87 . . . . 0.0 110.64 -177.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.2 p -65.18 160.32 58.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 121.684 -0.635 . . . . 0.0 110.796 171.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.11 -34.14 86.4 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.269 1.979 . . . . 0.0 113.219 174.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -77.17 -36.05 55.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.732 0.813 . . . . 0.0 112.376 178.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.14 80.5 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.256 0.935 . . . . 0.0 111.9 172.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -59.3 -41.31 88.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.554 1.142 . . . . 0.0 111.169 171.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -66.07 -39.88 90.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.96 0.904 . . . . 0.0 112.432 173.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.5 t -59.49 -41.96 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 119.586 1.085 . . . . 0.0 112.208 169.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.3 mm -60.76 -41.84 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.764 1.165 . . . . 0.0 111.081 176.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.47 -42.57 82.79 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.464 -0.773 . . . . 0.0 112.829 172.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.28 -38.93 93.07 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.829 0.852 . . . . 0.0 112.378 176.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.1 m -61.1 -40.81 95.15 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.961 0.905 . . . . 0.0 110.832 177.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.3 ttm -73.6 -34.07 64.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.289 1.036 . . . . 0.0 112.361 177.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.51 -32.47 71.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.107 0.963 . . . . 0.0 113.215 173.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -70.86 -39.53 72.85 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.262 -0.899 . . . . 0.0 111.113 169.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.14 -39.41 82.29 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.422 -0.799 . . . . 0.0 112.263 173.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -58.69 -40.2 82.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.371 0.669 . . . . 0.0 112.741 171.608 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -71.32 -22.74 61.89 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE2' ' A' ' 107' ' ' HIS . 4.2 mm? -83.97 -6.63 59.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.989 0.916 . . . . 0.0 112.535 167.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.65 16.41 80.2 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.876 1.227 . . . . 0.0 114.195 -175.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -90.21 140.08 30.02 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.674 1.19 . . . . 0.0 111.245 -178.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.5 p -85.54 9.82 14.83 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.814 1.246 . . . . 0.0 113.754 175.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.75 155.29 36.9 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.301 1.84 . . . . 0.0 111.885 -176.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.62 116.02 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.908 1.683 . . . . 0.0 110.271 178.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.39 176.98 47.02 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.286 0.946 . . . . 0.0 113.557 171.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.1 p -57.38 -41.43 80.21 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.567 -0.961 . . . . 0.0 110.698 172.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -47.82 -57.23 5.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 129.312 3.045 . . . . 0.0 111.455 169.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.424 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 56.8 m80 -67.58 -31.5 71.6 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.981 0.912 . . . . 0.0 113.291 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.87 -48.91 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.344 0.974 . . . . 0.0 110.518 170.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.4 tp -62.63 -43.23 99.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.392 177.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.9 mt -56.53 -38.89 72.47 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.185 0.902 . . . . 0.0 112.239 174.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.07 -40.52 98.22 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 121.469 -0.769 . . . . 0.0 114.076 172.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 81.5 mt -63.35 -45.85 89.3 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.477 1.111 . . . . 0.0 112.503 177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -68.51 -36.02 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 118.724 0.693 . . . . 0.0 112.464 175.635 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -67.2 -19.15 65.51 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 178.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -76.69 -27.51 55.56 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.957 0.799 . . . . 0.0 113.143 175.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.74 -40.03 0.4 Allowed Glycine 0 CA--C 1.539 1.59 0 C-N-CA 126.572 2.034 . . . . 0.0 118.046 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -104.85 -22.81 13.11 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.999 1.399 . . . . 0.0 113.684 -172.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.39 158.48 35.3 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.066 0.841 . . . . 0.0 112.64 178.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 74.3 t -55.2 -36.15 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.354 0.662 . . . . 0.0 111.545 -177.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.26 80.94 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.589 1.086 . . . . 0.0 113.403 176.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.27 -34.63 78.79 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.397 -0.814 . . . . 0.0 111.801 174.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -64.54 -45.13 88.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 112.377 177.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 45.3 t -58.95 -48.5 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 126.038 1.735 . . . . 0.0 110.994 174.098 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -61.44 -43.36 99.01 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.298 -0.382 . . . . 0.0 111.547 178.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -68.04 -33.43 74.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -65.4 -40.39 93.36 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.226 0.921 . . . . 0.0 112.051 173.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -75.32 -31.6 60.68 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.309 1.044 . . . . 0.0 112.551 178.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 126.19 2.26 7.12 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.748 1.642 . . . . 0.0 115.58 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 79.7 t -84.35 141.49 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.793 1.637 . . . . 0.0 111.228 177.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 54.3 p -114.44 172.52 6.97 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.468 1.507 . . . . 0.0 112.108 178.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -43.92 48.81 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.672 1.189 . . . . 0.0 111.248 169.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -75.1 -42.79 55.86 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.008 0.923 . . . . 0.0 112.744 -178.175 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -63.2 -46.13 88.5 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 119.353 0.979 . . . . 0.0 111.964 178.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -66.97 -43.13 83.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.734 175.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -55.04 -51.95 64.7 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.671 1.123 . . . . 0.0 111.916 172.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.6 -41.16 98.8 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.954 0.797 . . . . 0.0 112.46 -175.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -73.21 -35.5 66.33 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.949 1.249 . . . . 0.0 113.587 176.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.91 -45.71 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 119.698 1.135 . . . . 0.0 111.199 176.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.42 -26.24 66.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.553 1.141 . . . . 0.0 112.655 178.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -73.92 -51.98 14.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.119 0.968 . . . . 0.0 111.653 169.451 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.9 tp -79.51 -15.82 57.07 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.02 -3.78 11.23 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.55 -10.9 1.95 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.534 1.54 . . . . 0.0 114.042 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.4 m -76.32 -16.35 59.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.068 1.347 . . . . 0.0 114.005 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.045 1.738 . . . . 0.0 111.27 173.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 tmt? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -143.6 166.81 23.81 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.77 1.228 . . . . 0.0 111.807 171.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -137.2 140.67 41.91 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.351 1.46 . . . . 0.0 111.255 175.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.56 4.17 59.72 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.931 1.253 . . . . 0.0 114.682 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.58 128.26 34.5 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.991 1.316 . . . . 0.0 111.357 -174.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -107.2 155.14 20.24 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.999 1.72 . . . . 0.0 109.806 172.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -68.01 166.37 16.02 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 120.672 -1.267 . . . . 0.0 112.031 175.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -63.89 -34.02 77.02 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.79 -1.194 . . . . 0.0 111.51 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -62.46 -45.43 93.08 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.634 0.774 . . . . 0.0 111.547 171.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.73 -40.74 69.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.827 0.851 . . . . 0.0 111.413 -174.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -58.18 -37.13 74.15 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.538 -0.726 . . . . 0.0 111.785 170.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.08 -41.01 95.45 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.459 174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.76 -35.79 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 CA-C-N 120.469 1.486 . . . . 0.0 112.008 174.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.9 mt -73.69 -32.9 64.16 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.585 0.63 . . . . 0.0 112.433 177.78 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.38 88.44 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.274 -0.891 . . . . 0.0 111.597 169.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 70.2 mt -66.34 -33.04 74.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.52 0.728 . . . . 0.0 112.179 173.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.93 -41.12 99.38 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.369 0.986 . . . . 0.0 112.076 173.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -64.95 -43.58 92.22 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.416 0.686 . . . . 0.0 111.512 172.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.09 -38.33 85.51 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.637 -0.664 . . . . 0.0 112.23 -178.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.03 -38.24 69.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.303 1.041 . . . . 0.0 112.643 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.05 -47.96 81.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.021 0.828 . . . . 0.0 110.724 171.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.04 -38.19 90.04 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtm-85 -66.58 -32.67 74.15 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 119.501 1.046 . . . . 0.0 113.588 173.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.5 mt -78.95 -7.85 58.39 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.547 1.139 . . . . 0.0 113.286 172.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.54 20.24 78.64 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.348 0.975 . . . . 0.0 114.3 -176.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -93.12 128.62 39.11 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.267 1.427 . . . . 0.0 109.705 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.34 23.63 1.28 Allowed 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.387 -0.821 . . . . 0.0 112.576 169.019 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -136.47 146.07 45.89 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.053 1.341 . . . . 0.0 111.287 -171.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.5 mt -104.58 121.09 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.005 0.922 . . . . 0.0 108.971 168.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.8 174.07 23.17 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.718 1.628 . . . . 0.0 111.363 167.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.7 p -54.66 -38.63 67.17 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.63 0.772 . . . . 0.0 111.221 171.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.1 -49.8 40.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 129.025 2.93 . . . . 0.0 113.531 169.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -72.04 -33.87 68.33 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.528 0.731 . . . . 0.0 111.381 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.4 mt -67.59 -42.21 86.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 123.466 0.706 . . . . 0.0 110.65 174.006 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 64.5 tp -65.48 -44.67 86.37 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.088 0.858 . . . . 0.0 111.382 175.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.1 tp -64.07 -39.87 95.01 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.151 0.98 . . . . 0.0 111.703 176.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.64 -38.31 94.85 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.374 0.988 . . . . 0.0 112.725 171.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.38 -53.29 59.87 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.38 1.072 . . . . 0.0 112.659 172.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -25.68 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.6 -30.77 70.45 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.303 0.956 . . . . 0.0 112.464 169.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -70.78 -52.54 19.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.411 0.684 . . . . 0.0 109.874 171.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.62 10.53 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 117.824 1.89 . . . . 0.0 117.824 168.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -117.4 -28.98 5.96 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 120.252 2.026 . . . . 0.0 113.525 -174.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.09 157.49 22.91 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.856 1.217 . . . . 0.0 113.488 173.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -54.11 -43.13 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.374 1.07 . . . . 0.0 113.125 -169.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.69 87.97 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.71 -35.04 79.18 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.322 -0.861 . . . . 0.0 111.62 176.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -67.39 -38.22 84.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.412 1.085 . . . . 0.0 111.733 172.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.34 -40.55 89.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.785 1.234 . . . . 0.0 112.444 173.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.4 mt -61.61 -48.32 81.42 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.858 0.863 . . . . 0.0 111.385 173.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.42 -33.77 76.72 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 175.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.12 -33.78 76.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.353 0.979 . . . . 0.0 112.508 173.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.33 10.09 4.06 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.445 1.498 . . . . 0.0 113.292 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 5.13 89.26 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.475 1.512 . . . . 0.0 115.214 174.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.43 97.51 11.24 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.091 1.446 . . . . 0.0 111.254 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.59 155.6 53.37 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 123.663 0.649 . . . . 0.0 112.698 170.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.3 t -53.45 -43.27 67.94 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.329 1.051 . . . . 0.0 112.536 -178.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.46 -30.57 71.67 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -44.64 36.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.139 0.976 . . . . 0.0 111.575 179.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.55 -44.49 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.519 0.727 . . . . 0.0 110.285 172.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -61.01 -45.17 95.9 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.408 1.083 . . . . 0.0 112.371 176.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.53 -46.73 86.2 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.544 0.738 . . . . 0.0 111.574 176.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -71.43 -35.33 70.9 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.935 0.716 . . . . 0.0 112.935 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.4 t -58.95 -56.48 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 119.312 0.96 . . . . 0.0 110.281 170.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.91 -39.61 86.01 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 112.364 -178.241 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.0 m -66.41 -23.88 66.38 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.7 mt -96.59 -24.97 15.78 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -109.38 -39.95 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -178.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 34.91 -134.65 0.42 Allowed Glycine 0 CA--C 1.54 1.656 0 C-N-CA 126.565 2.031 . . . . 0.0 116.139 -179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 55.96 -58.41 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 130.982 3.713 . . . . 0.0 119.248 168.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.5 131.12 1.51 Allowed Glycine 0 CA--C 1.538 1.479 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -165.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.99 76.76 1.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.876 1.27 . . . . 0.0 110.332 -169.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.74 105.31 15.29 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.526 1.13 . . . . 0.0 112.009 -173.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.5 mtm -129.36 -6.14 4.78 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.903 2.081 . . . . 0.0 112.563 173.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.9 t -149.97 166.76 28.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.566 1.946 . . . . 0.0 111.4 178.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -95.36 -16.72 22.16 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.007 1.723 . . . . 0.0 112.531 177.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.15 155.46 34.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.226 1.41 . . . . 0.0 112.041 -179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 mp -83.7 147.15 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -169.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -126.5 138.14 53.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.415 1.886 . . . . 0.0 110.991 171.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -82.62 124.56 30.28 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.318 -0.863 . . . . 0.0 110.68 176.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.5 p -62.29 159.37 40.43 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.483 0.713 . . . . 0.0 111.727 173.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -56.2 -34.37 93.14 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.534 2.156 . . . . 0.0 113.228 172.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -65.3 -48.12 74.23 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.756 1.223 . . . . 0.0 111.381 175.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.63 -40.1 92.19 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.173 0.589 . . . . 0.0 112.419 175.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -61.57 -40.96 96.6 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.63 175.342 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -39.59 93.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.773 0.829 . . . . 0.0 112.042 174.316 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.21 -46.74 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 119.298 0.953 . . . . 0.0 112.027 169.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.39 -43.75 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.501 1.046 . . . . 0.0 111.143 179.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -62.16 -43.25 99.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.178 0.991 . . . . 0.0 112.526 173.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 75.5 mt -71.9 -26.53 62.35 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.26 -0.9 . . . . 0.0 112.788 177.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.3 m -65.68 -45.3 83.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.061 0.846 . . . . 0.0 110.815 176.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 22.4 ptp -71.99 -27.29 62.65 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 172.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.24 -37.64 71.98 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 172.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.98 -36.19 79.61 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.799 -1.188 . . . . 0.0 111.175 169.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.66 -45.91 81.13 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.185 -0.947 . . . . 0.0 112.616 176.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -70.09 -30.34 67.54 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.149 -0.97 . . . . 0.0 112.944 177.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -60.39 -37.45 80.85 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.537 1.135 . . . . 0.0 111.966 171.043 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -77.28 -2.33 34.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.182 1.393 . . . . 0.0 113.929 172.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 70.35 19.45 76.02 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.268 0.937 . . . . 0.0 113.924 -175.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -76.69 167.6 21.55 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.455 1.102 . . . . 0.0 112.496 -177.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.2 m -107.59 -13.46 15.05 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.896 -178.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -153.97 159.09 41.52 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 17.8 t -86.48 111.4 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.752 1.221 . . . . 0.0 110.445 -177.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.42 171.2 45.47 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.754 0.692 . . . . 0.0 113.743 174.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -52.94 -39.68 63.05 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.221 1.009 . . . . 0.0 112.558 169.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -57.71 7.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.918 2.087 . . . . 0.0 111.315 169.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -64.44 -30.14 71.18 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.525 1.13 . . . . 0.0 113.472 -178.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.1 mt -58.72 -49.18 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.008 0.822 . . . . 0.0 110.614 170.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 40.6 tp -66.75 -42.36 86.3 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.762 178.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 73.9 mt -52.39 -41.01 62.77 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.009 0.822 . . . . 0.0 111.152 172.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.66 -46.6 83.07 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.559 1.076 . . . . 0.0 114.069 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 mt -54.84 -45.15 74.47 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.794 1.237 . . . . 0.0 112.354 179.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.47 -35.27 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -65.49 -28.47 69.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.131 0.878 . . . . 0.0 112.871 177.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -67.45 -42.52 82.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.614 0.643 . . . . 0.0 112.012 177.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.45 -2.72 9.8 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 118.96 2.344 . . . . 0.0 118.96 167.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -112.73 -32.67 6.35 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.595 2.198 . . . . 0.0 112.903 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.0 159.38 43.77 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.38 0.991 . . . . 0.0 113.923 174.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 69.0 t -54.98 -35.15 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.404 1.482 . . . . 0.0 112.801 -177.197 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -55.19 -42.41 73.22 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.462 1.028 . . . . 0.0 113.748 -179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.58 80.8 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 121.554 -0.716 . . . . 0.0 112.256 175.128 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -67.44 -45.54 75.74 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.798 1.239 . . . . 0.0 111.302 177.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.8 t -55.29 -51.77 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.609 1.563 . . . . 0.0 111.116 178.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.26 -39.29 93.65 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.171 -0.33 . . . . 0.0 111.775 -178.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -70.31 -34.34 72.61 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 176.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -65.01 -38.4 90.79 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.033 0.833 . . . . 0.0 111.945 173.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.16 -33.07 63.37 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.167 0.987 . . . . 0.0 112.389 177.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.76 0.07 5.73 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.267 1.413 . . . . 0.0 115.926 169.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -87.51 145.95 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.551 1.541 . . . . 0.0 110.79 177.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.8 p -111.99 165.45 12.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.347 1.059 . . . . 0.0 112.082 -178.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.63 -47.61 40.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.405 1.482 . . . . 0.0 111.021 172.255 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.4 -45.33 60.21 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.452 0.701 . . . . 0.0 112.795 -179.271 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -61.55 -44.86 96.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.355 0.98 . . . . 0.0 112.078 -179.341 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.24 62.53 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.115 176.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -60.87 -40.0 91.29 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.61 1.096 . . . . 0.0 111.9 177.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -63.39 -41.6 98.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.497 1.044 . . . . 0.0 112.396 177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -67.86 -41.89 82.17 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.718 -1.239 . . . . 0.0 112.209 175.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.3 t -65.43 -45.59 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.89 0.768 . . . . 0.0 111.489 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.13 -24.74 65.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.468 1.107 . . . . 0.0 112.837 179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -79.38 -52.74 7.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.781 0.719 . . . . 0.0 111.547 168.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.5 tp -70.37 -18.98 63.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -168.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.18 -8.34 16.72 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 177.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 154.55 -15.39 0.55 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.507 1.051 . . . . 0.0 114.879 174.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 72.1 m -77.74 -26.22 49.79 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.864 -178.501 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.357 0 C-N-CA 127.294 2.237 . . . . 0.0 113.651 176.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.1 tpt -144.05 131.73 21.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.637 1.175 . . . . 0.0 110.152 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -86.86 -37.82 17.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -169.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.7 27.26 58.71 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.227 1.394 . . . . 0.0 114.773 -173.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 74.6 mtt85 -133.63 134.6 43.41 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.075 1.75 . . . . 0.0 111.188 -169.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.11 150.38 49.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.046 1.739 . . . . 0.0 110.54 -177.27 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -65.29 165.68 11.25 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.166 -0.959 . . . . 0.0 111.872 174.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.33 -34.43 78.13 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.638 -1.289 . . . . 0.0 112.464 176.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -69.58 -36.87 76.65 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.603 0.761 . . . . 0.0 111.569 172.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.13 -42.81 65.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.954 0.797 . . . . 0.0 112.001 178.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -57.12 -38.57 73.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.522 0.729 . . . . 0.0 111.324 169.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -64.79 -41.03 96.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.655 -1.164 . . . . 0.0 112.678 174.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -36.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-N 121.252 1.842 . . . . 0.0 111.85 174.226 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -73.77 -33.91 64.46 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.662 0.664 . . . . 0.0 112.738 177.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.25 -39.75 89.73 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.224 -0.922 . . . . 0.0 111.731 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.49 -32.66 71.68 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.419 -0.801 . . . . 0.0 111.88 173.395 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.7 90.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.524 1.056 . . . . 0.0 112.288 172.381 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -64.61 -42.93 95.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.656 0.782 . . . . 0.0 111.307 170.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -65.19 -37.23 86.67 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.63 -0.669 . . . . 0.0 112.181 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.79 -38.53 67.22 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.919 0.888 . . . . 0.0 112.669 172.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.8 -35.53 74.88 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.201 0.91 . . . . 0.0 112.008 173.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.73 -42.65 50.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.103 0.961 . . . . 0.0 113.091 173.078 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -65.99 -37.76 86.78 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.999 1.272 . . . . 0.0 113.797 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -81.62 -3.49 53.58 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.426 1.09 . . . . 0.0 113.227 177.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.11 21.27 76.97 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.028 0.823 . . . . 0.0 114.383 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -81.34 -31.28 33.53 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.895 1.348 . . . . 0.0 113.13 177.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . 0.266 0.7 OUTLIER 45.6 23.3 0.14 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.498 1.919 . . . . 0.0 115.38 -169.537 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -143.37 143.85 31.82 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.574 1.95 . . . . 0.0 108.952 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.9 mt -95.27 115.01 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.925 0.89 . . . . 0.0 109.413 174.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.66 178.58 30.0 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.506 1.527 . . . . 0.0 111.394 167.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 29.0 p -55.91 -40.43 73.06 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.589 -0.948 . . . . 0.0 111.062 172.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -49.11 -49.45 41.83 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.195 2.998 . . . . 0.0 113.633 169.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -72.94 -34.37 66.5 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.221 0.609 . . . . 0.0 111.699 -178.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 82.2 mt -65.12 -43.36 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.106 0.562 . . . . 0.0 110.407 172.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 61.9 tp -64.87 -43.85 91.59 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.188 0.904 . . . . 0.0 111.592 175.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.4 tp -67.53 -36.43 80.98 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.49 0.716 . . . . 0.0 111.987 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.07 -38.92 97.37 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.304 0.954 . . . . 0.0 112.538 169.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mt -57.28 -52.05 66.88 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.615 1.166 . . . . 0.0 112.725 173.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -26.82 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 178.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -70.32 -28.34 65.09 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.292 0.951 . . . . 0.0 112.126 171.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -70.08 -52.47 23.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.51 0.724 . . . . 0.0 109.838 169.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.91 -11.49 7.48 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 168.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -122.32 -16.9 7.26 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.066 1.933 . . . . 0.0 114.558 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.21 155.28 17.62 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.792 0.711 . . . . 0.0 111.939 169.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.4 mm -53.38 -41.79 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.387 1.075 . . . . 0.0 111.859 -176.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 109' ' ' LEU . . . -65.69 -43.85 87.98 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 176.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.61 -38.28 86.63 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.154 -0.966 . . . . 0.0 111.844 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.1 -35.35 80.26 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.763 0.825 . . . . 0.0 112.014 171.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.02 -41.26 86.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.487 1.039 . . . . 0.0 112.542 173.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.06 -46.92 87.95 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.004 0.82 . . . . 0.0 111.159 172.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -66.36 -33.8 76.54 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 176.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.83 74.52 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.501 1.121 . . . . 0.0 112.982 173.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.6 mt -73.94 7.62 2.5 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.112 1.365 . . . . 0.0 113.613 169.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.84 8.27 73.21 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.15 1.357 . . . . 0.0 114.868 174.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.1 mt -83.94 -176.93 6.51 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 118.363 1.081 . . . . 0.0 111.77 175.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.3 163.62 36.66 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.504 1.526 . . . . 0.0 111.222 177.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.2 p -58.45 -43.0 88.67 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.496 0.719 . . . . 0.0 112.704 -176.262 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.2 -39.64 95.22 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.169 0.987 . . . . 0.0 112.633 176.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -71.56 -40.81 69.75 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.009 0.923 . . . . 0.0 111.998 -177.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.3 mt -71.75 -41.9 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.342 0.657 . . . . 0.0 110.288 175.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -61.54 -41.69 97.73 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.973 0.909 . . . . 0.0 112.568 176.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -52.09 -54.69 27.36 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.96 1.304 . . . . 0.0 111.293 170.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -73.66 -30.67 63.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -175.183 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.85 -56.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 119.151 0.887 . . . . 0.0 110.132 169.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.71 -26.68 68.48 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.99 -1.069 . . . . 0.0 113.291 -179.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -66.37 -17.71 64.93 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 171.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.2 mt -110.52 -26.78 9.3 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.228 1.411 . . . . 0.0 113.603 -179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.8 pt -123.86 7.29 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 116.226 1.935 . . . . 0.0 116.226 -178.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.41 51.7 1.43 Allowed Glycine 0 CA--C 1.541 1.705 0 C-N-CA 125.598 1.57 . . . . 0.0 116.743 -171.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -138.2 -16.02 1.26 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.694 1.998 . . . . 0.0 115.447 -177.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.28 -176.45 30.85 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.441 1.02 . . . . 0.0 114.742 -177.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -140.75 -43.89 0.39 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.871 1.668 . . . . 0.0 112.303 177.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 45.61 72.61 0.21 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 128.236 2.615 . . . . 0.0 114.857 173.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 60.6 mtt -122.2 -22.99 5.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.268 1.827 . . . . 0.0 113.519 -178.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.3 t -148.63 169.45 20.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.198 1.399 . . . . 0.0 112.653 -179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tm0? -94.32 -19.24 20.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.166 1.786 . . . . 0.0 112.477 176.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.8 t -121.24 154.93 35.67 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 -176.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 mp -84.93 148.71 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -169.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -140.25 156.43 46.48 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.124 2.17 . . . . 0.0 109.722 168.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -95.18 137.34 34.37 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.275 1.03 . . . . 0.0 111.267 -178.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.6 p -67.02 161.02 66.72 Favored Pre-proline 0 N--CA 1.479 0.983 0 O-C-N 121.667 -0.645 . . . . 0.0 111.667 171.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -52.6 -35.46 67.48 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 122.634 2.223 . . . . 0.0 113.552 168.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -74.14 -39.39 63.32 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.805 0.73 . . . . 0.0 112.53 177.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.87 86.59 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.137 0.881 . . . . 0.0 111.87 173.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -61.71 -42.67 99.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.924 0.89 . . . . 0.0 111.682 173.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -59.71 -45.39 92.28 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.057 0.943 . . . . 0.0 112.202 171.017 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 t -57.44 -47.19 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.453 1.024 . . . . 0.0 111.684 172.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.8 mm -58.96 -44.87 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.489 1.041 . . . . 0.0 111.642 178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.35 -42.69 78.88 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.581 -0.699 . . . . 0.0 112.603 176.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.55 -34.24 77.47 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.909 0.884 . . . . 0.0 112.323 177.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.5 m -61.05 -42.92 99.39 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.856 0.863 . . . . 0.0 110.886 173.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ttm -75.99 -31.06 58.79 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.718 0.807 . . . . 0.0 112.76 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -64.56 -42.03 95.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.085 0.954 . . . . 0.0 111.862 170.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.75 -37.99 79.81 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.387 -0.821 . . . . 0.0 112.307 172.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.18 91.82 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.076 -1.015 . . . . 0.0 111.782 173.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.1 ttm105 -62.98 -40.55 98.09 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.959 0.904 . . . . 0.0 112.061 173.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -63.1 -36.07 82.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.627 1.171 . . . . 0.0 112.628 176.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.31 -10.34 59.38 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.95 17.76 79.49 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.625 1.107 . . . . 0.0 114.686 -177.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.0 133.72 33.9 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.451 1.126 . . . . 0.0 110.431 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.4 m -77.25 4.68 10.02 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -157.02 158.26 36.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.025 2.13 . . . . 0.0 110.469 -176.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.01 117.27 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.175 1.39 . . . . 0.0 110.362 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.99 171.87 47.08 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.769 0.7 . . . . 0.0 113.367 171.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -58.69 -39.76 81.64 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 121.493 -1.004 . . . . 0.0 110.968 170.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -48.15 -53.45 16.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.85 2.06 . . . . 0.0 111.305 169.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -69.0 -31.97 71.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.079 0.952 . . . . 0.0 112.924 -178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.22 -47.64 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 119.095 0.861 . . . . 0.0 110.767 170.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.402 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 32.6 tp -64.46 -42.74 95.76 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.549 176.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 27.8 mt -56.32 -36.29 68.55 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.189 0.904 . . . . 0.0 112.058 173.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 -44.93 91.64 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.972 0.806 . . . . 0.0 113.74 171.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.5 mt -58.64 -45.05 90.12 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.56 1.144 . . . . 0.0 112.585 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.411 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -71.82 -43.02 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.279 174.6 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 -65.17 -26.79 68.32 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.122 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -68.33 -37.7 80.8 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.369 0.986 . . . . 0.0 110.991 173.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.41 1.62 22.79 Favored Glycine 0 CA--C 1.538 1.472 0 N-CA-C 119.509 2.564 . . . . 0.0 119.509 166.402 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -129.38 -27.58 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.47 2.135 . . . . 0.0 113.832 -175.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 166.97 21.19 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.054 1.311 . . . . 0.0 113.713 175.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.88 -36.23 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 111.414 -178.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.65 84.92 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.333 0.969 . . . . 0.0 113.295 178.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.49 -36.74 85.18 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.624 -0.673 . . . . 0.0 111.847 176.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -70.06 -40.45 75.06 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.219 1.007 . . . . 0.0 113.055 176.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.17 -49.24 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.809 1.243 . . . . 0.0 111.226 172.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.21 -42.84 99.3 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.624 0.37 . . . . 0.0 111.468 178.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -68.54 -33.23 73.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.466 0.914 . . . . 0.0 113.466 176.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -64.04 -40.97 97.49 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.443 1.019 . . . . 0.0 111.75 172.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.75 -31.33 59.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.427 1.091 . . . . 0.0 112.704 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.23 3.99 7.87 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.65 1.595 . . . . 0.0 115.368 172.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 74.4 t -84.08 139.92 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.481 1.512 . . . . 0.0 110.939 174.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.5 p -116.61 172.43 7.23 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.834 1.653 . . . . 0.0 111.061 178.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.26 -30.84 66.89 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.929 -0.482 . . . . 0.0 111.617 170.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -77.79 -42.94 32.21 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.078 -1.014 . . . . 0.0 111.84 -179.641 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.84 -48.53 76.42 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.514 0.726 . . . . 0.0 111.119 176.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.411 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.37 -44.99 77.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.292 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -58.44 -50.17 74.68 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.071 1.305 . . . . 0.0 111.5 175.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.75 -41.2 98.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 119.507 1.049 . . . . 0.0 112.91 -176.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -70.88 -39.86 72.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.594 1.088 . . . . 0.0 112.728 178.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 92.1 t -69.3 -44.79 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-N 119.062 0.846 . . . . 0.0 111.255 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.46 -26.47 66.41 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.1 0.96 . . . . 0.0 112.706 179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -77.45 -55.76 5.11 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.654 0.661 . . . . 0.0 111.071 168.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.7 tp -68.12 -17.36 64.34 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -169.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 pp -68.98 -7.74 38.17 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 174.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.24 4.86 0.18 Allowed Glycine 0 CA--C 1.539 1.546 0 N-CA-C 116.935 1.534 . . . . 0.0 116.935 173.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.6 t -113.04 -1.08 14.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.762 1.625 . . . . 0.0 113.867 -177.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 125.842 1.657 . . . . 0.0 113.594 175.637 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 tpp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 94.6 mtp 58.8 172.15 0.06 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.633 1.973 . . . . 0.0 114.68 -174.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -75.77 -28.28 58.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.496 1.119 . . . . 0.0 113.92 -175.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.1 18.2 62.23 Favored Glycine 0 CA--C 1.538 1.517 0 N-CA-C 116.502 1.361 . . . . 0.0 116.502 169.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -115.36 138.2 51.24 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.692 1.597 . . . . 0.0 111.788 -173.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -113.38 151.91 30.68 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.796 1.638 . . . . 0.0 110.104 174.558 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -65.04 164.51 12.72 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.442 -0.786 . . . . 0.0 111.713 171.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -61.59 -38.71 88.57 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.949 -1.094 . . . . 0.0 110.77 169.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.7 mtm105 -60.41 -43.43 96.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.7 1.2 . . . . 0.0 111.899 176.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.38 -41.97 68.99 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.488 1.115 . . . . 0.0 112.178 178.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -62.23 -31.42 71.96 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.605 -0.684 . . . . 0.0 112.194 175.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.51 -43.44 97.19 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.184 -0.913 . . . . 0.0 112.753 169.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.61 -36.28 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-N 120.289 1.404 . . . . 0.0 111.688 176.159 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -34.73 62.89 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.54 -39.61 88.68 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.268 -0.895 . . . . 0.0 111.765 169.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.8 mt -68.02 -31.76 71.66 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.54 -0.725 . . . . 0.0 112.22 173.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.48 82.31 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.824 1.193 . . . . 0.0 112.551 173.685 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -66.72 -44.33 81.9 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.572 -0.705 . . . . 0.0 111.526 170.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -64.25 -39.26 93.58 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.806 -0.559 . . . . 0.0 112.105 179.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.11 -39.28 75.6 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.066 0.947 . . . . 0.0 112.773 174.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.56 -50.77 72.02 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.743 0.701 . . . . 0.0 110.567 172.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.3 mt -67.79 -35.02 77.91 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mtp85 -63.1 -37.76 88.48 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.09 0.956 . . . . 0.0 113.104 172.119 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.07 1.53 35.42 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.458 1.103 . . . . 0.0 112.905 172.655 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.26 18.61 78.21 Favored Glycine 0 CA--C 1.534 1.241 0 O-C-N 120.806 -1.184 . . . . 0.0 114.909 179.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -91.32 140.85 29.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.131 1.465 . . . . 0.0 110.676 172.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -89.32 5.86 43.11 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -143.05 154.1 43.63 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.311 1.045 . . . . 0.0 112.564 -170.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.85 123.22 51.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.968 1.707 . . . . 0.0 109.933 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.33 175.06 23.46 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.798 1.666 . . . . 0.0 111.48 167.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -54.05 -39.58 66.34 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 121.696 -0.885 . . . . 0.0 111.043 170.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -48.15 -49.73 31.29 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 129.091 2.957 . . . . 0.0 113.821 169.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -73.89 -31.41 63.11 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.357 0.663 . . . . 0.0 111.646 -178.71 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.5 mt -67.3 -41.99 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.279 0.631 . . . . 0.0 110.414 172.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.98 -41.48 91.09 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.099 0.863 . . . . 0.0 111.827 174.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.8 tp -70.0 -34.92 73.95 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.48 -0.762 . . . . 0.0 112.059 178.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -38.44 95.79 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.979 1.276 . . . . 0.0 112.776 170.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 mt -55.81 -55.66 29.74 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.506 1.122 . . . . 0.0 112.57 171.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -26.97 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.168 0.895 . . . . 0.0 113.408 179.046 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -72.02 -25.36 61.79 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 171.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -75.1 -50.72 15.45 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.612 0.765 . . . . 0.0 109.432 169.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.03 -1.66 8.01 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 118.499 2.159 . . . . 0.0 118.499 167.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.51 -23.81 7.02 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.147 1.974 . . . . 0.0 113.59 -179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.61 156.08 39.98 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.025 1.298 . . . . 0.0 113.656 173.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.22 -42.11 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.853 1.261 . . . . 0.0 112.142 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.55 -45.69 82.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.788 0.722 . . . . 0.0 112.901 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.78 88.68 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.308 -0.87 . . . . 0.0 111.602 177.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -68.31 -33.8 74.98 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.336 174.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.47 -41.42 84.65 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.663 1.185 . . . . 0.0 112.483 172.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.33 -47.86 83.83 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.005 0.82 . . . . 0.0 110.98 172.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.41 -33.26 74.82 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.02 74.86 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.597 1.159 . . . . 0.0 113.14 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.45 7.26 2.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.952 1.301 . . . . 0.0 113.596 170.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.59 8.15 70.85 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.102 1.334 . . . . 0.0 114.654 174.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.1 mt -81.28 178.25 8.5 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 118.462 1.131 . . . . 0.0 111.784 175.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.96 155.48 26.66 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.73 1.633 . . . . 0.0 111.112 178.323 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.5 m -60.24 -37.03 79.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.83 0.852 . . . . 0.0 113.072 -169.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -66.1 -37.71 86.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.14 0.976 . . . . 0.0 112.866 176.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -74.86 -39.53 61.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.739 0.816 . . . . 0.0 111.388 -178.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.4 mt -65.93 -43.64 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 110.273 171.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.05 -43.52 98.65 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.079 0.952 . . . . 0.0 112.799 176.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -53.41 -53.75 46.69 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.372 1.069 . . . . 0.0 111.465 171.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -70.89 -34.11 71.26 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -175.353 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.5 t -61.07 -57.87 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.105 0.866 . . . . 0.0 110.378 170.85 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -61.66 -35.13 77.06 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.687 -0.633 . . . . 0.0 112.689 -176.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -66.88 -18.21 65.27 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 177.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.02 -24.88 13.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.579 1.152 . . . . 0.0 113.708 179.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.2 pt -115.44 -19.4 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -175.365 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.06 -153.95 41.2 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-N 119.102 0.864 . . . . 0.0 114.107 -176.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.8 ptt180 -145.04 163.09 35.32 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.375 1.47 . . . . 0.0 113.014 -175.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.21 25.5 33.63 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 168.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -76.59 58.15 1.33 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 119.869 1.835 . . . . 0.0 110.415 168.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.57 88.17 6.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.623 1.569 . . . . 0.0 113.849 -166.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 77.3 mtm -133.25 43.18 2.95 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 108.154 168.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.5 m -90.09 134.06 34.48 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -166.238 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -158.04 -49.52 0.06 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.988 1.715 . . . . 0.0 110.336 167.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -135.89 129.97 33.1 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.552 1.541 . . . . 0.0 108.675 175.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.72 148.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -173.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -124.83 149.33 47.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.172 1.789 . . . . 0.0 110.886 176.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -95.72 126.17 40.8 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.565 0.746 . . . . 0.0 110.568 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -60.98 160.08 23.24 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 123.308 0.643 . . . . 0.0 111.724 172.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.36 -33.57 85.89 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.585 2.19 . . . . 0.0 113.618 174.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -72.64 -42.04 64.83 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.287 1.035 . . . . 0.0 112.274 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.18 88.74 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.111 0.869 . . . . 0.0 111.823 173.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -58.8 -40.87 85.33 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.17 0.988 . . . . 0.0 111.391 171.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -63.48 -37.45 87.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.165 173.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 64.4 t -65.93 -38.79 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 119.784 1.175 . . . . 0.0 112.381 171.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.95 -39.31 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.717 1.144 . . . . 0.0 111.325 174.035 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.86 -47.4 66.01 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.282 -0.886 . . . . 0.0 112.55 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.7 mt -69.49 -38.47 77.68 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.798 0.839 . . . . 0.0 112.633 -176.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.8 p -64.77 -36.11 83.24 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.69 1.132 . . . . 0.0 112.256 175.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 23.7 ttm -67.34 -37.7 83.67 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.329 0.652 . . . . 0.0 112.027 172.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.69 -34.27 67.06 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -66.34 -40.78 90.05 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 120.663 -1.273 . . . . 0.0 111.511 171.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.55 -38.42 87.39 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.65 169.716 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.36 -36.35 82.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.514 1.126 . . . . 0.0 113.106 173.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -63.12 -34.86 78.52 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.122 1.328 . . . . 0.0 112.038 174.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.24 -2.82 46.63 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.112 1.365 . . . . 0.0 113.434 172.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.63 18.83 72.43 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.828 1.204 . . . . 0.0 114.404 -179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -84.93 151.33 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.497 1.119 . . . . 0.0 112.769 -172.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 m -79.5 -14.22 59.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -159.7 163.58 34.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.315 1.446 . . . . 0.0 112.089 -176.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.91 118.08 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.939 1.296 . . . . 0.0 111.315 -177.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.16 171.84 44.77 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.63 1.109 . . . . 0.0 113.463 171.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 53.8 p -57.16 -40.9 78.19 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.493 -1.004 . . . . 0.0 110.884 170.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -46.72 -56.79 5.61 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.122 2.969 . . . . 0.0 111.112 169.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -67.51 -30.96 70.76 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.075 0.95 . . . . 0.0 113.195 179.455 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.88 -46.73 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 119.709 1.141 . . . . 0.0 110.544 169.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.3 tp -66.41 -37.59 85.55 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.41 1.005 . . . . 0.0 112.318 177.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.64 -33.67 71.82 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.867 0.758 . . . . 0.0 112.333 169.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -68.79 -45.25 65.7 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.09 0.852 . . . . 0.0 113.382 171.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.77 -43.62 94.26 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.66 1.184 . . . . 0.0 112.416 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 pt -70.29 -43.43 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.809 0.731 . . . . 0.0 112.791 174.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -64.16 -27.56 69.16 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.021 0.929 . . . . 0.0 113.259 -178.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -58.48 -47.38 84.24 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 110.866 173.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.54 -9.69 20.83 Favored Glycine 0 CA--C 1.538 1.502 0 N-CA-C 118.794 2.278 . . . . 0.0 118.794 167.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -124.18 -28.19 3.74 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.752 2.276 . . . . 0.0 113.752 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -60.2 161.81 19.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.166 1.365 . . . . 0.0 113.753 176.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.25 -34.68 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.932 0.893 . . . . 0.0 112.0 -174.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -58.22 -47.56 83.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.99 1.268 . . . . 0.0 113.147 177.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.77 -35.42 79.76 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.311 -0.868 . . . . 0.0 111.806 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -65.16 -45.86 83.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.548 1.539 . . . . 0.0 112.328 177.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.85 -48.95 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 126.199 1.8 . . . . 0.0 111.128 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.7 mt -59.89 -44.17 94.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.714 0.406 . . . . 0.0 111.378 178.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -70.91 -29.94 66.13 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 177.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -65.34 -40.95 94.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.521 1.055 . . . . 0.0 111.787 171.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.1 mt -78.35 -33.97 48.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.334 1.054 . . . . 0.0 112.962 -177.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.31 7.59 3.92 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.164 1.364 . . . . 0.0 115.885 172.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -91.14 141.66 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.719 1.608 . . . . 0.0 111.034 175.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.2 p -115.76 172.92 6.83 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.88 1.672 . . . . 0.0 111.021 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.418 ' H ' HD12 ' A' ' 131' ' ' LEU . 3.8 mp -55.24 -43.02 74.18 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 122.094 -0.379 . . . . 0.0 110.62 171.074 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -68.89 -43.15 75.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 0.0 112.375 -176.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.7 mtpt -66.65 -44.57 81.56 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.685 0.794 . . . . 0.0 111.624 178.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.95 81.89 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.875 -0.583 . . . . 0.0 111.654 174.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -54.01 -54.18 42.63 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.049 0.841 . . . . 0.0 111.228 174.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -62.4 -39.91 94.8 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.059 0.845 . . . . 0.0 112.601 -173.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -71.25 -43.9 66.35 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.025 -1.047 . . . . 0.0 112.753 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.23 -45.51 93.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.298 0.954 . . . . 0.0 111.246 179.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.08 -27.78 65.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.898 1.279 . . . . 0.0 112.702 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -76.69 -51.75 10.91 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 111.638 168.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.3 tp -69.93 -20.95 63.32 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -169.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.86 -9.0 49.08 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 176.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.43 -8.59 0.07 OUTLIER Glycine 0 CA--C 1.538 1.471 0 N-CA-C 117.66 1.824 . . . . 0.0 117.66 173.113 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.7 t -89.47 -30.51 18.24 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 119.499 1.65 . . . . 0.0 113.028 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.654 1.581 . . . . 0.0 113.177 177.595 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -74.67 155.2 38.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.839 0.856 . . . . 0.0 112.875 178.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -77.09 -35.61 56.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.88 0.93 22.28 Favored Glycine 0 CA--C 1.54 1.648 0 N-CA-C 116.652 1.421 . . . . 0.0 116.652 175.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -78.65 137.57 37.89 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.872 1.669 . . . . 0.0 111.697 -178.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -121.65 147.17 46.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.848 1.659 . . . . 0.0 109.709 169.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -66.02 165.23 13.72 Favored 'General case' 0 N--CA 1.482 1.138 0 O-C-N 121.133 -0.979 . . . . 0.0 111.786 176.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.64 -39.21 87.45 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.737 -1.227 . . . . 0.0 111.492 176.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -66.34 -40.31 89.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.835 0.854 . . . . 0.0 111.924 174.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.19 -42.35 75.92 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.842 0.746 . . . . 0.0 111.865 179.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -58.57 -37.63 76.17 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.406 0.683 . . . . 0.0 111.327 170.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -65.64 -40.51 92.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 117.716 -1.135 . . . . 0.0 112.759 174.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -38.44 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 120.761 1.619 . . . . 0.0 111.566 174.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.3 mt -73.11 -33.74 65.75 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 178.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.15 82.7 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.349 -0.845 . . . . 0.0 111.846 171.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.31 -33.82 71.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.411 0.685 . . . . 0.0 112.085 174.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.79 72.18 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.327 0.967 . . . . 0.0 112.532 174.176 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.8 -49.52 72.56 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.628 0.771 . . . . 0.0 111.763 173.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.07 -38.21 82.13 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.86 -0.525 . . . . 0.0 111.929 -178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.8 -37.94 85.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.801 0.84 . . . . 0.0 112.444 175.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.36 -51.0 65.53 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.629 0.65 . . . . 0.0 111.065 174.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.6 -32.6 74.11 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 45.3 ttm-85 -59.52 -39.08 82.73 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.538 1.135 . . . . 0.0 112.127 173.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -83.55 -0.39 50.13 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.245 1.418 . . . . 0.0 113.497 176.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.77 9.48 87.04 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.755 1.169 . . . . 0.0 114.509 -174.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -87.5 102.45 14.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.948 1.374 . . . . 0.0 109.405 174.033 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.7 33.37 0.52 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 120.916 -1.115 . . . . 0.0 113.174 173.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -144.33 149.67 36.58 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.045 2.138 . . . . 0.0 109.209 169.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mt -95.17 122.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.213 1.005 . . . . 0.0 110.187 172.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.84 179.14 25.17 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.993 1.759 . . . . 0.0 111.72 167.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.0 p -55.2 -41.01 71.43 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.621 -0.929 . . . . 0.0 111.379 173.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -49.9 -46.69 52.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 128.965 2.906 . . . . 0.0 113.698 171.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -76.47 -31.39 57.75 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.144 0.578 . . . . 0.0 111.724 -176.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 76.3 mt -66.8 -41.99 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.489 0.586 . . . . 0.0 110.297 170.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.47 -42.24 92.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.168 0.895 . . . . 0.0 111.762 175.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.78 -36.21 81.89 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.934 0.894 . . . . 0.0 111.98 176.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.32 97.62 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.65 1.119 . . . . 0.0 112.876 170.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.5 -53.03 62.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.552 1.141 . . . . 0.0 112.52 172.165 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.62 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 178.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -67.37 -30.65 70.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.382 0.992 . . . . 0.0 111.992 171.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -72.61 -50.41 25.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.827 0.851 . . . . 0.0 110.4 170.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.51 -12.18 3.67 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 118.373 2.109 . . . . 0.0 118.373 167.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -113.84 -27.27 7.83 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.855 1.827 . . . . 0.0 114.038 -170.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 160.86 29.18 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.72 1.152 . . . . 0.0 113.627 176.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.7 mm -53.74 -43.07 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.567 1.147 . . . . 0.0 112.34 -173.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.93 -44.9 83.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.045 0.838 . . . . 0.0 113.165 177.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.26 83.26 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.22 -0.925 . . . . 0.0 111.885 177.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -69.77 -33.1 71.95 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.036 0.935 . . . . 0.0 111.909 173.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.53 83.16 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.464 1.106 . . . . 0.0 112.374 171.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.29 -48.33 82.05 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.941 0.792 . . . . 0.0 110.819 172.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.49 -35.19 80.16 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.05 -33.09 75.21 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.979 -1.076 . . . . 0.0 113.138 173.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.6 mt -75.19 7.8 3.12 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.085 1.354 . . . . 0.0 113.564 171.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.78 6.63 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.161 1.363 . . . . 0.0 114.628 176.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 mt -81.86 -175.29 5.51 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 118.159 0.98 . . . . 0.0 111.255 174.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -174.75 163.93 34.53 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.964 1.269 . . . . 0.0 111.255 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.3 m -59.71 -41.32 90.53 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -171.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -66.36 -40.39 89.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.53 0.732 . . . . 0.0 112.368 177.363 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.66 -45.29 87.39 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.056 0.943 . . . . 0.0 111.549 179.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.4 mt -71.86 -42.81 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.029 0.931 . . . . 0.0 110.678 179.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -62.47 -40.62 97.26 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.952 0.901 . . . . 0.0 112.515 177.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -54.47 -53.06 59.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.337 1.055 . . . . 0.0 111.484 172.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -71.44 -35.92 71.08 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 45.5 t -59.01 -56.83 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.038 0.835 . . . . 0.0 110.301 171.047 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.49 -36.51 82.73 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.0 t -63.25 -35.09 79.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.742 0.817 . . . . 0.0 112.585 176.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.6 mt -85.83 -23.71 27.05 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.93 -24.28 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -177.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.65 -165.27 19.2 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.444 1.021 . . . . 0.0 114.659 -178.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -66.06 141.09 58.27 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.904 0.882 . . . . 0.0 111.327 173.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.28 -171.12 42.75 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.53 1.372 . . . . 0.0 116.53 -169.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -79.02 -22.78 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.112 1.765 . . . . 0.0 112.787 -169.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 48.24 63.65 1.98 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.703 2.401 . . . . 0.0 115.105 172.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 76.7 mtm -115.3 -14.59 11.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.9 1.68 . . . . 0.0 112.442 169.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 m 51.04 41.63 27.61 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.728 2.011 . . . . 0.0 115.004 169.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.45 20.37 10.69 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.424 1.89 . . . . 0.0 114.266 -171.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.334 1.1 t 59.99 167.18 0.07 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.113 2.165 . . . . 0.0 113.184 -166.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.8 mm -77.33 143.66 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -167.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -139.6 156.6 46.77 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.999 2.52 . . . . 0.0 108.198 165.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -96.07 137.81 34.6 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.128 -0.982 . . . . 0.0 111.102 -174.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.0 p -67.06 161.88 59.07 Favored Pre-proline 0 N--CA 1.477 0.914 0 O-C-N 121.669 -0.645 . . . . 0.0 111.29 171.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.4 -33.04 84.3 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.476 2.117 . . . . 0.0 113.431 173.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -76.64 -35.7 57.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.81 -38.95 83.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.048 1.294 . . . . 0.0 111.677 171.663 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.4 -43.86 92.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.002 0.921 . . . . 0.0 111.732 170.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.6 tttt -60.2 -43.16 96.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.443 1.097 . . . . 0.0 111.856 172.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.34 -49.06 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.923 1.238 . . . . 0.0 111.263 172.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.3 mm -58.69 -45.95 90.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.231 0.923 . . . . 0.0 111.32 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -67.31 -41.31 85.53 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.537 -0.727 . . . . 0.0 112.801 177.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.1 mt -67.1 -36.07 81.13 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.516 -0.74 . . . . 0.0 112.153 176.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 m -63.1 -45.25 92.94 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.563 1.145 . . . . 0.0 110.993 175.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.4 ttm -67.33 -36.17 80.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.173 0.589 . . . . 0.0 111.96 176.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -70.46 -31.92 69.26 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -69.51 -46.18 67.14 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.398 -1.439 . . . . 0.0 110.912 169.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -35.97 73.32 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.504 -0.747 . . . . 0.0 112.851 175.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttp85 -63.49 -52.51 60.99 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.132 1.773 . . . . 0.0 111.969 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -71.49 -28.21 63.76 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.69 -6.1 57.93 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.407 1.083 . . . . 0.0 112.854 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.59 22.46 69.78 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.733 1.159 . . . . 0.0 115.755 170.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -78.6 -29.69 46.19 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 118.992 1.396 . . . . 0.0 113.559 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 57.12 15.93 2.69 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -170.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -156.08 149.3 24.47 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.707 2.403 . . . . 0.0 109.92 169.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 18.4 t -90.15 115.28 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.143 1.377 . . . . 0.0 110.271 -177.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.81 173.61 49.21 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.952 0.787 . . . . 0.0 113.443 172.02 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.7 p -58.97 -39.3 81.3 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 121.584 -0.951 . . . . 0.0 110.779 171.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -48.94 -53.85 17.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.986 2.114 . . . . 0.0 111.64 169.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -67.8 -31.63 71.64 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.828 0.851 . . . . 0.0 113.07 179.743 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.52 -47.43 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.214 0.916 . . . . 0.0 110.825 170.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.18 -42.22 93.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.472 177.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.0 mt -56.25 -38.86 71.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.187 0.903 . . . . 0.0 111.565 172.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.29 -42.75 99.71 Favored Glycine 0 CA--C 1.535 1.337 0 CA-C-N 119.197 0.908 . . . . 0.0 113.909 171.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.2 mt -62.19 -45.59 92.68 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.659 1.23 . . . . 0.0 112.762 178.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.437 HD13 ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -72.5 -34.42 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 118.712 0.687 . . . . 0.0 112.591 175.003 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -70.96 -24.11 62.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.251 1.021 . . . . 0.0 113.421 178.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -62.45 -42.85 99.76 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.899 0.879 . . . . 0.0 110.995 174.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.38 53.19 Favored Glycine 0 CA--C 1.539 1.561 0 N-CA-C 119.188 2.435 . . . . 0.0 119.188 167.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.85 -31.61 1.72 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.417 2.109 . . . . 0.0 113.757 -174.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.3 172.03 31.57 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.074 1.797 . . . . 0.0 114.429 -176.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.81 -37.52 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.612 0.765 . . . . 0.0 111.22 -178.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.5 86.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 119.64 1.109 . . . . 0.0 113.303 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.76 -37.4 87.46 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.583 -0.698 . . . . 0.0 111.953 175.388 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.5 mtm180 -70.57 -38.78 74.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.327 1.051 . . . . 0.0 113.279 177.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 41.2 t -56.81 -49.88 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.915 1.286 . . . . 0.0 110.844 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.14 -43.63 98.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.678 0.391 . . . . 0.0 111.43 179.296 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -68.99 -32.95 72.88 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 178.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -64.58 -40.36 95.41 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.308 0.958 . . . . 0.0 111.824 172.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.3 mt -76.7 -33.06 58.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.332 1.053 . . . . 0.0 112.561 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 129.32 0.64 5.82 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.587 1.565 . . . . 0.0 115.639 170.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.5 t -84.24 141.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.47 1.508 . . . . 0.0 110.974 176.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 60.6 p -112.84 170.63 8.06 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.149 1.38 . . . . 0.0 111.932 179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.13 -43.81 61.25 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.249 1.019 . . . . 0.0 111.138 170.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -72.27 -43.57 64.07 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.776 0.83 . . . . 0.0 112.629 -178.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.41 -45.14 85.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 118.948 0.794 . . . . 0.0 111.965 179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' HB3' HD13 ' A' ' 113' ' ' ILE . . . -67.3 -42.26 84.02 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.321 -0.847 . . . . 0.0 111.92 175.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -55.53 -52.78 62.55 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 119.8 1.182 . . . . 0.0 111.401 172.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.36 -43.99 97.93 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.561 0.619 . . . . 0.0 112.333 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -71.8 -37.31 70.42 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.249 0.931 . . . . 0.0 113.19 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 82.2 t -69.03 -44.91 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 119.333 0.969 . . . . 0.0 111.252 176.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.43 -27.34 66.97 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.278 1.031 . . . . 0.0 112.85 178.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -77.19 -50.02 13.87 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.624 0.77 . . . . 0.0 111.744 171.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 25.1 tp -75.38 -16.07 60.4 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -171.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.13 -6.12 36.9 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 176.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 165.72 -22.74 0.13 Allowed Glycine 0 CA--C 1.535 1.332 0 N-CA-C 116.341 1.296 . . . . 0.0 116.341 170.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 51.3 m -72.28 -31.42 65.74 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 118.91 1.355 . . . . 0.0 113.399 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.255 1.357 0 C-N-CA 128.354 2.662 . . . . 0.0 114.631 169.889 . . . . . . . . 0 0 . 1 stop_ save_